NCT02750826,3136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01674140,1900,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02927249,2936,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02465060,6452,"null"
NCT02488967,990,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03373760,132,"null"
NCT01901094,2918,"null"
NCT02193282,450,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02834013,707,"null"
NCT01515787,1120,"null"
NCT02445391,562,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PAM50 Gene Expression Signature","name":"PAM50 Gene Expression Signature","synonyms":["Prediction Analysis of Microarray 50","PAM50"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01863550,1080,"null"
NCT02595905,333,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02595944,714,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT01953588,2060,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02154490,10000,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND3 Gene Amplification","name":"CCND3 Gene Amplification","synonyms":["Cyclin D3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131784","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND2 Gene Amplification","name":"CCND2 Gene Amplification","synonyms":["Cyclin D2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131785","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Response Assessment, Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Amplification","name":"CCND1 Gene Amplification","synonyms":["Cyclin D1 Gene Activation","BCL1 Gene Amplification","PRAD1 Gene Amplification","BCL-1 Gene Amplification","Cyclin D1 Gene Amplification","CCND1 Gene Activation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36652","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK4 Gene Amplification","name":"CDK4 Gene Amplification","synonyms":["Cell Division Kinase 4 Gene Amplification","Cyclin Dependent Kinase 4 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131786","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Repair Deficiency Positive","name":"Homologous Recombination Repair Deficiency Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"}]"
NCT00632853,729,"null"
NCT03365882,130,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS NP_002515.1:p.G13X","name":"NRAS G13 Mutation","synonyms":["NRAS G13X","NRAS NP_002515.1:p.G13X","Transforming Protein N-Ras G13X","NRAS NP_002515.1 :p.Gly12Xxx","GTPase NRas G13X","NRAS p.G13X","NRAS Gly12Xxx","NP_002515.1 :p.Gly12Xxx","NRAS p.Gly12Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107484","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Exon 4 Gene Mutation","name":"NRAS Exon 4 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Exon 4 Gene Mutation","name":"KRAS Exon 4 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS NP_002515.1:p.G12X","name":"NRAS G12 Mutation","synonyms":["GTPase NRas G12X","NRAS p.Gly12Xxx","NRAS Gly12Xxx","NRAS NP_002515.1 :p.Gly12Xxx","NP_002515.1 :p.Gly12Xxx","NRAS NP_002515.1:p.G12X","Transforming Protein N-Ras G12X","NRAS G12X","NRAS p.G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107483","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Exon 3 Gene Mutation","name":"KRAS Exon 3 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Exon 3 Gene Mutation","name":"NRAS Exon 3 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT02196181,280,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT03244384,739,"null"
NCT02500797,195,"null"
NCT02115282,600,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02224781,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01872975,1636,"null"
NCT03382561,150,"null"
NCT03033576,94,"null"
NCT02761057,180,"null"
NCT02595424,126,"null"
NCT03468985,169,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MET Exon 14 Mutation","name":"MET Exon 14 Mutation","synonyms":["HGFR Exon 14 Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Mutation","c-Met Exon 14 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C127129","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"}]"
NCT03092674,1670,"null"
NCT02912559,700,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Gene Mutation","name":"MMR Mutation","synonyms":["Mismatch Repair Gene Mutation","DNA Mismatch Repair Gene Mutation","MMR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133706","eligibility_criterion":"inclusion"}]"
NCT02601209,137,"null"
NCT03067181,1680,"null"
NCT02734537,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT02954874,1000,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02839707,488,"null"
NCT02032823,1500,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT03419234,210,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01368588,2580,"null"
NCT02893930,40,"null"
NCT01101451,360,"null"
NCT02003222,509,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein Negative","name":"BCR-ABL1 Fusion Protein Negative","synonyms":["BCR/ABL1 Fusion Protein Negative","BCR ABL Fusion Protein Negative","Breakpoint Cluster Region/Tyrosine-Protein Kinase ABL1 Fusion Protein Negative","BCR/ABL Fusion Protein Negative","BCR/ABL Oncoprotein Negative","BCR/ABL1 Protein Negative","BCR-ABL1 Protein Negative","BCR/ABL Chimeric Protein Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131067","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"}]"
NCT02180867,340,"null"
NCT02516423,110,"null"
NCT02567435,337,"null"
NCT03269669,150,"null"
NCT02306161,330,"null"
NCT03191149,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"}]"
NCT00492778,164,"null"
NCT03233711,200,"null"
NCT03070886,612,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.2","name":"PSA Level 0.2 or Greater","synonyms":["PSA Level Greater than or Equal to 0.2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138952","eligibility_criterion":"inclusion"}]"
NCT02152137,20,"null"
NCT02997228,347,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"}]"
NCT02883049,5956,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"exclusion"}]"
NCT02176967,621,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Gain of Chromosome 1q","name":"1q Amplification","synonyms":["Gain of Chromosome 1q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36482","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 3p","name":"Loss of Chromosome 3p","synonyms":["del(3p)","3p Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36502","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 11q","name":"11q Deletion","synonyms":["del11q","Loss of Chromosome 11q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C37312","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Loss of Heterozygosity","name":"LOH","synonyms":["Loss of Heterozygosity"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C18016","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 1p","name":"1p Deletion","synonyms":["del(1p)","Loss of Chromosome 1p"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36501","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Gain of Chromosome 2p","name":"Gain of Chromosome 2p","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36439","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 4p","name":"Loss of Chromosome 4p","synonyms":["del(4p)","4p Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Gain of Chromosome 17q","name":"Gain of Chromosome 17q","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36484","eligibility_criterion":"inclusion"}]"
NCT03267433,689,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT01096368,500,"null"
NCT03055013,766,"null"
NCT02101853,598,"null"
NCT02521493,256,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Trisomy 21","name":"Trisomy 21","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43224","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Trisomy 21 Mosaicism","name":"Trisomy 21 Mosaicism","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142099","eligibility_criterion":"inclusion"}]"
NCT02339740,158,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PML/RARA Fusion Positive","name":"PML/RARA Fusion Positive","synonyms":["PML-RARA Positive","PML-RAR Alpha Fusion Positive","PML-RAR Alpha Positive","PML-RARA Fusion Positive","PML/RAR Alpha Fusion Positive","PML/RAR Alpha Positive","PML/RARA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128836","eligibility_criterion":"inclusion"}]"
NCT02004275,97,"null"
NCT02828358,116,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MLL Gene Rearrangement","name":"MLL Gene Rearrangement","synonyms":["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila) Gene Rearrangement","Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement","KMT2A Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122623","eligibility_criterion":"inclusion"}]"
NCT02166463,600,"null"
NCT00887146,360,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosomes 1p/19q","name":"1p/19q Codeletion","synonyms":["Loss of Chromosomes 1p/19q","1p/19q Co-deletion","del(1p/19q)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C79099","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT02724579,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTNNB1 Gene Mutation","name":"CTNNB1 Gene Mutation","synonyms":["Cadherin-Associated Protein, Beta Gene Mutation","Catenin Beta 1 Gene Mutation","Beta Catenin Gene Mutation","CTNNB Gene Mutation","Cadherin-Associated Protein, Beta 1 (88kD) Gene Mutation","Catenin Beta-1 Gene Mutation","Beta-Catenin Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36659","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTNNB1 Positive","name":"CTNNB1 Positive","synonyms":["Catenin Beta-1 Positive","Beta-Catenin Positive","Beta Catenin Positive","CTNNB Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142133","eligibility_criterion":"inclusion"}]"
NCT03137771,186,"null"
NCT02443077,302,"null"
NCT02179086,606,"null"
NCT02775851,77,"null"
NCT01595061,52,"null"
NCT01979536,140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02135042,924,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus DNA Positive","name":"Epstein-Barr Virus DNA Positive","synonyms":["HHV4 DNA Positive","Human Herpesvirus 4 Positive","Human Herpesvirus-4 DNA Positive","EBV DNA Positive","HHV-4 DNA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141397","eligibility_criterion":"inclusion"}]"
NCT03007147,700,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT01220583,252,"null"
NCT02844816,148,"null"
NCT00980954,285,"null"
NCT02364557,360,"null"
NCT03371719,324,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03367702,606,"null"
NCT03228537,28,"null"
NCT03091660,969,"null"
NCT03150693,324,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome","name":"t(9;22)(q34;q11)","synonyms":["Philadelphia Translocation","t(9;22)(q34.1;q11.2)","Philadelphia chromosome","t(9;22)(q34;q11.2)","Philadelphia Chromosome","Ph"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C28452","eligibility_criterion":"exclusion"}]"
NCT02143414,44,"null"
NCT03304639,100,"null"
NCT01042522,128,"null"
NCT03180268,148,"null"
NCT02867592,146,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MITF Positive","name":"MITF Positive","synonyms":["Class E Basic Helix-Loop-Helix Protein 32 Positive","bHLHe32 Positive","Microphthalmia-Associated Transcription Factor Positive","MI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146659","eligibility_criterion":"inclusion"}]"
NCT01622868,143,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT03233204,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Damage Response Deficiency Gene Signature","name":"DDRD Signature","synonyms":["Deficient DNA Damage Response Gene Signature","DNA Damage Response Deficiency Gene Signature","DNA Damage Response and Repair Deficiency Gene Signature","DNA Damage Repair Deficiency Gene Signature"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129891","eligibility_criterion":"inclusion"}]"
NCT03220035,49,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT03210714,49,"null"
NCT03213652,98,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Alteration Positive","name":"ALK Gene Alteration Positive","synonyms":["CD246 Gene Alteration Positive","Anaplastic Lymphoma Kinase Gene Alteration Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Alteration Positive","name":"ROS1 Gene Alteration Positive","synonyms":["ROS Gene Alteration Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Alteration Positive","c-ros-1 Gene Alteration Positive","MCF3 Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134454","eligibility_criterion":"inclusion"}]"
NCT02375204,420,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"}]"
NCT03213704,49,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK2 Fusion Positive","name":"NTRK2 Fusion Positive","synonyms":["NTRK2 Fusion","BDNF/NT-3 Growth Factors Receptor Fusion Positive","TRKB Tyrosine Kinase Fusion Positive","TrkB Fusion Positive","Tropomyosin-Related Kinase B Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132235","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK3 Fusion Positive","name":"NTRK3 Fusion Positive","synonyms":["TRKC Tyrosine Kinase Fusion Positive","TrkC Fusion Positive","Neurotrophic Tyrosine Kinase Receptor Type 3 Fusion Positive","NTRK3 Fusion","NT-3 Growth Factor Receptor Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132236","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"}]"
NCT03224767,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT03375320,395,"null"
NCT03213678,144,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"TSC1 Gene Mutation","name":"TSC1 Gene Mutation","synonyms":["TSC1 Mutation","Tuberous Sclerosis 1 Gene Mutation","TSC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118398","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"TSC2 Gene Mutation","name":"TSC2 Gene Mutation","synonyms":["Tuberous Sclerosis 2 Gene Mutation","TSC2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118399","eligibility_criterion":"inclusion"}]"
NCT03533582,1220,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCB1 Positive","name":"SMARCB1 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"}]"
NCT02513394,5600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02849496,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02888743,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03190915,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 7","name":"Monosomy 7","synonyms":["-7","Deletion of chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPN11 Gene Mutation","name":"PTPN11 Gene Mutation","synonyms":["SHP-2 Gene Mutation","Protein Tyrosine Phosphatase, Non-Receptor Type 11 Gene Mutation","PTP-1D Gene Mutation","BPTP3 Gene Mutation","PTP2C Gene Mutation","SHP2 Gene Mutation","SH-PTP2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82612","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CBL Gene Mutation","name":"CBL Gene Mutation","synonyms":["RNF55 Gene Mutation","Cbl Proto-Oncogene Gene Mutation","C-CBL Gene Mutation","Casitas B-Lineage Lymphoma Proto-Oncogene Mutation","Cas-Br-M Murine Ecotropic Retroviral Transforming Sequence Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136645","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein Negative","name":"BCR-ABL1 Fusion Protein Negative","synonyms":["BCR/ABL1 Fusion Protein Negative","BCR ABL Fusion Protein Negative","Breakpoint Cluster Region/Tyrosine-Protein Kinase ABL1 Fusion Protein Negative","BCR/ABL Fusion Protein Negative","BCR/ABL Oncoprotein Negative","BCR/ABL1 Protein Negative","BCR-ABL1 Protein Negative","BCR/ABL Chimeric Protein Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131067","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Peripheral Blood White Cells","name":"Blasts Under 20 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36220","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating RAS Mutation","name":"Activating RAS Mutation","synonyms":["Activating RAS Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128901","eligibility_criterion":"inclusion"}]"
NCT02466971,188,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT03141684,35,"null"
NCT02468024,272,"null"
NCT03493425,134,"null"
NCT02275533,80,"null"
NCT03148275,27,"null"
NCT03038100,1300,"null"
NCT02408861,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT02900976,90,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02715284,535,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT02614794,480,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02567409,90,"null"
NCT03201458,82,"null"
NCT03126916,774,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT02875314,160,"null"
NCT01771107,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT02500121,104,"null"
NCT03139604,436,"null"
NCT02989857,186,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT02304458,484,"null"
NCT01730937,368,"null"
NCT03024996,664,"null"
NCT03213691,49,"null"
NCT02928224,645,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02753127,1250,"null"
NCT02715804,570,"null"
NCT02568267,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Gene Rearrangement","name":"NTRK3 Gene Rearrangement","synonyms":["Neurotrophic Tyrosine Kinase Receptor Type 3 Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 3 Gene Rearrangement","NTRK3 Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 3 Gene Rearrangement","TRKC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131325","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Rearrangement","name":"NTRK1 Gene Rearrangement","synonyms":["TRK1 Gene Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Rearrangement","MTC Gene Rearrangement","TRKA Gene Rearrangement","Neurotrophic Receptor Tyrosine Kinase 1 Gene Rearrangement","Trk-A Gene Rearrangement","TRK Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Gene Rearrangement","name":"NTRK2 Gene Rearrangement","synonyms":["TRKB Tyrosine Kinase Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 2 Gene Rearrangement","Tropomyosin-Related Kinase B Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor Type 2 Gene Rearrangement","NTRK2 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131321","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02016781,400,"null"
NCT02975882,51,"null"
NCT02808650,65,"null"
NCT02723994,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2 Gene Mutation","name":"JAK2 Gene Mutation","synonyms":["JAK2 Mutation","JAK2 Gene Variant","Janus Kinase 2 Gene Variant","Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK1 Gene Mutation","name":"JAK1 Gene Mutation","synonyms":["Janus Kinase 1 Gene Mutation","JAK1 Mutation","Janus Kinase 1 (A Protein Tyrosine Kinase) Gene Mutation","JTK3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129949","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CRLF2 Gene Rearrangement","name":"CRLF2 Rearrangement","synonyms":["TSLPR Gene Rearrangement","Cytokine Receptor-Like Factor 2 Gene Rearrangement","CRLF2 Gene Rearrangement","Thymic Stromal-Derived Lymphopoietin Receptor Gene","Cytokine Receptor Crl2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129969","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Trisomy 21","name":"Trisomy 21","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43224","eligibility_criterion":"exclusion"}]"
NCT02414165,380,"null"
NCT02008656,300,"null"
NCT03030378,36,"null"
NCT03008278,49,"null"
NCT02979899,124,"null"
NCT02926911,1200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02924376,140,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Translocation","name":"FGFR2 Gene Translocation","synonyms":["BEK Gene Translocation","ECT1 Gene Translocation","Fibroblast Growth Factor Receptor 2 Gene Translocation","KGFR Gene Translocation","CD332 Gene Translocation","FGFR-2 Gene Translocation","K-SAM Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138068","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Negative","name":"FGFR Family Alteration Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150613","eligibility_criterion":"inclusion"}]"
NCT02323880,81,"null"
NCT02095132,154,"null"
NCT01878617,440,"null"
NCT01670500,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT01570998,1260,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"}]"
NCT03526250,49,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND3 Gene Amplification","name":"CCND3 Gene Amplification","synonyms":["Cyclin D3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131784","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Amplification","name":"CCND1 Gene Amplification","synonyms":["Cyclin D1 Gene Activation","BCL1 Gene Amplification","PRAD1 Gene Amplification","BCL-1 Gene Amplification","Cyclin D1 Gene Amplification","CCND1 Gene Activation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36652","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK6 Gene Amplification","name":"CDK6 Gene Amplification","synonyms":["Cyclin-Dependent Kinase 6 Gene Amplification","Cyclin Dependent Kinase 6 Gene Amplification","PLSTIRE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132897","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK4 Gene Amplification","name":"CDK4 Gene Amplification","synonyms":["Cell Division Kinase 4 Gene Amplification","Cyclin Dependent Kinase 4 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131786","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND2 Gene Amplification","name":"CCND2 Gene Amplification","synonyms":["Cyclin D2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131785","eligibility_criterion":"inclusion"}]"
NCT03323034,76,"null"
NCT03219333,200,"null"
NCT03047213,209,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC2 Gene Mutation","name":"TSC2 Gene Mutation","synonyms":["Tuberous Sclerosis 2 Gene Mutation","TSC2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118399","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC1 Gene Mutation","name":"TSC1 Gene Mutation","synonyms":["TSC1 Mutation","Tuberous Sclerosis 1 Gene Mutation","TSC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118398","eligibility_criterion":"inclusion"}]"
NCT02952586,640,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT02831959,270,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Gene Mutation","name":"ROS1 Gene Mutation","synonyms":["ROS Gene Mutation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Mutation","ROS1 Mutation","c-ros-1 Gene Mutation","MCF3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130952","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"}]"
NCT02793583,500,"null"
NCT02750514,504,"null"
NCT02655822,534,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"}]"
NCT02606461,279,"null"
NCT02603341,1716,"null"
NCT02564198,67,"null"
NCT01956669,154,"null"
NCT03320330,75,"null"
NCT03138499,340,"null"
NCT02744092,940,"null"
NCT02743494,760,"null"
NCT02595931,51,"null"
NCT02562443,360,"null"
NCT02553460,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 25 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140330","eligibility_criterion":"inclusion"}]"
NCT02450331,800,"null"
NCT02091141,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMO Gene Mutation","name":"SMO Gene Mutation","synonyms":["Smoothened Homolog (Drosophila) Gene Mutation","Smoothened Homolog Gene Mutation","Smoothened, Frizzled Class Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C124793","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTCH1 Gene Mutation","name":"PTCH1 Gene Mutation","synonyms":["PTCH Gene Mutation","PTC Gene Mutation","Patched Homolog (Drosophila) Gene Mutation","Patched Homolog 1 Gene Mutation","PTC1 Gene Mutation","Patched 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133669","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ERBB2 Mutation","name":"Activating ERBB2 Mutation","synonyms":["CD340 Activating Mutation","Activating HER2 Mutation","HER2/Neu Activating Mutation","HER-2 Activating Mutation","c-erbB2 Activating Mutation","ERBB2 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129700","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Amplification","name":"ALK Gene Amplification","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Amplification","Anaplastic Lymphoma Kinase Receptor Gene Amplification","CD246 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131136","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Twenty","name":"EGFR Exon 20 Mutation","synonyms":["ERBB Exon 20 Mutation","HER1 Exon 20 Mutation","ERBB1 Exon 20","mENA Exon 20","Epidermal Growth Factor Receptor Gene Exon 20 Mutation","ERBB Exon 20","HER1 Exon 20","ERBB1 Exon 20 Mutation","PIG61 Exon 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128663","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01922076,77,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"H3 K27M Mutation","name":"Histone 3 K27M Mutation","synonyms":["Histone H3 K28M","H3 K28M Mutation","H3 Lys28Met","H3 K27M","Histone H3 Lys27Met","H3 K28M","Histone H3 Lys28Met","H3 Lys27Met","Histone H3 K27M","H3 p.Lys28Met","H3 K27M Mutation","H3 p.K28M"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129310","eligibility_criterion":"inclusion"}]"
NCT01822522,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT01734512,65,"null"
NCT01617161,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Twenty","name":"PSA Level Less Than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137688","eligibility_criterion":"inclusion"}]"
NCT03112603,324,"null"
NCT03009981,504,"null"
NCT02817633,627,"null"
NCT02595892,70,"null"
NCT02580552,75,"null"
NCT02572453,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Positive","name":"BCL6 Positive","synonyms":["BCL5 Positive","LAZ3 Positive","B-Cell Lymphoma 6 Positive","ZNF51 Positive","B-Cell CLL/Lymphoma 6 Positive","LAZ-3 Positive","ZBTB27 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132011","eligibility_criterion":"inclusion"}]"
NCT02455245,160,"null"
NCT02440464,138,"null"
NCT02143726,34,"null"
NCT01993810,330,"null"
NCT01969643,306,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SLC39A6 Positive","name":"SLC39A6 Positive","synonyms":["Zinc Transporter ZIP6 Positive","Solute Carrier Family 39 Member 6 Positive","LIV-1 Positive","LIV1 Positive","ZIP-6 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141360","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01748149,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.T599_V600insT","name":"BRAF ins(T)","synonyms":["Serine/Threonine-Protein Kinase B-raf T599_V600insT","BRAF Thr599_Val600insThr","NP_004324.2:p.T599_V600insT","BRAF Ins T","NM_004333.4:c.1796_1797insTAC","NM_004333.4:c.1795_1797dup","BRAF NM_004333.4:c.1796_1797insTAC","BRAF c.1798insTAC","v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1797_1798insACA","NP_004324.2:p.Thr599_Val600insThr","BRAF c.1795_1797dup","BRAF c.1797_1798insACA","B-RAF1 c.1797_1798insACA","Serine/Threonine-Protein Kinase B-raf Thr599dup","BRAF c.1796_1797insTAC","BRAF p.Thr599dup","BRAF NP_004324.2:p.T599_V600insT","NM_004333.4:c.1797_1798insACA","B-RAF c.1796_1797insTAC","BRAF NP_004324.2:p.Thr599_Val600insThr","BRAFinsT","BRAF NM_004333.4:c.1797_1798insACA","BRAF p.Thr599_Val600insThr","v-raf Murine Sarcoma Viral Oncogene Homolog B1 c.1796_1797insTAC","BRAF T599_V600insT","Serine/Threonine-Protein Kinase B-raf Thr599_Val600insThr","BRAF p.T599_V600insT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118894","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01597778,410,"null"
NCT02993731,1132,"null"
NCT02983045,480,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02927301,180,"null"
NCT02796261,280,"null"
NCT02780804,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"}]"
NCT02713386,147,"null"
NCT02628067,1350,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT02521870,234,"null"
NCT02332668,310,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02286921,194,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"}]"
NCT02219711,260,"null"
NCT02091999,215,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NECTIN4 Positive","name":"NECTIN4 Positive","synonyms":["Nectin Cell Adhesion Molecule 4 Positive","Poliovirus Receptor-Related 4 Positive","Poliovirus Receptor-Like 4 Positive","Ig Superfamily Receptor LNIR Positive","Nectin 4 Positive","Nectin-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134486","eligibility_criterion":"inclusion"}]"
NCT01670877,77,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"}]"
NCT03284385,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SETD2 Loss","name":"SETD2 Loss","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03072238,1100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03070392,327,"null"
NCT02997202,346,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating FLT3-ITD Gene Mutation","name":"Activating FLT3-ITD Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02974621,70,"null"
NCT02972840,546,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14)(q13;q32)","name":"t(11;14)(q13;q32)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27490","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02960230,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"H3.3 K27M Mutation","name":"H3.3 K27M Mutation","synonyms":["Histone H3.3 Lys27Met Mutation","H3.3 Lys27Met Mutation","Histone H3.3 Lys28Met Mutation","H3.3 K28M Mutation","H3.3K27M Mutation","H3.3 Lys28Met Mutation","Histone H3.3 K28M Mutation","Histone H3.3 K27M Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148096","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02952534,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious ATM Gene Mutation","name":"Deleterious ATM Gene Mutation","synonyms":["Deleterious Ataxia Telangiectasia Mutated Gene Mutation","Deleterious AT Mutated Gene Mutation","Deleterious A-T Mutated Gene Mutation","Deleterious ATM Serine/Threonine Kinase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134513","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02947685,496,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02893917,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02793128,74,"null"
NCT02709889,378,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DLL3 Positive","name":"DLL3 Positive","synonyms":["Delta3 Positive","Delta-Like 3 Positive","Drosophila Delta Homolog 3 Positive","Delta Like Canonical Notch Ligand 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140465","eligibility_criterion":"inclusion"}]"
NCT02659020,310,"null"
NCT02601313,130,"null"
NCT02595320,200,"null"
NCT02448381,120,"null"
NCT01656603,9999,"null"
NCT03367741,54,"null"
NCT03273153,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Wild Type","name":"BRAF V600 Wild Type","synonyms":["BRAF V600V","BRAF p.V600V","BRAF V600 wt","B-RAF1 V600 Wild Type","Serine/Threonine-Protein Kinase B-raf V600 Wild Type","B-RAF V600 Wild Type"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134468","eligibility_criterion":"inclusion"}]"
NCT03201965,370,"null"
NCT03165734,150,"null"
NCT02883062,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02741570,930,"null"
NCT02728102,188,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells More than 20 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells More than 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138322","eligibility_criterion":"inclusion"}]"
NCT02719574,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1-R132 gene mutation","name":"IDH1-R132 gene mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02632708,144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT02614066,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02568553,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02554812,560,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02519348,440,"null"
NCT02484430,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT02425904,85,"null"
NCT02322320,450,"null"
NCT03391466,350,"null"
NCT03220022,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Negative","name":"CD20 Negative","synonyms":["Leu-16 Negative","MS4A1 Negative","CD20 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137690","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03149549,150,"null"
NCT03142334,950,"null"
NCT02996110,200,"null"
NCT02959944,186,"null"
NCT02915744,350,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02854436,215,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Repair Abnormality","name":"DNA Repair Abnormality","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02853604,450,"null"
NCT02799602,1300,"null"
NCT02684032,120,"null"
NCT02677116,79,"null"
NCT02667587,693,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Methylated MGMT","name":"Methylated MGMT","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02658981,100,"null"
NCT02617589,550,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02576431,151,"null"
NCT02573324,640,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT02539719,108,"null"
NCT02520778,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"}]"
NCT02492711,530,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02285439,126,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating NRAS Mutation","name":"Activating NRAS Mutation","synonyms":["NRAS Proto-Oncogene, GTPase Activating Mutation","NRAS Activating Mutation","NRAS1 Activating Mutation","Neuroblastoma RAS Viral Oncogene Homolog Activating Mutation","N-RAS Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139796","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NF1 Gene","name":"NF1","synonyms":["Watson Disease","WSS","Neurofibromin","Neurofibromin 1","Neurofibromatosis","Von Recklinghausen Disease","Neurofibromatosis-related protein NF-1","VRNF"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17424","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Activating Mutation","name":"Activating KRAS Mutation","synonyms":["KRAS-2 Activating Mutation","KRAS Activating Mutation","c-K-ras Activating Mutation","KRAS2 Activating Mutation","KRAS Proto-Oncogene, GTPase Activating Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118391","eligibility_criterion":"inclusion"}]"
NCT02059499,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT01625234,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT01528046,42,"null"
NCT01089101,180,"null"
NCT01042379,1920,"null"
NCT03353753,120,"null"
NCT03318939,174,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Exon 20 Insertion Mutation","name":"ERBB2 Exon 20 Insertion Mutation","synonyms":["HER-2 Exon 20 Insertion Mutation","Erb-B2 Receptor Tyrosine Kinase Exon 20 Insertion Mutation","c-erbB2 Exon 20 Insertion Mutation","v-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 Exon 20 Insertion Mutation","CD340 Exon 20 Insertion Mutation","Neu Exon 20 Insertion Mutation","HER2 Exon 20 Insertion Mutation","HER2/Neu Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150633","eligibility_criterion":"inclusion"}]"
NCT03288545,85,"null"
NCT03274492,875,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HTLV-1 Positive","name":"HTLV-1 Positive","synonyms":["HTLV-I Positive","Human T-Lymphotropic Virus 1 Positive","Human T-Cell Lymphotropic Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142127","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"}]"
NCT03157128,570,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Fusion Positive","name":"RET Fusion","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Positive","RET Fusion Positive","Proto-Oncogene c-Ret Fusion Positive","Ret Proto-Oncogene Fusion Positive","RET/PTC Fusion Positive","Tyrosine-Protein Kinase Receptor RET Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131069","eligibility_criterion":"inclusion"}]"
NCT02927067,550,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02807558,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RARA Positive","name":"RARA Positive","synonyms":["RARalpha Positive","Retinoic Acid Receptor Alpha Positive","Nuclear Receptor Subfamily 1 Group B Member 1 Positive","RAR Positive","NR1B1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146655","eligibility_criterion":"inclusion"}]"
NCT02764541,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02718300,78,"null"
NCT02680184,144,"null"
NCT02658890,907,"null"
NCT02658279,44,"null"
NCT02631044,274,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT02574455,328,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02570542,120,"null"
NCT02537548,46,"null"
NCT02498613,126,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02437136,202,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT02431208,300,"null"
NCT02101736,19,"null"
NCT02052778,371,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Fusion","name":"FGFR2 Gene Fusion","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Fusion Positive","name":"FGFR3 Gene Fusion Positive","synonyms":["CD333 Gene Fusion Positive","JKT4 Gene Mutation Fusion Positive","FGFR-3 Gene Fusion Positive","Fibroblast Growth Factor Receptor 3 Gene Fusion Positive","FGFR3 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148097","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF19 Gene Amplification","name":"FGF19 Gene Amplification","synonyms":["HBGF-1 Gene Amplification","FGF-19 Gene Amplification","FGF19 Amplification","Fibroblast Growth Factor 19 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150612","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF9 Gene Amplification","name":"FGF9 Gene Amplification","synonyms":["Fibroblast Growth Factor 9 (Glia-Activating Factor) Gene Amplification","Glia-Activating Factor Gene Amplification","Fibroblast Growth Factor 9 Gene Amplification","FGF-9 Gene Amplification","FGF9 Amplification","HBFG-9 Gene Amplification","Fibroblast Growth Factor-9 Gene Amplification","SYNS3 Gene Amplification","GAF Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating FGFR Gene Mutation","name":"Activating FGFR Gene Mutation","synonyms":["Activating FGF Receptor Gene Family Mutation","Activating FGFR Family Mutation","Activating FGF Receptor Gene Mutation","Activating FGFR Family Gene Mutation","Gain-of-Function FGFR Gene Mutation","Activating Fibroblast Growth Factor Receptor Family Gene Mutation","Activating FGFR Mutation","Activating Fibroblast Growth Factor Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153103","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Rearrangement","name":"FGFR2 Gene Rearrangement","synonyms":["KGFR Gene Rearrangement","K-SAM Gene Rearrangement","CD332 Gene Rearrangement","FGFR-2 Gene Rearrangement","BEK Gene Rearrangement","Keratinocyte Growth Factor Receptor Gene Rearrangement","Fibroblast Growth Factor Receptor 2 Gene Rearrangement","ECT1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153241","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating FGFR3 Gene Mutation","name":"Activating FGFR3 Gene Mutation","synonyms":["Activating CD333 Gene Mutation","Activating JKT4 Gene Mutation","Activating Fibroblast Growth Factor Receptor 3 Gene Mutation","Activating FGFR-3 Gene Mutation","FGFR3 Gene Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142132","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Gene Fusion Positive","name":"FGFR Gene Fusion Positive","synonyms":["FGFR Gene Family Fusion Positive","FGF Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Family Fusion Positive","FGF Receptor Gene Family Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132244","eligibility_criterion":"inclusion"}]"
NCT01953926,392,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ERBB3 Mutation","name":"Activating ERBB3 Mutation","synonyms":["Activating c-erbB3 Gene Mutation","Activating V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","Activating HER3 Gene Mutation","Activating Erb-B2 Receptor Tyrosine Kinase 3 Gene Mutation","Activating HER-3 Gene Mutation","Activating ErbB-3 Gene Mutation","Activating V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","Activating c-erbB-3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141370","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Activating ERBB2 Mutation","name":"Activating ERBB2 Mutation","synonyms":["CD340 Activating Mutation","Activating HER2 Mutation","HER2/Neu Activating Mutation","HER-2 Activating Mutation","c-erbB2 Activating Mutation","ERBB2 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129700","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT01822509,113,"null"
NCT01413100,30,"null"
NCT03365791,160,"null"
NCT03267940,70,"null"
NCT03203473,83,"null"
NCT03106779,222,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR-ABL V299L Mutation","name":"BCR-ABL V299L Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"exclusion"}]"
NCT03097328,40,"null"
NCT03041688,58,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 wt Allele","name":"TP53 wt Allele","synonyms":["Tumor Protein p53 wt Allele","Tumor Protein P53 (Li-Fraumeni Syndrome) wt Allele","TRP53","P53","LFS1","p53 wild type","BCC7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03013491,300,"null"
NCT03012321,415,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03005782,546,"null"
NCT02993523,400,"null"
NCT02967692,538,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02945800,72,"null"
NCT02935634,300,"null"
NCT02927769,80,"null"
NCT02923921,566,"null"
NCT02857426,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02852655,35,"null"
NCT02760498,182,"null"
NCT02725268,242,"null"
NCT02650401,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Fusion Positive","name":"NTRK3 Fusion Positive","synonyms":["TRKC Tyrosine Kinase Fusion Positive","TrkC Fusion Positive","Neurotrophic Tyrosine Kinase Receptor Type 3 Fusion Positive","NTRK3 Fusion","NT-3 Growth Factor Receptor Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Fusion Positive","name":"NTRK2 Fusion Positive","synonyms":["NTRK2 Fusion","BDNF/NT-3 Growth Factors Receptor Fusion Positive","TRKB Tyrosine Kinase Fusion Positive","TrkB Fusion Positive","Tropomyosin-Related Kinase B Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Fusion","name":"ALK Gene Fusion","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02639182,134,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ENPP3 Positive","name":"ENPP3 Positive","synonyms":["PD-Ibeta Positive","CD203c Positive","PDNP3 Positive","Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 Positive","Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146756","eligibility_criterion":"inclusion"}]"
NCT02632045,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02592577,28,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-B*15:01 Positive","name":"HLA-B*15:01 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-B*46:01","name":"HLA-B*46:01","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"}]"
NCT02538666,940,"null"
NCT02535312,58,"null"
NCT02414139,348,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"}]"
NCT02384239,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02243605,90,"null"
NCT02184195,144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02133924,90,"null"
NCT02048371,150,"null"
NCT01585805,107,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"}]"
NCT00585195,600,"null"
NCT03141671,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.1","name":"PSA Level 0.1 or Greater","synonyms":["PSA Level Greater than or Equal to 0.1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138940","eligibility_criterion":"inclusion"}]"
NCT03132636,137,"null"
NCT03105336,50,"null"
NCT02952989,308,"null"
NCT02942290,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"}]"
NCT02917993,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02904226,498,"null"
NCT02772731,360,"null"
NCT02750358,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02716116,105,"null"
NCT02684617,138,"null"
NCT02628405,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02625961,260,"null"
NCT02601950,250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of INI 1 Protein Expression","name":"Loss of INI1 Protein Expression","synonyms":["Loss of BAF47 Protein Expression","Loss of SMARCB1 Protein Expression","Loss of INI1 Protein Expression","Loss of SNF5 Homolog Protein Expression","Loss of SWI/SNF-Related Matrix-Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121966","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCB1 Gene Mutation","name":"SMARCB1 Gene Mutation","synonyms":["SNF5L1 Gene Mutation","hSNFS Gene Mutation","SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily B, Member 1 Gene Mutation","Ini1 Gene Mutation","SNF5 Gene Mutation","BAF47 Gene Mutation","Snr1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136623","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EZH2 Gene Mutation","name":"EZH2 Gene Mutation","synonyms":["ENX1 Gene Mutation","ENX-1 Gene Mutation","KMT6 Gene Mutation","Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene Mutation","EZH2b Gene Mutation","Enhancer of Zeste 2 Gene Mutation","KTM6A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C97311","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(X;18)(p11;q11)","name":"t(x;18)(p11.2;q11.2)","synonyms":["t(X;18)(p11;q11)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCA4 Gene Mutation","name":"SMARCA4 Gene Mutation","synonyms":["SWI1 Gene Mutation","BRG-1 Gene Mutation","BAF190A Gene Mutation","SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 Gene Mutation","SNF2L4 Mutation","BRM/SWI2-Related Gene 1 Mutation","SNF2 Gene Mutation","BAF190 Gene Mutation","SNF2-Beta Gene Mutation","hSNF2b Gene Mutation","BRG1 Gene Mutation","SNF2LB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142126","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of BRG1 Protein Expression","name":"Loss of BRG1 Protein Expression","synonyms":["Loss of SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 4 Protein Expression","Loss of Protein Brahma Homolog 1 Protein Expression","Loss of Brahma Protein Homolog 1 Protein Expression","Loss of Possible Global Transcription Activator SNF2L4 Protein Expression","Loss of BRG-1 Protein Expression","Loss of BAF190A Protein Expression","Loss of  ATP-Dependent Helicase SMARCA4 Protein Expression","Loss of SNF2-Beta Protein Expression","Loss of SMARCA4 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129500","eligibility_criterion":"inclusion"}]"
NCT02580448,175,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02571036,250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDR Gene Mutation","name":"KDR Gene Mutation","synonyms":["CD309 Gene Mutation","Kinase Insert Domain Receptor Gene Mutation","VEGFR-2 Gene Mutation","Vascular Endothelial Growth Factor Receptor 2 Gene Mutation","FLK1 Gene Mutation","VEGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129628","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CSF1R Gene Mutation","name":"CSF1R Gene Mutation","synonyms":["CD115 Gene Mutation","M-CSF-R Gene Mutation","CSFR Gene Mutation","CSF-1R Gene Mutation","C-FMS Gene Mutation","McDonough Feline Sarcoma Viral (V-Fms) Oncogene Homolog Gene Mutation","Macrophage Colony-Stimulating Factor 1 Receptor Gene Mutation","Colony Stimulating Factor 1 Receptor Gene Mutation","FMS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133687","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"}]"
NCT02520791,46,"null"
NCT02520011,119,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02467270,276,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"inclusion"}]"
NCT02387216,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"exclusion"}]"
NCT02301611,120,"null"
NCT02289950,210,"null"
NCT02268253,100,"null"
NCT02253316,240,"null"
NCT02164019,263,"null"
NCT02143401,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hepatitis B Virus Positive","name":"HBV Positive","synonyms":["Hepatitis B Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141405","eligibility_criterion":"inclusion"}]"
NCT02117219,72,"null"
NCT02114229,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of BRG1 Protein Expression","name":"Loss of BRG1 Protein Expression","synonyms":["Loss of SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 4 Protein Expression","Loss of Protein Brahma Homolog 1 Protein Expression","Loss of Brahma Protein Homolog 1 Protein Expression","Loss of Possible Global Transcription Activator SNF2L4 Protein Expression","Loss of BRG-1 Protein Expression","Loss of BAF190A Protein Expression","Loss of  ATP-Dependent Helicase SMARCA4 Protein Expression","Loss of SNF2-Beta Protein Expression","Loss of SMARCA4 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129500","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCB1 Gene Mutation","name":"SMARCB1 Gene Mutation","synonyms":["SNF5L1 Gene Mutation","hSNFS Gene Mutation","SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily B, Member 1 Gene Mutation","Ini1 Gene Mutation","SNF5 Gene Mutation","BAF47 Gene Mutation","Snr1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136623","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCA4 Gene Mutation","name":"SMARCA4 Gene Mutation","synonyms":["SWI1 Gene Mutation","BRG-1 Gene Mutation","BAF190A Gene Mutation","SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 Gene Mutation","SNF2L4 Mutation","BRM/SWI2-Related Gene 1 Mutation","SNF2 Gene Mutation","BAF190 Gene Mutation","SNF2-Beta Gene Mutation","hSNF2b Gene Mutation","BRG1 Gene Mutation","SNF2LB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142126","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of INI 1 Protein Expression","name":"Loss of INI1 Protein Expression","synonyms":["Loss of BAF47 Protein Expression","Loss of SMARCB1 Protein Expression","Loss of INI1 Protein Expression","Loss of SNF5 Homolog Protein Expression","Loss of SWI/SNF-Related Matrix-Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121966","eligibility_criterion":"inclusion"}]"
NCT02099058,191,"null"
NCT02091245,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02070549,68,"null"
NCT01996865,500,"null"
NCT01968109,1000,"null"
NCT01767675,98,"null"
NCT01500304,88,"null"
NCT01294670,53,"null"
NCT03318861,64,"null"
NCT03184870,260,"null"
NCT03181126,42,"null"
NCT03150862,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MGMT Gene Promoter Hypermethylation","name":"MGMT Gene Promoter Hypermethylation","synonyms":["Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation","O-6-Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139588","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT03150056,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03144765,100,"null"
NCT03117309,160,"null"
NCT03108495,47,"null"
NCT03102320,348,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03098836,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03056755,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03033992,25,"null"
NCT03026166,42,"null"
NCT03013998,500,"null"
NCT02998528,642,"null"
NCT02993146,47,"null"
NCT02988817,292,"null"
NCT02987543,340,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Repair Gene Mutation","name":"Homologous Recombination Repair Gene Mutation","synonyms":["Recombination Repair Gene Mutation","HHR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133695","eligibility_criterion":"inclusion"}]"
NCT02971501,98,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02954991,209,"null"
NCT02920008,404,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02890329,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02872714,140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF Family Alteration Positive","name":"FGF Alteration","synonyms":["Fibroblast Growth Factor Family Alteration Positive","Fibroblast Growth Factor Alteration","Fibroblast Growth Factor Family Alteration","FGF Family Alteration Positive","FGF Alteration Positive","Fibroblast Growth Factor Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"}]"
NCT02811783,160,"null"
NCT02799745,222,"null"
NCT02783625,90,"null"
NCT02726581,348,"null"
NCT02712905,215,"null"
NCT02683941,216,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT02678572,240,"null"
NCT02633059,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 17","name":"Monosomy 17","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36509","eligibility_criterion":"inclusion"}]"
NCT02587598,270,"null"
NCT02581215,95,"null"
NCT02567422,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT02562755,600,"null"
NCT02559492,159,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02535078,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02499328,465,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02494570,30,"null"
NCT02393690,60,"null"
NCT02383927,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HRAS Gene Mutation","name":"HRAS Gene Mutation","synonyms":["HRas Proto-Oncogene, GTPase Gene Mutation","Ha-ras Gene Mutation","RASH1 Gene Mutation","C-HA-RAS1 Gene Mutation","v-Ha-ras Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","C-H-RAS Gene Mutation","H-ras Gene Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","HRAS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45934","eligibility_criterion":"inclusion"}]"
NCT02376699,410,"null"
NCT02343939,156,"null"
NCT02251548,85,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"exclusion"}]"
NCT02212574,13,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 6","name":"Monosomy 6","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36627","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Wnt Positive","name":"Wnt Positive","synonyms":["Wnt Family Positive","Wingless-Type MMTV Integration Site Family Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129451","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease Negativity","name":"MRD Negative","synonyms":["MRDneg","Minimal Residual Disease Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C124428","eligibility_criterion":"inclusion"}]"
NCT02138617,100,"null"
NCT02122185,160,"null"
NCT01908777,33,"null"
NCT01871727,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IL2RA Positive","name":"IL2RA Positive","synonyms":["IL-2R Subunit Alpha Positive","IL-2 Receptor Subunit Alpha Positive","Interleukin-2 Receptor Subunit Alpha Positive","IL-2R Positive","IL-2 Receptor Positive","IL-2-RA Positive","Interleukin 2 Receptor Subunit Alpha Positive","IL2-RA Positive","CD25 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129706","eligibility_criterion":"inclusion"}]"
NCT01868451,117,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01807091,25,"null"
NCT01659203,120,"null"
NCT01614197,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 25 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140330","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01554397,415,"null"
NCT00715611,81,"null"
NCT03414684,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03389802,45,"null"
NCT03317119,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT03186898,186,"null"
NCT03173248,392,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"}]"
NCT03151304,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 6-19 Percent of Bone Marrow Nucleated Cells","name":"Blasts 6-19 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147056","eligibility_criterion":"inclusion"}]"
NCT03144687,42,"null"
NCT03141177,630,"null"
NCT03130959,170,"null"
NCT03077451,36,"null"
NCT03068351,86,"null"
NCT03061812,411,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DLL3 Positive","name":"DLL3 Positive","synonyms":["Delta3 Positive","Delta-Like 3 Positive","Drosophila Delta Homolog 3 Positive","Delta Like Canonical Notch Ligand 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140465","eligibility_criterion":"inclusion"}]"
NCT03057600,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03037385,250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"}]"
NCT03036098,897,"null"
NCT03020030,400,"null"
NCT03016312,730,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03012100,280,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02981940,42,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"exclusion"}]"
NCT02978625,68,"null"
NCT02975934,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT02962167,24,"null"
NCT02958774,76,"null"
NCT02955069,110,"null"
NCT02953509,72,"null"
NCT02949219,40,"null"
NCT02931539,351,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02921022,88,"null"
NCT02907359,408,"null"
NCT02898207,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02876302,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02833610,40,"null"
NCT02798406,48,"null"
NCT02772588,58,"null"
NCT02764593,120,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02758717,75,"null"
NCT02743819,70,"null"
NCT02718833,55,"null"
NCT02709512,386,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ASS1 Gene Deficiency","name":"ASS1 Gene Deficiency","synonyms":["Argininosuccinate Synthase 1 Low","Argininosuccinate Synthase 1 Gene Deficiency","ASS1 Low Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138072","eligibility_criterion":"inclusion"}]"
NCT02689284,72,"null"
NCT02677922,127,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT02675439,75,"null"
NCT02670044,140,"null"
NCT02665065,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPRC Positive","name":"CD45 Positive","synonyms":["PTPRC Positive","T200 Positive","Leukocyte Common Antigen Positive","Receptor-Type Tyrosine-Protein Phosphatase C Positive","CD45 Antigen Positive","L-CA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134500","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Human Anti-Mouse Antibodies Positive","name":"Human Anti-Mouse Antibodies Positive","synonyms":["Human Anti-Mouse Antibodies Present","HAMA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139787","eligibility_criterion":"exclusion"}]"
NCT02658929,66,"null"
NCT02653755,690,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02637687,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ETV6 Gene","name":"ETV6","synonyms":["ETS Variant Gene 6 Protein","ETS Translocation Variant 6","Transcription Factor ETV6","ets variant 6, TEL","ETS-Related Protein Tel1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C18312","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"}]"
NCT02632409,640,"null"
NCT02599324,261,"null"
NCT02595866,60,"null"
NCT02561988,85,"null"
NCT02539459,43,"null"
NCT02524847,48,"null"
NCT02503423,230,"null"
NCT02496663,82,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"}]"
NCT02400476,312,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT02393794,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02360579,85,"null"
NCT02340975,135,"null"
NCT02326974,165,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02308020,247,"null"
NCT02305654,400,"null"
NCT02300545,56,"null"
NCT02264613,130,"null"
NCT02253992,200,"null"
NCT02138734,256,"null"
NCT02122913,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"}]"
NCT02113982,120,"null"
NCT02101905,33,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT02101034,96,"null"
NCT02098343,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02008383,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"exclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Response Assessment, Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT01994382,283,"null"
NCT01893307,360,"null"
NCT01815359,212,"null"
NCT01659658,248,"null"
NCT01459497,238,"null"
NCT01296555,724,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT01261728,54,"null"
NCT03523351,74,"null"
NCT03377179,39,"null"
NCT03361748,140,"null"
NCT03345784,33,"null"
NCT03310957,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03291288,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"}]"
NCT03248492,230,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03222609,34,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More Than 10 Percent of Peripheral Blood White Cells","name":"Blasts More Than 10 Percent of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More Than 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts More Than 10 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03218683,30,"null"
NCT03217188,88,"null"
NCT03194542,70,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146669","eligibility_criterion":"exclusion"}]"
NCT03193190,185,"null"
NCT03189719,700,"null"
NCT03178552,580,"null"
NCT03176277,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 1 Percent or More of Peripheral Blood White Cells","name":"Blasts 1 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 1 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147055","eligibility_criterion":"inclusion"}]"
NCT03170960,360,"null"
NCT03163667,252,"null"
NCT03126110,450,"null"
NCT03123588,120,"null"
NCT03122522,60,"null"
NCT03102242,63,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT03098030,470,"null"
NCT03085914,421,"null"
NCT03069326,25,"null"
NCT03043313,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03033511,740,"null"
NCT02989584,49,"null"
NCT02978222,120,"null"
NCT02974647,52,"null"
NCT02973997,60,"null"
NCT02971761,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02964507,294,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02929862,105,"null"
NCT02923570,132,"null"
NCT02922764,150,"null"
NCT02897765,50,"null"
NCT02890069,350,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02889900,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"exclusion"}]"
NCT02872116,1649,"null"
NCT02864992,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Exon 14 Skipping Mutation","name":"MET Exon 14 Skipping Mutation","synonyms":["Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Alteration","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Mutation","c-Met Exon 14 Skipping Mutation","HGFR Exon 14 Skipping Mutation","Loss of MET Exon 14","Deletion of MET Exon 14","Loss of c-MET Exon 14","c-Met Exon 14 Skipping Alteration","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Alteration","Deletion of c-MET Exon 14","MET Exon 14 Skipping Alteration","HGFR Exon 14 Skipping Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131179","eligibility_criterion":"inclusion"}]"
NCT02793544,80,"null"
NCT02778685,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02771626,299,"null"
NCT02760485,78,"null"
NCT02752035,540,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"}]"
NCT02717455,50,"null"
NCT02712723,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02693535,1440,"null"
NCT02676323,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Increasing Levels of Minimal Residual Disease","name":"Increasing Levels of Minimal Residual Disease","synonyms":["Increasing MRD"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142131","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02674763,104,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD33 Positive","name":"CD33 Positive","synonyms":["CD33 Molecule Positive","gp67 Positive","p67 Positive","CD33 Antigen Positive","Myeloid Cell Surface Antigen CD33 Positive","SIGLEC3 Positive","SIGLEC-3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132228","eligibility_criterion":"inclusion"}]"
NCT02673398,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02663518,260,"null"
NCT02656303,300,"null"
NCT02644967,100,"null"
NCT02641002,71,"null"
NCT02635360,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Papillomavirus Protein E2","name":"HPV E2","synonyms":["HPV Oncogene Protein E2","Papillomavirus Protein E2","HPV Protein E2","Regulatory Protein E2","Oncogene Protein E2","HPV Regulatory Protein E2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C20053","eligibility_criterion":"inclusion"}]"
NCT02625480,75,"null"
NCT02589522,46,"null"
NCT02581631,146,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02575794,23,"null"
NCT02570308,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02561234,100,"null"
NCT02531516,1500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Twenty","name":"PSA Level Twenty or Greater","synonyms":["PSA Level Greater than or Equal to Twenty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137702","eligibility_criterion":"inclusion"}]"
NCT02517398,587,"null"
NCT02500407,665,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02475213,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02397083,270,"null"
NCT02393248,280,"null"
NCT02362997,83,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"}]"
NCT02357810,148,"null"
NCT02315066,210,"null"
NCT02303821,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02301039,146,"null"
NCT02290951,198,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02236013,70,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"}]"
NCT02203695,122,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"PSA Level 0.1 to 0.7","name":"PSA Level 0.1 to 0.7","synonyms":["PSA Level Between 0.1 and 0.7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142100","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02131805,29,"null"
NCT02101385,136,"null"
NCT02092324,50,"null"
NCT02048917,180,"null"
NCT02034110,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02013154,224,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Wnt Family Gene Alteration Positive","name":"Wnt Family Gene Alteration Positive","synonyms":["Wnt Signaling Gene Alteration Positive","Wnt Gene Alteration","Wnt Gene Alteration Positive","Wnt Signaling Gene Alteration","Wingless-Type MMTV Integration Site Family Gene Alteration Positive","Wingless-Type MMTV Integration Site Family Gene Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141399","eligibility_criterion":"inclusion"}]"
NCT01928589,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01928576,132,"null"
NCT01876511,140,"null"
NCT01534598,68,"null"
NCT01522768,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT01483027,420,"null"
NCT01048853,195,"null"
NCT03587844,58,"null"
NCT03556332,46,"null"
NCT03542175,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03532880,24,"null"
NCT03524326,16,"null"
NCT03523312,48,"null"
NCT03520504,26,"null"
NCT03490344,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells Under 5 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Neoplastic Plasma Cells Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150421","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03488693,2140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03486821,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Twenty","name":"PSA Level Less Than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137688","eligibility_criterion":"inclusion"}]"
NCT03465891,50,"null"
NCT03434379,480,"null"
NCT03428217,298,"null"
NCT03422627,124,"null"
NCT03408366,20,"null"
NCT03399552,36,"null"
NCT03397706,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03377387,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03374254,220,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"exclusion"}]"
NCT03374085,80,"null"
NCT03368859,100,"null"
NCT03336333,467,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03336216,160,"null"
NCT03332797,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03331198,205,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BTK Gene Mutation","name":"BTK Gene Mutation","synonyms":["XLA Gene Mutation","AGMX1 Gene Mutation","Bruton Tyrosine Kinase Gene Mutation","IMD1 Gene Mutation","Bruton Agammaglobulinemia Tyrosine Kinase Gene Mutation","BPK Gene Mutation","PSCTK1 Gene Mutation","AT Gene Mutation","ATK Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132254","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PLCG2 Gene Mutation","name":"PLCG2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03330405,316,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT03326193,90,"null"
NCT03323463,80,"null"
NCT03319537,42,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Loss of NF2 Protein Expression","name":"Loss of NF2 Protein Expression","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"}]"
NCT03308942,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation Negative","name":"ALK Gene Translocation Negative","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation Negative","Anaplastic Lymphoma Kinase Gene Translocation Negative","CD246 Gene Translocation Negative","ALK Translocation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134488","eligibility_criterion":"inclusion"}]"
NCT03303339,116,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 20 Percent or More of Peripheral Blood White Cells","name":"Lymphoblasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Lymphoblasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146662","eligibility_criterion":"inclusion"}]"
NCT03295240,18,"null"
NCT03290950,41,"null"
NCT03289039,152,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT03287908,115,"null"
NCT03245151,132,"null"
NCT03241745,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT03237780,78,"null"
NCT03230318,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"}]"
NCT03215511,93,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TRK Receptor Family Fusion Negative","name":"NTRK Fusion Negative","synonyms":["Non-fusion NTRK","TRK Receptor Family Fusion Negative","TRK Non-fusion","TRK Receptor Non-fusion","Non-fusion TRK","TRK Receptor Family Non-fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138158","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TRK Receptor Family Fusion Positive","name":"NTRK Fusion Positive","synonyms":["TRK Receptor Fusion","TRK Receptor Family Fusion","TRK Fusion","TRK Receptor Family Fusion Positive","NTRK Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138156","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TRK Receptor Family Alteration Positive","name":"NTRK Alteration Positive","synonyms":["NTRK Alteration","TRK Alteration Positive","TRK Receptor Alteration","TRK Alteration","TRK Receptor Family Alteration Positive","TRK Receptor Family Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138155","eligibility_criterion":"inclusion"}]"
NCT03179930,78,"null"
NCT03172624,64,"null"
NCT03158064,29,"null"
NCT03155997,3580,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03151408,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"}]"
NCT03149003,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*24:02 Positive Cells Present","name":"HLA-A*24:02 Positive Cells Present","synonyms":["HLA-A2402 Positive","HLA-A2402 Positive Cells Present","HLA-A*24:02 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142110","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT03147287,220,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03144674,120,"null"
NCT03122496,12,"null"
NCT03120676,57,"null"
NCT03112174,287,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cyclin D1 Protein Overexpression","name":"Cyclin D1 Protein Overexpression","synonyms":["B-Cell Lymphoma 1 Protein Overexpression","BCL-1 Protein Overexpression","CCND1 Protein Overexpression","BCL1 Protein Overexpression","Cyclin D1 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36485","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT03107780,86,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"TP53 wt Allele","name":"TP53 wt Allele","synonyms":["Tumor Protein p53 wt Allele","Tumor Protein P53 (Li-Fraumeni Syndrome) wt Allele","TRP53","P53","LFS1","p53 wild type","BCC7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52271","eligibility_criterion":"inclusion"}]"
NCT03104699,75,"null"
NCT03096808,65,"null"
NCT03092323,110,"null"
NCT03091192,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FH Gene Mutation","name":"FH Gene Mutation","synonyms":["Fumarate Hydratase, Mitochondrial Gene Mutation","Fumarate Hydratase Gene Mutation","MCUL1 Gene Mutation","FMRD Gene Mutation","Fumarase Gene Mutation","MCL Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51305","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"VHL Gene Mutation","name":"VHL Gene Mutation","synonyms":["HRCA1 Gene Mutation","Von Hippel-Lindau Tumor Supressor Gene Mutation","VHL Mutation","VHL1 Gene Mutation","Von Hippel-Lindau Syndrome Gene Mutation","RCA1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118400","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT03077841,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03076164,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT03069950,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAF Wild Type","name":"RAF wt Allele","synonyms":["Wild Type RAF","RAF Wild Type","RAF Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132848","eligibility_criterion":"inclusion"}]"
NCT03056638,223,"null"
NCT03054363,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03052205,62,"null"
NCT03036488,1150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03016819,219,"null"
NCT03015129,80,"null"
NCT03011372,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Rearrangement","name":"FGFR1 Gene Rearrangement","synonyms":["FLG Gene Rearrangement","BFGFR Gene Rearrangement","CEK Gene Rearrangement","CD331 Gene Rearrangement","Fibroblast Growth Factor Receptor 1 Gene Rearrangement","FLT-2 Gene Rearrangement","OGD Gene Rearrangement","FLT2 Gene Rearrangement","FGFBR Gene Rearrangement","KAL2 Gene Rearrangement","FMS-Like Tyrosine Kinase 2 Gene Rearrangement","N-SAM Gene Rearrangement","FGFR-1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84273","eligibility_criterion":"inclusion"}]"
NCT02987829,80,"null"
NCT02983799,260,"null"
NCT02981303,95,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02966782,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"}]"
NCT02966730,23,"null"
NCT02954536,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02947347,440,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02937571,37,"null"
NCT02908451,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AG7 Antigen Positive","name":"AG7 Antigen Positive","synonyms":["AG7 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146724","eligibility_criterion":"inclusion"}]"
NCT02879643,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02873819,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02869789,1100,"null"
NCT02864251,465,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02843165,146,"null"
NCT02831686,38,"null"
NCT02826434,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02812875,300,"null"
NCT02811861,735,"null"
NCT02803203,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02799485,42,"null"
NCT02799095,150,"null"
NCT02792192,70,"null"
NCT02792114,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02787005,370,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02750319,244,"null"
NCT02748837,125,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GPC3 Positive","name":"GPC3 Positive","synonyms":["Glypican-3 Positive","Glypican Proteoglycan 3 Positive","OCI-5 Positive","MXR7 Positive","Glypican 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134492","eligibility_criterion":"inclusion"}]"
NCT02743078,85,"null"
NCT02732119,51,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02730299,120,"null"
NCT02716038,30,"null"
NCT02702492,175,"null"
NCT02684253,60,"null"
NCT02684227,69,"null"
NCT02671435,262,"null"
NCT02667886,83,"null"
NCT02648477,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02646748,237,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Protein Deficient","synonyms":["MMR Protein Deficiency","MMR Protein Deficient","Mismatch Repair Protein Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137827","eligibility_criterion":"inclusion"}]"
NCT02643498,36,"null"
NCT02638909,391,"null"
NCT02637531,175,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02611323,134,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD20 Negative","name":"CD20 Negative","synonyms":["Leu-16 Negative","MS4A1 Negative","CD20 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137690","eligibility_criterion":"exclusion"}]"
NCT02605486,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02603432,668,"null"
NCT02598661,225,"null"
NCT02591615,90,"null"
NCT02578641,330,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02577406,316,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT02564900,278,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02549989,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating PIK3R1 Gene Mutation","name":"Activating PIK3R1 Gene Mutation","synonyms":["Activating GRB1 Gene Mutation","PIK3R1 Activating Mutation","Activating p85-ALPHA Gene Mutation","Activating Phosphoinositide-3-Kinase Regulatory Subunit 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142117","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating AKT1 Gene Mutation","name":"Activating AKT1 Gene Mutation","synonyms":["AKT1 Activating Mutation","Activating v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Mutation","Activating AKT Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142115","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating PIK3CA Gene Mutation","name":"Activating PIK3CA Gene Mutation","synonyms":["Activating p110-alpha Gene Mutation","Activating Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation","PIK3CA Activating Mutation","Activating PI3KCA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating PIK3R2 Gene Mutation","name":"Activating PIK3R2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142118","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating MTOR Gene Mutation","name":"Activating MTOR Gene Mutation","synonyms":["Activating FK506 Binding Protein 12-Rapamycin Associated Protein 1 Gene Mutation","Activating Rapamycin and FKBP12 Target 1 Gene Mutation","Activating Mechanistic Target of Rapamycin Gene Mutation","MTOR Activating Mutation","Activating Mammalian Target of Rapamycin Gene Mutation","Activating FRAP1 Gene Mutation","Activating FRAP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142101","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating RAF Mutation","name":"Activating RAF Mutation","synonyms":["RAF Family Activating Gene Mutation","Activating RAF Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134499","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating RAS Mutation","name":"Activating RAS Mutation","synonyms":["Activating RAS Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128901","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"exclusion"}]"
NCT02549651,207,"null"
NCT02538198,100,"null"
NCT02535338,46,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"}]"
NCT02525653,41,"null"
NCT02524275,43,"null"
NCT02521363,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02513472,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02508532,250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"}]"
NCT02508467,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF19 Positive","name":"FGF19 Positive","synonyms":["FGF-19 Positive","Fibroblast Growth Factor 19 Positive","Fibroblast Growth Factor-19 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142119","eligibility_criterion":"inclusion"}]"
NCT02503774,308,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02503709,37,"null"
NCT02498951,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02496208,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02488759,600,"null"
NCT02460224,515,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02428712,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02417701,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KEAP1 Gene Mutation","name":"KEAP1 Gene Mutation","synonyms":["INRF2 Gene Mutation","Kelch-Like ECH-Associated Protein 1 Gene Mutation","KLHL19 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NFE2L2 Gene Mutation","name":"NFE2L2 Gene Mutation","synonyms":["Nuclear Factor, Erythroid 2 Like 2 Gene Mutation","NRF2 Gene Mutation","Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129684","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT02414269,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT02407054,144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02406742,152,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02401815,200,"null"
NCT02348216,200,"null"
NCT02298348,18,"null"
NCT02288897,225,"null"
NCT02279719,114,"null"
NCT02270463,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02269280,240,"null"
NCT02257567,250,"null"
NCT02215096,64,"null"
NCT02213913,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Positive","name":"BCL2 Positive","synonyms":["B-Cell Leukemia/Lymphoma 2 Positive","Apoptosis Regulator Bcl-2 Positive","BCL-2 Positive","B-Cell CLL/Lymphoma 2 Positive","BCL2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134463","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Positive","name":"Myc Positive","synonyms":["c-MYC Positive","Myc Proto-Oncogene Positive","Proto-Oncogene c-Myc Positive","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131061","eligibility_criterion":"inclusion"}]"
NCT02199236,24,"null"
NCT02143466,308,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02133183,40,"null"
NCT02124772,142,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02061761,132,"null"
NCT02048722,31,"null"
NCT01995578,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLL Gene Rearrangement","name":"MLL Gene Rearrangement","synonyms":["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila) Gene Rearrangement","Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement","KMT2A Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122623","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 7","name":"Monosomy 7","synonyms":["-7","Deletion of chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Peripheral Blood White Cells","name":"Blasts Under 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41399","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 5","name":"Monosomy 5","synonyms":["-5","Deletion of chromosome 5"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36523","eligibility_criterion":"inclusion"}]"
NCT01974765,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT01899989,35,"null"
NCT01864109,53,"null"
NCT01862315,86,"null"
NCT01849146,36,"null"
NCT01841723,44,"null"
NCT01755195,55,"null"
NCT01724606,24,"null"
NCT01677741,86,"null"
NCT01639508,68,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"MET Overexpression Positive","name":"MET Overexpression Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Overexpression Positive","Hepatocyte Growth Factor Receptor Overexpression Positive","HGFR Overexpression Positive","c-met Overexpression Positive","Met Proto-Oncogene Overexpression Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148403","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"AXL Overexpression Positive","name":"AXL Overexpression Positive","synonyms":["ARK Overexpression Positive","Tyrosine-Protein Kinase Receptor UFO Overexpression Positive","Tyro7 Overexpression Positive","AXL Receptor Tyrosine Kinase Overexpression Positive","JTK11 Overexpression Positive","UFO Overexpression Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148406","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"AXL Gene Amplification","name":"AXL Gene Amplification","synonyms":["UFO Gene Amplification","AXL Receptor Tyrosine Kinase Gene Amplification","Tyro7 Gene Amplification","JTK11 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141275","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KIF5B/RET Fusion Protein KIF5B/RET Fusion Gene","name":"KIF5B-RET Fusion","synonyms":["KIF5B/RET Fusion","Kinesin-1 Heavy Chain/Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Protein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C114800:C114799","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"AXL Gene Mutation","name":"AXL Gene Mutation","synonyms":["Tyro7 Gene Mutation","UFO Gene Mutation","JTK11 Gene Mutation","AXL Receptor Tyrosine Kinase Gene Mutation","ARK Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141276","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"RET Fusion Positive","name":"RET Fusion","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Positive","RET Fusion Positive","Proto-Oncogene c-Ret Fusion Positive","Ret Proto-Oncogene Fusion Positive","RET/PTC Fusion Positive","Tyrosine-Protein Kinase Receptor RET Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131069","eligibility_criterion":"inclusion"}]"
NCT01391962,70,"null"
NCT01362803,104,"null"
NCT01312857,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"}]"
NCT01226316,304,"null"
NCT00846742,80,"null"
NCT00826241,50,"null"
NCT03423628,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT03411915,87,"null"
NCT03392142,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03343197,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 NM_005896.3:c.395_396delGTinsAC IDH1 NM_005896.3:c.395G>A IDH1 NP_005887.2:p.R132H","name":"IDH1 R132H","synonyms":["IDH1 NP_005887.2:p.Arg132His","IDH c.395G>A","IDH1 p.R132H","IDH1 NM_005896.3:c.395_396GT>AC","Cytosolic NADP-Isocitrate Dehydrogenase Protein Arg132His","Isocitrate Dehydrogenase [NADP] Cytoplasmic R132H","Cytosolic NADP-Isocitrate Dehydrogenase Protein R132H","Isocitrate Dehydrogenase [NADP] Cytoplasmic Arg132His","Isocitrate Dehydrogenase 1 (NADP(+)), Cytosolic c.395_396GT>AC","NP_005887.2:p.Arg132His","IDH1 NP_005887.2:p.R132H","NM_005896.3:c.395_396delGTinsAC","IDH1 NM_005896.3:c.395_396delGTinsAC","IDH1 NM_005896.3:c.395G>A","NM_005896.3:c.395G>A","IDH1 c.395_396GT>AC","IDH1 c.395G>A","NM_005896.3:c.395_396GT>AC","IDH1 Arg132His","Isocitrate Dehydrogenase 1 (NADP+), Soluble c.395_396GT>AC","IDH1 c.395_396delGTinsAC","Isocitrate Dehydrogenase 1 (NADP+), Soluble c.395G>A","Isocitrate Dehydrogenase 1 (NADP(+)), Cytosolic c.395G>A","NP_005887.2:p.R132H","IDH1 p.Arg132His","G395A","IDH c.395_396GT>AC"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128900:C128826:C128827","eligibility_criterion":"inclusion"}]"
NCT03337724,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Alteration","name":"PTEN Gene Alteration","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Alteration Positive","name":"AKT1 Gene Alteration Positive","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Alteration Positive","RAC Gene Alteration Positive","RAC-PK-Alpha Gene Alteration Positive","PKB Gene Alteration Positive","PRKBA Gene Alteration Positive","RAC-ALPHA Gene Alteration Positive","AKT Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Alteration","name":"PIK3CA Gene Alteration","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03328078,120,"null"
NCT03323398,75,"null"
NCT03301220,360,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10-60 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10-60 Percent of Bone Marrow Nucleated Cells","synonyms":["Neoplastic Plasma Cells Between 10 and 60 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150711","eligibility_criterion":"inclusion"}]"
NCT03289962,567,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD8 Positive","name":"CD8 Positive","synonyms":["T-Cell Surface Glycoprotein CD8 Positive","CD8 Antigen Positive","CD8 Co-Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Low-Frequency Microsatellite Instability","name":"Low-Frequency Microsatellite Instability","synonyms":["MSI-L","Microsatellite Instability Low"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03287245,20,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More than 20 Percent of Peripheral Blood White Cells","name":"Blasts Over 20 Percent of Peripheral Blood White Cells","synonyms":["Blasts More than 20 Percent of Peripheral Blood White Cells","Blasts Greater than 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150461","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts Over 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Over 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03284424,100,"null"
NCT03280563,111,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03269422,30,"null"
NCT03257267,436,"null"
NCT03241810,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Heregulin Positive","name":"Heregulin Positive","synonyms":["Neuregulin Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138951","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03241173,651,"null"
NCT03236857,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Positive","name":"BCL2 Positive","synonyms":["B-Cell Leukemia/Lymphoma 2 Positive","Apoptosis Regulator Bcl-2 Positive","BCL-2 Positive","B-Cell CLL/Lymphoma 2 Positive","BCL2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134463","eligibility_criterion":"inclusion"}]"
NCT03229200,500,"null"
NCT03220646,78,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 wt Allele","name":"IDH2 wt Allele","synonyms":["IDHM","IDH","mNADP-IDH","ICD-M","IDPM","Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial wt Allele","D2HGA2","IDP"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84949","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 wt Allele","name":"IDH1 wt Allele","synonyms":["HEL-S-26","HEL-216","PICD","IDPC","Isocitrate Dehydrogenase 1 (NADP+), Soluble wt Allele","IDP","IDCD","IDH"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C77216","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 wt Allele","name":"RB1 wt Allele","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03189030,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"exclusion"}]"
NCT03180684,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-18 Positive","name":"HPV-18 Positive","synonyms":["Human Papilloma Virus 18 Positive","HPV18 Positive","Human Papillomavirus-18 Positive","Human Papilloma Virus-18 Positive","Human Papillomavirus 18 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131711","eligibility_criterion":"inclusion"}]"
NCT03179917,22,"null"
NCT03168061,150,"null"
NCT03164616,1000,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Protein Expression","name":"ALK Fusion Protein Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Protein Expression","ALK Fusion Protein Expression","CD246 Antigen Fusion Protein Expression","ALK Fusion Protein Positive","Anaplastic Lymphoma Kinase Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81946","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"inclusion"}]"
NCT03162224,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-18 Positive","name":"HPV-18 Positive","synonyms":["Human Papilloma Virus 18 Positive","HPV18 Positive","Human Papillomavirus-18 Positive","Human Papilloma Virus-18 Positive","Human Papillomavirus 18 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131711","eligibility_criterion":"inclusion"}]"
NCT03144661,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF19 Gene Amplification","name":"FGF19 Gene Amplification","synonyms":["HBGF-1 Gene Amplification","FGF-19 Gene Amplification","FGF19 Amplification","Fibroblast Growth Factor 19 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150612","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR4 Alteration Positive","name":"FGFR4 Alteration Positive","synonyms":["TKF Alteration Positive","FGFR-4 Alteration Positive","JKT2 Alteration Positive","Fibroblast Growth Factor Receptor 4 Alteration Positive","CD334 Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150621","eligibility_criterion":"inclusion"}]"
NCT03138512,800,"null"
NCT03123393,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Translocation","name":"BCL6 Gene Translocation","synonyms":["Zinc Finger Protein 51 Gene Translocation","BCL5 Gene Translocation","ZNF51 Gene Translocation","Bcl-6 Gene Translocation","BCL6 Translocation","B-Cell CLL/Lymphoma 6 Gene Translocation","ZBTB27 Gene Translocation","LAZ3 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134901","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Translocation","name":"BCL2 Gene Translocation","synonyms":["B-Cell CLL/Lymphoma 2 Gene Translocation","B-Cell CLL-Lymphoma 2 Gene Translocation","BCL2, Apoptosis Regulator Gene Translocation","BCL-2 Translocation","Bcl-2 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C38176","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"C-Myc Translocation","name":"C-Myc Translocation","synonyms":["v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Translocation","C-MycT","MYC Translocation","bHLHe39 Gene Translocation","MYCC Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27703","eligibility_criterion":"inclusion"}]"
NCT03118466,40,"null"
NCT03106428,228,"null"
NCT03083873,47,"null"
NCT03077698,72,"null"
NCT03071276,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03063632,30,"null"
NCT03051659,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03040999,780,"null"
NCT03035279,128,"null"
NCT03033914,26,"null"
NCT03006172,156,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02997176,24,"null"
NCT02997163,24,"null"
NCT02993159,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02992743,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(12;16)(q13;p11)","name":"t(12;16)(q13;p11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36317","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(12;22)(q13;q12)","name":"t(12;22)(q13;q12)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36374","eligibility_criterion":"inclusion"}]"
NCT02965716,64,"null"
NCT02962063,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02960022,470,"null"
NCT02954406,100,"null"
NCT02952508,80,"null"
NCT02921919,150,"null"
NCT02915783,31,"null"
NCT02914938,133,"null"
NCT02912572,70,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"POLE Gene Mutation","name":"POLE Gene Mutation","synonyms":["POLE1 Exonuclease Gene Mutation","DNA Polymerase Epsilon, Catalytic Subunit Exonuclease Gene Mutation","DNA Polymerase Epsilon Catalytic Subunit A Exonuclease Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131797","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT02909777,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Positive","name":"Myc Positive","synonyms":["c-MYC Positive","Myc Proto-Oncogene Positive","Proto-Oncogene c-Myc Positive","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131061","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYCN Positive","name":"N-Myc Positive","synonyms":["Neuroblastoma MYC Positive","MYCN Positive","NMYC Positive","v-myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Positive","N-Myc Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131062","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"}]"
NCT02903368,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02880371,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02869633,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NOTCH Family Gene Mutation","name":"NOTCH Family Gene Mutation","synonyms":["NOTCH Gene Mutation","Notch Receptor Gene Family Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136644","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02858895,52,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"exclusion"}]"
NCT02841748,100,"null"
NCT02829372,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02805660,119,"null"
NCT02740270,264,"null"
NCT02737475,435,"null"
NCT02735980,131,"null"
NCT02734615,312,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02724878,60,"null"
NCT02724371,400,"null"
NCT02723955,304,"null"
NCT02723331,50,"null"
NCT02722538,26,"null"
NCT02718131,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"}]"
NCT02715531,430,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02711956,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02703571,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT02677324,33,"null"
NCT02668653,536,"null"
NCT02642913,73,"null"
NCT02639546,50,"null"
NCT02635672,120,"null"
NCT02633137,47,"null"
NCT02628535,114,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"}]"
NCT02608268,250,"null"
NCT02606305,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT02594384,75,"null"
NCT02592967,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EML4-ALK translocation mutation","name":"EML4-ALK translocation mutation","synonyms":["C25756:C45576:C2002015","EML4/ALK"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99733:C99724","eligibility_criterion":"inclusion"}]"
NCT02575963,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Peripheral Blood White Cells","name":"Blasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36213","eligibility_criterion":"inclusion"}]"
NCT02565758,220,"null"
NCT02553941,24,"null"
NCT02553642,70,"null"
NCT02551991,54,"null"
NCT02537613,50,"null"
NCT02520154,30,"null"
NCT02516670,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02507960,17,"null"
NCT02505269,34,"null"
NCT02503722,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"}]"
NCT02495415,140,"null"
NCT02486718,1127,"null"
NCT02477826,2220,"null"
NCT02463877,45,"null"
NCT02453620,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02437851,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT02435433,383,"null"
NCT02424617,66,"null"
NCT02419495,588,"null"
NCT02413320,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02401542,261,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Fusion Positive","name":"FGFR3 Gene Fusion Positive","synonyms":["CD333 Gene Fusion Positive","JKT4 Gene Mutation Fusion Positive","FGFR-3 Gene Fusion Positive","Fibroblast Growth Factor Receptor 3 Gene Fusion Positive","FGFR3 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148097","eligibility_criterion":"inclusion"}]"
NCT02391480,150,"null"
NCT02365766,81,"null"
NCT02323191,310,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02315326,54,"null"
NCT02305563,126,"null"
NCT02281955,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02281383,75,"null"
NCT02276443,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02248805,103,"null"
NCT02218606,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02158858,114,"null"
NCT02152956,124,"null"
NCT02152943,42,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02064387,85,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF17 Positive","name":"TNFRSF17 Positive","synonyms":["CD269 Antigen Positive","BCMA Positive","CD269 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128845","eligibility_criterion":"inclusion"}]"
NCT02031419,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02026271,48,"null"
NCT01926197,172,"null"
NCT01912625,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Activating Mutation","name":"Activating KRAS Mutation","synonyms":["KRAS-2 Activating Mutation","KRAS Activating Mutation","c-K-ras Activating Mutation","KRAS2 Activating Mutation","KRAS Proto-Oncogene, GTPase Activating Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118391","eligibility_criterion":"inclusion"}]"
NCT01872260,253,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT01858168,93,"null"
NCT01787409,713,"null"
NCT01763944,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01744223,36,"null"
NCT01674842,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01657942,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT01644669,1200,"null"
NCT01638533,132,"null"
NCT01592370,375,"null"
NCT01556243,265,"null"
NCT01434316,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT01355926,68,"null"
NCT01351103,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RSPO Gene Fusion","name":"RSPO Gene Fusion","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RNF43 Gene Mutation","name":"RNF43 Gene Mutation","synonyms":["URCC Gene Mutation","Ring Finger Protein 43 Gene Mutation","RNF124 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141252","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01343043,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT01325441,390,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01141231,240,"null"
NCT00601003,100,"null"
NCT00062868,116,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03452137,400,"null"
NCT03430895,27,"null"
NCT03409458,52,"null"
NCT03384940,90,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"}]"
NCT03373877,30,"null"
NCT03359850,16,"null"
NCT03349710,1046,"null"
NCT03334409,91,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT03333616,57,"null"
NCT03330197,24,"null"
NCT03326674,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03310619,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT03288480,34,"null"
NCT03286530,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03285412,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03274219,50,"null"
NCT03269136,80,"null"
NCT03260491,63,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"MET Exon 14 Skipping Mutation","name":"MET Exon 14 Skipping Mutation","synonyms":["Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Alteration","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Mutation","c-Met Exon 14 Skipping Mutation","HGFR Exon 14 Skipping Mutation","Loss of MET Exon 14","Deletion of MET Exon 14","Loss of c-MET Exon 14","c-Met Exon 14 Skipping Alteration","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Alteration","Deletion of c-MET Exon 14","MET Exon 14 Skipping Alteration","HGFR Exon 14 Skipping Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131179","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Positive","name":"ALK Fusion Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Positive","CD246 Antigen Fusion Positive","Anaplastic Lymphoma Kinase Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142135","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT03254927,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT03248479,96,"null"
NCT03239392,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD8 Positive","name":"CD8 Positive","synonyms":["T-Cell Surface Glycoprotein CD8 Positive","CD8 Antigen Positive","CD8 Co-Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clonal Gene Rearrangement","name":"Clonal Gene Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36333","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD3 Positive","name":"CD3 Positive","synonyms":["T3 Complex Positive","CD3 Complex Positive","T-Cell Surface Glycoprotein CD3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131386","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD57 Positive","name":"CD57 Positive","synonyms":["L2/HNK-1 Positive","Leu7 Positive","CD57 Antigen Positive","Human Natural Killer-1 Antigen Positive","HNK-1 Positive","HNK1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139790","eligibility_criterion":"inclusion"}]"
NCT03233347,82,"null"
NCT03225105,24,"null"
NCT03221426,860,"null"
NCT03217266,80,"null"
NCT03214250,105,"null"
NCT03206203,106,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03175224,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Fusion Gene Positive","name":"MET Gene Fusion Positive","synonyms":["MET Gene Fusion","Hepatocyte Growth Factor Receptor Gene Fusion Positive","HGFR Gene Fusion Positive","MET Proto-Oncogene, Receptor Tyrosine Kinase Fusion Gene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Overexpression Positive","name":"MET Overexpression Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Overexpression Positive","Hepatocyte Growth Factor Receptor Overexpression Positive","HGFR Overexpression Positive","c-met Overexpression Positive","Met Proto-Oncogene Overexpression Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148403","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Deletion","name":"MET Gene Deletion","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Deletion","c-MET Gene Deletion","HGFR Gene Deletion","Hepatocyte Growth Factor Receptor Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147081","eligibility_criterion":"inclusion"}]"
NCT03139370,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA6 Positive","name":"MAGE-A6 Positive","synonyms":["MAGE3B Positive","MAGEA6 Positive","Melanoma-Associated Antigen 6 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-DPB1*0401 Positive Cells Present","name":"HLA-DPB1*0401 Positive Cells Present","synonyms":["HLA-DPB1*04:01 Positive Cells Present","HLA-DPB1*04:01 Positive","HLA-DPB1*0401 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146725","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA3 Positive","name":"MAGEA3 Positive","synonyms":["Melanoma-Associated Antigen 3 Positive","HYPD Positive","MAGE-3 Positive","HIP8 Positive","MAGE3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135575","eligibility_criterion":"inclusion"}]"
NCT03138408,174,"null"
NCT03132792,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*02:642 Positive Cells Present","name":"HLA-A*02:642 Positive Cells Present","synonyms":["HLA-A*02:642 Positive","HLA-A*02:642 Positive Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150470","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A*0202 Positive Cells Present","name":"HLA-A*0202 Positive Cells Present","synonyms":["HLA-A*02:02 Positive Cells Present","HLA-A0202 Positive","HLA-A*02:02 Positive","HLA-A*0202 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147058","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-B*5103 Positive Cells Present","name":"HLA-B*5103 Positive Cells Present","synonyms":["HLA-B*51:03 Positive","HLA-B5103 Positive","HLA-B*5103 Positive","HLA-B*51:03 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147059","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-C*0404 Positive Cells Present","name":"HLA-C*0404 Positive Cells Present","synonyms":["HLA-C*0404 Positive","HLA-C*04:04 Positive","HLA-C0404 Positive","HLA-C*04:04 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147060","eligibility_criterion":"exclusion"}]"
NCT03132675,48,"null"
NCT03127735,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT03113643,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Greater than or Equal to 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137694","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Interleukin-3 Receptor Subunit Alpha Positive","name":"IL3RA Positive","synonyms":["IL3R-Alpha Positive","CD123 Positive","IL-3R-Alpha Positive","IL-3R Subunit Alpha Positive","Interleukin-3 Receptor Subunit Alpha Positive","CD123 Antigen Positive","IL-3 Receptor Subunit Alpha Positive","Interleukin 3 Receptor Alpha Chain Positive","Interleukin 3 Receptor Positive","Interleukin 3 Receptor Alpha Positive","IL-3RA Positive","IL3R Positive","IL3RX Positive","Low Affinity Interleukin 3 Receptor Alpha Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132655","eligibility_criterion":"inclusion"}]"
NCT03113422,56,"null"
NCT03110562,364,"null"
NCT03093870,490,"null"
NCT03084640,76,"null"
NCT03077828,40,"null"
NCT03073967,30,"null"
NCT03072043,51,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT03071874,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"exclusion"}]"
NCT03064854,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement Negative","name":"ROS1 Gene Rearrangement Negative","synonyms":["c-ros-1 Gene Rearrangement Negative","ROS Gene Rearrangement Negative","MCF3 Gene Rearrangement Negative","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147054","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"inclusion"}]"
NCT03059485,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03054896,20,"null"
NCT03037645,124,"null"
NCT03035253,30,"null"
NCT03006848,40,"null"
NCT03002805,46,"null"
NCT03002519,24,"null"
NCT02982941,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"}]"
NCT02971956,50,"null"
NCT02968940,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosomes 1p/19q","name":"1p/19q Codeletion","synonyms":["Loss of Chromosomes 1p/19q","1p/19q Co-deletion","del(1p/19q)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C79099","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Gene Mutation","name":"MMR Mutation","synonyms":["Mismatch Repair Gene Mutation","DNA Mismatch Repair Gene Mutation","MMR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133706","eligibility_criterion":"inclusion"}]"
NCT02965885,175,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02964013,356,"null"
NCT02963493,78,"null"
NCT02955550,46,"null"
NCT02950064,95,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Repair Mutation","name":"DNA Repair Gene Mutation","synonyms":["DNA Repair Mutation","DNA Repair Mutation Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131783","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02939183,64,"null"
NCT02936323,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor 2 Positive","name":"Somatostatin Receptor 2 Positive","synonyms":["Somatostatin Receptor Type 2 Positive","SSR2 Positive","SSTR2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131558","eligibility_criterion":"inclusion"}]"
NCT02927340,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02927262,354,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT02926833,31,"null"
NCT02924402,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02923349,157,"null"
NCT02919969,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02913313,170,"null"
NCT02903069,72,"null"
NCT02900560,20,"null"
NCT02879695,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02873338,75,"null"
NCT02864290,100,"null"
NCT02848001,70,"null"
NCT02847429,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA NP_006197.1:p.D842V","name":"PDGFRA D842V Mutation","synonyms":["PDGFRA NP_006197.1:p.Asp842Val","PDGFRA c.2525A>T","PDGFRA p.D842V","NM_006206.4:c.2525A>T","PDGFR-Alpha Asp842Val","CD140a Antigen Asp842Val","PDGFRA D842V","CD140A c.2525A>T","PDGFR2 c.2525A>T","PDGFRA Asp842Val","CD140a Antigen D842V","RHEPDGFRA c.2525A>T","PDGFRA NP_006197.1:p.D842V","Platelet-Derived Growth Factor Receptor Alpha D842V","Platelet-Derived Growth Factor Receptor, Alpha Polypeptide c.2525A>T","PDGFRA p.Asp842Val","Platelet-Derived Growth Factor Receptor Alpha Asp842Val","PDGFR-Alpha D842V","NP_006197.1:p.D842V","PDGFRA NM_006206.4:c.2525A>T","PDGFR-2 c.2525A>T","NP_006197.1:p.Asp842Val"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107568:C107570","eligibility_criterion":"inclusion"}]"
NCT02840994,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"}]"
NCT02819999,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DLL3 Positive","name":"DLL3 Positive","synonyms":["Delta3 Positive","Delta-Like 3 Positive","Drosophila Delta Homolog 3 Positive","Delta Like Canonical Notch Ligand 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140465","eligibility_criterion":"inclusion"}]"
NCT02819518,858,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02807636,1200,"null"
NCT02805894,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Ten to Twenty","name":"PSA Level Ten to Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137687","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02779751,75,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT02770014,100,"null"
NCT02767804,402,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02756845,18,"null"
NCT02756364,153,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02746081,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 NP_005887.2:p.R132X","name":"IDH1 R132X Mutation","synonyms":["DH1 Arg132Xxx","IDH1 p.Arg132Xxx","Cytosolic NADP-Isocitrate Dehydrogenase Protein R132X","Isocitrate Dehydrogenase [NADP] Cytoplasmic Arg132Xxx","NP_005887.2:p.Arg132Xxx","NP_005887.2:p.R132X","IDH1 R132X","IDH1 NP_005887.2:p.Arg132Xxx","Isocitrate Dehydrogenase [NADP] Cytoplasmic R132X","IDH1 p.R132X","Cytosolic NADP-Isocitrate Dehydrogenase Protein Arg132Xxx","IDH1 NP_005887.2:p.R132X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117280","eligibility_criterion":"inclusion"}]"
NCT02742090,50,"null"
NCT02730481,30,"null"
NCT02730312,105,"null"
NCT02723864,60,"null"
NCT02706626,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02702388,152,"null"
NCT02700386,150,"null"
NCT02697591,146,"null"
NCT02694809,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02684461,35,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EML4-ALK translocation mutation","name":"EML4-ALK translocation mutation","synonyms":["C25756:C45576:C2002015","EML4/ALK"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99733:C99724","eligibility_criterion":"exclusion"}]"
NCT02684292,300,"null"
NCT02684058,142,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02675452,100,"null"
NCT02664961,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"}]"
NCT02661022,32,"null"
NCT02659514,70,"null"
NCT02658097,48,"null"
NCT02657005,45,"null"
NCT02651662,172,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02648724,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"}]"
NCT02643550,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT02628574,146,"null"
NCT02621151,54,"null"
NCT02616185,133,"null"
NCT02611908,17,"null"
NCT02609503,29,"null"
NCT02608125,50,"null"
NCT02595372,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02594267,30,"null"
NCT02588651,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Low","name":"TNFRSF8 Low","synonyms":["Ki-1 Low","CD30 Antigen Low","Low Expression of CD30","Ki-1 Antigen Low","Low Expression of TNFRSF8","CD30 Low","Tumor Necrosis Factor Receptor Superfamily Member 8 Low"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131485","eligibility_criterion":"inclusion"}]"
NCT02566993,600,"null"
NCT02560779,39,"null"
NCT02560025,39,"null"
NCT02559778,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT02555189,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02523469,91,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02515110,145,"null"
NCT02514668,64,"null"
NCT02504489,554,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR sensitizing mutation","name":"EGFR sensitizing mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02501096,191,"null"
NCT02500199,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"}]"
NCT02498665,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*24:02 Positive Cells Present","name":"HLA-A*24:02 Positive Cells Present","synonyms":["HLA-A2402 Positive","HLA-A2402 Positive Cells Present","HLA-A*24:02 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142110","eligibility_criterion":"inclusion"}]"
NCT02471716,75,"null"
NCT02454972,325,"null"
NCT02452268,110,"null"
NCT02446704,106,"null"
NCT02440685,51,"null"
NCT02423343,75,"null"
NCT02419560,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"}]"
NCT02404441,319,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02390427,86,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02384954,86,"null"
NCT02367456,72,"null"
NCT02366819,36,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02336087,21,"null"
NCT02334527,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Protein Overexpression","name":"CCND1 Protein Overexpression","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Negative","name":"CDKN2A Negative","synonyms":["CDKN2A Loss","Cyclin-Dependent Kinase 4 Inhibitor A Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131787","eligibility_criterion":"inclusion"}]"
NCT02318277,192,"null"
NCT02307149,59,"null"
NCT02296580,32,"null"
NCT02289209,48,"null"
NCT02278250,151,"null"
NCT02257424,53,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02242097,36,"null"
NCT02240706,200,"null"
NCT02222922,190,"null"
NCT02217709,46,"null"
NCT02162732,200,"null"
NCT02141542,24,"null"
NCT02128282,209,"null"
NCT02118337,96,"null"
NCT02111681,55,"null"
NCT02102022,225,"null"
NCT02081378,290,"null"
NCT02077166,129,"null"
NCT02066532,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT02037048,66,"null"
NCT02030067,72,"null"
NCT02012296,116,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01948297,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"}]"
NCT01925131,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT01897571,420,"null"
NCT01896856,117,"null"
NCT01884285,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CB Gene Mutation","name":"PIK3CB Gene Mutation","synonyms":["PI3KBETA Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Gene Mutation","p110-Beta Gene Mutation","P110BETA Gene Mutation","PIK3C1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141340","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CB Gene Amplification","name":"PIK3CB Gene Amplification","synonyms":["Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Gene Amplification","PIK3C1 Gene Amplification","P110BETA Gene Amplification","PI3KBETA Gene Amplification","p110-Beta Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141339","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT01861093,500,"null"
NCT01783587,38,"null"
NCT01775475,90,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT01773395,152,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"}]"
NCT01763970,20,"null"
NCT01750073,125,"null"
NCT01562405,34,"null"
NCT01465659,39,"null"
NCT01462630,30,"null"
NCT01442051,41,"null"
NCT01295944,46,"null"
NCT01282502,36,"null"
NCT01270724,28,"null"
NCT01251575,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT01084252,341,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD38 Positive","name":"CD38 Positive","synonyms":["CD38 Molecule Positive","CD38 Antigen Positive","ADP-Ribosyl Cyclase 1 Positive","T10 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147087","eligibility_criterion":"inclusion"}]"
NCT01046825,168,"null"
NCT00293475,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03541902,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Xp11.2 Translocation","name":"Xp11.2 Translocation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03520491,45,"null"
NCT03504644,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Lymphoblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142103","eligibility_criterion":"inclusion"}]"
NCT03491683,52,"null"
NCT03480646,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03474640,78,"null"
NCT03465722,460,"null"
NCT03456063,302,"null"
NCT03451162,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03445533,308,"null"
NCT03435640,393,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03430011,118,"null"
NCT03420508,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Alteration Positive","name":"ALK Gene Alteration Positive","synonyms":["CD246 Gene Alteration Positive","Anaplastic Lymphoma Kinase Gene Alteration Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Fusion Gene Positive","name":"ALK Fusion Gene Positive","synonyms":["Anaplastic Lymphoma Kinase Fusion Gene Positive","CD246 Fusion Gene Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Fusion Gene Alteration Positive","ALK Fusion Gene Present","ALK Fusion Oncogene Positive","Anaplastic Lymphoma Kinase Fusion Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142114","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALKATI Positive","name":"ALKATI Alteration Positive","synonyms":["Anaplastic Lymphoma Kinase Alternative Transcription Initiation Positive","ALKATI Positive","CD246 Alternative Transcription Initiation Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Alternative Transcription Initiation Positive","CD246 Antigen Alternative Transcription Initiation Positive","ALK-ATI Positive","ALK Intron 19 ATI Isoform Positive","ALK ATI Positive","ALK(ATI) Positive","ALK Alternative Transcription Initiation Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150446","eligibility_criterion":"inclusion"}]"
NCT03414983,180,"null"
NCT03410927,204,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Protein Overexpression","name":"ERBB2 Protein Overexpression","synonyms":["Receptor Tyrosine-Protein Kinase erbB-2 Protein Overexpression","Tyrosine Kinase-Type Cell Surface Receptor HER2 Protein Overexpression","HER2 Protein Overexpression","Proto-Oncogene Neu Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36639","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB3 Gene Mutation","name":"ERBB3 Gene Mutation","synonyms":["V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER-3 Gene Mutation","c-erbB3 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 3 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER3 Gene Mutation","c-erbB-3 Gene Mutation","ErbB-3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138064","eligibility_criterion":"inclusion"}]"
NCT03397394,200,"null"
NCT03394365,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03387020,45,"null"
NCT03386513,155,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Interleukin-3 Receptor Subunit Alpha Positive","name":"IL3RA Positive","synonyms":["IL3R-Alpha Positive","CD123 Positive","IL-3R-Alpha Positive","IL-3R Subunit Alpha Positive","Interleukin-3 Receptor Subunit Alpha Positive","CD123 Antigen Positive","IL-3 Receptor Subunit Alpha Positive","Interleukin 3 Receptor Alpha Chain Positive","Interleukin 3 Receptor Positive","Interleukin 3 Receptor Alpha Positive","IL-3RA Positive","IL3R Positive","IL3RX Positive","Low Affinity Interleukin 3 Receptor Alpha Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132655","eligibility_criterion":"inclusion"}]"
NCT03383458,530,"null"
NCT03381274,98,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT03380871,15,"null"
NCT03372057,120,"null"
NCT03371979,78,"null"
NCT03369223,300,"null"
NCT03368963,64,"null"
NCT03344965,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Repair Mutation","name":"DNA Repair Gene Mutation","synonyms":["DNA Repair Mutation","DNA Repair Mutation Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131783","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT03343301,10,"null"
NCT03331250,16,"null"
NCT03330561,78,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03326752,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03323151,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT03322566,148,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"}]"
NCT03319940,92,"null"
NCT03319901,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 20 Percent or more of Bone Marrow Nucleated Cells","name":"Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Lymphoblasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146661","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Lymphoblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142103","eligibility_criterion":"inclusion"}]"
NCT03317496,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation Negative","name":"ALK Gene Translocation Negative","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation Negative","Anaplastic Lymphoma Kinase Gene Translocation Negative","CD246 Gene Translocation Negative","ALK Translocation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"inclusion"}]"
NCT03316794,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03316599,25,"null"
NCT03314181,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"}]"
NCT03310541,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT2 Gene Mutation","name":"AKT2 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 2 Gene Mutation","PRKBB Gene Mutation","PKBBETA Gene Mutation","PKBB Gene Mutation","HIHGHH Gene Mutation","AKT Serine/Threonine Kinase 2 Gene Mutation","RAC-PK-Beta Gene Mutation","RAC-BETA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141362","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Mutation","name":"AKT1 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Mutation","AKT Gene Mutation","PKB Gene Mutation","RAC Gene Mutation","RAC-PK-Alpha Gene Mutation","PRKBA Gene Mutation","RAC-ALPHA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98304","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating HRAS Mutation","name":"Activating HRAS Mutation","synonyms":["HRAS1 Activating Mutation","C-H-RAS Activating Mutation","HRAS Activating Mutation","Ha-ras Activating Mutation","HRas Proto-Oncogene, GTPase Activating Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Activating Mutation","H-ras Activating Mutation","RASH1 Activating Mutation","C-HA-RAS1 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139798","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating NRAS Mutation","name":"Activating NRAS Mutation","synonyms":["NRAS Proto-Oncogene, GTPase Activating Mutation","NRAS Activating Mutation","NRAS1 Activating Mutation","Neuroblastoma RAS Viral Oncogene Homolog Activating Mutation","N-RAS Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139796","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Activating Mutation","name":"Activating KRAS Mutation","synonyms":["KRAS-2 Activating Mutation","KRAS Activating Mutation","c-K-ras Activating Mutation","KRAS2 Activating Mutation","KRAS Proto-Oncogene, GTPase Activating Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118391","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT3 Gene Mutation","name":"AKT3 Gene Mutation","synonyms":["STK-2 Gene Mutation","PRKBG Gene Mutation","PKB-GAMMA Gene Mutation","PKBG Gene Mutation","v-akt Murine Thymoma Viral Oncogene Homolog 3 Gene Mutation","AKT Serine/Threonine Kinase 3 Gene Mutation","RAC-Gamma Gene Mutation","RAC-PK-Gamma Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150442","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"exclusion"}]"
NCT03309111,125,"null"
NCT03306264,132,"null"
NCT03304080,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"exclusion"}]"
NCT03298516,110,"null"
NCT03298451,1200,"null"
NCT03294694,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03292406,84,"null"
NCT03288493,40,"null"
NCT03285321,108,"null"
NCT03284957,156,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03284723,95,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03281369,357,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03279692,24,"null"
NCT03275103,80,"null"
NCT03274414,25,"null"
NCT03271372,100,"null"
NCT03268057,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT03263091,184,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 5q","name":"5q Deletion","synonyms":["del(5q)","5q-","Loss of Chromosome 5q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27712","eligibility_criterion":"exclusion"}]"
NCT03256136,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"}]"
NCT03250832,260,"null"
NCT03246529,207,"null"
NCT03239145,60,"null"
NCT03238248,71,"null"
NCT03237390,49,"null"
NCT03224819,50,"null"
NCT03220477,57,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT03219268,131,"null"
NCT03216499,35,"null"
NCT03215706,420,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT03207867,260,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03192462,45,"null"
NCT03192345,130,"null"
NCT03179904,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03178851,152,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Wild Type","name":"BRAF V600 Wild Type","synonyms":["BRAF V600V","BRAF p.V600V","BRAF V600 wt","B-RAF1 V600 Wild Type","Serine/Threonine-Protein Kinase B-raf V600 Wild Type","B-RAF V600 Wild Type"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134468","eligibility_criterion":"inclusion"}]"
NCT03168438,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT03151811,450,"null"
NCT03148418,546,"null"
NCT03145909,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PRLR Positive","name":"PRLR Positive","synonyms":["PRL-R Positive","Prolactin Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147075","eligibility_criterion":"inclusion"}]"
NCT03144245,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03139916,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 wt Allele","name":"IDH1 wt Allele","synonyms":["HEL-S-26","HEL-216","PICD","IDPC","Isocitrate Dehydrogenase 1 (NADP+), Soluble wt Allele","IDP","IDCD","IDH"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C77216","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 wt Allele","name":"IDH2 wt Allele","synonyms":["IDHM","IDH","mNADP-IDH","ICD-M","IDPM","Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial wt Allele","D2HGA2","IDP"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84949","eligibility_criterion":"inclusion"}]"
NCT03139331,28,"null"
NCT03138889,75,"null"
NCT03137888,36,"null"
NCT03136055,42,"null"
NCT03135262,140,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD20 Negative","name":"CD20 Negative","synonyms":["Leu-16 Negative","MS4A1 Negative","CD20 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137690","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03131206,78,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating RET Mutation","name":"Activating RET Mutation","synonyms":["Activating Ret Proto-Oncogene Mutation","RET Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129702","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"}]"
NCT03129139,54,"null"
NCT03126591,37,"null"
NCT03126019,100,"null"
NCT03125902,540,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03123783,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ROS1 Gene Mutation","name":"Activating ROS1 Gene Mutation","synonyms":["Activating c-ros-1 Gene Mutation","Activating MCF3 Gene Mutation","Activating ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Mutation","Activating ROS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146723","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ALK Gene Mutation","name":"Activating ALK Gene Mutation","synonyms":["Activating Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","Activating CD246 Gene Mutation","Activating ALK Gene Mutation Activating ALK Receptor Tyrosine Kinase Gene Mutation","Activating Anaplastic Lymphoma Kinase Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146722","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"inclusion"}]"
NCT03123055,74,"null"
NCT03122717,64,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"}]"
NCT03119467,60,"null"
NCT03114319,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAF Wild Type","name":"RAF wt Allele","synonyms":["Wild Type RAF","RAF Wild Type","RAF Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132848","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Activating Mutation","name":"Activating KRAS Mutation","synonyms":["KRAS-2 Activating Mutation","KRAS Activating Mutation","c-K-ras Activating Mutation","KRAS2 Activating Mutation","KRAS Proto-Oncogene, GTPase Activating Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118391","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating PTPN11 Mutation","name":"Activating PTPN11 Mutation","synonyms":["SHP-2 Activating Mutation","SH-PTP2 Activating Mutation","Protein Tyrosine Phosphatase, Non-Receptor Type 11 Activating Mutation","PTP2C Activating Mutation","PTP-1D Activating Mutation","SHP2 Activating Mutation","PTPN11 Activating Mutation","BPTP3 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139794","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating HRAS Mutation","name":"Activating HRAS Mutation","synonyms":["HRAS1 Activating Mutation","C-H-RAS Activating Mutation","HRAS Activating Mutation","Ha-ras Activating Mutation","HRas Proto-Oncogene, GTPase Activating Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Activating Mutation","H-ras Activating Mutation","RASH1 Activating Mutation","C-HA-RAS1 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139798","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating NRAS Mutation","name":"Activating NRAS Mutation","synonyms":["NRAS Proto-Oncogene, GTPase Activating Mutation","NRAS Activating Mutation","NRAS1 Activating Mutation","Neuroblastoma RAS Viral Oncogene Homolog Activating Mutation","N-RAS Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139796","eligibility_criterion":"exclusion"}]"
NCT03113825,110,"null"
NCT03110354,60,"null"
NCT03107988,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Fusion Protein Expression","name":"ALK Fusion Protein Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Protein Expression","ALK Fusion Protein Expression","CD246 Antigen Fusion Protein Expression","ALK Fusion Protein Positive","Anaplastic Lymphoma Kinase Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81946","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Alteration Positive","name":"ALK Gene Alteration Positive","synonyms":["CD246 Gene Alteration Positive","Anaplastic Lymphoma Kinase Gene Alteration Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Amplification","name":"ALK Gene Amplification","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Amplification","Anaplastic Lymphoma Kinase Receptor Gene Amplification","CD246 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131136","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"}]"
NCT03095781,50,"null"
NCT03095352,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03093116,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Rearrangement","name":"NTRK1 Gene Rearrangement","synonyms":["TRK1 Gene Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Rearrangement","MTC Gene Rearrangement","TRKA Gene Rearrangement","Neurotrophic Receptor Tyrosine Kinase 1 Gene Rearrangement","Trk-A Gene Rearrangement","TRK Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Gene Rearrangement","name":"NTRK2 Gene Rearrangement","synonyms":["TRKB Tyrosine Kinase Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 2 Gene Rearrangement","Tropomyosin-Related Kinase B Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor Type 2 Gene Rearrangement","NTRK2 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131321","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Gene Rearrangement","name":"NTRK3 Gene Rearrangement","synonyms":["Neurotrophic Tyrosine Kinase Receptor Type 3 Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 3 Gene Rearrangement","NTRK3 Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 3 Gene Rearrangement","TRKC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131325","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT03088527,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"exclusion"}]"
NCT03077243,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03076372,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03066648,175,"null"
NCT03065062,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT03057795,65,"null"
NCT03051035,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HRAS Gene Mutation","name":"HRAS Gene Mutation","synonyms":["HRas Proto-Oncogene, GTPase Gene Mutation","Ha-ras Gene Mutation","RASH1 Gene Mutation","C-HA-RAS1 Gene Mutation","v-Ha-ras Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","C-H-RAS Gene Mutation","H-ras Gene Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","HRAS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45934","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT03048344,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NPM1 Gene Mutation","name":"NPM1 Gene Mutation","synonyms":["Mutation of the Nucleophosmin Gene","Nucleophosmin Gene Mutation","NPM1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82429","eligibility_criterion":"inclusion"}]"
NCT03043872,984,"null"
NCT03042611,459,"null"
NCT03036904,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Translocation","name":"BCL2 Gene Translocation","synonyms":["B-Cell CLL/Lymphoma 2 Gene Translocation","B-Cell CLL-Lymphoma 2 Gene Translocation","BCL2, Apoptosis Regulator Gene Translocation","BCL-2 Translocation","Bcl-2 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C38176","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Translocation","name":"BCL6 Gene Translocation","synonyms":["Zinc Finger Protein 51 Gene Translocation","BCL5 Gene Translocation","ZNF51 Gene Translocation","Bcl-6 Gene Translocation","BCL6 Translocation","B-Cell CLL/Lymphoma 6 Gene Translocation","ZBTB27 Gene Translocation","LAZ3 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134901","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"C-Myc Translocation","name":"C-Myc Translocation","synonyms":["v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Translocation","C-MycT","MYC Translocation","bHLHe39 Gene Translocation","MYCC Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27703","eligibility_criterion":"inclusion"}]"
NCT03032107,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03030287,60,"null"
NCT03029585,61,"null"
NCT03022825,100,"null"
NCT03007407,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03006926,104,"null"
NCT02988960,198,"null"
NCT02978443,73,"null"
NCT02967770,58,"null"
NCT02963168,24,"null"
NCT02955251,172,"null"
NCT02953782,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT02952729,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02949700,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02939300,18,"null"
NCT02939274,15,"null"
NCT02930109,40,"null"
NCT02918292,30,"null"
NCT02909972,60,"null"
NCT02903914,346,"null"
NCT02903160,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02901899,38,"null"
NCT02900664,432,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02900651,113,"null"
NCT02896335,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Negative","name":"CDKN2A Negative","synonyms":["CDKN2A Loss","Cyclin-Dependent Kinase 4 Inhibitor A Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131787","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND2 Gene Amplification","name":"CCND2 Gene Amplification","synonyms":["Cyclin D2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131785","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCNE1 Gene Amplification","name":"CCNE1 Gene Amplification","synonyms":["Cyclin E1 Gene Amplification","CCNE1 Amplification","CCNE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36682","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Amplification","name":"CCND1 Gene Amplification","synonyms":["Cyclin D1 Gene Activation","BCL1 Gene Amplification","PRAD1 Gene Amplification","BCL-1 Gene Amplification","Cyclin D1 Gene Amplification","CCND1 Gene Activation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36652","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND3 Gene Amplification","name":"CCND3 Gene Amplification","synonyms":["Cyclin D3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131784","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDK6 Gene Amplification","name":"CDK6 Gene Amplification","synonyms":["Cyclin-Dependent Kinase 6 Gene Amplification","Cyclin Dependent Kinase 6 Gene Amplification","PLSTIRE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132897","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDK4 Gene Amplification","name":"CDK4 Gene Amplification","synonyms":["Cell Division Kinase 4 Gene Amplification","Cyclin Dependent Kinase 4 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131786","eligibility_criterion":"inclusion"}]"
NCT02891161,42,"null"
NCT02890368,240,"null"
NCT02886585,101,"null"
NCT02880319,150,"null"
NCT02875613,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02871791,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02867007,50,"null"
NCT02855944,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02845297,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"}]"
NCT02834611,24,"null"
NCT02834247,126,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02833883,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02832167,250,"null"
NCT02823990,33,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Rearrangement","name":"EGFR Gene Rearrangement","synonyms":["HER1 Gene Rearrangement","Epidermal Growth Factor Receptor Gene Rearrangement","ERBB Gene Rearrangement","c-erbB1 Gene Rearrangement","ERBB1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148095","eligibility_criterion":"exclusion"}]"
NCT02819843,34,"null"
NCT02807844,175,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02802267,110,"null"
NCT02797470,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT02795858,43,"null"
NCT02794571,300,"null"
NCT02784834,15,"null"
NCT02784795,163,"null"
NCT02779777,58,"null"
NCT02774681,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02773030,118,"null"
NCT02768766,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GNA11 Gene Mutation","name":"GNA11 Gene Mutation","synonyms":["G Protein Subunit Alpha 11 Gene Mutation","Guanine Nucleotide-Binding Protein, Alpha-11 Gene Mutation","GNA-11 Gene Mutation","GA11 Gene Mutation","Guanine Nucleotide Binding Protein (G Protein), Alpha 11 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C89714","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GNAQ Gene Mutation","name":"GNAQ Gene Mutation","synonyms":["G Protein Subunit Alpha q Gene Mutation","GAQ Gene Mutation","SWS Gene Mutation","CMC1 Gene Mutation","Guanine Nucleotide Binding Protein (G Protein), Q Polypeptide Gene Mutation","G-ALPHA-q Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C89713","eligibility_criterion":"inclusion"}]"
NCT02768389,15,"null"
NCT02766465,200,"null"
NCT02755272,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02748135,36,"null"
NCT02730338,866,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT02729298,140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02720068,340,"null"
NCT02718066,78,"null"
NCT02705482,70,"null"
NCT02704858,43,"null"
NCT02689219,58,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"}]"
NCT02683395,60,"null"
NCT02675946,72,"null"
NCT02663622,204,"null"
NCT02660034,230,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Damage Response Deficiency Gene Signature","name":"DDRD Signature","synonyms":["Deficient DNA Damage Response Gene Signature","DNA Damage Response Deficiency Gene Signature","DNA Damage Response and Repair Deficiency Gene Signature","DNA Damage Repair Deficiency Gene Signature"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129891","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02659631,152,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDH3 Positive","name":"CDH3 Positive","synonyms":["Cadherin-3 Positive","Placental Cadherin Positive","Cadherin 3 Positive","CADP Positive","Cadherin, Placental Positive","P-Cadherin Positive","PCAD Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133703","eligibility_criterion":"inclusion"}]"
NCT02659293,180,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02657551,33,"null"
NCT02657434,568,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Positive","name":"ALK Fusion Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Positive","CD246 Antigen Fusion Positive","Anaplastic Lymphoma Kinase Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142135","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT02657343,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02654119,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02648997,25,"null"
NCT02644460,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RB1 Gene Mutation","name":"RB1 Gene Mutation","synonyms":["Retinoblastoma Gene Mutation","RB Gene Mutation","Retinoblastoma 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133696","eligibility_criterion":"exclusion"}]"
NCT02643303,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02636036,30,"null"
NCT02627274,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02623972,25,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02619253,57,"null"
NCT02609776,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02605915,98,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02600897,128,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02584647,43,"null"
NCT02581384,25,"null"
NCT02576496,84,"null"
NCT02576444,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"}]"
NCT02574728,40,"null"
NCT02573259,150,"null"
NCT02557321,144,"null"
NCT02556463,135,"null"
NCT02555644,70,"null"
NCT02551185,41,"null"
NCT02547987,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02546661,140,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MYCL Gene Amplification","name":"MYCL Gene Amplification","synonyms":["MYCL1 Gene Amplification","LMYC Gene Amplification","v-MYC Avian Myelocytomatosis Viral Oncogene Lung Carcinoma Derived Homolog Gene Amplification","L-myc Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36675","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCNE1 Gene Amplification","name":"CCNE1 Gene Amplification","synonyms":["Cyclin E1 Gene Amplification","CCNE1 Amplification","CCNE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36682","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Deletion","name":"CDKN2A Gene Deletion","synonyms":["p14ARF Gene Deletion","CDKN2A-p16 Gene Deletion","p19ARF Gene Deletion","CDKN2A Deletion","p16INK4a Gene Deletion","p16-INK4A Gene Deletion","CDK4I Gene Deletion","p16 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41615","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"RB1 Gene Inactivation","name":"Inactivating RB1 Gene Mutation","synonyms":["RB1 Tumor-Suppressor Gene Inactivation","RB1 Gene Inactivation","Inactivating Retinoblastoma 1 Gene Mutation","Inactivation of Retinoblastoma Tumor-Suppressor Gene","Inactivating Retinoblastoma Gene Mutation","Inactivating RB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36328","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"RB1 Gene Deletion","name":"RB1 Gene Deletion","synonyms":["RB1 Gene Deletion Retinoblastoma 1 Gene Deletion","RB Gene Deletion","Retinoblastoma Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146654","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR Gene Fusion Positive","name":"FGFR Gene Fusion Positive","synonyms":["FGFR Gene Family Fusion Positive","FGF Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Family Fusion Positive","FGF Receptor Gene Family Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132244","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Inactivation","name":"Inactivating CDKN2A Gene Mutation","synonyms":["Inactivating p16 Gene Mutation","Inactivating p14ARF Gene Mutation","Inactivating p19ARF Gene Mutation","Inactivating p16INK4a Gene Mutation","Inactivating CDK4I Gene Mutation","Inactivating CDKN2A-p16 Gene Mutation","CDKN2A Gene Inactivation","p16/CMM2 Gene Inactivation","Inactivating p16-INK4A Gene Mutation","p16 Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39629","eligibility_criterion":"inclusion"}]"
NCT02543879,160,"null"
NCT02542657,52,"null"
NCT02540291,23,"null"
NCT02531932,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02528357,264,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02524119,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT02522715,39,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02501902,100,"null"
NCT02500914,102,"null"
NCT02494921,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02493530,112,"null"
NCT02491099,51,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02481310,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Protein Overexpression","name":"MYC Overexpression","synonyms":["Myc Proto-Oncogene Protein Overexpression","MYC Protein Overexpression","MYC Transcription Factor Protein Overexpression","bHLHe39 Protein Overexpression","Proto-Oncogene c-Myc Protein Overexpression","Class E Basic Helix-Loop-Helix Protein 39 Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133692","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT02478164,32,"null"
NCT02474173,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02468661,135,"null"
NCT02464228,30,"null"
NCT02448251,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02439450,120,"null"
NCT02432235,140,"null"
NCT02422641,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02411448,543,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02365597,210,"null"
NCT02363491,40,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 5q","name":"5q Deletion","synonyms":["del(5q)","5q-","Loss of Chromosome 5q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27712","eligibility_criterion":"exclusion"}]"
NCT02343042,321,"null"
NCT02332850,66,"null"
NCT02325739,238,"null"
NCT02320825,150,"null"
NCT02317874,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA Rearrangement","name":"BRCA Rearrangement","synonyms":["BRCA Gene Rearrangement","BRCA Family Gene Rearrangement","BRCA Family Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122866","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT02312245,240,"null"
NCT02307240,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NUT Rearrangement","name":"NUT Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02301117,48,"null"
NCT02296112,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Exclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"exclusion"}]"
NCT02278315,33,"null"
NCT02270814,70,"null"
NCT02266745,80,"null"
NCT02262910,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02260531,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02232516,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"}]"
NCT02227251,130,"null"
NCT02224872,20,"null"
NCT02222363,48,"null"
NCT02206984,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02204085,53,"null"
NCT02201212,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC2 Gene Inactivation","name":"TSC2 Gene Inactivation","synonyms":["Inactivating TSC2 Gene Mutation","TSC2 Tumor-Suppressor Gene Inactivation","Tuberous Sclerosis 2 Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36696","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC1 Gene Inactivation","name":"TSC1 Gene Inactivation","synonyms":["Inactivating TSC1 Gene Mutation","TSC1 Tumor-Suppressor Gene Inactivation","Tuberous Sclerosis 1 Gene Inactivation","TSC Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40462","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating MTOR Gene Mutation","name":"Activating MTOR Gene Mutation","synonyms":["Activating FK506 Binding Protein 12-Rapamycin Associated Protein 1 Gene Mutation","Activating Rapamycin and FKBP12 Target 1 Gene Mutation","Activating Mechanistic Target of Rapamycin Gene Mutation","MTOR Activating Mutation","Activating Mammalian Target of Rapamycin Gene Mutation","Activating FRAP1 Gene Mutation","Activating FRAP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142101","eligibility_criterion":"inclusion"}]"
NCT02200705,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02187133,30,"null"
NCT02181218,18,"null"
NCT02180711,80,"null"
NCT02176031,30,"null"
NCT02155920,18,"null"
NCT02150967,120,"null"
NCT02130466,219,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02106312,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(12;16)(q13;p11)","name":"t(12;16)(q13;p11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36317","eligibility_criterion":"inclusion"}]"
NCT02095184,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02089334,23,"null"
NCT02081755,336,"null"
NCT02057939,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PSA Level Greater than Four","name":"PSA Level Greater than Four","synonyms":["PSA Level Greater than 4"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147088","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"}]"
NCT02057133,198,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02043587,100,"null"
NCT02003092,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01994850,32,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01989585,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01970722,50,"null"
NCT01954979,61,"null"
NCT01948180,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01931046,30,"null"
NCT01920737,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"}]"
NCT01905228,132,"null"
NCT01886105,20,"null"
NCT01877382,80,"null"
NCT01868386,52,"null"
NCT01859819,24,"null"
NCT01858558,90,"null"
NCT01853644,30,"null"
NCT01835626,24,"null"
NCT01813734,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Translocation","name":"RET Translocation","synonyms":["RET Gene Translocation","RET/PTC Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129252","eligibility_criterion":"inclusion"}]"
NCT01812252,60,"null"
NCT01805037,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01782443,43,"null"
NCT01753089,25,"null"
NCT01743950,80,"null"
NCT01740323,60,"null"
NCT01739764,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01730833,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01723774,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01694277,208,"null"
NCT01669798,56,"null"
NCT01665794,117,"null"
NCT01553942,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01553071,36,"null"
NCT01464034,117,"null"
NCT01436968,711,"null"
NCT01345552,150,"null"
NCT01345539,44,"null"
NCT01333046,44,"null"
NCT01288235,100,"null"
NCT01265030,15,"null"
NCT01230866,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT01158651,23,"null"
NCT00999401,90,"null"
NCT00881920,54,"null"
NCT00859781,140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT00781612,720,"null"
NCT00716066,40,"null"
NCT00670358,144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT00368082,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT00358657,20,"null"
NCT03542877,44,"null"
NCT03537690,36,"null"
NCT03525678,155,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Hepatitis B Surface Antigen","name":"HBsAg","synonyms":["Hepatitis B Surface Antigen"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C62786","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Hepatitis B Virus Core Antibody","name":"HBcAb","synonyms":["Hepatitis B Core Antibody"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C62797","eligibility_criterion":"exclusion"}]"
NCT03521570,51,"null"
NCT03519178,220,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03517488,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03512756,115,"null"
NCT03502733,50,"null"
NCT03495323,28,"null"
NCT03485729,30,"null"
NCT03485209,200,"null"
NCT03483324,9,"null"
NCT03483012,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03459222,230,"null"
NCT03455764,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT03446040,260,"null"
NCT03435250,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MTAP Loss","name":"MTAP Loss","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Negative","name":"CDKN2A Negative","synonyms":["CDKN2A Loss","Cyclin-Dependent Kinase 4 Inhibitor A Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131787","eligibility_criterion":"inclusion"}]"
NCT03434678,366,"null"
NCT03429803,120,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating NRAS Mutation","name":"Activating NRAS Mutation","synonyms":["NRAS Proto-Oncogene, GTPase Activating Mutation","NRAS Activating Mutation","NRAS1 Activating Mutation","Neuroblastoma RAS Viral Oncogene Homolog Activating Mutation","N-RAS Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139796","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"MEK Family Gene Mutation","name":"MEK Family Gene Mutation","synonyms":["MEK Family Mutation","Mitogen-Activated Protein Kinase Kinase Family Gene Mutation","MAP2K Family Gene Mutation","MAPKK Family Gene Mutation","MEK Mutation","Mutant MEK","Mutant MEK Family Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136422","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"ERK Family Gene Mutation","name":"ERK Family Gene Mutation","synonyms":["MAP Kinase Family Gene Mutation","ERK Family Mutation","Mitogen-Activated Protein Kinase Family Gene Mutation","ERK Mutation","Mutant ERK","Extracellular Signal-Regulated Kinase Family Gene Mutation","MAPK Family Gene Mutation","Mutant ERK Family Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136423","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Activating Mutation","name":"Activating KRAS Mutation","synonyms":["KRAS-2 Activating Mutation","KRAS Activating Mutation","c-K-ras Activating Mutation","KRAS2 Activating Mutation","KRAS Proto-Oncogene, GTPase Activating Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118391","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating RAS Mutation","name":"Activating RAS Mutation","synonyms":["Activating RAS Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128901","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality KIAA1549/BRAF Fusion Gene","name":"KIAA1549-BRAF Fusion mutation","synonyms":["KIAA1549/BRAF Fusion","C45576:C99843"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99844:C99843","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Activating RAF Mutation","name":"Activating RAF Mutation","synonyms":["RAF Family Activating Gene Mutation","Activating RAF Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134499","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"RAF Family Gene Mutation","name":"RAF Family Gene Mutation","synonyms":["RAF Family Mutation","RAF Mutation","Mutant RAF Family Gene","Mutant RAF"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136425","eligibility_criterion":"inclusion"}]"
NCT03425643,786,"null"
NCT03425331,80,"null"
NCT03417739,25,"null"
NCT03417544,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03414658,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03414047,180,"null"
NCT03412565,180,"null"
NCT03408587,10,"null"
NCT03407170,60,"null"
NCT03402607,90,"null"
NCT03395080,94,"null"
NCT03393000,264,"null"
NCT03392246,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"}]"
NCT03391362,111,"null"
NCT03379584,75,"null"
NCT03377361,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF NP_004324.2:p.V600X","name":"BRAF NP_004324.2:p.V600X","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03367819,134,"null"
NCT03364049,40,"null"
NCT03362723,50,"null"
NCT03362060,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03360006,80,"null"
NCT03355066,42,"null"
NCT03347123,141,"null"
NCT03345485,158,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03341936,58,"null"
NCT03340883,41,"null"
NCT03339297,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03334617,200,"null"
NCT03332017,210,"null"
NCT03329937,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03325816,64,"null"
NCT03321643,30,"null"
NCT03319628,120,"null"
NCT03316573,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03313778,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation Negative","name":"ALK Gene Translocation Negative","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation Negative","Anaplastic Lymphoma Kinase Gene Translocation Negative","CD246 Gene Translocation Negative","ALK Translocation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT03310879,38,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Mutation","name":"CCND1 Gene Mutation","synonyms":["BCL1 Gene Mutation","PRAD1 Gene Mutation","Cyclin D1 Gene Mutation","BCL-1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142846","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND2 Gene Amplification","name":"CCND2 Gene Amplification","synonyms":["Cyclin D2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131785","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK4 Gene Amplification","name":"CDK4 Gene Amplification","synonyms":["Cell Division Kinase 4 Gene Amplification","Cyclin Dependent Kinase 4 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131786","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND1 Splice Variant Positive","name":"CCND1 Splice Variant Positive","synonyms":["BCL1 Splice Variant Positive","CCND1 Splice Variant","Cyclin D1 Splice Variant Positive","BCL-1 Splice Variant Positive","Cyclin-D1 Splice Variant Positive","PRAD1 Splice Variant Positive","CCND1 Splice Variant Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150464","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND3 Gene Amplification","name":"CCND3 Gene Amplification","synonyms":["Cyclin D3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131784","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK6 Gene Amplification","name":"CDK6 Gene Amplification","synonyms":["Cyclin-Dependent Kinase 6 Gene Amplification","Cyclin Dependent Kinase 6 Gene Amplification","PLSTIRE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132897","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Amplification","name":"CCND1 Gene Amplification","synonyms":["Cyclin D1 Gene Activation","BCL1 Gene Amplification","PRAD1 Gene Amplification","BCL-1 Gene Amplification","Cyclin D1 Gene Amplification","CCND1 Gene Activation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36652","eligibility_criterion":"inclusion"}]"
NCT03302234,548,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03301636,624,"null"
NCT03301350,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03300557,40,"null"
NCT03298984,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"}]"
NCT03291054,23,"null"
NCT03283202,82,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03282344,100,"null"
NCT03281954,1520,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03278626,56,"null"
NCT03277469,100,"null"
NCT03271047,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03269994,890,"null"
NCT03268954,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Peripheral Blood White Cells","name":"Blasts 20-30 Percent of Peripheral Blood White Cells","synonyms":["Blasts Between 20 and 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150452","eligibility_criterion":"inclusion"}]"
NCT03264066,250,"null"
NCT03260322,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03258398,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03255096,94,"null"
NCT03255070,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03250676,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03249792,135,"null"
NCT03241940,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03238365,50,"null"
NCT03236792,30,"null"
NCT03236428,40,"null"
NCT03226249,30,"null"
NCT03225716,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYD88 Gene Mutation","name":"MYD88 Gene Mutation","synonyms":["Myeloid Differentiation Primary Response 88 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128175","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CXCR4 Gene Mutation","name":"CXCR4 Gene Mutation","synonyms":["CD184 Gene Mutation","Chemokine (C-X-C Motif) Receptor 4 Gene Mutation","C-X-C Chemokine Receptor Type 4 Gene Mutation","CXCR-4 Gene Mutation","CXC-R4 Gene Mutation","LAP3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150493","eligibility_criterion":"inclusion"}]"
NCT03215030,69,"null"
NCT03199963,330,"null"
NCT03199586,60,"null"
NCT03198234,30,"null"
NCT03197935,204,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03197012,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT03194932,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03194685,99,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"}]"
NCT03187262,30,"null"
NCT03179449,10,"null"
NCT03173560,20,"null"
NCT03170206,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT03167359,86,"null"
NCT03162536,120,"null"
NCT03159117,40,"null"
NCT03152526,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 30 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 30 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141297","eligibility_criterion":"inclusion"}]"
NCT03152318,108,"null"
NCT03150810,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03145181,60,"null"
NCT03143270,28,"null"
NCT03143153,939,"null"
NCT03141034,40,"null"
NCT03138538,21,"null"
NCT03137758,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03134638,117,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03132584,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Positive","name":"Myc Positive","synonyms":["c-MYC Positive","Myc Proto-Oncogene Positive","Proto-Oncogene c-Myc Positive","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131061","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Positive","name":"BCL2 Positive","synonyms":["B-Cell Leukemia/Lymphoma 2 Positive","Apoptosis Regulator Bcl-2 Positive","BCL-2 Positive","B-Cell CLL/Lymphoma 2 Positive","BCL2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134463","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD52 Positive","name":"CD52 Positive","synonyms":["CD52-Positive","CD52 Antigen Positive","CDw52 Positive","CAMPATH-1 Antigen Positive","CD52 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153221","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT03125239,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"}]"
NCT03119428,30,"null"
NCT03114527,48,"null"
NCT03113500,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03110107,452,"null"
NCT03109158,80,"null"
NCT03101566,64,"null"
NCT03101254,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT03099564,30,"null"
NCT03099109,172,"null"
NCT03093350,22,"null"
NCT03093272,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03091478,18,"null"
NCT03090412,114,"null"
NCT03087903,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03087019,44,"null"
NCT03086993,295,"null"
NCT03085719,26,"null"
NCT03081910,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT03076203,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03075878,16,"null"
NCT03075527,40,"null"
NCT03075072,196,"null"
NCT03074006,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142113","eligibility_criterion":"inclusion"}]"
NCT03070301,41,"null"
NCT03069937,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"exclusion"}]"
NCT03069469,55,"null"
NCT03063762,270,"null"
NCT03059823,207,"null"
NCT03058289,60,"null"
NCT03057145,24,"null"
NCT03055286,45,"null"
NCT03054038,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT03052608,280,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT03051672,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03044613,32,"null"
NCT03041701,24,"null"
NCT03034135,20,"null"
NCT03030417,38,"null"
NCT03026517,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT03018405,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03013218,142,"null"
NCT03012477,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03010176,97,"null"
NCT03008187,86,"null"
NCT03007979,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03003468,36,"null"
NCT03001882,250,"null"
NCT02999477,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02996825,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02994953,185,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK wt Allele","name":"ALK wt Allele","synonyms":["CD246","Anaplastic Lymphoma Receptor Tyrosine Kinase wt Allele","Anaplastic Lymphoma Kinase (Ki-1) wt Allele","NBLST3"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51738","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"}]"
NCT02992483,67,"null"
NCT02989064,22,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-B*46:01 Positive","name":"HLA-B*46:01 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-B*15:01 Positive","name":"HLA-B*15:01 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"exclusion"}]"
NCT02981108,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02978859,31,"null"
NCT02973789,534,"null"
NCT02973113,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02963831,78,"null"
NCT02956382,41,"null"
NCT02955394,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02954523,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"}]"
NCT02951156,304,"null"
NCT02946996,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02944578,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus Negative","name":"HIV Negative","synonyms":["Human Immunodeficiency Virus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137693","eligibility_criterion":"inclusion"}]"
NCT02943317,98,"null"
NCT02937675,96,"null"
NCT02936752,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 21-30 Percent of Bone Marrow Nucleated Cells","name":"Blasts 21-30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136627","eligibility_criterion":"inclusion"}]"
NCT02936102,212,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02935361,51,"null"
NCT02928029,112,"null"
NCT02925000,51,"null"
NCT02924038,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02920996,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Exon 14 Mutation","name":"MET Exon 14 Mutation","synonyms":["HGFR Exon 14 Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Mutation","c-Met Exon 14 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C127129","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Rearrangement","name":"NTRK1 Gene Rearrangement","synonyms":["TRK1 Gene Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Rearrangement","MTC Gene Rearrangement","TRKA Gene Rearrangement","Neurotrophic Receptor Tyrosine Kinase 1 Gene Rearrangement","Trk-A Gene Rearrangement","TRK Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Gene Rearrangement","name":"NTRK2 Gene Rearrangement","synonyms":["TRKB Tyrosine Kinase Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 2 Gene Rearrangement","Tropomyosin-Related Kinase B Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor Type 2 Gene Rearrangement","NTRK2 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131321","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Gene Rearrangement","name":"NTRK3 Gene Rearrangement","synonyms":["Neurotrophic Tyrosine Kinase Receptor Type 3 Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 3 Gene Rearrangement","NTRK3 Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 3 Gene Rearrangement","TRKC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131325","eligibility_criterion":"inclusion"}]"
NCT02919683,40,"null"
NCT02917629,39,"null"
NCT02917083,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02916771,41,"null"
NCT02916745,20,"null"
NCT02910063,332,"null"
NCT02908906,229,"null"
NCT02908477,214,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02892123,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK wt Allele","name":"ALK wt Allele","synonyms":["CD246","Anaplastic Lymphoma Receptor Tyrosine Kinase wt Allele","Anaplastic Lymphoma Kinase (Ki-1) wt Allele","NBLST3"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51738","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Fusion Negative","name":"ROS1 Fusion Negative","synonyms":["c-Ros-1 Fusion Negative","Proto-Oncogene c-Ros Fusion Negative","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Negative","MCF3 Fusion Negative","Receptor Tyrosine Kinase c-Ros Oncogene 1 Fusion Negative","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Negative","Proto-Oncogene c-Ros-1 Fusion Negative","ROS Fusion Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142839","eligibility_criterion":"inclusion"}]"
NCT02891278,50,"null"
NCT02885974,15,"null"
NCT02876224,51,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"exclusion"}]"
NCT02875548,300,"null"
NCT02874014,56,"null"
NCT02873975,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51D Gene Mutation","name":"RAD51D Gene Mutation","synonyms":["R51H3 Gene Mutation","RAD51L3 Gene Mutation","BROVCA4 Gene Mutation","TRAD Gene Mutation","RAD51-Like 3 Gene Mutation","RAD51 Homolog D Gene Mutation","RAD51 Paralog D Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131481","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK2 Gene Mutation","name":"CHEK2 Gene Mutation","synonyms":["LFS2 Gene Mutation","CHK2 Gene Mutation","CHK2 Checkpoint Homolog (S. pombe) Gene Mutation","CDS1 Gene Mutation","Checkpoint Kinase 2 Gene Mutation","hCds1 Gene Mutation","RAD53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51C Gene Mutation","name":"RAD51C Gene Mutation","synonyms":["RAD51L2 Gene Mutation","FANCO Gene Mutation","RAD51 Paralog C Gene Mutation","BROVCA3 Gene Mutation","RAD51 Homolog C Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131480","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FBXW7 Gene Mutation","name":"FBXW7 Gene Mutation","synonyms":["FBX30 Gene Mutation","FBW7 Gene Mutation","F-Box and WD Repeat Domain Containing 7 Gene Mutation","F-box and WD-40 Domain Protein 7 (Archipelago Homolog, Drosophila) Gene Mutation","CDC4 Gene Mutation","FBXW6 Gene Mutation","SEL10 Gene Mutation","Archipelago Homolog Gene Mutation","FBW6 Gene Mutation","SEL-10 Gene Mutation","AGO Gene Mutation","Archipelago Homolog, Drosophila Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131484","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATR Gene Mutation","name":"ATR Gene Mutation","synonyms":["FRP1 Gene Mutation","ATR Serine/Threonine Kinase Gene Mutation","Ataxia Telangiectasia and Rad3 Related Gene Mutation","MEC1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131479","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Negative","name":"RB1 Negative","synonyms":["Rb Loss","Retinoblastoma Negative","RB1 Loss","Retinoblastoma 1 Negative","RB Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131482","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCNE1 Gene Amplification","name":"CCNE1 Gene Amplification","synonyms":["Cyclin E1 Gene Amplification","CCNE1 Amplification","CCNE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36682","eligibility_criterion":"inclusion"}]"
NCT02871843,39,"null"
NCT02863991,42,"null"
NCT02862275,40,"null"
NCT02859857,40,"null"
NCT02858869,30,"null"
NCT02857270,252,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating RAS Mutation","name":"Activating RAS Mutation","synonyms":["Activating RAS Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128901","eligibility_criterion":"inclusion"}]"
NCT02853500,10,"null"
NCT02847559,27,"null"
NCT02843945,80,"null"
NCT02843568,120,"null"
NCT02841995,48,"null"
NCT02837042,35,"null"
NCT02829918,52,"null"
NCT02829723,151,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02824029,35,"null"
NCT02823405,15,"null"
NCT02818023,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT02807272,20,"null"
NCT02801097,24,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Homozygosity UGT1A1*28 Allele","name":"UGT1A1 *28*/*28","synonyms":["Homozygous UGT1A1*28"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45826:C72564","eligibility_criterion":"exclusion"}]"
NCT02788981,64,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NR3C1 Positive","name":"NR3C1 Positive","synonyms":["GRL Positive","Glucocorticoid Receptor Positive","GCR Positive","Nuclear Receptor Subfamily 3 Group C Member 1 Positive","GR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132237","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02786719,13,"null"
NCT02785250,40,"null"
NCT02783690,82,"null"
NCT02776813,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT02775435,635,"null"
NCT02773238,50,"null"
NCT02769520,45,"null"
NCT02768792,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146669","eligibility_criterion":"inclusion"}]"
NCT02765854,90,"null"
NCT02763579,500,"null"
NCT02763384,20,"null"
NCT02763319,330,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02763254,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02762981,146,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02762266,160,"null"
NCT02762006,54,"null"
NCT02759575,47,"null"
NCT02754141,221,"null"
NCT02750215,20,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Exon 14 Skipping Mutation","name":"MET Exon 14 Skipping Mutation","synonyms":["Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Alteration","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Mutation","c-Met Exon 14 Skipping Mutation","HGFR Exon 14 Skipping Mutation","Loss of MET Exon 14","Deletion of MET Exon 14","Loss of c-MET Exon 14","c-Met Exon 14 Skipping Alteration","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Alteration","Deletion of c-MET Exon 14","MET Exon 14 Skipping Alteration","HGFR Exon 14 Skipping Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131179","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"exclusion"}]"
NCT02740985,206,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT02731729,70,"null"
NCT02714374,36,"null"
NCT02713373,42,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"exclusion"}]"
NCT02711345,125,"null"
NCT02708680,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02703714,42,"null"
NCT02703272,96,"null"
NCT02700724,100,"null"
NCT02697734,69,"null"
NCT02694822,48,"null"
NCT02693990,60,"null"
NCT02680535,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Fifteen","name":"PSA Level Less Than Fifteen","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137699","eligibility_criterion":"inclusion"}]"
NCT02678741,45,"null"
NCT02674750,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT02670707,125,"null"
NCT02668666,71,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02667873,50,"null"
NCT02664181,60,"null"
NCT02654990,240,"null"
NCT02650804,25,"null"
NCT02649790,103,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells","name":"Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36229","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 5-19 Percent of Peripheral Blood White Cells","name":"Myeloblasts 5-19 Percent of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02641236,28,"null"
NCT02641093,80,"null"
NCT02635061,41,"null"
NCT02632721,170,"null"
NCT02632396,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT02632344,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02630043,21,"null"
NCT02629692,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02624986,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02620839,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02614859,66,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Thirty","name":"PSA Level Less Than 30","synonyms":["PSA Level Less than Thirty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142128","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02611024,100,"null"
NCT02607813,212,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAPK Gene Alteration Positive","name":"MAPK Gene Alteration Positive","synonyms":["ERK Family Gene Alteration Positive","Extracellular Signal-Regulated Kinase Family Gene Alteration Positive","ERK Alteration Positive","Mitogen-Activated Protein Kinase Family Gene Alteration Positive","MAPK Family Gene Alteration Positive","ERK Family Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142130","eligibility_criterion":"inclusion"}]"
NCT02599454,33,"null"
NCT02588105,225,"null"
NCT02587962,135,"null"
NCT02579967,224,"null"
NCT02576301,105,"null"
NCT02573493,80,"null"
NCT02549833,20,"null"
NCT02549209,46,"null"
NCT02547662,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells More than 5 Percent of Peripheral Blood White Cells","name":"Neoplastic Plasma Cells More than 5 Percent of Peripheral Blood White Cells","synonyms":["Neoplastic Plasma Cells Greater than 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142111","eligibility_criterion":"inclusion"}]"
NCT02546531,50,"null"
NCT02546284,18,"null"
NCT02542202,25,"null"
NCT02541903,29,"null"
NCT02540876,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Mutation","name":"CDKN2A Gene Mutation","synonyms":["p16-INK4A Gene Mutation","p14ARF Gene Mutation","p16INK4a Gene Mutation","CDK4I Gene Mutation","p16INK4 Gene Mutation","p16 Gene Mutation","p19ARF Gene Mutation","Cyclin-Dependent Kinase Inhibitor 2A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128817","eligibility_criterion":"inclusion"}]"
NCT02534675,1150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02523040,12,"null"
NCT02521844,75,"null"
NCT02520427,50,"null"
NCT02514525,150,"null"
NCT02514031,20,"null"
NCT02511795,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02511106,700,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02506114,75,"null"
NCT02504359,35,"null"
NCT02494167,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02489903,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Resistant Mutation","name":"EGFR Tyrosine Kinase Inhibitor Resistant Mutation","synonyms":["EGFR-TKI Resistant Mutation","EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96862","eligibility_criterion":"inclusion"}]"
NCT02488408,75,"null"
NCT02477878,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02475707,28,"null"
NCT02474368,56,"null"
NCT02470897,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT02466009,60,"null"
NCT02463799,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02459119,35,"null"
NCT02452983,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"}]"
NCT02451553,48,"null"
NCT02451423,60,"null"
NCT02433626,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02423863,100,"null"
NCT02423057,46,"null"
NCT02419417,150,"null"
NCT02407405,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"}]"
NCT02406651,27,"null"
NCT02402036,40,"null"
NCT02400658,290,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"}]"
NCT02394548,25,"null"
NCT02393625,86,"null"
NCT02375958,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDH3 Positive","name":"CDH3 Positive","synonyms":["Cadherin-3 Positive","Placental Cadherin Positive","Cadherin 3 Positive","CADP Positive","Cadherin, Placental Positive","P-Cadherin Positive","PCAD Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133703","eligibility_criterion":"inclusion"}]"
NCT02372006,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ErbB Family Pathway Deregulation","name":"ErbB Family Pathway Deregulation","synonyms":["EGFR Family Pathway Deregulation","ErbB Pathway Deregulation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138058","eligibility_criterion":"inclusion"}]"
NCT02367196,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02364713,134,"null"
NCT02362451,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02361346,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT02359994,324,"null"
NCT02359929,24,"null"
NCT02359565,110,"null"
NCT02354534,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02350673,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Carcinoembryonic Antigen Positive","name":"Carcinoembryonic Antigen Positive","synonyms":["CEA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128808","eligibility_criterion":"inclusion"}]"
NCT02343406,270,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT02336451,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02334735,31,"null"
NCT02332980,68,"null"
NCT02328014,126,"null"
NCT02320292,128,"null"
NCT02315625,120,"null"
NCT02315612,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT02312258,761,"null"
NCT02312102,28,"null"
NCT02311582,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosomes 1p/19q","name":"1p/19q Codeletion","synonyms":["Loss of Chromosomes 1p/19q","1p/19q Co-deletion","del(1p/19q)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C79099","eligibility_criterion":"inclusion"}]"
NCT02311361,60,"null"
NCT02309892,40,"null"
NCT02309580,24,"null"
NCT02303392,50,"null"
NCT02296684,77,"null"
NCT02287311,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02286167,25,"null"
NCT02264678,250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Deficient Tumor","name":"ATM Deficient Tumor","synonyms":["Ataxia Telangiectasia Mutated Deficient Tumor","A-T Mutated Deficient Tumor","AT Mutated Deficient Tumor","ATM Serine/Threonine Kinase Deficient Tumor","Serine-Protein Kinase ATM Deficient Tumor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150447","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02255461,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT02250157,70,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Homozygosity UGT1A1*28 Allele","name":"UGT1A1 *28*/*28","synonyms":["Homozygous UGT1A1*28"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45826:C72564","eligibility_criterion":"exclusion"}]"
NCT02244463,53,"null"
NCT02240238,209,"null"
NCT02239861,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SSX2 Positive","name":"SSX2 Positive","synonyms":["Cancer/Testis Antigen 5.2 Positive","Synovial Sarcoma, X Breakpoint 2 Positive","SSX2A Positive","CT5.2 Positive","Tumor Antigen HOM-MEL-40 Positive","SSX Family Member 2 Positive","SSX2B Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA4 Positive","name":"MAGEA4 Positive","synonyms":["MAGE-X2 Positive","MAGE4 Positive","MAGE4B Positive","Cancer/Testis Antigen 1.4 Positive","MAGE A4 Positive","MAGE-41 Positive","MAGE4A Positive","CT1.4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147078","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PRAME Positive","name":"PRAME Positive","synonyms":["Cancer/Testis Antigen 130 Positive","CT130 Positive","Preferentially Expressed Antigen in Melanoma Positive","MAPE Positive","Melanoma Antigen Preferentially Expressed in Tumors Positive","OIP-4 Positive","OIP4 Positive","Opa-Interacting Protein 4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Survivin Positive","name":"Survivin Positive","synonyms":["Baculoviral IAP Repeat-Containing 5 Positive","BIRC5 Positive","Survivin Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131872","eligibility_criterion":"inclusion"}]"
NCT02228772,28,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Surface Immunoglobulin Positive Cells Present","name":"Surface Immunoglobulin Positive Cells Present","synonyms":["Surface Ig Present Presence of Surface Immunoglobulin","Cells with Surface Ig","Cells with Surface Immunoglobulins Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150655","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(2;8)","name":"t(2;8)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131808","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(8;14)(q24;q32)","name":"t(8;14)(q24;q32)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36319","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(8;22)","name":"t(8;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131810","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(8;14)(q24;q11)","name":"t(8;14)(q24;q11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36347","eligibility_criterion":"inclusion"}]"
NCT02222688,78,"null"
NCT02220985,80,"null"
NCT02205762,1100,"null"
NCT02203604,82,"null"
NCT02203513,153,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02197897,19,"null"
NCT02193958,68,"null"
NCT02174549,63,"null"
NCT02166905,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTAG2 Positive","name":"CTAG2 Positive","synonyms":["LAGE1 Positive","ESO2 Positive","Cancer/Testis Antigen 2 Positive","LAGE-1 Positive","NY-ESO-2 Positive","LAGE 1 Positive","L Antigen Family Member 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138947","eligibility_criterion":"inclusion"}]"
NCT02160106,50,"null"
NCT02153229,102,"null"
NCT02143635,206,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 wt Allele","name":"TP53 wt Allele","synonyms":["Tumor Protein p53 wt Allele","Tumor Protein P53 (Li-Fraumeni Syndrome) wt Allele","TRP53","P53","LFS1","p53 wild type","BCC7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52271","eligibility_criterion":"inclusion"}]"
NCT02137759,90,"null"
NCT02133196,85,"null"
NCT02129647,17,"null"
NCT02128906,160,"null"
NCT02126579,75,"null"
NCT02122172,95,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"ERBB4 Gene Mutation","name":"ERBB4 Gene Mutation","synonyms":["HER-4 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 4 Gene Mutation","HER4 Gene Mutation","V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4 Gene Mutation","ERBB-4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138060","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"ERBB3 Gene Mutation","name":"ERBB3 Gene Mutation","synonyms":["V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER-3 Gene Mutation","c-erbB3 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 3 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER3 Gene Mutation","c-erbB-3 Gene Mutation","ErbB-3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138064","eligibility_criterion":"inclusion"}]"
NCT02101944,28,"null"
NCT02098512,20,"null"
NCT02086175,25,"null"
NCT02085941,30,"null"
NCT02073968,39,"null"
NCT02073097,50,"null"
NCT02072148,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02057107,92,"null"
NCT02050347,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02041936,12,"null"
NCT02035787,32,"null"
NCT02031250,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Negative","name":"Epstein-Barr Virus Negative","synonyms":["HHV4 Negative","Human Herpesvirus 4 Negative","Human Herpesvirus-4 Negative","Epstein Barr Virus Negative","HHV-4 Negative","EBV Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141321","eligibility_criterion":"inclusion"}]"
NCT02028455,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02019693,22,"null"
NCT02009332,40,"null"
NCT01995708,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEC1 Positive","name":"MAGEC1 Positive","synonyms":["Cancer/Testis Antigen 7.1 Positive","CT7.1 Positive","Melanoma-Associated Antigen C1 Positive","MAGE-C1 Positive","CT7 Positive","Melanoma Antigen Family C1 Positive","MAGE Family Member C1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA3 Positive","name":"MAGEA3 Positive","synonyms":["Melanoma-Associated Antigen 3 Positive","HYPD Positive","MAGE-3 Positive","HIP8 Positive","MAGE3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135575","eligibility_criterion":"inclusion"}]"
NCT01993719,64,"null"
NCT01990209,86,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT01987830,17,"null"
NCT01986348,110,"null"
NCT01976741,224,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR Gene Mutation","name":"FGFR Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor Family Gene Mutation","FGFR Mutation","FGF Receptor Gene Mutation","FGFR Family Mutation","FGF Receptor Gene Family Mutation","Fibroblast Growth Factor Receptor Gene Mutation","FGFR Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146713","eligibility_criterion":"inclusion"}]"
NCT01962896,30,"null"
NCT01953900,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT01947140,90,"null"
NCT01943851,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Overexpression","name":"BCL2 Overexpression","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Protein Overexpression","name":"MYC Overexpression","synonyms":["Myc Proto-Oncogene Protein Overexpression","MYC Protein Overexpression","MYC Transcription Factor Protein Overexpression","bHLHe39 Protein Overexpression","Proto-Oncogene c-Myc Protein Overexpression","Class E Basic Helix-Loop-Helix Protein 39 Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133692","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Overexpression Positive","name":"BCL6 Overexpression Positive","synonyms":["LAZ3 Overexpression Positive","BCL5 Overexpression Positive","LAZ-3 Overexpression Positive","BCL6 Overexpression","B-Cell Lymphoma 6 Overexpression Positive","B-Cell CLL/Lymphoma 6 Overexpression Positive","ZNF51 Overexpression Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150450","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"}]"
NCT01918683,40,"null"
NCT01902225,24,"null"
NCT01894061,40,"null"
NCT01871766,100,"null"
NCT01864018,51,"null"
NCT01857271,55,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT01851369,140,"null"
NCT01845805,60,"null"
NCT01841333,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT01833208,15,"null"
NCT01818479,12,"null"
NCT01814501,25,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"}]"
NCT01804465,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01794520,186,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"}]"
NCT01772420,60,"null"
NCT01770418,61,"null"
NCT01759771,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal Ten","name":"PSA Level Ten or Less","synonyms":["PSA Level Less than or Equal 10","PSA Level 10 or Less","PSA Level Less than or Equal Ten"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138945","eligibility_criterion":"inclusion"}]"
NCT01758445,220,"null"
NCT01748825,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT01732107,50,"null"
NCT01730118,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01716806,100,"null"
NCT01715909,20,"null"
NCT01712659,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HTLV-1 Antibody Positive","name":"HTLV-1 Antibody Positive","synonyms":["Anti-Human T-Cell Lymphotropic Virus 1 Antibody Positive","Human T-Lymphotropic Virus 1 Antibody Positive","Anti-Human T-Lymphotropic Virus 1 Antibody Positive","Anti-HTLV-I Antibody Positive","HTLV-I Antibody Positive","Human T-Cell Lymphotropic Virus 1 Antibody Positive","Anti-HTLV-1 Antibody Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141313","eligibility_criterion":"inclusion"}]"
NCT01700946,40,"null"
NCT01697293,56,"null"
NCT01684397,66,"null"
NCT01661400,13,"null"
NCT01655225,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01644253,123,"null"
NCT01642342,94,"null"
NCT01639131,40,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"CHFR Gene Methylation Index","name":"CHFR Methylation Index","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128659","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"}]"
NCT01586403,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Tyrosinase Positive","name":"TYR Positive","synonyms":["Tyrosinase Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128846","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01583686,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT01572480,53,"null"
NCT01562626,75,"null"
NCT01550367,39,"null"
NCT01525966,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01506973,124,"null"
NCT01492972,192,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT01489813,44,"null"
NCT01471106,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01463423,260,"null"
NCT01417546,83,"null"
NCT01408160,18,"null"
NCT01325207,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01188096,24,"null"
NCT01174121,332,"null"
NCT01130519,85,"null"
NCT01066663,26,"null"
NCT00975520,100,"null"
NCT00924027,112,"null"
NCT00923013,177,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD11c Positive","name":"ITGAX Positive","synonyms":["Axb2 Positive","CD11c Antigen Positive","p150 95 Integrin Alpha Chain Positive","Leukocyte Adhesion Glycoprotein P150,95, Alpha Chain Positive","Integrin Alpha X Positive","Leukocyte Surface Antigen P150, 95 Positive","Integrin Alpha-X Positive","Leu M5 Positive","CD11 Antigen-Like Family Member C Positive","Antigen Cd11c (P150), Alpha Polypeptide Positive","Leukocyte Adhesion Receptor P150,95 Positive","Cr4 Positive","ITGAX Positive","Alphax Integrin Chain Positive","Myeloid Membrane Antigen, Alpha Subunit Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133812","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT00919503,120,"null"
NCT00719888,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 13 Abnormality","name":"Chromosome 13 Abnormality","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141237","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Beta-2-Microglobulin Greater than 3 g/mL","name":"Beta-2-Microglobulin Greater than 3 g/mL","synonyms":["Beta-2 Microglobulin Greater than 3 g/mL","Beta-2-Microglobulin Greater than Three g/mL","Beta-2 Microglobulin Greater than Three g/mL","B2M Greater than 3 g/mL","B2M Greater than Three g/mL"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141234","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT00613626,74,"null"
NCT00592592,80,"null"
NCT00267865,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT00092222,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"}]"
NCT03600701,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03587311,96,"null"
NCT03586024,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03583086,140,"null"
NCT03579472,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03574571,738,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03573700,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03573544,58,"null"
NCT03570827,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Two","name":"PSA Level Less Than Two","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136415","eligibility_criterion":"inclusion"}]"
NCT03566485,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03566199,24,"null"
NCT03565406,24,"null"
NCT03558750,48,"null"
NCT03556228,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Amplification","name":"NTRK1 Gene Amplification","synonyms":["Trk-A Gene Amplification","TRK Amplification","TRK1 Gene Amplification","p140-TrkA Gene Amplification","NTRK1 Amplification","TRK Gene Amplification","Neurotrophic Receptor Tyrosine Kinase 1 Gene Amplification","TRKA Gene Amplification","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Amplification","MTC Gene Amplification","TRKA Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153062","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Translocation","name":"NTRK1 Gene Translocation","synonyms":["TRKA Gene Translocation","TRK1 Gene Translocation","Trk-A Gene Translocation","Neurotrophic Receptor Tyrosine Kinase 1 Gene Translocation","TRK Translocation","p140-TrkA Gene Translocation","TRK Gene Translocation","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Translocation","TRKA Translocation","MTC Gene Translocation","NTRK1 Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153061","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Mutation","name":"NTRK1 Gene Mutation","synonyms":["Neurotrophic Receptor Tyrosine Kinase 1 Gene Mutation","TRK Mutation","Trk-A Gene Mutation","TRK Gene Mutation","p140-TrkA Gene Mutation","NTRK1 Mutation","TRKA Mutation","TRK1 Gene Mutation","TRKA Gene Mutation","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Mutation","MTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153059","eligibility_criterion":"inclusion"}]"
NCT03554473,53,"null"
NCT03548961,19,"null"
NCT03547115,63,"null"
NCT03544125,8,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03543969,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT03538613,60,"null"
NCT03531840,40,"null"
NCT03531827,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03531736,15,"null"
NCT03530683,156,"null"
NCT03529422,24,"null"
NCT03525795,134,"null"
NCT03524170,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03522584,20,"null"
NCT03519997,34,"null"
NCT03519984,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Peripheral Blood White Cells","name":"Blasts 10 Percent or More of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138056","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 30,000 or Less of Peripheral Blood White Cells","name":"Blasts 30,000 or Less of Peripheral Blood White Cells","synonyms":["Absolute Blasts 30,000 or Less of Peripheral Blood White Cells","Absolute Blasts in Peripheral Blood Less Than or Equal to 30000","Absolute Blasts in Peripheral Blood Less Than or Equal to 30,000","Absolute Blasts 30000 or Less of Peripheral Blood White Cells","Blasts 30000 or Less of Peripheral Blood White Cells","Blasts Less than or Equal to 30000 in Peripheral Blood White Cells","Blasts Less than or Equal to 30,000 in Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153117","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT03519256,436,"null"
NCT03518112,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"}]"
NCT03516591,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Peripheral Blood White Cells","name":"Blasts Under 20 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36220","eligibility_criterion":"inclusion"}]"
NCT03515512,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT03515200,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03514407,21,"null"
NCT03514069,36,"null"
NCT03511196,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Decline Greater Than 75 Percent","name":"PSA Decline Greater Than 75 Percent","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03510104,45,"null"
NCT03508752,80,"null"
NCT03506802,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT03506360,41,"null"
NCT03505320,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CLDN18.2 Positive","name":"CLDN18.2 Positive","synonyms":["Claudin 18 Isoform A2 Positive","Claudin-18 Isoform A2 Positive","Claudin 18.2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153150","eligibility_criterion":"inclusion"}]"
NCT03502785,85,"null"
NCT03502577,18,"null"
NCT03501381,46,"null"
NCT03501368,27,"null"
NCT03498612,33,"null"
NCT03494569,36,"null"
NCT03493945,113,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03492138,42,"null"
NCT03492125,47,"null"
NCT03490292,24,"null"
NCT03489525,129,"null"
NCT03489369,30,"null"
NCT03488667,40,"null"
NCT03488472,20,"null"
NCT03488225,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"}]"
NCT03483675,40,"null"
NCT03483103,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"}]"
NCT03482791,40,"null"
NCT03482102,70,"null"
NCT03481816,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03481556,80,"null"
NCT03480360,20,"null"
NCT03480152,64,"null"
NCT03477539,50,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03477110,30,"null"
NCT03473756,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Positive","name":"FGFR1 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03472885,12,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"C5 Gene Mutation","name":"C5 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03472586,35,"null"
NCT03472573,24,"null"
NCT03471767,66,"null"
NCT03471351,57,"null"
NCT03471260,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT03470922,700,"null"
NCT03468075,29,"null"
NCT03467867,25,"null"
NCT03467386,24,"null"
NCT03466294,42,"null"
NCT03465774,208,"null"
NCT03463460,40,"null"
NCT03463161,30,"null"
NCT03460067,78,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03459040,30,"null"
NCT03458546,10,"null"
NCT03457948,32,"null"
NCT03457142,19,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD28 Positive","name":"CD28 Positive","synonyms":["T-Cell Specific Surface Glycoprotein CD28 Positive","T-Cell Antigen CD28 Positive","T44 Positive","Antigen CD28 Positive","CD28 Molecule Positive","CD28 Antigen Positive","T90/44 Positive","Tp44 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD86 Positive","name":"CD86 Positive","synonyms":["LAB7-2 Positive","CD28LG2 Positive","B-Lymphocyte Activation Antigen B7-2 Positive","Antigen CD86 Positive","CD86 Antigen Positive","FUN-1 Positive","Activation B7-2 Antigen Positive","CTLA-4 Counter-Receptor B7.2 Positive","B7.2 Positive","LAB72 Positive","CD86 Molecule Positive","B-Lymphocyte Antigen B7-2 Positive","T-Lymphocyte Activation Antigen CD86 Positive","B7-2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150472","eligibility_criterion":"inclusion"}]"
NCT03456843,190,"null"
NCT03456804,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03456700,48,"null"
NCT03454529,50,"null"
NCT03454165,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03453489,6,"null"
NCT03452579,90,"null"
NCT03451773,41,"null"
NCT03451331,44,"null"
NCT03449901,75,"null"
NCT03449108,80,"null"
NCT03448718,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Damage Response Deficiency","name":"DNA Damage Response Deficiency","synonyms":["Deficient DNA Damage Response","DNA Damage Response and Repair Deficiency","DDRD","DNA Damage Repair Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123152","eligibility_criterion":"inclusion"}]"
NCT03448393,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT03448042,449,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03447808,31,"null"
NCT03446417,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"}]"
NCT03444753,90,"null"
NCT03444714,18,"null"
NCT03441555,44,"null"
NCT03441178,100,"null"
NCT03441061,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03440567,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03439891,40,"null"
NCT03438708,50,"null"
NCT03438318,70,"null"
NCT03437941,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03436732,40,"null"
NCT03436654,76,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03436563,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT03434769,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03434730,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT03434418,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NM_005228.3:c.2303G>T EGFR NP_005219.2:p.S768I","name":"EGFR S768I","synonyms":["ERBB c.2303G>T","EGFR Ser768Ile","EGFR p.Ser768Ile","ERBB1 c.2303G>T","EGFR NP_005219.2:p.Ser768Ile","Proto-Oncogene c-ErbB-1 S768I","Epidermal Growth Factor Receptor S768I","EGFR p.S768I","Epidermal Growth Factor Receptor Gene c.2303G>T","EGFR NM_005228.3:c.2303G>T","NP_005219.2:p.Ser768Ile","HER1 c.2303G>T","EGFR NP_005219.2:p.S768I","Receptor Tyrosine-Protein Kinase erbB-1 S768I","NM_005228.3:c.2303G>T","EGFR c.2303G>T"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125209:C125210","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"}]"
NCT03434262,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTCH1 Gene Mutation","name":"PTCH1 Gene Mutation","synonyms":["PTCH Gene Mutation","PTC Gene Mutation","Patched Homolog (Drosophila) Gene Mutation","Patched Homolog 1 Gene Mutation","PTC1 Gene Mutation","Patched 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133669","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 9q","name":"Loss of Chromosome 9q","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03433781,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts Under 20 Percent of Peripheral Blood White Cells","name":"Myeloblasts Under 20 Percent of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TET2 Gene Mutation","name":"TET2 Gene Mutation","synonyms":["Tet Oncogene Family Member 2 Gene Mutation","KIAA1546 Gene Mutation","Tet Methylcytosine Dioxygenase 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148283","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03433469,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT03431948,60,"null"
NCT03430882,50,"null"
NCT03430518,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03428984,24,"null"
NCT03428802,40,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"POLE Gene Mutation","name":"POLE Gene Mutation","synonyms":["POLE1 Exonuclease Gene Mutation","DNA Polymerase Epsilon, Catalytic Subunit Exonuclease Gene Mutation","DNA Polymerase Epsilon Catalytic Subunit A Exonuclease Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131797","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"POLD1 Gene Mutation","name":"POLD1 Gene Mutation","synonyms":["Polymerase (DNA Directed), Delta 1, Catalytic Subunit (125kD) Gene Mutation","CRCS10 Gene Mutation","POLD Gene Mutation","MDPL Gene Mutation","CDC2 Homolog (S. cerevisiae) Gene Mutation","DNA Polymerase Delta 1, Catalytic Subunit Gene Mutation","Polymerase (DNA) Delta 1, Catalytic Subunit Gene Mutation","Polymerase (DNA Directed), Delta 1, Catalytic Subunit Gene Mutation","CDC2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131798","eligibility_criterion":"inclusion"}]"
NCT03428126,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03427866,54,"null"
NCT03427411,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03426969,12,"null"
NCT03426891,32,"null"
NCT03426605,48,"null"
NCT03425526,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Adenovirus Positive","name":"Adenovirus Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141278","eligibility_criterion":"inclusion"}]"
NCT03425461,60,"null"
NCT03425279,120,"null"
NCT03424850,30,"null"
NCT03424603,220,"null"
NCT03424005,260,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03422536,74,"null"
NCT03422393,24,"null"
NCT03422302,30,"null"
NCT03422198,108,"null"
NCT03421782,123,"null"
NCT03421353,213,"null"
NCT03420521,64,"null"
NCT03420183,156,"null"
NCT03419559,24,"null"
NCT03418532,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT03416530,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"H3 K27M Mutation","name":"Histone 3 K27M Mutation","synonyms":["Histone H3 K28M","H3 K28M Mutation","H3 Lys28Met","H3 K27M","Histone H3 Lys27Met","H3 K28M","Histone H3 Lys28Met","H3 Lys27Met","Histone H3 K27M","H3 p.Lys28Met","H3 K27M Mutation","H3 p.K28M"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129310","eligibility_criterion":"inclusion"}]"
NCT03414229,30,"null"
NCT03414034,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03412877,210,"null"
NCT03412773,660,"null"
NCT03412396,45,"null"
NCT03411031,60,"null"
NCT03410901,15,"null"
NCT03410875,28,"null"
NCT03410043,143,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT03409432,37,"null"
NCT03407976,119,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"}]"
NCT03407144,400,"null"
NCT03406949,165,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"}]"
NCT03406715,41,"null"
NCT03405155,73,"null"
NCT03404791,15,"null"
NCT03404193,160,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 11-20 Percent of Bone Marrow Nucleated Cells","name":"Blasts 11-20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137706","eligibility_criterion":"inclusion"}]"
NCT03403634,12,"null"
NCT03401853,37,"null"
NCT03401788,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"VHL Gene Mutation","name":"VHL Gene Mutation","synonyms":["HRCA1 Gene Mutation","Von Hippel-Lindau Tumor Supressor Gene Mutation","VHL Mutation","VHL1 Gene Mutation","Von Hippel-Lindau Syndrome Gene Mutation","RCA1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118400","eligibility_criterion":"inclusion"}]"
NCT03401385,160,"null"
NCT03400332,260,"null"
NCT03400176,60,"null"
NCT03399799,60,"null"
NCT03398720,100,"null"
NCT03398694,44,"null"
NCT03398161,50,"null"
NCT03397173,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TET2 Gene Mutation","name":"TET2 Gene Mutation","synonyms":["Tet Oncogene Family Member 2 Gene Mutation","KIAA1546 Gene Mutation","Tet Methylcytosine Dioxygenase 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148283","eligibility_criterion":"inclusion"}]"
NCT03396952,43,"null"
NCT03396926,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03396497,18,"null"
NCT03395847,30,"null"
NCT03394885,40,"null"
NCT03394755,24,"null"
NCT03394027,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03392064,41,"null"
NCT03391869,270,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK wt Allele","name":"ALK wt Allele","synonyms":["CD246","Anaplastic Lymphoma Receptor Tyrosine Kinase wt Allele","Anaplastic Lymphoma Kinase (Ki-1) wt Allele","NBLST3"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51738","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Mutation","name":"ROS1 Gene Mutation","synonyms":["ROS Gene Mutation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Mutation","ROS1 Mutation","c-ros-1 Gene Mutation","MCF3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130952","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"}]"
NCT03390504,631,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Gene Mutation","name":"FGFR Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor Family Gene Mutation","FGFR Mutation","FGF Receptor Gene Mutation","FGFR Family Mutation","FGF Receptor Gene Family Mutation","Fibroblast Growth Factor Receptor Gene Mutation","FGFR Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146713","eligibility_criterion":"inclusion"}]"
NCT03390296,138,"null"
NCT03389477,29,"null"
NCT03389230,51,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03388632,50,"null"
NCT03388619,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03387553,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03386929,130,"null"
NCT03386214,18,"null"
NCT03384914,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03384836,47,"null"
NCT03383575,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT03383094,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03382977,18,"null"
NCT03382886,12,"null"
NCT03379493,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03378128,50,"null"
NCT03377023,104,"null"
NCT03375086,30,"null"
NCT03373188,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03371017,350,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03370718,18,"null"
NCT03370276,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03367715,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Gene Promoter","name":"Unmethylated MGMT Gene Promoter","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03366766,34,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating ALK Mutation","name":"Activating ALK Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"}]"
NCT03364348,91,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03364231,40,"null"
NCT03363373,37,"null"
NCT03361735,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.2","name":"PSA Level 0.2 or Greater","synonyms":["PSA Level Greater than or Equal to 0.2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138952","eligibility_criterion":"inclusion"}]"
NCT03360721,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD56 Negative","name":"CD56 Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromogranin Negative","name":"Chromogranin Negative","synonyms":["CHG Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153223","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RB1 Negative","name":"RB1 Negative","synonyms":["Rb Loss","Retinoblastoma Negative","RB1 Loss","Retinoblastoma 1 Negative","RB Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131482","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation Negative","name":"TP53 Gene Mutation Negative","synonyms":["TRP53 Gene Mutation Negative","LFS1 Gene Mutation Negative","TP53 Mutation Negative","TP53 wt","TP53 Wildtype","BCC7 Gene Mutation Negative","Tumor Protein p53 Gene Mutation Negative","p53 Gene Mutation Negative","Li-Fraumeni Syndrome Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148092","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03359954,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03359811,140,"null"
NCT03358719,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less Than 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138057","eligibility_criterion":"inclusion"}]"
NCT03358563,30,"null"
NCT03353896,15,"null"
NCT03352765,32,"null"
NCT03352427,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGF-A Fusion Mutation","name":"PDGF-A Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFB Gene Amplification","name":"PDGFB Gene Amplification","synonyms":["SIS Gene Amplification","PDGF2 Gene Amplification","c-sis Gene Amplification","PDGF-2 Gene Amplification","IBGC5 Gene Amplification","Platelet Derived Growth Factor Subunit B Gene Amplification","PDGF-B Gene Amplification","Platelet-Derived Growth Factor Beta Polypeptide Gene Amplification","SSV Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148120","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF3 Fusion Mutation","name":"FGF3 Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Fusion Positive","name":"FGFR3 Gene Fusion Positive","synonyms":["CD333 Gene Fusion Positive","JKT4 Gene Mutation Fusion Positive","FGFR-3 Gene Fusion Positive","Fibroblast Growth Factor Receptor 3 Gene Fusion Positive","FGFR3 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148097","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF1 Gene Amplification","name":"FGF1 Gene Amplification","synonyms":["ECGFA Gene Amplification","ECGF-beta Gene Amplification","HBGF1 Gene Amplification","ECGF Gene Amplification","ECGFB Gene Amplification","HBGF-1 Gene Amplification","FGF-1 Gene Amplification","FGFA Gene Amplification","ECGF-alpha Gene Amplification","Fibroblast Growth Factor 1 (Acidic) Gene Amplification","Fibroblast Growth Factor 1, Acidic Gene Amplification","Fibroblast Growth Factor 1 Gene Amplification","AFGF Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148112","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF3 Gene Mutation","name":"FGF3 Gene Mutation","synonyms":["HBGF-3 Gene Mutation","Fibroblast Growth Factor 3 Gene Mutation","INT2 Gene Mutation","FGF-3 Gene Mutation","INT-2 Gene Mutation","Murine Mammary Tumor Virus Integration Site 2 Gene Mutation","HBGF3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148113","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFR-B Fusion Mutation","name":"PDGFR-B Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFB Gene Mutation","name":"PDGFB Gene Mutation","synonyms":["Platelet-Derived Growth Factor Beta Polypeptide Gene Mutation","PDGF-2 Gene Mutation","PDGF-B Gene Mutation","c-sis Gene Mutation","SIS Gene Mutation","IBGC5 Gene Mutation","Platelet Derived Growth Factor Subunit B Gene Mutation","PDGF2 Gene Mutation","SSV Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148122","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF3 Gene Amplification","name":"FGF3 Gene Amplification","synonyms":["FGF-3 Gene Amplification","HBGF-3 Gene Amplification","Murine Mammary Tumor Virus Integration Site 2 Gene Amplification","INT-2 Gene Amplification","Fibroblast Growth Factor 3 Gene Amplification","INT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147064","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Fusion Positive","name":"FGFR1 Gene Fusion Positive","synonyms":["FLT2 Gene Fusion Positive","FGFR1 Fusion","FGFR-1 Gene Fusion Positive","Fibroblast Growth Factor Receptor 1 Gene Fusion Positive","N-SAM Gene Fusion Positive","FLT-2 Gene Fusion Positive","CEK Gene Fusion Positive","CD331 Gene Fusion Positive","FLG Gene Fusion Positive","KAL2 Gene Fusion Positive","FMS-Like Tyrosine Kinase 2 Gene Fusion Positive","BFGFR Gene Mutation Fusion Positive","OGD Gene Fusion Positive","FGFBR Gene Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148114","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Mutation","name":"PDGFRB Gene Mutation","synonyms":["Platelet Derived Growth Factor Receptor Beta Gene Mutation","CD140b Gene Mutation","JTK12 Gene Mutation","PDGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF1 Gene Mutation","name":"FGF1 Gene Mutation","synonyms":["Fibroblast Growth Factor 1, Acidic Gene Mutation","ECGF-alpha Gene Mutation","ECGF-beta Gene Mutation","HBGF-1 Gene Mutation","ECGFA Gene Mutation","Fibroblast Growth Factor 1 Gene Mutation","FGF-1 Gene Mutation","Fibroblast Growth Factor 1 (Acidic) Gene Mutation","ECGF Gene Mutation","HBGF1 Gene Mutation","AFGF Gene Mutation","FGFA Gene Mutation","ECGFB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148111","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGF-B Fusion Mutation","name":"PDGF-B Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFA Gene Amplification","name":"PDGFA Gene Amplification","synonyms":["PDGF-1 Gene Amplification","Platelet Derived Growth Factor Subunit A Gene Amplification","Platelet-Derived Growth Factor Alpha Polypeptide Gene Amplification","PDGF1 Gene Amplification","PDGF-A Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148119","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFR-A Fusion Mutation","name":"PDGFR-A Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Amplification","name":"PDGFRB Amplification","synonyms":["PDGFR-1 Gene Amplification","Platelet-Derived Growth Factor Receptor Beta Gene Amplification","JTK12 Gene Amplification","CD140b Gene Amplification","PDGFRbeta Gene Amplification","PDGFR1 Gene Amplification","PDGFRB Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129619","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF1 Fusion Mutation","name":"FGF1 Fusion Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Amplification","name":"PDGFRA Amplification","synonyms":["CD140A Gene Amplification","PDGFRalpha Gene Amplification","PDGFRA Gene Amplification","RHEPDGFRA Gene Amplification","Platelet-Derived Growth Factor Receptor Alpha Gene Amplification","PDGFR2 Gene Amplification","PDGFR-2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96868","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFA Gene Mutation","name":"PDGFA Gene Mutation","synonyms":["PDGF-1 Gene Mutation","Platelet Derived Growth Factor Subunit A Gene Mutation","Platelet-Derived Growth Factor Alpha Polypeptide Gene Mutation","PDGF-A Gene Mutation","PDGF1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148121","eligibility_criterion":"inclusion"}]"
NCT03347617,45,"null"
NCT03347422,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"C3D Positive","name":"C3D Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03347292,40,"null"
NCT03345420,102,"null"
NCT03344536,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Gene Amplification","name":"FGFR Gene Amplification","synonyms":["FGFR Family Amplification","Fibroblast Growth Factor Receptor Gene Amplification","FGF Receptor Gene Family Amplification","FGF Receptor Gene Amplification","FGFR Family Gene Amplification","FGFR Amplification","Fibroblast Growth Factor Receptor Family Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118378","eligibility_criterion":"inclusion"}]"
NCT03344172,120,"null"
NCT03343613,290,"null"
NCT03342937,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03342911,37,"null"
NCT03342196,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"i(17q)","name":"i(17q)","synonyms":["Isochromosome 17q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36477","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142113","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"inv(3)","name":"inv(3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C111789","eligibility_criterion":"inclusion"}]"
NCT03341143,20,"null"
NCT03340974,48,"null"
NCT03340558,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT03340506,100,"null"
NCT03340402,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03339401,141,"null"
NCT03338972,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF17 Positive","name":"TNFRSF17 Positive","synonyms":["CD269 Antigen Positive","BCMA Positive","CD269 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128845","eligibility_criterion":"inclusion"}]"
NCT03338959,26,"null"
NCT03338816,74,"null"
NCT03338790,300,"null"
NCT03338062,15,"null"
NCT03337698,292,"null"
NCT03337451,57,"null"
NCT03335540,50,"null"
NCT03333746,18,"null"
NCT03333486,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT03332498,42,"null"
NCT03332160,40,"null"
NCT03331562,24,"null"
NCT03330847,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03330821,53,"null"
NCT03330691,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT03330028,48,"null"
NCT03329742,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Five","name":"PSA Level Five or Greater","synonyms":["PSA Level Greater than or Equal to 5","PSA Level Greater than or Equal to Five","PSA Level 5 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139792","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03329001,80,"null"
NCT03328104,12,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03328026,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03326921,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT03325634,30,"null"
NCT03325166,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03325101,39,"null"
NCT03322540,148,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"}]"
NCT03322384,56,"null"
NCT03321747,67,"null"
NCT03321188,20,"null"
NCT03319745,20,"null"
NCT03319459,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03318445,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51D Gene Mutation","name":"RAD51D Gene Mutation","synonyms":["R51H3 Gene Mutation","RAD51L3 Gene Mutation","BROVCA4 Gene Mutation","TRAD Gene Mutation","RAD51-Like 3 Gene Mutation","RAD51 Homolog D Gene Mutation","RAD51 Paralog D Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131481","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51C Gene Mutation","name":"RAD51C Gene Mutation","synonyms":["RAD51L2 Gene Mutation","FANCO Gene Mutation","RAD51 Paralog C Gene Mutation","BROVCA3 Gene Mutation","RAD51 Homolog C Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131480","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51 Gene Mutation","name":"RAD51 Gene Mutation","synonyms":["HRAD51 Gene Mutation","FANCR Gene Mutation","BRCC5 Gene Mutation","HsRad51 Gene Mutation","RAD51A Gene Mutation","RAD51, S. cerevisiae, Homolog of A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131795","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRIP1 Gene Mutation","name":"BRIP1 Gene Mutation","synonyms":["BRCA1 Interacting Protein C-Terminal Helicase 1 Gene Mutation","BACH1 Gene Mutation","FANCJ Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132002","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NBN Gene Mutation","name":"NBN Gene Mutation","synonyms":["AT-V2 Gene Mutation","P95 Gene Mutation","AT-V1 Gene Mutation","Nijmegen Breakage Syndrome 1 Gene Mutation","ATV Gene Mutation","NBS1 Gene Mutation","NBS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131806","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDK12 Gene Mutation","name":"CDK12 Gene Mutation","synonyms":["Cyclin-Dependent Kinase 1 Gene Mutation","CRK7 Gene Mutation","CRKR Gene Mutation","Cdc2-Related Kinase, Arginine/Serine-Rich Gene Mutation","CDC2 Related Protein Kinase 7 Gene Mutation","CRKRS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131796","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BARD1 Gene Mutation","name":"BARD1 Gene Mutation","synonyms":["BARD-1 Gene Mutation","BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD54L Gene Mutation","name":"RAD54L Gene Mutation","synonyms":["HR54 Gene Mutation","RAD54 Homolog Gene Mutation","RAD54-like (S. cerevisiae) Gene Mutation","HRAD54 Gene Mutation","RAD54A Gene Mutation","hHR54 Gene Mutation","RAD54L Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51B Gene Mutation","name":"RAD51B Gene Mutation","synonyms":["REC2 Gene Mutation","R51H2 Gene Mutation","RAD51L1 Gene Mutation","RAD51 Paralog B Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK2 Gene Mutation","name":"CHEK2 Gene Mutation","synonyms":["LFS2 Gene Mutation","CHK2 Gene Mutation","CHK2 Checkpoint Homolog (S. pombe) Gene Mutation","CDS1 Gene Mutation","Checkpoint Kinase 2 Gene Mutation","hCds1 Gene Mutation","RAD53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCA Gene Mutation","name":"FANCA Gene Mutation","synonyms":["FA Gene Mutation","FA1 Gene Mutation","Fanconi Anemia, Complementation Group H Gene Mutation","Fanconi Anemia, Complementation Group A Gene Mutation","FACA Gene Mutation","FA-H Gene Mutation","FAA Gene Mutation","Fanconi Anemia Complementation Group A Gene Mutation","FAH Gene Mutation","Fanconi Anemia, Type 1 Gene Mutation","FANCH Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131794","eligibility_criterion":"inclusion"}]"
NCT03318016,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03317899,140,"null"
NCT03316586,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03315871,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03315754,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal Ten","name":"PSA Level Ten or Less","synonyms":["PSA Level Less than or Equal 10","PSA Level 10 or Less","PSA Level Less than or Equal Ten"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138945","eligibility_criterion":"inclusion"}]"
NCT03315741,30,"null"
NCT03315039,33,"null"
NCT03315026,28,"null"
NCT03314935,249,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03313804,55,"null"
NCT03313557,52,"null"
NCT03312114,29,"null"
NCT03311958,15,"null"
NCT03311555,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PSA Level Greater than or Equal to Four","name":"PSA Level Four or Greater","synonyms":["PSA Level Greater than or Equal to Four"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137705","eligibility_criterion":"exclusion"}]"
NCT03311412,24,"null"
NCT03311334,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*24:02 Positive Cells Present","name":"HLA-A*24:02 Positive Cells Present","synonyms":["HLA-A2402 Positive","HLA-A2402 Positive Cells Present","HLA-A*24:02 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142110","eligibility_criterion":"inclusion"}]"
NCT03311308,30,"null"
NCT03311126,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT03307785,102,"null"
NCT03307616,40,"null"
NCT03307044,65,"null"
NCT03306992,200,"null"
NCT03306420,266,"null"
NCT03305445,38,"null"
NCT03304418,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Testosterone greater or equal to 100","name":"Testosterone greater or equal to 100","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03300843,86,"null"
NCT03300544,21,"null"
NCT03299946,15,"null"
NCT03299309,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT03298412,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT03298399,18,"null"
NCT03297710,24,"null"
NCT03297424,166,"null"
NCT03296696,82,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFRvIII Positive","name":"EGFRvIII Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03295942,30,"null"
NCT03295396,39,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"H3 K27M Mutation","name":"Histone 3 K27M Mutation","synonyms":["Histone H3 K28M","H3 K28M Mutation","H3 Lys28Met","H3 K27M","Histone H3 Lys27Met","H3 K28M","Histone H3 Lys28Met","H3 Lys27Met","Histone H3 K27M","H3 p.Lys28Met","H3 K27M Mutation","H3 p.K28M"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129310","eligibility_criterion":"inclusion"}]"
NCT03295227,30,"null"
NCT03294304,41,"null"
NCT03292536,16,"null"
NCT03292172,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03292133,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT03291990,30,"null"
NCT03291938,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03291353,10,"null"
NCT03290937,32,"null"
NCT03290677,40,"null"
NCT03290417,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT03290079,30,"null"
NCT03289741,50,"null"
NCT03287271,88,"null"
NCT03287050,20,"null"
NCT03286335,100,"null"
NCT03286114,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03285152,30,"null"
NCT03283917,20,"null"
NCT03283696,60,"null"
NCT03283631,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR variant III","name":"EGFRvIII","synonyms":["C101140","Epidermal Growth Factor Receptor variant III","C101139"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101139:C101140","eligibility_criterion":"inclusion"}]"
NCT03283137,36,"null"
NCT03281889,20,"null"
NCT03281811,10,"null"
NCT03279250,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Ten","name":"PSA Level Greater Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137686","eligibility_criterion":"inclusion"}]"
NCT03278782,39,"null"
NCT03278106,28,"null"
NCT03277729,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03277690,35,"null"
NCT03277638,34,"null"
NCT03277105,480,"null"
NCT03276832,10,"null"
NCT03275597,21,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT03274258,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of INI 1 Protein Expression","name":"Loss of INI1 Protein Expression","synonyms":["Loss of BAF47 Protein Expression","Loss of SMARCB1 Protein Expression","Loss of INI1 Protein Expression","Loss of SNF5 Homolog Protein Expression","Loss of SWI/SNF-Related Matrix-Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121966","eligibility_criterion":"inclusion"}]"
NCT03273712,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT03272464,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT03272334,37,"null"
NCT03269552,24,"null"
NCT03269526,22,"null"
NCT03267888,24,"null"
NCT03267836,12,"null"
NCT03267498,40,"null"
NCT03266692,30,"null"
NCT03264989,55,"null"
NCT03264404,37,"null"
NCT03264131,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HTLV-1 Antibody Positive","name":"HTLV-1 Antibody Positive","synonyms":["Anti-Human T-Cell Lymphotropic Virus 1 Antibody Positive","Human T-Lymphotropic Virus 1 Antibody Positive","Anti-Human T-Lymphotropic Virus 1 Antibody Positive","Anti-HTLV-I Antibody Positive","HTLV-I Antibody Positive","Human T-Cell Lymphotropic Virus 1 Antibody Positive","Anti-HTLV-1 Antibody Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141313","eligibility_criterion":"inclusion"}]"
NCT03263936,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03263650,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lactate Dehydrogenase","name":"LDH","synonyms":["lactate dehydrogenase"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C25184","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal Ten","name":"PSA Level Ten or Less","synonyms":["PSA Level Less than or Equal 10","PSA Level 10 or Less","PSA Level Less than or Equal Ten"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Loss","name":"TP53 Loss","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Negative","name":"RB1 Negative","synonyms":["Rb Loss","Retinoblastoma Negative","RB1 Loss","Retinoblastoma 1 Negative","RB Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131482","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated CEA","name":"Elevated CEA","synonyms":["Carcinoembryonic Antigen"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138073","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Gene Mutation","name":"RB1 Gene Mutation","synonyms":["Retinoblastoma Gene Mutation","RB Gene Mutation","Retinoblastoma 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133696","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT03263572,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT03263429,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03263026,235,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03262935,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03262103,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Four","name":"PSA Level Four or Greater","synonyms":["PSA Level Greater than or Equal to Four"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137705","eligibility_criterion":"inclusion"}]"
NCT03261947,160,"null"
NCT03259867,80,"null"
NCT03259581,10,"null"
NCT03259425,20,"null"
NCT03258593,40,"null"
NCT03258567,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03258359,9,"null"
NCT03258008,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT03257631,36,"null"
NCT03257033,300,"null"
NCT03256045,40,"null"
NCT03255083,118,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"MET Exon 14 Skipping Mutation","name":"MET Exon 14 Skipping Mutation","synonyms":["Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Alteration","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Mutation","c-Met Exon 14 Skipping Mutation","HGFR Exon 14 Skipping Mutation","Loss of MET Exon 14","Deletion of MET Exon 14","Loss of c-MET Exon 14","c-Met Exon 14 Skipping Alteration","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Alteration","Deletion of c-MET Exon 14","MET Exon 14 Skipping Alteration","HGFR Exon 14 Skipping Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131179","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Positive","name":"ALK Fusion Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Positive","CD246 Antigen Fusion Positive","Anaplastic Lymphoma Kinase Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142135","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF V600E Mutation Present","name":"BRAF V600E Mutation Present","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"exclusion"}]"
NCT03255018,52,"null"
NCT03253744,52,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PSA Level Greater than or Equal to Twenty","name":"PSA Level Twenty or Greater","synonyms":["PSA Level Greater than or Equal to Twenty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137702","eligibility_criterion":"exclusion"}]"
NCT03253289,13,"null"
NCT03252600,36,"null"
NCT03252353,50,"null"
NCT03251924,277,"null"
NCT03251378,18,"null"
NCT03251027,100,"null"
NCT03249584,250,"null"
NCT03248570,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Two","name":"PSA Level Greater than Two","synonyms":["PSA Level Greater than 2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138948","eligibility_criterion":"inclusion"}]"
NCT03248375,30,"null"
NCT03247309,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT03247088,74,"null"
NCT03246958,54,"null"
NCT03246906,160,"null"
NCT03246685,87,"null"
NCT03246074,18,"null"
NCT03245892,20,"null"
NCT03245450,111,"null"
NCT03244306,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT03243331,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03242824,22,"null"
NCT03241927,125,"null"
NCT03241550,60,"null"
NCT03240861,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT03240016,36,"null"
NCT03238196,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF4 Gene Amplification","name":"FGF4 Gene Amplification","synonyms":["Fibroblast Growth Factor 4 Gene Amplification","KFGF Gene Amplification","K-FGF Gene Amplification","HST Gene Amplification","FGF-4 Gene Amplification","HSTF-1 Gene Amplification","HBGF-4 Gene Amplification","HSTF1 Gene Amplification","HST-1 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41379","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGF3 Gene Amplification","name":"FGF3 Gene Amplification","synonyms":["FGF-3 Gene Amplification","HBGF-3 Gene Amplification","Murine Mammary Tumor Virus Integration Site 2 Gene Amplification","INT-2 Gene Amplification","Fibroblast Growth Factor 3 Gene Amplification","INT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147064","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"}]"
NCT03237572,15,"null"
NCT03237325,190,"null"
NCT03235544,120,"null"
NCT03234712,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Protein Overexpression","name":"EGFR Protein Overexpression","synonyms":["Proto-Oncogene c-ErbB-1 Overexpression","Receptor Tyrosine-Protein Kinase erbB-1 Overexpression","Epidermal Growth Factor Receptor Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39716","eligibility_criterion":"inclusion"}]"
NCT03233854,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03233724,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Sensitizing ALK Gene Mutation","name":"Sensitizing ALK Gene Mutation","synonyms":["Sensitizing Anaplastic Lymphoma Kinase Receptor Gene Mutation","Sensitizing Anaplastic Lymphoma Kinase (Ki-1) Gene Mutation","ALK Sensitizing Mutation","Sensitizing CD246 Gene Mutation","Sensitizing Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147074","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"}]"
NCT03232892,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.Q61X","name":"KRAS Q61 Mutation","synonyms":["NP_004976.2:p.Gln61Xxx","KRAS Gln61Xxx","K-Ras 2 Q61X","KRAS NP_004976.2:p.Gln61Xxx","KRAS Q61X","KRAS p.Q61X","Ki-Ras Q61X","KRAS NP_004976.2:p.Q61X","KRAS p.Gln61Xxx","c-K-ras Q61X","GTPase KRas Q61X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107478","eligibility_criterion":"exclusion"}]"
NCT03226574,36,"null"
NCT03226418,75,"null"
NCT03225664,217,"null"
NCT03225547,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03224871,10,"null"
NCT03224507,82,"null"
NCT03224182,500,"null"
NCT03224000,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT03223922,24,"null"
NCT03223779,56,"null"
NCT03223610,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"}]"
NCT03223155,80,"null"
NCT03222076,45,"null"
NCT03220854,41,"null"
NCT03217747,174,"null"
NCT03217071,40,"null"
NCT03216421,265,"null"
NCT03215810,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Antibody Positive","name":"Epstein-Barr Virus Antibody Positive","synonyms":["HHV4 Antibody Positive","Epstein Barr Virus Antibody Positive","EBV Antibody Positive","HHV-4 Antibody Positive","Human Herpesvirus 4 Antibody Positive","Human Herpesvirus-4 Antibody Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150499","eligibility_criterion":"inclusion"}]"
NCT03215719,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT03215095,11,"null"
NCT03214562,56,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"}]"
NCT03213964,20,"null"
NCT03213626,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Protein Overexpression","name":"EGFR Protein Overexpression","synonyms":["Proto-Oncogene c-ErbB-1 Overexpression","Receptor Tyrosine-Protein Kinase erbB-1 Overexpression","Epidermal Growth Factor Receptor Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39716","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT03213041,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Circulating Tumor Cells Positive","name":"Circulating Tumor Cells Positive","synonyms":["Circulating Tumor Cells Present","CTC Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146691","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03212079,42,"null"
NCT03211988,40,"null"
NCT03211416,27,"null"
NCT03210662,70,"null"
NCT03209869,6,"null"
NCT03209401,146,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"}]"
NCT03208712,22,"null"
NCT03207958,10,"null"
NCT03207555,50,"null"
NCT03206073,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT03206060,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Succinate Dehydrogenase Mutation","name":"SDH Complex Gene Mutation","synonyms":["Mitochondrial Complex II Gene Mutation","Succinate-Coenzyme Q Reductase Gene Mutation","SDH Family Gene Mutation","Mitochondrial Respiratory Chain Complex II Gene Mutation","Succinate-CoQ Reductase Gene Mutation","SDH Gene Mutation","Succinate Dehydrogenase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48301","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT03204812,27,"null"
NCT03203369,72,"null"
NCT03203304,50,"null"
NCT03202940,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT03202628,25,"null"
NCT03202316,33,"null"
NCT03201913,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03201250,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"}]"
NCT03200717,100,"null"
NCT03200587,20,"null"
NCT03199274,52,"null"
NCT03199040,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03198026,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03197506,90,"null"
NCT03197025,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT03196232,30,"null"
NCT03194373,40,"null"
NCT03193918,34,"null"
NCT03193437,25,"null"
NCT03192202,9,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03190967,125,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03190941,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A1101 Positive Cells Present","name":"HLA-A*1101 Positive Cells Present","synonyms":["HLA-A1101 Positive Cells Present","HLA-A1101 Positive","HLA-A*1101 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140184","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HRAS NP_005334.1:p.G12V","name":"HRAS NP_005334.1:p.G12V","synonyms":["c-H-ras G12V","NP_005334.1:p.Gly12Val","Ha-Ras1 Gly12Val","GTPase Hras Gly12Val","Ha-Ras G12V","Ha-Ras1 G12V","H-Ras-1 G12V","H-Ras G12V","Harvey Rat Sarcoma Viral Oncoprotein G12V","HRAS G12V Mutation","H-Ras-1 Gly12Val","c-H-ras Gly12Val","HRAS p.Gly12Val","HRAS p.G12V","HRAS G12V","GTPase Hras G12V","Ha-Ras Gly12Val","Harvey Rat Sarcoma Viral Oncoprotein Gly12Val","HRAS Gly12Val","HRAS NP_005334.1:p.Gly12Val","H-Ras Gly12Val","NP_005334.1:p.G12V"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140253","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS NP_002515.1:p.G12X","name":"NRAS G12 Mutation","synonyms":["GTPase NRas G12X","NRAS p.Gly12Xxx","NRAS Gly12Xxx","NRAS NP_002515.1 :p.Gly12Xxx","NP_002515.1 :p.Gly12Xxx","NRAS NP_002515.1:p.G12X","Transforming Protein N-Ras G12X","NRAS G12X","NRAS p.G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107483","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G12V","name":"KRAS NP_004976.2:p.G12V","synonyms":["GTPase KRas G12V","c-K-ras G12V","K-Ras 2 Gly12Val","K-Ras 2 G12V","KRAS p.G12V","NP_004976.2:p.G12V","KRAS G12V","c-K-ras Gly12Val","NP_004976.2:p.Gly12Val","Ki-Ras Gly12Val","KRAS p.Gly12Val","Ki-Ras G12V","KRAS Gly12Val","GTPase KRas Gly12Val","KRAS NP_004976.2:p.Gly12Val"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98391","eligibility_criterion":"inclusion"}]"
NCT03190824,50,"null"
NCT03190278,156,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Interleukin-3 Receptor Subunit Alpha Positive","name":"IL3RA Positive","synonyms":["IL3R-Alpha Positive","CD123 Positive","IL-3R-Alpha Positive","IL-3R Subunit Alpha Positive","Interleukin-3 Receptor Subunit Alpha Positive","CD123 Antigen Positive","IL-3 Receptor Subunit Alpha Positive","Interleukin 3 Receptor Alpha Chain Positive","Interleukin 3 Receptor Positive","Interleukin 3 Receptor Alpha Positive","IL-3RA Positive","IL3R Positive","IL3RX Positive","Low Affinity Interleukin 3 Receptor Alpha Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132655","eligibility_criterion":"inclusion"}]"
NCT03190213,40,"null"
NCT03189914,50,"null"
NCT03189836,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03189706,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT03189381,50,"null"
NCT03188965,278,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Damage Response Deficiency","name":"DNA Damage Response Deficiency","synonyms":["Deficient DNA Damage Response","DNA Damage Response and Repair Deficiency","DDRD","DNA Damage Repair Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123152","eligibility_criterion":"inclusion"}]"
NCT03188432,40,"null"
NCT03188328,24,"null"
NCT03186118,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03184558,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03181308,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03179410,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03178201,20,"null"
NCT03177460,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Testosterone Greater than 150 ng/dL","name":"Testosterone Greater than 150 ng/dL","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03177291,66,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT03176173,85,"null"
NCT03175978,9,"null"
NCT03175432,40,"null"
NCT03174275,39,"null"
NCT03173976,15,"null"
NCT03173950,180,"null"
NCT03172936,175,"null"
NCT03171025,28,"null"
NCT03170882,300,"null"
NCT03166085,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03165994,16,"null"
NCT03165721,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHC Gene Mutation","name":"SDHC Gene Mutation","synonyms":["cybL Gene Mutation","SDH3 Gene Mutation","CYB560 Gene Mutation","Succinate Dehydrogenase Complex Subunit C Gene Mutation","QPS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48303","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Caused by mutation in the succinate dehydrogenase complex, subunit A, flavoprotein gene (SDHA, {600857.0001})","name":"SDHA variant 600857.0001","synonyms":["C1850616","mutation in succinate dehydrogenase complex, subunit A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C126831:C126833","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation Negative","name":"KIT Gene Mutation Negative","synonyms":["KIT wt","CD117 Gene Mutation Negative","c-KIT Gene Mutation Negative","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation Negative","KIT Wild Type","KIT Wildtype","KIT Mutation Negative","Wild-type KIT"," v-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation Negative","name":"PDGFRA Gene Mutation Negative","synonyms":["Platelet-Derived Growth Factor Receptor Alpha Gene Mutation Negative","PDGFRalpha Gene Mutation Negative","Wild-type PDGFRA","PDGFRA wt","PDGFRA Wild Type","PDGFRA Wildtype","PDGFR2 Gene Mutation Negative","PDGFRA Mutation Negative","CD140A Gene Mutation Negative","PDGFR-2 Gene Mutation Negative","RHEPDGFRA Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138193","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHD Gene Mutation","name":"SDHD Gene Mutation","synonyms":["Succinate Dehydrogenase Complex Subunit D Gene Mutation","SDH4 Gene Mutation","cybS Gene Mutation","CII-4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48304","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHB Gene Mutation","name":"SDHB Gene Mutation","synonyms":["SDH1 Gene Mutation","SDHIP Gene Mutation","SDH2 Gene Mutation","Succinate Dehydrogenase Complex Iron Sulfur Subunit B Gene Mutation","IP Gene Mutation","SDH Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48302","eligibility_criterion":"inclusion"}]"
NCT03164772,56,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"exclusion"}]"
NCT03164603,36,"null"
NCT03164460,100,"null"
NCT03162627,90,"null"
NCT03161522,100,"null"
NCT03161223,141,"null"
NCT03160079,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 50 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 50 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater Than 50 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138065","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT03158883,26,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT03158129,66,"null"
NCT03157089,62,"null"
NCT03154996,10,"null"
NCT03154827,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Quantifiable Minimal Residual Disease Positivity","name":"Quantifiable Minimal Residual Disease Positivity","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03153982,35,"null"
NCT03153202,52,"null"
NCT03152786,50,"null"
NCT03152370,68,"null"
NCT03151057,50,"null"
NCT03150329,60,"null"
NCT03149822,55,"null"
NCT03149081,60,"null"
NCT03149029,50,"null"
NCT03148795,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNA Damage","name":"DNA Damage","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16507","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03148327,105,"null"
NCT03147885,44,"null"
NCT03147612,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL positive","name":"BCR-ABL positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT03147196,27,"null"
NCT03146871,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146712","eligibility_criterion":"inclusion"}]"
NCT03146663,64,"null"
NCT03146650,63,"null"
NCT03144804,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Inactivation","name":"TP53 Gene Inactivation","synonyms":["Inactivation of p53 Tumor-Suppressor Gene","Inactivating TP53 Gene Mutation","P53 Gene Inactivation","TRP53 Gene Inactivation","LFS1 Gene Inactivation","P53 Tumor-Suppressor Gene Inactivation","Tumor Protein p53 Gene Inactivation","TP53 Tumor-Suppressor Gene Inactivation","Li-Fraumeni Syndrome Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36329","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Deletion","name":"TP53 Deletion","synonyms":["TP53 Gene Deletion","p53 Gene Deletion","p53 Deletion","Tumor Protein p53 Gene Deleltion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133694","eligibility_criterion":"inclusion"}]"
NCT03144778,28,"null"
NCT03137693,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"}]"
NCT03136146,42,"null"
NCT03133650,36,"null"
NCT03133390,118,"null"
NCT03133221,34,"null"
NCT03132922,42,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HLA-A*0207 Positive Cells Present","name":"HLA-A*0207 Positive Cells Present","synonyms":["HLA-A*0207 Positive","HLA-A*02:07 Positive","HLA-A0207 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142818","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA4 Positive","name":"MAGEA4 Positive","synonyms":["MAGE-X2 Positive","MAGE4 Positive","MAGE4B Positive","Cancer/Testis Antigen 1.4 Positive","MAGE A4 Positive","MAGE-41 Positive","MAGE4A Positive","CT1.4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147078","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT03132532,117,"null"
NCT03132467,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03132454,54,"null"
NCT03131908,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"}]"
NCT03130439,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03128879,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BTK Gene Mutation","name":"BTK Gene Mutation","synonyms":["XLA Gene Mutation","AGMX1 Gene Mutation","Bruton Tyrosine Kinase Gene Mutation","IMD1 Gene Mutation","Bruton Agammaglobulinemia Tyrosine Kinase Gene Mutation","BPK Gene Mutation","PSCTK1 Gene Mutation","AT Gene Mutation","ATK Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132254","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PLCG2 Gene Mutation","name":"PLCG2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03128866,80,"null"
NCT03128619,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03128034,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPRC Positive","name":"CD45 Positive","synonyms":["PTPRC Positive","T200 Positive","Leukocyte Common Antigen Positive","Receptor-Type Tyrosine-Protein Phosphatase C Positive","CD45 Antigen Positive","L-CA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134500","eligibility_criterion":"inclusion"}]"
NCT03128008,51,"null"
NCT03127774,30,"null"
NCT03126864,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Greater than 5 Percent of Peripheral Blood White Cells","Blasts Over 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146656","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD33 Positive","name":"CD33 Positive","synonyms":["CD33 Molecule Positive","gp67 Positive","p67 Positive","CD33 Antigen Positive","Myeloid Cell Surface Antigen CD33 Positive","SIGLEC3 Positive","SIGLEC-3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132228","eligibility_criterion":"inclusion"}]"
NCT03126630,134,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT03126331,40,"null"
NCT03125928,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03125642,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT03125226,12,"null"
NCT03122509,33,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"exclusion"}]"
NCT03122106,15,"null"
NCT03121534,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03121417,35,"null"
NCT03121352,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03120624,33,"null"
NCT03118492,12,"null"
NCT03118349,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated CA19-9","name":"Elevated CA19-9","synonyms":["Elevated CA19-9 Antigen","Elevated Cancer Antigen 19-9","Elevated Carbohydrate Antigen 19-9"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CA19-9 Positive","name":"CA19-9 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03117920,35,"null"
NCT03117751,1000,"null"
NCT03116529,35,"null"
NCT03114462,50,"null"
NCT03113695,10,"null"
NCT03113188,42,"null"
NCT03113071,100,"null"
NCT03112590,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03111992,70,"null"
NCT03111732,19,"null"
NCT03110978,140,"null"
NCT03109015,36,"null"
NCT03108131,60,"null"
NCT03107416,30,"null"
NCT03107182,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT03106610,12,"null"
NCT03106077,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT03104491,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03104439,80,"null"
NCT03103971,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"}]"
NCT03101839,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT03101748,99,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03101358,24,"null"
NCT03099499,36,"null"
NCT03099486,15,"null"
NCT03099356,19,"null"
NCT03098160,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03096782,25,"null"
NCT03096418,20,"null"
NCT03096340,45,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"UGT1A1*28 Allele","name":"UGT1A1*28","synonyms":["UGT1A1 Variant Allele (TA)7"," NM_000463.2:c.-55_-54dupAT","UGT1A1 (TA)7 Allele","UGT1A1*28 Allele","UGT1A1 TATA Element ins TA Allele","UGT1A1, 2-BP ins, TA, TATAA Element Allele","UDP Glycosyltransferase 1 Family, Polypeptide A1*28 Allele","UGT1A1 c.-55_-54dupAT","UGT1A1 NM_000463.2:c.-55_-54insAT","UGT1A1 A(TA)7TAA Allele","UGT1A1 c.-55_-54insAT","NM_000463.2:c.-55_-54insAT","UGT1A1 Variant (TA)7 Allele","UGT1A1 NM_000463.2:c.-55_-54dupAT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564","eligibility_criterion":"exclusion"}]"
NCT03095612,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT03094884,40,"null"
NCT03094637,40,"null"
NCT03094611,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"}]"
NCT03094052,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03093909,44,"null"
NCT03093844,50,"null"
NCT03092856,104,"null"
NCT03092635,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03092518,40,"null"
NCT03091257,60,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"}]"
NCT03090165,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03089554,93,"null"
NCT03088930,260,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Exon 14 Skipping Mutation","name":"MET Exon 14 Skipping Mutation","synonyms":["Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Alteration","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Skipping Mutation","c-Met Exon 14 Skipping Mutation","HGFR Exon 14 Skipping Mutation","Loss of MET Exon 14","Deletion of MET Exon 14","Loss of c-MET Exon 14","c-Met Exon 14 Skipping Alteration","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Skipping Alteration","Deletion of c-MET Exon 14","MET Exon 14 Skipping Alteration","HGFR Exon 14 Skipping Alteration"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131179","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET NP_000236.2:p.Y1003X","name":"MET Y1003X Mutation","synonyms":["HGFR Tyr1003Xxx","Hepatocyte Growth Factor Receptor Y1003X","NP_000236.2:p.Y1003X","C-MET Tyr1003Xxx","HGF Receptor Tyr1003Xxx","Tyrosine-Protein Kinase Met Tyr1003Xxx","Tyrosine-Protein Kinase Met Y1003X","Scatter Factor Receptor Tyr1003Xxx","Scatter Factor Receptor Y1003X","HGF Receptor Y1003X","MET NP_000236.2:p.Y1003X","Proto-Oncogene c-Met Tyr1003Xxx","HGFR Y1003X","NP_000236.2:p.Tyr1003Xxx","MET NP_000236.2:p.Tyr1003Xxx","C-MET Y1003X","Proto-Oncogene c-Met Y1003X","Hepatocyte Growth Factor Receptor Tyr1003Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136287","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Fusion Gene Positive","name":"MET Gene Fusion Positive","synonyms":["MET Gene Fusion","Hepatocyte Growth Factor Receptor Gene Fusion Positive","HGFR Gene Fusion Positive","MET Proto-Oncogene, Receptor Tyrosine Kinase Fusion Gene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"}]"
NCT03087760,41,"null"
NCT03087591,11,"null"
NCT03087448,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT03086642,16,"null"
NCT03086616,35,"null"
NCT03086369,186,"null"
NCT03085849,22,"null"
NCT03085173,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03085095,915,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"}]"
NCT03085056,12,"null"
NCT03083808,35,"null"
NCT03082534,83,"null"
NCT03082209,155,"null"
NCT03081858,16,"null"
NCT03081780,29,"null"
NCT03078400,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD44 Positive","name":"CD44 Positive","synonyms":["CD44 Molecule Positive","CDw44 Positive","CD44 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147057","eligibility_criterion":"inclusion"}]"
NCT03078010,144,"null"
NCT03077685,30,"null"
NCT03077659,30,"null"
NCT03076554,24,"null"
NCT03076281,72,"null"
NCT03076216,20,"null"
NCT03075553,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HTLV-1 Positive","name":"HTLV-1 Positive","synonyms":["HTLV-I Positive","Human T-Lymphotropic Virus 1 Positive","Human T-Cell Lymphotropic Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142127","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"}]"
NCT03074318,28,"null"
NCT03073785,44,"null"
NCT03072771,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03072160,32,"null"
NCT03072134,36,"null"
NCT03071406,50,"null"
NCT03070327,36,"null"
NCT03070002,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03069378,20,"null"
NCT03069352,210,"null"
NCT03068819,12,"null"
NCT03067610,72,"null"
NCT03067571,36,"null"
NCT03066947,40,"null"
NCT03066206,80,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Twenty","name":"EGFR Exon 20 Mutation","synonyms":["ERBB Exon 20 Mutation","HER1 Exon 20 Mutation","ERBB1 Exon 20","mENA Exon 20","Epidermal Growth Factor Receptor Gene Exon 20 Mutation","ERBB Exon 20","HER1 Exon 20","ERBB1 Exon 20 Mutation","PIG61 Exon 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128663","eligibility_criterion":"inclusion"}]"
NCT03065400,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Peripheral Blood White Cells","name":"Blasts 10 Percent or More of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138056","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT03065387,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB4 Gene Mutation","name":"ERBB4 Gene Mutation","synonyms":["HER-4 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 4 Gene Mutation","HER4 Gene Mutation","V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4 Gene Mutation","ERBB-4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138060","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB3 Gene Mutation","name":"ERBB3 Gene Mutation","synonyms":["V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER-3 Gene Mutation","c-erbB3 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 3 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER3 Gene Mutation","c-erbB-3 Gene Mutation","ErbB-3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138064","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"}]"
NCT03065179,25,"null"
NCT03064490,38,"null"
NCT03063203,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"}]"
NCT03059147,18,"null"
NCT03057613,37,"null"
NCT03056833,40,"null"
NCT03056339,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03052127,45,"null"
NCT03051516,345,"null"
NCT03051477,50,"null"
NCT03050814,81,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"exclusion"}]"
NCT03050554,56,"null"
NCT03050216,24,"null"
NCT03050060,120,"null"
NCT03049618,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Alteration Positive","name":"ROS1 Gene Alteration Positive","synonyms":["ROS Gene Alteration Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Alteration Positive","c-ros-1 Gene Alteration Positive","MCF3 Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134454","eligibility_criterion":"inclusion"}]"
NCT03049449,79,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03048500,51,"null"
NCT03047993,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Peripheral Blood White Cells","name":"Blasts 20-30 Percent of Peripheral Blood White Cells","synonyms":["Blasts Between 20 and 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150452","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","name":"Blasts 20-30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146712","eligibility_criterion":"inclusion"}]"
NCT03047135,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious RAD51C Gene Mutation","name":"Deleterious RAD51C Gene Mutation","synonyms":["Deleterious BROVCA3 Gene Mutation","Deleterious FANCO Gene Mutation","Deleterious RAD51 Paralog C Gene Mutation","Deleterious RAD51L2 Gene Mutation","Deleterious RAD51 Homolog C Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131781","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BARD1 Gene Mutation","name":"Deleterious BARD1 Gene Mutation","synonyms":["Deleterious BARD-1 Gene Mutation","Deleterious BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131776","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious FANCL Gene Mutation","name":"Deleterious FANCL Gene Mutation","synonyms":["Deleterious Fanconi Anemia Complementation Group L Gene Mutation","Deleterious Fanconi Anemia, Complementation Group L Gene Mutation","Deleterious FAAP43 Gene Mutation","Deleterious PHD Finger Protein 9 Gene Mutation","Deleterious PHF9 Gene Mutation","Deleterious POG Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134510","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious CDK12 Gene Mutation","name":"Deleterious CDK12 Gene Mutation","synonyms":["Deleterious CRKRS Gene Mutation","Deleterious CRK7 Gene Mutation","Deleterious Cyclin-Dependent Kinase 12 Gene Mutation","Deleterious CRKR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134505","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious ATM Gene Mutation","name":"Deleterious ATM Gene Mutation","synonyms":["Deleterious Ataxia Telangiectasia Mutated Gene Mutation","Deleterious AT Mutated Gene Mutation","Deleterious A-T Mutated Gene Mutation","Deleterious ATM Serine/Threonine Kinase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134513","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious RAD51B Gene Mutation","name":"Deleterious RAD51B Gene Mutation","synonyms":["Deleterious RAD51L1 Gene Mutation","Deleterious R51H2 Gene Mutation","Deleterious RAD51 Paralog B Gene Mutation","Deleterious REC2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134504","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PALB2 Gene Mutation","name":"Deleterious PALB2 Gene Mutation","synonyms":["Deleterious Partner and Localizer of BRCA2 Gene Mutation","Deleterious FANCN Gene Mutation","Deleterious Fanconi Anemia, Complementation Group N Gene Mutation","Deleterious PNCA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131775","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PPP2R2A Gene Mutation","name":"Deleterious PPP2R2A Gene Mutation","synonyms":["Deleterious PR55-Alpha Gene Mutation","Deleterious B55A Gene Mutation","Deleterious B55ALPHA Gene Mutation","Deleterious PR55A Gene Mutation","Deleterious PR52A Gene Mutation","Deleterious B55-Alpha Gene Mutation","Deleterious PR55alpha Gene Mutation","Deleterious Protein Phosphatase 2 Regulatory Subunit Balpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134509","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious CHEK1 Gene Mutation","name":"Deleterious CHEK1 Gene Mutation","synonyms":["Deleterious CHK1 Gene Mutation","Deleterious CHK1 Checkpoint Homolog (S. pombe) Gene Mutation","Deleterious Checkpoint Kinase 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134512","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious CHEK2 Gene Mutation","name":"Deleterious CHEK2 Gene Mutation","synonyms":["Deleterious CHK2 Gene Mutation","Deleterious Checkpoint Kinase 2 Gene Mutation","Deleterious CHK2 Checkpoint Homolog (S. pombe) Gene Mutation","Deleterious LFS2 Gene Mutation","Deleterious CDS1 Gene Mutation","Deleterious hCds1 Gene Mutation","Deleterious RAD53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134511","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRIP1 Gene Mutation","name":"Deleterious BRIP1 Gene Mutation","synonyms":["Deleterious BRCA1 Interacting Protein C-Terminal Helicase 1 Gene Mutation","Deleterious FANCJ Gene Mutation","Deleterious BACH1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131774","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious RAD51D Gene Mutation","name":"Deleterious RAD51D Gene Mutation","synonyms":["Deleterious RAD51 Homolog D Gene Mutation","Deleterious R51H3 Gene Mutation","Deleterious BROVCA4 Gene Mutation","Deleterious TRAD Gene Mutation","Deleterious RAD51L3 Gene Mutation","Deleterious RAD51-Like 3 Gene Mutation","Deleterious RAD51 Paralog D Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131782","eligibility_criterion":"inclusion"}]"
NCT03045328,20,"null"
NCT03044977,20,"null"
NCT03043989,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03043807,33,"null"
NCT03043664,26,"null"
NCT03043391,20,"null"
NCT03042689,28,"null"
NCT03042312,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03041636,40,"null"
NCT03040024,60,"null"
NCT03039114,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03038672,106,"null"
NCT03037437,73,"null"
NCT03036813,400,"null"
NCT03035331,44,"null"
NCT03034395,60,"null"
NCT03034200,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromogranin Positive","name":"Chromogranin Positive","synonyms":["CHG Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147079","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Synaptophysin Positive Neoplastic Cells Present","name":"Synaptophysin Positive Neoplastic Cells Present","synonyms":["Synaptophysin-Positive Neoplastic Cells Present","SYP Positive Neoplastic Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81013","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NCAM1 Positive","name":"NCAM1 Positive","synonyms":["CD56 Positive","CD56 Antigen Positive","Neural Cell Adhesion Molecule 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129251","eligibility_criterion":"inclusion"}]"
NCT03033303,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT03032783,45,"null"
NCT03032484,24,"null"
NCT03030885,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03030261,40,"null"
NCT03029611,38,"null"
NCT03029598,27,"null"
NCT03029416,50,"null"
NCT03028337,80,"null"
NCT03028311,12,"null"
NCT03026062,100,"null"
NCT03025256,30,"null"
NCT03024437,112,"null"
NCT03024216,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03023722,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT03023046,28,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT03022578,34,"null"
NCT03022409,44,"null"
NCT03021993,19,"null"
NCT03021460,28,"null"
NCT03020602,10,"null"
NCT03020017,8,"null"
NCT03019666,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03019640,40,"null"
NCT03019003,59,"null"
NCT03018288,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH Family Wildtype","name":"IDH Gene Family Wildtype","synonyms":["Isocitrate Dehydrogenase (NADP+) Gene Family Wildtype","IDH Family Wildtype","IDH Wild Type","IDH wt Allele","Isocitrate Dehydrogenase Gene Family Wild Type","IDH Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136567","eligibility_criterion":"inclusion"}]"
NCT03017833,76,"null"
NCT03017820,36,"null"
NCT03017131,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT03016871,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03016377,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"inclusion"}]"
NCT03015896,102,"null"
NCT03015792,63,"null"
NCT03015740,60,"null"
NCT03015324,43,"null"
NCT03014648,111,"null"
NCT03014297,30,"null"
NCT03013933,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03012880,80,"null"
NCT03012672,50,"null"
NCT03012425,24,"null"
NCT03012230,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03011814,58,"null"
NCT03010358,12,"null"
NCT03009240,30,"null"
NCT03009201,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT03008369,25,"null"
NCT03008018,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03007732,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Two","name":"PSA Level Greater than Two","synonyms":["PSA Level Greater than 2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138948","eligibility_criterion":"inclusion"}]"
NCT03007238,24,"null"
NCT03007030,55,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03006562,666,"null"
NCT03005002,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT03004534,60,"null"
NCT03003676,12,"null"
NCT03000257,173,"null"
NCT03000179,25,"null"
NCT02997761,20,"null"
NCT02996773,160,"null"
NCT02996240,222,"null"
NCT02995330,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"}]"
NCT02994069,80,"null"
NCT02993900,54,"null"
NCT02992522,60,"null"
NCT02990481,70,"null"
NCT02990468,66,"null"
NCT02989870,24,"null"
NCT02989714,23,"null"
NCT02989636,57,"null"
NCT02988466,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T315I gene mutation","name":"T315I gene mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02987998,20,"null"
NCT02987959,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02987166,21,"null"
NCT02986178,62,"null"
NCT02985554,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02985125,44,"null"
NCT02983578,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"}]"
NCT02983279,42,"null"
NCT02983006,36,"null"
NCT02982720,44,"null"
NCT02981914,26,"null"
NCT02981524,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT02980029,51,"null"
NCT02979977,50,"null"
NCT02979366,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT02977468,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02974738,125,"null"
NCT02974725,127,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT02973711,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR/ABL1 Fusion Negative","name":"BCR/ABL1 Fusion Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02971748,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02970539,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02970448,45,"null"
NCT02969837,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142107","eligibility_criterion":"inclusion"}]"
NCT02964559,29,"null"
NCT02964078,26,"null"
NCT02963051,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02961881,33,"null"
NCT02960646,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT02960555,61,"null"
NCT02959463,24,"null"
NCT02959164,42,"null"
NCT02957968,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02955758,25,"null"
NCT02955290,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"}]"
NCT02953860,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02953561,58,"null"
NCT02953457,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Protein Deficient","synonyms":["MMR Protein Deficiency","MMR Protein Deficient","Mismatch Repair Protein Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137827","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"}]"
NCT02952248,105,"null"
NCT02950480,90,"null"
NCT02950220,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cyclin D1 Protein Overexpression","name":"Cyclin D1 Protein Overexpression","synonyms":["B-Cell Lymphoma 1 Protein Overexpression","BCL-1 Protein Overexpression","CCND1 Protein Overexpression","BCL1 Protein Overexpression","Cyclin D1 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36485","eligibility_criterion":"inclusion"}]"
NCT02950025,100,"null"
NCT02949843,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating MET Mutation","name":"Activating MET Mutation","synonyms":["Activating HGFR Mutation","Activating Hepatocyte Growth Factor Receptor Mutation","Activating MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Activating Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Mutation","MET Activating Mutation","Activating c-Met Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129701","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ERBB2 Mutation","name":"Activating ERBB2 Mutation","synonyms":["CD340 Activating Mutation","Activating HER2 Mutation","HER2/Neu Activating Mutation","HER-2 Activating Mutation","c-erbB2 Activating Mutation","ERBB2 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129700","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating RET Mutation","name":"Activating RET Mutation","synonyms":["Activating Ret Proto-Oncogene Mutation","RET Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129702","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating BRAF V600E Mutation","name":"Activating BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"inclusion"}]"
NCT02949284,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02948426,40,"null"
NCT02947386,67,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"}]"
NCT02946918,20,"null"
NCT02945631,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02945579,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02943668,25,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"exclusion"}]"
NCT02943473,36,"null"
NCT02942264,152,"null"
NCT02942095,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"inclusion"}]"
NCT02941926,3775,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02940496,15,"null"
NCT02940301,17,"null"
NCT02939807,39,"null"
NCT02937272,199,"null"
NCT02936206,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02935309,28,"null"
NCT02935205,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02934503,60,"null"
NCT02933255,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02932280,59,"null"
NCT02931110,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02930902,30,"null"
NCT02929498,74,"null"
NCT02927964,30,"null"
NCT02927912,176,"null"
NCT02926768,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02926690,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02924766,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02924272,250,"null"
NCT02923986,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02923180,32,"null"
NCT02923115,132,"null"
NCT02922777,30,"null"
NCT02921893,34,"null"
NCT02921061,41,"null"
NCT02918162,40,"null"
NCT02917096,18,"null"
NCT02916979,20,"null"
NCT02914977,12,"null"
NCT02913430,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02913417,18,"null"
NCT02913261,308,"null"
NCT02912312,290,"null"
NCT02911142,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"}]"
NCT02910700,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT02909036,15,"null"
NCT02907918,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"exclusion"}]"
NCT02907099,15,"null"
NCT02906670,134,"null"
NCT02906059,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02902484,20,"null"
NCT02902107,10,"null"
NCT02901717,700,"null"
NCT02901548,34,"null"
NCT02900716,50,"null"
NCT02900469,35,"null"
NCT02899221,24,"null"
NCT02899078,30,"null"
NCT02898259,42,"null"
NCT02897375,90,"null"
NCT02893982,45,"null"
NCT02892734,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02892305,10,"null"
NCT02889861,60,"null"
NCT02888665,47,"null"
NCT02886572,40,"null"
NCT02885324,10,"null"
NCT02884648,35,"null"
NCT02882321,48,"null"
NCT02881125,18,"null"
NCT02880293,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"}]"
NCT02880020,40,"null"
NCT02879994,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02879617,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02878785,171,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"}]"
NCT02877303,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"}]"
NCT02876510,31,"null"
NCT02876107,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02874430,46,"null"
NCT02874404,24,"null"
NCT02873598,18,"null"
NCT02872025,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02867618,42,"null"
NCT02865135,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02864368,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02864316,44,"null"
NCT02861417,200,"null"
NCT02861300,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02860000,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02858310,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT02855125,124,"null"
NCT02853318,40,"null"
NCT02851056,100,"null"
NCT02849990,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02846987,30,"null"
NCT02846935,36,"null"
NCT02846792,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02846623,72,"null"
NCT02845323,44,"null"
NCT02844582,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Four","name":"PSA Level Four or Greater","synonyms":["PSA Level Greater than or Equal to Four"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137705","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02839720,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"}]"
NCT02839265,29,"null"
NCT02838745,36,"null"
NCT02837263,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT02837029,40,"null"
NCT02835729,40,"null"
NCT02835222,72,"null"
NCT02833805,20,"null"
NCT02833701,21,"null"
NCT02830724,113,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD70 Positive","name":"CD70 Positive","synonyms":["Tumor Necrosis Factor Ligand Superfamily, Member 7 Positive","CD70 Molecule Positive","CD27 Ligand Positive","CD27LG Positive"," Ki-24 Antigen Positive","TNFSF7 Positive","CD27L Positive","CD70 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132239","eligibility_criterion":"inclusion"}]"
NCT02830594,14,"null"
NCT02830165,12,"null"
NCT02827877,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02827838,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02827370,45,"null"
NCT02826772,93,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02824575,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02822586,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02821754,90,"null"
NCT02818920,32,"null"
NCT02817113,55,"null"
NCT02816021,71,"null"
NCT02815995,150,"null"
NCT02812667,38,"null"
NCT02812420,15,"null"
NCT02811679,28,"null"
NCT02810418,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT02809053,308,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02808143,27,"null"
NCT02807883,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLL Positive","name":"MLL Positive","synonyms":["KMT2A Positive","Zinc Finger Protein HRX Positive","Histone-Lysine N-Methyltransferase MLL Positive","Myeloid/Lymphoid or Mixed-Lineage Leukemia Positive","Lysine (K)-Specific Methyltransferase 2A Positive","Histone-Lysine N-Methyltransferase 2A Positive","ALL-1 Positive","Lysine N-Methyltransferase 2A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146657","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Greater than 5 Percent of Peripheral Blood White Cells","Blasts Over 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146656","eligibility_criterion":"exclusion"}]"
NCT02807805,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AR-v7 Positive","name":"AR-v7 Positive","synonyms":["Androgen Receptor Splice Variant 3 Positive","AR3 Positive","Androgen Receptor Splice Variant 7 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135616","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02805179,80,"null"
NCT02804945,50,"null"
NCT02798536,34,"null"
NCT02798029,35,"null"
NCT02795520,60,"null"
NCT02794883,45,"null"
NCT02794675,43,"null"
NCT02794246,25,"null"
NCT02792582,140,"null"
NCT02792036,18,"null"
NCT02791334,115,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02790515,52,"null"
NCT02788708,30,"null"
NCT02788201,20,"null"
NCT02786797,300,"null"
NCT02784288,90,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02783300,208,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02782715,28,"null"
NCT02782546,60,"null"
NCT02782403,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"inclusion"}]"
NCT02782182,28,"null"
NCT02781883,54,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(15;17)(q22;q12)","name":"t(15;17)(q24;q21)","synonyms":["t(15;17)(q22;q12)","t(15;17)(q22;q21)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27758","eligibility_criterion":"exclusion"}]"
NCT02781506,35,"null"
NCT02780648,36,"null"
NCT02780609,56,"null"
NCT02780128,94,"null"
NCT02779855,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02779283,24,"null"
NCT02777385,44,"null"
NCT02775292,12,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02774421,30,"null"
NCT02774291,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02770820,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated WT1","name":"Elevated WT1","synonyms":["Elevated Wilms Tumor 1","WT1 Elevated"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02770391,120,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Ten","name":"PSA Level Ten or Greater","synonyms":["PSA Level 10 or Greater","PSA Level Ten or Greater","PSA Level Greater than or Equal to Ten","PSA Level Greater than or Equal to 10"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136534","eligibility_criterion":"inclusion"}]"
NCT02770326,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clostridium difficile Positive","name":"Clostridium difficile Positive","synonyms":["C. diff. Positive","C. difficile Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146650","eligibility_criterion":"inclusion"}]"
NCT02769962,138,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02769832,32,"null"
NCT02767934,21,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD19 Negative","name":"CD19 Negative","synonyms":["CD19 Antigen Negative","B4 Negative","CD19 Molecule Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132245","eligibility_criterion":"exclusion"}]"
NCT02767921,30,"null"
NCT02766699,20,"null"
NCT02762513,40,"null"
NCT02761694,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating PI3K Mutation","name":"Activating PI3K Gene Mutation","synonyms":["Activating 1-Phosphatidylinositol 3-Kinase Gene Mutation","Activating Phosphatidylinositol 3-Kinase Gene Mutation","Activating PI3K Mutation","Activating PIK3 Gene Mutation","Activating PI3 Kinase Gene Mutation","Activating Phosphatidylinositol 3 Kinase Gene Mutation","Activating Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Gene Mutation","Activating PI3-Kinase Gene Mutation","Activating PI3K Family Gene Mutation","Activating Phosphatidylinositol-3-Kinase Gene Mutation","Activating Phosphatidylinositide 3-Kinase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C126340","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Alteration Positive","name":"AKT1 Gene Alteration Positive","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Alteration Positive","RAC Gene Alteration Positive","RAC-PK-Alpha Gene Alteration Positive","PKB Gene Alteration Positive","PRKBA Gene Alteration Positive","RAC-ALPHA Gene Alteration Positive","AKT Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT2 Gene Alteration Positive","name":"AKT2 Gene Alteration Positive","synonyms":["AKT Serine/Threonine Kinase 2 Gene Alteration Positive","RAC-PK-Beta Gene Alteration Positive","HIHGHH Gene Alteration Positive","PKBB Gene Alteration Positive","v-akt Murine Thymoma Viral Oncogene Homolog 2 Gene Alteration Positive","PKBBETA Gene Alteration Positive","RAC-BETA Gene Alteration Positive","PRKBB Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146652","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT3 Gene Alteration Positive","name":"AKT3 Gene Alteration Positive","synonyms":["STK-2 Alteration Positive","RAC-GAMMA Alteration Positive","AKT Serine/Threonine Kinase 3 Alteration Positive","RAC-PK-Gamma Alteration Positive","PKBG Alteration Positive","v-akt Murine Thymoma Viral Oncogene Homolog 3 Gene Alteration Positive","PKB-GAMMA Alteration Positive","PRKBG Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146653","eligibility_criterion":"inclusion"}]"
NCT02760030,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02759835,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"}]"
NCT02757326,74,"null"
NCT02757248,26,"null"
NCT02756962,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NPM1 Gene Mutation","name":"NPM1 Gene Mutation","synonyms":["Mutation of the Nucleophosmin Gene","Nucleophosmin Gene Mutation","NPM1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82429","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"exclusion"}]"
NCT02756897,160,"null"
NCT02756572,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT02756013,34,"null"
NCT02754856,35,"null"
NCT02753790,35,"null"
NCT02753309,30,"null"
NCT02752685,62,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02749708,35,"null"
NCT02747537,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous MAP2K Family Gene Mutation","name":"Non-synonymous MEK Family Gene Mutation","synonyms":["Non-synonymous Mitogen-Activated Protein Kinase Kinase Family Gene Mutation","MEK Family Gene Missense Mutation","Non-synonymous MAPKK Family Gene Mutation","Non-synonymous MAP2K Family Gene Mutation","MAP2K Family Gene Missense Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136639","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous STAT Family Gene Mutation","name":"Non-synonymous STAT Family Gene Mutation","synonyms":["STAT Family Gene Missense Mutation","Non-synonymous Signal Transducer and Activator of Transcription Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136640","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous KIT Gene Mutation","name":"Non-synonymous KIT Gene Mutation","synonyms":["KIT Missense Mutation","Non-synonymous V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation","Non-synonymous CD117 Gene Mutation","Non-synonymous c-KIT Gene Mutation","Non-synonymous KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","C-KIT Missense Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous PDGFR Family Gene Mutation","name":"Non-synonymous PDGFR Family Gene Mutation","synonyms":["PDGFR Family Gene Missense Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136643","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous RAF Family Gene Mutation","name":"Non-synonymous RAF Family Gene Mutation","synonyms":["RAF Family Gene Missense Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136637","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous RAS Family Gene Mutation","name":"Non-synonymous RAS Family Gene Mutation","synonyms":["RAS Family Gene Missense Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous JAK Family Gene Mutation","name":"Non-synonymous JAK Family Gene Mutation","synonyms":["JAK Family Gene Missense Mutation","Non-synonymous Janus Kinase Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous MAPK Family Gene Mutation","name":"Non-synonymous ERK Family Gene Mutation","synonyms":["MAPK Family Gene Missense Mutation","Non-synonymous Extracellular Signal-Regulated Kinase Family Gene Mutation","Non-synonymous Mitogen-Activated Protein Kinase Family Gene Mutation","ERK Family Gene Missense Mutation","Non-synonymous MAPK Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous FLT3 Gene Mutation","name":"Non-synonymous FLT3 Gene Mutation","synonyms":["Non-synonymous FMS-Related Tyrosine Kinase 3 Gene Mutation","Non-synonymous FLT3 Gene Mutant","FLT3 Missense Mutation","Non-synonymous FLK2 Gene Mutation","Non-synonymous CD135 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136634","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Non-synonymous VEGFR Family Gene Mutation","name":"Non-synonymous VEGFR Family Gene Mutation","synonyms":["VEGFR Family Gene Missense Mutation","Non-synonymous Vascular Endothelial Growth Factor Receptor Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136642","eligibility_criterion":"inclusion"}]"
NCT02747303,166,"null"
NCT02746952,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02744612,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02743611,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PRAME Positive","name":"PRAME Positive","synonyms":["Cancer/Testis Antigen 130 Positive","CT130 Positive","Preferentially Expressed Antigen in Melanoma Positive","MAPE Positive","Melanoma Antigen Preferentially Expressed in Tumors Positive","OIP-4 Positive","OIP4 Positive","Opa-Interacting Protein 4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02738866,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02738606,80,"null"
NCT02736617,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT02734004,288,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02730884,35,"null"
NCT02730546,68,"null"
NCT02730247,80,"null"
NCT02730195,26,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02729961,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02728830,20,"null"
NCT02728050,71,"null"
NCT02727803,100,"null"
NCT02727777,75,"null"
NCT02726997,30,"null"
NCT02722941,30,"null"
NCT02722668,163,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT02721979,33,"null"
NCT02721732,275,"null"
NCT02721459,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02721043,20,"null"
NCT02720185,19,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02719717,150,"null"
NCT02719691,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02718911,178,"null"
NCT02717962,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02717156,60,"null"
NCT02716974,33,"null"
NCT02716948,90,"null"
NCT02715609,18,"null"
NCT02713269,60,"null"
NCT02710734,38,"null"
NCT02710253,165,"null"
NCT02709993,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROPN1 Positive","name":"ROPN1 Positive","synonyms":["Ropporin Positive","Ropporin-1A Positive","CT91 Positive","Cancer/Testis Antigen 91 Positive","ROPN1A Positive","Rhophilin Associated Tail Protein Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTTG1 Positive","name":"PTTG1 Positive","synonyms":["PTTG Positive","Securin Positive","TUTR1 Positive","Tumor-Transforming Protein 1 Positive","Pituitary Tumor-Transforming 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKAP4 Positive","name":"AKAP4 Positive","synonyms":["Cancer/Testis Antigen 99 Positive","PRKA4 Positive","Major Sperm Fibrous Sheath Protein Positive","AKAP-4 Positive","Protein Kinase A-Anchoring Protein 4 Positive","AKAP 82 Positive","A-Kinase Anchor Protein 4 Positive","CT99 Positive","Testis-Specific Gene HI Positive","AKAP82 Positive","HI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142842","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SPA17 Positive","name":"SPA17 Positive","synonyms":["Sperm Surface Protein Sp17 Positive","CT22 Positive","Cancer/Testis Antigen 22 Positive","Sperm Protein 17 Positive","SP17 Positive","Sperm Autoantigenic Protein 17 Positive","Sp17-1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142841","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SPANXB1 Positive","name":"SPANXB1 Positive","synonyms":["SPANX-B Positive","Sperm Protein Associated With the Nucleus on the X Chromosome B/F Positive","CT11.2 Positive","Cancer/Testis Antigen 11.2 Positive","SPAN-Xb Positive","SPANX Family Member B1 Positive","Sperm Protein Associated With the Nucleus on the X Chromosome B1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142845","eligibility_criterion":"inclusion"}]"
NCT02709226,24,"null"
NCT02708641,40,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"FLT3 wt Allele","name":"FLT3 wt Allele","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NPM1 Gene Mutation","name":"NPM1 Gene Mutation","synonyms":["Mutation of the Nucleophosmin Gene","Nucleophosmin Gene Mutation","NPM1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82429","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(16;16)(p13.1;q22)","name":"t(16;16)(p13;q22)","synonyms":["t(16;16)(p13q22)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27759","eligibility_criterion":"exclusion"}]"
NCT02707666,15,"null"
NCT02706691,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Translocation","name":"FGFR3 Gene Translocation","synonyms":["CD333 Gene Translocation","Fibroblast Growth Factor Receptor 3 Gene Translocation","FGFR-3 Gene Translocation","JKT4 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150619","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Translocation","name":"FGFR2 Gene Translocation","synonyms":["BEK Gene Translocation","ECT1 Gene Translocation","Fibroblast Growth Factor Receptor 2 Gene Translocation","KGFR Gene Translocation","CD332 Gene Translocation","FGFR-2 Gene Translocation","K-SAM Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138068","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Translocation","name":"FGFR1 Gene Translocation","synonyms":["KAL2 Gene Translocation","FMS-Like Tyrosine Kinase 2 Gene Translocation","CEK Gene Translocation","FGFR-1 Gene Translocation","CD331 Gene Translocation","N-SAM Gene Translocation","FLT-2 Gene Translocation","Fibroblast Growth Factor Receptor 1 Gene Translocation","OGD Gene Translocation","FGFBR Gene Translocation","BFGFR Gene Translocation","FLG Gene Translocation","FLT2 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150615","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"}]"
NCT02706405,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT02706392,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROR1 Positive","name":"ROR1 Positive","synonyms":["Receptor Tyrosine Kinase-Like Orphan Receptor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142123","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02706353,41,"null"
NCT02705963,24,"null"
NCT02705196,26,"null"
NCT02703779,100,"null"
NCT02703623,265,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02701400,20,"null"
NCT02701153,51,"null"
NCT02700230,30,"null"
NCT02698254,40,"null"
NCT02697344,63,"null"
NCT02696993,80,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02694029,10,"null"
NCT02693717,25,"null"
NCT02692755,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02690558,39,"null"
NCT02690545,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02689453,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD52-Positive Neoplastic Cells Present","name":"CD52-Positive Neoplastic Cells Present","synonyms":["CD52 Molecule-Positive Neoplastic Cells Present","CAMPATH-1 Antigen-Positive Neoplastic Cells Present","CD52 Antigen-Positive Neoplastic Cells Present","CDw52-Positive Neoplastic Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71597","eligibility_criterion":"inclusion"}]"
NCT02689440,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02689427,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02689336,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2.p.V617F","name":"JAK2 V617F mutation","synonyms":["JAK2 Val617Phe","JAK2 NM_004972.3:c.1848_1849TG>CT","JTK10 c.1849G>T","NP_004963.1:p.V617F","Janus Kinase 2 Val617Phe","NM_004972.3:c.1848_1849TG>CT","JAK2 c.1848_1849delTGinsCT","JAK2 V617F","Janus Kinase- 2 V617F","Janus Kinase-2 Val617Phe","Janus Kinase 2 c.1848_1849TG>CT","JAK2 NM_004972.3:c.1849G>T","JAK2 NP_004963.1:p.V617F","JTK10 c.1848_1849TG>CT","Janus Kinase-2 V617F Mutation","NM_004972.3:c.1848_1849delTGinsCT","JAK-2 c.1849G>T","JAK2 c.1849G>T","JAK2 c.1848_1849TG>CT","NM_004972.3:c.1849G>T","Janus Kinase 2 V617F","JAK2 p.Val617Phe","NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 Val617Phe","Janus Kinase 2 c.1849G>T","JAK2 NM_004972.3:c.1848_1849delTGinsCT","JAK2 NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 V617F","JAK-2 c.1848_1849TG>CT","JAK2 p.V617F"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105909:C105910:C105908","eligibility_criterion":"inclusion"}]"
NCT02688608,21,"null"
NCT02687009,24,"null"
NCT02685332,60,"null"
NCT02684162,90,"null"
NCT02683200,20,"null"
NCT02683148,47,"null"
NCT02681549,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02679196,53,"null"
NCT02677038,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation Negative","name":"BRCA1 Gene Mutation Negative","synonyms":["Breast Cancer 1, Early Onset Gene Mutation Negative","BRCA1 wt","Breast Cancer Type 1 Susceptibility Gene Mutation Negative","BRCA1 Wildtype","BROVCA1 Gene Mutation Negative","BRCA1 Mutation Negative","Breast Cancer 1 Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148084","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation Negative","name":"BRCA2 Gene Mutation Negative","synonyms":["FANCD1 Gene Mutation Negative","BRCA2 wt","BROVCA2 Gene Mutation Negative","Breast Cancer Type 2 Susceptibility Gene Mutation Negative","BRCA2 Mutation Negative","Breast Cancer 2, Early Onset Gene Mutation Negative","Breast Cancer 2 Gene Mutation Negative","BRCC2 Gene Mutation Negative","BRCA2 Wildtype"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148085","eligibility_criterion":"inclusion"}]"
NCT02675829,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ERBB2 Mutation","name":"Activating ERBB2 Mutation","synonyms":["CD340 Activating Mutation","Activating HER2 Mutation","HER2/Neu Activating Mutation","HER-2 Activating Mutation","c-erbB2 Activating Mutation","ERBB2 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129700","eligibility_criterion":"inclusion"}]"
NCT02673333,39,"null"
NCT02672917,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CA19-9 Antigen Positive","name":"CA19-9 Antigen Positive","synonyms":["CA 19-9 Positive","Carbohydrate Antigen 19-9 Positive","Sialyl LeA Positive","Sialyl LewisA Positive","Sialyl Le(a) Antigen Positive","Sialylated Lewis a Antigen Positive","Sialyl-Lewis A Positive","Cancer Antigen 19-9 Positive","c-erbB1 Positive","Sialylated Lewis (a) Antigen Positive","SLeA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142809","eligibility_criterion":"inclusion"}]"
NCT02672475,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"exclusion"}]"
NCT02672033,10,"null"
NCT02669251,34,"null"
NCT02669173,12,"null"
NCT02668770,85,"null"
NCT02666950,102,"null"
NCT02666105,56,"null"
NCT02665143,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PML Gene RARA Gene Chromosomal mutation","name":"PML-RAR alpha mutation","synonyms":["PML/RAR Alpha Fusion","PML/RARA Fusion","PML/RAR","C24686:C21571:C0948447","PML-RARA Fusion","PML-RAR Alpha Fusion","PML-RAR","PML/RARalpha"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C53622:C99186","eligibility_criterion":"exclusion"}]"
NCT02664363,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR variant III","name":"EGFRvIII","synonyms":["C101140","Epidermal Growth Factor Receptor variant III","C101139"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101139:C101140","eligibility_criterion":"inclusion"}]"
NCT02663271,18,"null"
NCT02661542,84,"null"
NCT02661282,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Cytomegalovirus Negative","name":"CMV Negative","synonyms":["HHV-5 Negative","Cytomegalovirus Negative","Human Herpesvirus 5 Negative","HHV5 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131807","eligibility_criterion":"exclusion"}]"
NCT02661035,124,"null"
NCT02660710,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02659943,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02659930,77,"null"
NCT02658968,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Anti-Mouse Antibodies Negative","name":"HAMA Negative","synonyms":["Human Anti-Mouse Antibodies Absent","Human Anti-Mouse Antibodies Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128838","eligibility_criterion":"inclusion"}]"
NCT02658565,400,"null"
NCT02657486,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating FGFR3 Gene Mutation","name":"Activating FGFR3 Gene Mutation","synonyms":["Activating CD333 Gene Mutation","Activating JKT4 Gene Mutation","Activating Fibroblast Growth Factor Receptor 3 Gene Mutation","Activating FGFR-3 Gene Mutation","FGFR3 Gene Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142132","eligibility_criterion":"inclusion"}]"
NCT02655601,66,"null"
NCT02655458,15,"null"
NCT02654587,325,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02652871,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20,000 in Peripheral Blood White Cells","name":"Blasts Under 20,000 in Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148071","eligibility_criterion":"inclusion"}]"
NCT02652468,14,"null"
NCT02652455,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02650999,12,"null"
NCT02650986,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02650648,36,"null"
NCT02649972,30,"null"
NCT02649855,74,"null"
NCT02649764,40,"null"
NCT02649387,35,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02648919,30,"null"
NCT02648633,18,"null"
NCT02646852,72,"null"
NCT02645487,180,"null"
NCT02644291,27,"null"
NCT02642809,18,"null"
NCT02641691,22,"null"
NCT02640209,15,"null"
NCT02639559,48,"null"
NCT02639065,26,"null"
NCT02639026,30,"null"
NCT02638090,108,"null"
NCT02636322,60,"null"
NCT02635009,302,"null"
NCT02632071,24,"null"
NCT02631590,25,"null"
NCT02630823,18,"null"
NCT02629809,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","name":"IGHV Gene Mutation","synonyms":["IgVH Mutation","Immunoglobulin Heavy Chain Variable Region Mutation","Immunoglobulin Heavy Chain Locus Variable Region Mutation","IGHV Locus Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C111690","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"exclusion"}]"
NCT02626455,546,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02626364,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Amplification","name":"PDGFRA Amplification","synonyms":["CD140A Gene Amplification","PDGFRalpha Gene Amplification","PDGFRA Gene Amplification","RHEPDGFRA Gene Amplification","Platelet-Derived Growth Factor Receptor Alpha Gene Amplification","PDGFR2 Gene Amplification","PDGFR-2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96868","eligibility_criterion":"inclusion"}]"
NCT02626312,88,"null"
NCT02624700,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02621021,170,"null"
NCT02619682,30,"null"
NCT02619669,13,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02616965,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02613650,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Positive","name":"KRAS Positive","synonyms":["p21 K-Ras Positive","KRAS Proto-Oncogene, GTPase Positive","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Positive","c-K-ras Positive","RASK Positive","GTPase Kras Positive","KRAS-2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142134","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Homozygosity UGT1A1*28 Allele","name":"UGT1A1 *28*/*28","synonyms":["Homozygous UGT1A1*28"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45826:C72564","eligibility_criterion":"exclusion"}]"
NCT02613598,24,"null"
NCT02612558,37,"null"
NCT02611661,40,"null"
NCT02611037,32,"null"
NCT02609230,66,"null"
NCT02608385,138,"null"
NCT02608229,43,"null"
NCT02608034,32,"null"
NCT02605967,114,"null"
NCT02605421,12,"null"
NCT02603757,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Vitamin D Less than 66","name":"Vitamin D Less than 66","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02602327,24,"null"
NCT02601378,112,"null"
NCT02601014,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AR-v7 Positive","name":"AR-v7 Positive","synonyms":["Androgen Receptor Splice Variant 3 Positive","AR3 Positive","Androgen Receptor Splice Variant 7 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135616","eligibility_criterion":"inclusion"}]"
NCT02600949,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"cfDNA Mutation","name":"cfDNA Mutation","synonyms":["Mutated Cell-Free DNA","Cell-Free DNA Mutation","Mutated cfDNA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138069","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated CA19-9","name":"Elevated CA19-9","synonyms":["Elevated CA19-9 Antigen","Elevated Cancer Antigen 19-9","Elevated Carbohydrate Antigen 19-9"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated CEA","name":"Elevated CEA","synonyms":["Carcinoembryonic Antigen"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138073","eligibility_criterion":"inclusion"}]"
NCT02599363,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT02598895,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Biallelic Inactivation","name":"ATM Biallelic Inactivation","synonyms":["AT Mutated Biallelic Gene Inactivation","Ataxia Telangiectasia Mutated Biallelic Gene Inactivation","ATM Serine/Threonine Kinase Biallelic Gene Inactivation","ATM Biallelic Gene Inactivation","A-T Mutated Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142120","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Biallelic Inactivation","name":"BRCA2 Biallelic Inactivation","synonyms":["Breast Cancer Type 2 Susceptibility Biallelic Gene Inactivation","BRCA2 Biallelic Gene Inactivation","BROVCA2 Biallelic Gene Inactivation","Breast Cancer 2, Early Onset Biallelic Gene Inactivation","BRCC2 Biallelic Gene Inactivation","Breast Cancer 2 Biallelic Gene Inactivation","FANCD1 Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142122","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Biallelic Inactivation","name":"BRCA1 Biallelic Inactivation","synonyms":["Breast Cancer Type 1 Susceptibility Biallelic Gene Inactivation","BRCA1 Biallelic Gene Inactivation","BROVCA1 Biallelic Gene Inactivation","Breast Cancer 1 Biallelic Gene Inactivation","Breast Cancer 1, Early Onset Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142121","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02595918,29,"null"
NCT02593175,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02593123,60,"null"
NCT02592551,20,"null"
NCT02591654,20,"null"
NCT02589145,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activated B-Cell Positive","name":"Activated B-Cell Positive","synonyms":["Activated B Cells Present","Activated B Lymphocytes Present","Activated B-Lymphocytes Present","Activated B Cell Positive","Activated B-Lymphocyte Positive","ABC Positive","Activated B-Cells Present","Activated B Lymphocyte Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142124","eligibility_criterion":"inclusion"}]"
NCT02588456,15,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT02587650,44,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF Fusion Positive","name":"BRAF Fusion Positive","synonyms":["v-raf Murine Sarcoma Viral Oncogene Homolog B1 Fusion Positive","BRAF1 Fusion Positive","Serine/Threonine-Protein Kinase B-raf Fusion Positive","B-RAF Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147077","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK2 Fusion Positive","name":"NTRK2 Fusion Positive","synonyms":["NTRK2 Fusion","BDNF/NT-3 Growth Factors Receptor Fusion Positive","TRKB Tyrosine Kinase Fusion Positive","TrkB Fusion Positive","Tropomyosin-Related Kinase B Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132235","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"RET Fusion Positive","name":"RET Fusion","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Positive","RET Fusion Positive","Proto-Oncogene c-Ret Fusion Positive","Ret Proto-Oncogene Fusion Positive","RET/PTC Fusion Positive","Tyrosine-Protein Kinase Receptor RET Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131069","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MET Fusion Gene Positive","name":"MET Gene Fusion Positive","synonyms":["MET Gene Fusion","Hepatocyte Growth Factor Receptor Gene Fusion Positive","HGFR Gene Fusion Positive","MET Proto-Oncogene, Receptor Tyrosine Kinase Fusion Gene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136235","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Exclusion","long_name":"Activating NRAS Mutation","name":"Activating NRAS Mutation","synonyms":["NRAS Proto-Oncogene, GTPase Activating Mutation","NRAS Activating Mutation","NRAS1 Activating Mutation","Neuroblastoma RAS Viral Oncogene Homolog Activating Mutation","N-RAS Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139796","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Exclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ALK Fusion Gene Positive","name":"ALK Fusion Gene Positive","synonyms":["Anaplastic Lymphoma Kinase Fusion Gene Positive","CD246 Fusion Gene Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Fusion Gene Alteration Positive","ALK Fusion Gene Present","ALK Fusion Oncogene Positive","Anaplastic Lymphoma Kinase Fusion Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142114","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NTRK3 Fusion Positive","name":"NTRK3 Fusion Positive","synonyms":["TRKC Tyrosine Kinase Fusion Positive","TrkC Fusion Positive","Neurotrophic Tyrosine Kinase Receptor Type 3 Fusion Positive","NTRK3 Fusion","NT-3 Growth Factor Receptor Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132236","eligibility_criterion":"inclusion"}]"
NCT02586207,39,"null"
NCT02585973,24,"null"
NCT02584829,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Merkel Cell Polyomavirus T Antigen Positive","name":"MCPyV TAg Positive","synonyms":["Merkel Cell Polyomavirus T Antigen Positive","Merkel Cell Polyomavirus TAg Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142093","eligibility_criterion":"inclusion"}]"
NCT02584478,48,"null"
NCT02584309,65,"null"
NCT02583893,65,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(15;17)(q22;q12)","name":"t(15;17)(q24;q21)","synonyms":["t(15;17)(q22;q12)","t(15;17)(q22;q21)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27758","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PML Gene RARA Gene Chromosomal mutation","name":"PML-RAR alpha mutation","synonyms":["PML/RAR Alpha Fusion","PML/RARA Fusion","PML/RAR","C24686:C21571:C0948447","PML-RARA Fusion","PML-RAR Alpha Fusion","PML-RAR","PML/RARalpha"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C53622:C99186","eligibility_criterion":"exclusion"}]"
NCT02582359,54,"null"
NCT02581982,27,"null"
NCT02581943,40,"null"
NCT02581787,60,"null"
NCT02579824,28,"null"
NCT02576665,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCA4 Gene Mutation","name":"SMARCA4 Gene Mutation","synonyms":["SWI1 Gene Mutation","BRG-1 Gene Mutation","BAF190A Gene Mutation","SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 Gene Mutation","SNF2L4 Mutation","BRM/SWI2-Related Gene 1 Mutation","SNF2 Gene Mutation","BAF190 Gene Mutation","SNF2-Beta Gene Mutation","hSNF2b Gene Mutation","BRG1 Gene Mutation","SNF2LB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142126","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"XPO1 Gene Mutation","name":"XPO1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MSH6 Gene Mutation","name":"MSH6 Gene Mutation","synonyms":["MutS Homolog 6 Gene Mutation","MSH6 Mutation","MutS, E. coli, Homolog of, 6 Gene Mutation","HNPCC5 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118395","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MGMT Gene Promoter Hypermethylation","name":"MGMT Gene Promoter Hypermethylation","synonyms":["Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation","O-6-Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139588","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NOTCH1 Gene Mutation","name":"NOTCH1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RUNX1 Gene Mutation","name":"RUNX1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDR Gene Mutation","name":"KDR Gene Mutation","synonyms":["CD309 Gene Mutation","Kinase Insert Domain Receptor Gene Mutation","VEGFR-2 Gene Mutation","Vascular Endothelial Growth Factor Receptor 2 Gene Mutation","FLK1 Gene Mutation","VEGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129628","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Mutation","name":"CDKN2A Gene Mutation","synonyms":["p16-INK4A Gene Mutation","p14ARF Gene Mutation","p16INK4a Gene Mutation","CDK4I Gene Mutation","p16INK4 Gene Mutation","p16 Gene Mutation","p19ARF Gene Mutation","Cyclin-Dependent Kinase Inhibitor 2A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128817","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTCH1 Gene Mutation","name":"PTCH1 Gene Mutation","synonyms":["PTCH Gene Mutation","PTC Gene Mutation","Patched Homolog (Drosophila) Gene Mutation","Patched Homolog 1 Gene Mutation","PTC1 Gene Mutation","Patched 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133669","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"XK Gene Mutation","name":"XK Gene Mutation","synonyms":["XKR1 Gene Mutation","XK Locus Gene Mutation","Precursor Substance, Kell Blood Group Gene Mutation","NA Gene Mutation","Neuroacanthocytosis Gene Mutation","X1k Gene Mutation","KX Gene Mutation","NAC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150708","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAP3K1 Gene Mutation","name":"MAP3K1 Gene Mutation","synonyms":["Mitogen-Activated Protein Kinase Kinase Kinase 1 Gene Mutation","MEKK1 Gene Mutation","MEKK Gene Mutation","MAPKKK1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SETD2 Gene Mutation","name":"SETD2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GATA3 Gene Mutation","name":"GATA3 Gene Mutation","synonyms":["GATA Binding Protein 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150628","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MED12 Gene Mutation","name":"MED12 Gene Mutation","synonyms":["TRAP230 Gene Mutation","Trinucleotide Repeat-Containing Gene 11 Gene Mutation","CAGH45 Gene Mutation","ARC240 Gene Mutation","TNRC11 Gene Mutation","HOPA Gene Mutation","Human Opposite Paired Gene Mutation","Mediator Complex Subunit 12 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150689","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TAF1 Gene Mutation","name":"TAF1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"APC Gene Mutation","name":"APC Gene Mutation","synonyms":["FPC Gene Mutation","BTPS2 Gene Mutation","PPP1R46 Gene Mutation","APC, WNT Signaling Pathway Regulator Gene Mutation","Adenomatosis Polyposis Gene Mutation","FAP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134473","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGI2 Gene Mutation","name":"MAGI2 Gene Mutation","synonyms":["Membrane Associated Guanylate Kinase, WW and PDZ Domain Containing 2 Gene Mutation","ACVRINP1 Gene Mutation","ARIP1 Gene Mutation","SSCAM Gene Mutation","AIP-1 Gene Mutation","MAGI-2 Gene Mutation","ACVRIP1 Gene Mutation","AIP1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150683","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDK12 Gene Mutation","name":"CDK12 Gene Mutation","synonyms":["Cyclin-Dependent Kinase 1 Gene Mutation","CRK7 Gene Mutation","CRKR Gene Mutation","Cdc2-Related Kinase, Arginine/Serine-Rich Gene Mutation","CDC2 Related Protein Kinase 7 Gene Mutation","CRKRS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131796","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KMT2D Gene Mutation","name":"KMT2D Gene Mutation","synonyms":["TNRC21 Gene Mutation","Myeloid/Lymphoid or Mixed-Lineage Leukemia 2 Gene Mutation","Lysine (K)-Specific Methyltransferase 2D Gene Mutation","KMS Gene Mutation","Lysine Methyltransferase 2D Gene Mutation","KABUK1 Gene Mutation","CAGL114 Gene Mutation","ALR Gene Mutation","MLL2 Gene Mutation","MLL4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EZH2 Gene Mutation","name":"EZH2 Gene Mutation","synonyms":["ENX1 Gene Mutation","ENX-1 Gene Mutation","KMT6 Gene Mutation","Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene Mutation","EZH2b Gene Mutation","Enhancer of Zeste 2 Gene Mutation","KTM6A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C97311","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DICER1 Gene Mutation.","name":"DICER1 Gene Mutation","synonyms":["DCR1 Gene Mutation","RMSE2 Gene Mutation","Dicer 1, Ribonuclease III Gene Mutation","Dicer 1, Double-Stranded RNA-Specific Endoribonuclease Gene Mutation","HERNA Gene Mutation","DCR-1 Gene Mutation","Dicer 1, Ribonuclease Type III Gene Mutation","MNG1 Gene Mutation","DICER Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137691","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB3 Gene Mutation","name":"ERBB3 Gene Mutation","synonyms":["V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER-3 Gene Mutation","c-erbB3 Gene Mutation","Erb-B2 Receptor Tyrosine Kinase 3 Gene Mutation","V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 3 Gene Mutation","HER3 Gene Mutation","c-erbB-3 Gene Mutation","ErbB-3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138064","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN1A Gene Mutation","name":"CDKN1A Gene Mutation","synonyms":["Cyclin Dependent Kinase Inhibitor 1A Gene Mutation","p21CIP1 Gene Mutation","MDA6 Gene Mutation","CDKN1 Gene Mutation","MDA-6 Gene Mutation","P21 Gene Mutation","CIP1 Gene Mutation","SDI1 Gene Mutation","WAF1 Gene Mutation","PIC1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150475","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KEAP1 Gene Mutation","name":"KEAP1 Gene Mutation","synonyms":["INRF2 Gene Mutation","Kelch-Like ECH-Associated Protein 1 Gene Mutation","KLHL19 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TET2 Gene Mutation","name":"TET2 Gene Mutation","synonyms":["Tet Oncogene Family Member 2 Gene Mutation","KIAA1546 Gene Mutation","Tet Methylcytosine Dioxygenase 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148283","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPN11 Gene Mutation","name":"PTPN11 Gene Mutation","synonyms":["SHP-2 Gene Mutation","Protein Tyrosine Phosphatase, Non-Receptor Type 11 Gene Mutation","PTP-1D Gene Mutation","BPTP3 Gene Mutation","PTP2C Gene Mutation","SHP2 Gene Mutation","SH-PTP2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82612","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HGF Gene Mutation","name":"HGF Gene Mutation","synonyms":["HPTA Gene Mutation","Scatter Factor Gene Mutation","HGF/SF Gene Mutation","SF Gene Mutation","Hepatocyte Growth Factor Gene Mutation","F-TCF Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MSH2 Gene Mutation","name":"MSH2 Gene Mutation","synonyms":["MutS, E. coli, Homolog of, 2 Gene Mutation","COCA1 Gene Mutation","MutS Homolog 2 Gene Mutation","HNPCC1 Gene Mutation","HNPCC Gene Mutation","MSH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128821","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NOTCH2 Gene Mutation","name":"NOTCH2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DNMT3A Gene Mutation","name":"DNMT3A Gene Mutation","synonyms":["DNA Methyltransferase 3 Alpha Gene Mutation","DNA Methyltransferase 3A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDM6A Gene Mutation","name":"KDM6A Gene Mutation","synonyms":["Lysine (K)-Specific Demethylase 6A Gene Mutation","UTX Gene Mutation","Lysine Demethylase 6A Gene Mutation","KABUK2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150649","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ABL2 Gene Mutation","name":"ABL2 Gene Mutation","synonyms":["ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase Gene Mutation","ARG Gene Mutation","ABLL Gene Mutation","v-Abl Abelson Murine Leukemia Viral Oncogene Homolog 2 Gene Mutation","Abelson-Related Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150432","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TBX3 Gene Mutation","name":"TBX3 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN1B Gene Mutation","name":"CDKN1B Gene Mutation","synonyms":["Cyclin Dependent Kinase Inhibitor 1B Gene Mutation","KIP1 Gene Mutation","p27Kip1 Gene Mutation","CDKN4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150476","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SOX9 Gene Mutation","name":"SOX9 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ASXL1 Gene Mutation","name":"ASXL1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CB Gene Mutation","name":"PIK3CB Gene Mutation","synonyms":["PI3KBETA Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Gene Mutation","p110-Beta Gene Mutation","P110BETA Gene Mutation","PIK3C1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141340","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3C2B Gene Mutation","name":"PIK3C2B Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3R1 Gene Mutation","name":"PIK3R1 Gene Mutation","synonyms":["Phosphoinositide-3-Kinase Regulatory Subunit 1 Gene Mutation","p85-ALPHA Gene Mutation","GRB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132894","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NSD1 Gene Mutation","name":"NSD1 Gene Mutation","synonyms":["SOTOS Gene Mutation","Nuclear Receptor Binding SET Domain Protein 1 Gene Mutation","Nuclear Receptor-Binding Su-Var, Enhancer of Zeste, and Trithorax Domain Protein 1 Gene Mutation","STO Gene Mutation","KMT3B Gene Mutation","SOTOS1 Gene Mutation","ARA267 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153267","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHD4 Gene Mutation","name":"CHD4 Gene Mutation","synonyms":["Mi2-BETA Gene Mutation","Mi-2b Gene Mutation","Chromodomain Helicase DNA Binding Protein 4 Gene Mutation","CHD-4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150477","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Gene Mutation","name":"RB1 Gene Mutation","synonyms":["Retinoblastoma Gene Mutation","RB Gene Mutation","Retinoblastoma 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133696","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BLM Gene Mutation","name":"BLM Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CYLD Gene Mutation","name":"CYLD Gene Mutation","synonyms":["CYLDI Gene Mutation","USPL2 Gene Mutation","CYLD Lysine 63 Deubiquitinase Gene Mutation","Ubiquitin Specific Peptidase Like 2 Gene Mutation","CDMT Gene Mutation","CYLD1 Gene Mutation","EAC Gene Mutation","Cylindromatosis (Turban Tumor Syndrome) Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ACVR1B Gene Mutation","name":"ACVR1B Gene Mutation","synonyms":["ACVRLK4 Gene Mutation","Activin A Receptor, Type IB Gene Mutation","SKR2 Gene Mutation","ACTRIB Gene Mutation","Activin Receptor-Like Kinase 4 Gene Mutation","Activin A Receptor, Type II-Like Kinase 4 Gene Mutation","ALK4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150440","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"STAG2 Gene Mutation","name":"STAG2 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Mutation","name":"MYC Gene Mutation","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Mutation","MRTL Gene Mutation","c-myc Gene Mutation","BHLHE39 Gene Mutation","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Mutation","MYCC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43597","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATR Gene Mutation","name":"ATR Gene Mutation","synonyms":["FRP1 Gene Mutation","ATR Serine/Threonine Kinase Gene Mutation","Ataxia Telangiectasia and Rad3 Related Gene Mutation","MEC1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131479","eligibility_criterion":"inclusion"}]"
NCT02575222,38,"null"
NCT02575027,10,"null"
NCT02572284,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Eighty","name":"PSA Level Eighty or Less","synonyms":["PSA Level Less than or Equal to Eighty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137700","eligibility_criterion":"inclusion"}]"
NCT02571725,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT02566772,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02566304,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142113","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 5q","name":"5q Deletion","synonyms":["del(5q)","5q-","Loss of Chromosome 5q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27712","eligibility_criterion":"inclusion"}]"
NCT02565992,50,"null"
NCT02565901,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02564744,75,"null"
NCT02558348,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"}]"
NCT02557854,14,"null"
NCT02553447,312,"null"
NCT02552953,35,"null"
NCT02551718,25,"null"
NCT02549937,36,"null"
NCT02546167,18,"null"
NCT02545283,440,"null"
NCT02542124,10,"null"
NCT02541565,30,"null"
NCT02540161,65,"null"
NCT02536794,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02535533,31,"null"
NCT02535325,15,"null"
NCT02535286,12,"null"
NCT02534376,70,"null"
NCT02532231,30,"null"
NCT02530489,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02530476,52,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"FLT3 NP_004110.2:p.D835X","name":"FLT3 D835 Mutation","synonyms":["Fms-Related Tyrosine Kinase 3 D835X","Stem Cell Tyrosine Kinase 1 Asp835Xxx","FLT3 NP_004110.2:p.D835X","Flt-3 Receptor D835X","CD135 Antigen Asp835Xxx","Receptor-Type Tyrosine-Protein Kinase FLT3 D835X","CD135 Antigen D835X","Stem Cell Tyrosine Kinase 1 D835X","NP_004110.2:p.D835X","FLT3 Asp835 Mutation","FLT3  NP_004110.2:p.Asp835Xxx","Fetal Liver Kinase-2 Asp835Xxx","NP_004110.2:p.Asp835Xxx","FLT3-D835","FLT3 D835X","FLT3 p.Asp835Xxx","Flt-3 Receptor Asp835Xxx","FLT3 p.D835X","FLT3 Asp835Xxx","Fetal Liver Kinase-2 D835X","Receptor-Type Tyrosine-Protein Kinase FLT3 Asp835Xxx","Fms-Related Tyrosine Kinase 3 Asp835Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128921","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT02530463,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137695","eligibility_criterion":"inclusion"}]"
NCT02530437,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GLI1 Positive","name":"GLI1 Positive","synonyms":["GLI Positive","Zinc Finger Protein GLI1 Positive","GLI Family Zinc Finger 1 Positive","Glioma Associated Oncogene Homolog 1 Positive","Glioma-Associated Oncogene Family Zinc Finger 1 Positive","Glioma-Associated Oncogene 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134862","eligibility_criterion":"inclusion"}]"
NCT02529813,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02529072,66,"null"
NCT02527304,12,"null"
NCT02521051,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02520141,50,"null"
NCT02520063,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02516969,80,"null"
NCT02516813,82,"null"
NCT02516241,1200,"null"
NCT02514915,50,"null"
NCT02514382,18,"null"
NCT02513667,33,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02513563,60,"null"
NCT02513199,30,"null"
NCT02512926,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02512692,24,"null"
NCT02512497,30,"null"
NCT02512172,30,"null"
NCT02511236,225,"null"
NCT02509546,43,"null"
NCT02509507,244,"null"
NCT02509052,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142107","eligibility_criterion":"inclusion"}]"
NCT02508038,36,"null"
NCT02507765,45,"null"
NCT02506959,80,"null"
NCT02503358,54,"null"
NCT02502786,39,"null"
NCT02502708,115,"null"
NCT02501954,450,"null"
NCT02501265,600,"null"
NCT02500576,36,"null"
NCT02500459,18,"null"
NCT02499835,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02498912,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MUC16 Ectodomain Antigen Positive","name":"MUC16 Ectodomain Antigen Positive","synonyms":["Mucin 16 Ectodomain Antigen Positive","MUC16 ecto Antigen Positive","Mucin-16 Ectodomain Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148381","eligibility_criterion":"inclusion"}]"
NCT02495896,80,"null"
NCT02495103,73,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Succinate Dehydrogenase Mutation","name":"SDH Complex Gene Mutation","synonyms":["Mitochondrial Complex II Gene Mutation","Succinate-Coenzyme Q Reductase Gene Mutation","SDH Family Gene Mutation","Mitochondrial Respiratory Chain Complex II Gene Mutation","Succinate-CoQ Reductase Gene Mutation","SDH Gene Mutation","Succinate Dehydrogenase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48301","eligibility_criterion":"inclusion"}]"
NCT02494882,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"exclusion"}]"
NCT02494700,50,"null"
NCT02492867,25,"null"
NCT02489123,20,"null"
NCT02487095,70,"null"
NCT02485990,120,"null"
NCT02484404,421,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02484391,60,"null"
NCT02483000,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02482532,3,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Anti-Mouse Antibodies Negative","name":"HAMA Negative","synonyms":["Human Anti-Mouse Antibodies Absent","Human Anti-Mouse Antibodies Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128838","eligibility_criterion":"inclusion"}]"
NCT02482389,40,"null"
NCT02482376,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02482168,43,"null"
NCT02479698,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BK Virus Positive","name":"BK Virus Positive","synonyms":["BKV Papovavirus Positive","Polyomavirus BK Positive","BK Polyomavirus Positive","BKV Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141400","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JC Virus Positive","name":"JC Virus Positive","synonyms":["JC Polyomavirus Virus Positive","Polyomavirus JC Positive","JCV Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141402","eligibility_criterion":"inclusion"}]"
NCT02479230,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02478320,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Deletion","name":"CDKN2A Gene Deletion","synonyms":["p14ARF Gene Deletion","CDKN2A-p16 Gene Deletion","p19ARF Gene Deletion","CDKN2A Deletion","p16INK4a Gene Deletion","p16-INK4A Gene Deletion","CDK4I Gene Deletion","p16 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41615","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Mutation","name":"CDKN2A Gene Mutation","synonyms":["p16-INK4A Gene Mutation","p14ARF Gene Mutation","p16INK4a Gene Mutation","CDK4I Gene Mutation","p16INK4 Gene Mutation","p16 Gene Mutation","p19ARF Gene Mutation","Cyclin-Dependent Kinase Inhibitor 2A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128817","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CDKN2A Gene Mutation Negative","name":"CDKN2A Gene Mutation Negative","synonyms":["p14ARF Gene Mutation Negative","CDK4I Gene Mutation Negative","CDKN2A wt","p16INK4 Gene Mutation Negative","p16INK4a Gene Mutation Negative","Cyclin-Dependent Kinase Inhibitor 2A Gene Mutation Negative","CDKN2A Mutation Negative","p19ARF Gene Mutation Negative","p16-INK4A Gene Mutation Negative","p16 Gene Mutation Negative","CDKN2A Wildtype"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148083","eligibility_criterion":"exclusion"}]"
NCT02476955,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Mutation","name":"AKT1 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Mutation","AKT Gene Mutation","PKB Gene Mutation","RAC Gene Mutation","RAC-PK-Alpha Gene Mutation","PRKBA Gene Mutation","RAC-ALPHA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98304","eligibility_criterion":"inclusion"}]"
NCT02476786,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02473536,29,"null"
NCT02467738,30,"null"
NCT02466802,37,"null"
NCT02464657,75,"null"
NCT02462252,25,"null"
NCT02460874,63,"null"
NCT02460367,115,"null"
NCT02458014,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02457910,73,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02456857,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02456389,1456,"null"
NCT02454140,30,"null"
NCT02454010,54,"null"
NCT02453191,32,"null"
NCT02452775,42,"null"
NCT02452697,100,"null"
NCT02452008,60,"null"
NCT02451982,75,"null"
NCT02446964,42,"null"
NCT02446600,549,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA Rearrangement","name":"BRCA Rearrangement","synonyms":["BRCA Gene Rearrangement","BRCA Family Gene Rearrangement","BRCA Family Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122866","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02446366,36,"null"
NCT02444741,104,"null"
NCT02442297,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02441803,75,"null"
NCT02438904,30,"null"
NCT02437370,32,"null"
NCT02436993,157,"null"
NCT02436408,50,"null"
NCT02434354,32,"null"
NCT02432378,38,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Elevated Serum CA-125 Tumor Antigen","name":"Elevated Serum CA-125 Tumor Antigen","synonyms":["Elevated Serum Carbohydrate Antigen 125","Elevated Serum CA-125","Elevated Serum CA125","Elevated Serum Cancer Antigen 125","Elevated Serum CA-125 Tumor Antigen Levels"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142104","eligibility_criterion":"inclusion"}]"
NCT02432274,108,"null"
NCT02427841,44,"null"
NCT02427620,131,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02427581,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02426723,60,"null"
NCT02426658,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Sensitizing ROS-1 Fusion","name":"Sensitizing ROS-1 Fusion","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Gene Positive","name":"ALK Fusion Gene Positive","synonyms":["Anaplastic Lymphoma Kinase Fusion Gene Positive","CD246 Fusion Gene Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Fusion Gene Alteration Positive","ALK Fusion Gene Present","ALK Fusion Oncogene Positive","Anaplastic Lymphoma Kinase Fusion Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142114","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"}]"
NCT02424968,22,"null"
NCT02420912,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02420860,100,"null"
NCT02420847,57,"null"
NCT02420717,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CRLF2 Positive","name":"CRLF2 Positive","synonyms":["Cytokine Receptor-Like Factor 2 Positive","Thymic Stromal-Derived Lymphopoietin Receptor Positive","TSLPR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131217","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Lymphoblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142103","eligibility_criterion":"inclusion"}]"
NCT02420613,18,"null"
NCT02420509,50,"null"
NCT02415621,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02414516,36,"null"
NCT02411656,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02409108,10,"null"
NCT02408887,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02408432,45,"null"
NCT02403193,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02402920,80,"null"
NCT02401347,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious Homologous Recombination Pathway Gene Mutation","name":"Deleterious Homologous Recombination Pathway Gene Mutation","synonyms":["Deleterious Recombination Repair Gene Mutation","Deleterious HHR Gene Mutation","Deleterious Homologous Recombination Pathway Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141248","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"exclusion"}]"
NCT02401061,36,"null"
NCT02400814,45,"null"
NCT02400463,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IL2RA Positive","name":"IL2RA Positive","synonyms":["IL-2R Subunit Alpha Positive","IL-2 Receptor Subunit Alpha Positive","Interleukin-2 Receptor Subunit Alpha Positive","IL-2R Positive","IL-2 Receptor Positive","IL-2-RA Positive","Interleukin 2 Receptor Subunit Alpha Positive","IL2-RA Positive","CD25 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129706","eligibility_criterion":"inclusion"}]"
NCT02400255,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 NP_004110.2:p.D835X","name":"FLT3 D835 Mutation","synonyms":["Fms-Related Tyrosine Kinase 3 D835X","Stem Cell Tyrosine Kinase 1 Asp835Xxx","FLT3 NP_004110.2:p.D835X","Flt-3 Receptor D835X","CD135 Antigen Asp835Xxx","Receptor-Type Tyrosine-Protein Kinase FLT3 D835X","CD135 Antigen D835X","Stem Cell Tyrosine Kinase 1 D835X","NP_004110.2:p.D835X","FLT3 Asp835 Mutation","FLT3  NP_004110.2:p.Asp835Xxx","Fetal Liver Kinase-2 Asp835Xxx","NP_004110.2:p.Asp835Xxx","FLT3-D835","FLT3 D835X","FLT3 p.Asp835Xxx","Flt-3 Receptor Asp835Xxx","FLT3 p.D835X","FLT3 Asp835Xxx","Fetal Liver Kinase-2 D835X","Receptor-Type Tyrosine-Protein Kinase FLT3 Asp835Xxx","Fms-Related Tyrosine Kinase 3 Asp835Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128921","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT02397720,182,"null"
NCT02394535,30,"null"
NCT02392793,60,"null"
NCT02392572,120,"null"
NCT02392039,75,"null"
NCT02390843,36,"null"
NCT02390518,117,"null"
NCT02389517,86,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02389309,36,"null"
NCT02385110,40,"null"
NCT02384746,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02383498,55,"null"
NCT02382406,67,"null"
NCT02381561,30,"null"
NCT02379520,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02378428,61,"null"
NCT02372409,12,"null"
NCT02370329,19,"null"
NCT02370160,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02369458,70,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Negative","name":"p16 Negative","synonyms":["Cyclin-Dependent Kinase 4 Inhibitor A Negative","p16INK4 Negative","CDKN2A-p16 Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative","p16(INK4a) Negative","p16-INK4 Negative","CDKN2A-p16(INK4a) Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132226","eligibility_criterion":"inclusion"}]"
NCT02367859,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02367040,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02365207,25,"null"
NCT02364609,38,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"inclusion"}]"
NCT02364076,26,"null"
NCT02363647,120,"null"
NCT02358863,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02358187,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02356159,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02355535,65,"null"
NCT02354547,18,"null"
NCT02353819,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Twenty","name":"PSA Level Twenty or Greater","synonyms":["PSA Level Greater than or Equal to Twenty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137702","eligibility_criterion":"inclusion"}]"
NCT02352025,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02350764,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"}]"
NCT02349867,36,"null"
NCT02348320,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02346526,22,"null"
NCT02346253,163,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than One Hundred Fifty","name":"PSA Level Less than 150","synonyms":["PSA Level Less than One Hundred Fifty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142098","eligibility_criterion":"inclusion"}]"
NCT02344355,90,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT02343666,13,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT02343224,20,"null"
NCT02343120,235,"null"
NCT02342782,24,"null"
NCT02342613,26,"null"
NCT02340728,170,"null"
NCT02339922,36,"null"
NCT02339324,30,"null"
NCT02339168,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02337517,12,"null"
NCT02337478,39,"null"
NCT02335944,177,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02334865,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A3 Positive Cells Present","name":"HLA-A*03 Positive","synonyms":["HLA-A3 Positive Cells Present","HLA-A*03 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69409","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A11 Positive Cells Present","name":"HLA-A*011 Positive","synonyms":["HLA-A11 Positive Cells Present","HLA-A*011 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131871","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A24 Positive Cells Present","name":"HLA-A*024 Positive","synonyms":["HLA-A24 Positive Cells Present","HLA-A*024 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69410","eligibility_criterion":"inclusion"}]"
NCT02333162,30,"null"
NCT02332863,40,"null"
NCT02328755,35,"null"
NCT02324621,79,"null"
NCT02324608,20,"null"
NCT02323126,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02323113,106,"null"
NCT02321501,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"}]"
NCT02319369,156,"null"
NCT02319304,30,"null"
NCT02318095,40,"null"
NCT02316340,76,"null"
NCT02315768,32,"null"
NCT02315196,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02314364,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Protein Translocation","name":"EGFR Translocation","synonyms":["ERBB1 Translocation","EGFR Protein Translocation","HER1 Translocation","Epidermal Growth Factor Receptor Protein Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129572","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Mutation","name":"ROS1 Gene Mutation","synonyms":["ROS Gene Mutation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Mutation","ROS1 Mutation","c-ros-1 Gene Mutation","MCF3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130952","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"inclusion"}]"
NCT02311998,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02311621,82,"null"
NCT02308709,20,"null"
NCT02303990,70,"null"
NCT02303977,37,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EML4-ALK translocation mutation","name":"EML4-ALK translocation mutation","synonyms":["C25756:C45576:C2002015","EML4/ALK"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99733:C99724","eligibility_criterion":"exclusion"}]"
NCT02303678,90,"null"
NCT02302833,22,"null"
NCT02299505,318,"null"
NCT02299141,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Amplification","name":"PDGFRB Amplification","synonyms":["PDGFR-1 Gene Amplification","Platelet-Derived Growth Factor Receptor Beta Gene Amplification","JTK12 Gene Amplification","CD140b Gene Amplification","PDGFRbeta Gene Amplification","PDGFR1 Gene Amplification","PDGFRB Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129619","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT1 Gene Mutation","name":"FLT1 Gene Mutation","synonyms":["VEGFR-1 Gene Mutation","FMS-Related Tyrosine Kinase 1 Gene Mutation","FLT Gene Mutation","Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor Gene Mutation","FLT-1 Gene Mutation","Fms Related Tyrosine Kinase 1 Gene Mutation","Vascular Endothelial Growth Factor Receptor 1 Gene Mutation","FRT Gene Mutation","VEGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129625","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Mutation","name":"PDGFRB Gene Mutation","synonyms":["Platelet Derived Growth Factor Receptor Beta Gene Mutation","CD140b Gene Mutation","JTK12 Gene Mutation","PDGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Amplification","name":"PDGFRA Amplification","synonyms":["CD140A Gene Amplification","PDGFRalpha Gene Amplification","PDGFRA Gene Amplification","RHEPDGFRA Gene Amplification","Platelet-Derived Growth Factor Receptor Alpha Gene Amplification","PDGFR2 Gene Amplification","PDGFR-2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96868","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT4 Gene Mutation","name":"FLT4 Gene Mutation","synonyms":["PCL Gene Mutation","FMS Related Tyrosine Kinase 4 Gene Mutation","VEGFR-3 Gene Mutation","Vascular Endothelial Growth Factor Receptor 3 Gene Mutation","VEGFR3 Gene Mutation","VGR3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129629","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDR Gene Amplification","name":"KDR Gene Amplification","synonyms":["VEGFR2 Amplification","CD309 Gene Amplification","VEGFR-2 Gene Amplification","FLK1 Gene Amplification","Vascular Endothelial Growth Factor Receptor 2 Gene Amplification","Kinase Insert Domain Receptor Gene Amplification","VEGFR2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129613","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Amplification","name":"TP53 Amplification","synonyms":["LFS1 Gene Amplification","P53 Gene Amplification","Tumor Protein p53 Gene Amplification","Li-Fraumeni Syndrome Gene Amplification","TP53 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129622","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDR Gene Mutation","name":"KDR Gene Mutation","synonyms":["CD309 Gene Mutation","Kinase Insert Domain Receptor Gene Mutation","VEGFR-2 Gene Mutation","Vascular Endothelial Growth Factor Receptor 2 Gene Mutation","FLK1 Gene Mutation","VEGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129628","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT1 Gene Amplification","name":"FLT1 Gene Amplification","synonyms":["FLT-1 Gene Amplification","Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor Gene Amplification","VEGFR-1 Gene Amplification","FLT Gene Amplification","FMS-Related Tyrosine Kinase 1 Gene Amplification","VEGFR1 Amplification","VEGFR1 Gene Amplification","FRT Gene Amplification","Fms Related Tyrosine Kinase 1 Gene Amplification","Vascular Endothelial Growth Factor Receptor 1 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT4 Gene Amplification","name":"FLT4 Gene Amplification","synonyms":["FMS Related Tyrosine Kinase 4 Gene Amplification","PCL Gene Amplification","VEGFR-3 Gene Amplification","VEGFR3 Gene Amplification","Vascular Endothelial Growth Factor Receptor 3 Gene Amplification","VGR3 Gene Amplification","VEGFR3 Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129618","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"}]"
NCT02296918,72,"null"
NCT02296229,220,"null"
NCT02293109,18,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"exclusion"}]"
NCT02292173,34,"null"
NCT02291848,36,"null"
NCT02289144,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"}]"
NCT02288507,18,"null"
NCT02281409,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02278744,24,"null"
NCT02277392,30,"null"
NCT02273375,1360,"null"
NCT02272998,45,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"cKIT D816V Mutation","name":"cKIT D816V Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating RET Mutation","name":"Activating RET Mutation","synonyms":["Activating Ret Proto-Oncogene Mutation","RET Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129702","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"FGFR3 NP_000133.1:p.K650E","name":"FGFR3 NP_000133.1:p.K650E","synonyms":["NP_001156685.1:p.Lys652Glu","CD333 Antigen Lys650Glu","Tyrosine Kinase JKT4 K650E","Fibroblast Growth Factor Receptor 3 Lys650Glu","Fibroblast Growth Factor Receptor 3 K650E","FGFR3 NP_001156685.1:p.Lys652Glu","Tyrosine Kinase JKT4 Lys650Glu","NP_001156685.1:p.K652E","FGFR3 NP_000133.1:p.Lys650Glu","FGFR3 p.Lys650Glu","FGFR3 p.K650E","FGFR3 K652E Mutation","FGFR-3 p.K650E","FGFR-3 K650E","CD333 Antigen K650E","NP_000133.1:p.K650E","FGFR-3 Lys650Glu","FGFR3 Lys650Glu","FGFR-3 p.Lys650Glu","NP_000133.1:p.Lys650Glu","FGFR3 K650E","FGFR3 NP_001156685.1:p.K652E"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142088","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"FLT3 NP_004110.2:p.D835X","name":"FLT3 D835 Mutation","synonyms":["Fms-Related Tyrosine Kinase 3 D835X","Stem Cell Tyrosine Kinase 1 Asp835Xxx","FLT3 NP_004110.2:p.D835X","Flt-3 Receptor D835X","CD135 Antigen Asp835Xxx","Receptor-Type Tyrosine-Protein Kinase FLT3 D835X","CD135 Antigen D835X","Stem Cell Tyrosine Kinase 1 D835X","NP_004110.2:p.D835X","FLT3 Asp835 Mutation","FLT3  NP_004110.2:p.Asp835Xxx","Fetal Liver Kinase-2 Asp835Xxx","NP_004110.2:p.Asp835Xxx","FLT3-D835","FLT3 D835X","FLT3 p.Asp835Xxx","Flt-3 Receptor Asp835Xxx","FLT3 p.D835X","FLT3 Asp835Xxx","Fetal Liver Kinase-2 D835X","Receptor-Type Tyrosine-Protein Kinase FLT3 Asp835Xxx","Fms-Related Tyrosine Kinase 3 Asp835Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128921","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Fusion Positive","name":"RET Fusion","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Positive","RET Fusion Positive","Proto-Oncogene c-Ret Fusion Positive","Ret Proto-Oncogene Fusion Positive","RET/PTC Fusion Positive","Tyrosine-Protein Kinase Receptor RET Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131069","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Gene Fusion Positive","name":"FGFR Gene Fusion Positive","synonyms":["FGFR Gene Family Fusion Positive","FGF Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Fusion Positive","Fibroblast Growth Factor Receptor Gene Family Fusion Positive","FGF Receptor Gene Family Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132244","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"FLT3 NP_004110.2:p.Y842C","name":"FLT3 NP_004110.2:p.Y842C","synonyms":["Fetal Liver Kinase-2 Y842C","FLT3 Y842C Mutation","Stem Cell Tyrosine Kinase 1 Tyr842Cys","FLT3 Y842C","NP_004110.2:p.Y842C","Receptor-Type Tyrosine-Protein Kinase FLT3 Y842C","Fetal Liver Kinase-2 Tyr842Cys","FLT3 NP_004110.2:p.Tyr842Cys","FLT3 Tyr842Cys","CD135 Antigen Tyr842Cys","Fms-Related Tyrosine Kinase 3 Y842C","CD135 Antigen Y842C","FLT3 p.Y842C","Stem Cell Tyrosine Kinase 1 Y842C","Fms-Related Tyrosine Kinase 3 Tyr842Cys","Flt-3 Receptor Y842C","NP_004110.2:p.Tyr842Cys","Flt-3 Receptor Tyr842Cys","FLT3 p.Tyr842Cys"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142090","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ABL1 Gene Rearrangement","name":"ABL1 Gene Rearrangement","synonyms":["JTK7 Gene Rearrangement","c-ABL1 Gene Rearrangement","ABL Proto-Oncogene 1, Non-Receptor Tyrosine Kinase Gene Rearrangement","v-Abl Abelson Murine Leukemia Viral Oncogene Homolog 1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131490","eligibility_criterion":"inclusion"}]"
NCT02271919,1500,"null"
NCT02271711,24,"null"
NCT02262325,34,"null"
NCT02259621,30,"null"
NCT02257138,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Peripheral Blood White Cells","name":"Blasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36213","eligibility_criterion":"inclusion"}]"
NCT02254239,26,"null"
NCT02251821,33,"null"
NCT02250937,116,"null"
NCT02250781,30,"null"
NCT02248597,24,"null"
NCT02248389,10,"null"
NCT02245997,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT02239900,120,"null"
NCT02236000,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02232152,34,"null"
NCT02231775,78,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT02228525,20,"null"
NCT02227940,72,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ROS1 Positive","name":"ROS1 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02227667,48,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"}]"
NCT02227199,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02225275,30,"null"
NCT02224391,750,"null"
NCT02222545,89,"null"
NCT02220192,39,"null"
NCT02213497,30,"null"
NCT02213289,104,"null"
NCT02210117,105,"null"
NCT02210078,30,"null"
NCT02210065,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Cytomegalovirus Negative","name":"CMV Negative","synonyms":["HHV-5 Negative","Cytomegalovirus Negative","Human Herpesvirus 5 Negative","HHV5 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131807","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease Negativity","name":"MRD Negative","synonyms":["MRDneg","Minimal Residual Disease Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C124428","eligibility_criterion":"inclusion"}]"
NCT02208362,92,"null"
NCT02207465,42,"null"
NCT02207439,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Negative","name":"p16 Negative","synonyms":["Cyclin-Dependent Kinase 4 Inhibitor A Negative","p16INK4 Negative","CDKN2A-p16 Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative","p16(INK4a) Negative","p16-INK4 Negative","CDKN2A-p16(INK4a) Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132226","eligibility_criterion":"inclusion"}]"
NCT02207062,20,"null"
NCT02204098,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SCGB2A2 Positive","name":"SCGB2A2 Positive","synonyms":["Mammaglobin 1 Positive","UGB2 Positive","MGB1 Positive","Mammaglobin A Positive","Secretoglobin 2A2 Positive","Secretoglobin Family 2A Member 2 Positive","Mammaglobin-A Positive","Mammaglobin-1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141407","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02201355,60,"null"
NCT02200757,132,"null"
NCT02199184,40,"null"
NCT02199171,30,"null"
NCT02195973,59,"null"
NCT02193880,33,"null"
NCT02193347,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 NM_005896.3:c.395_396delGTinsAC IDH1 NM_005896.3:c.395G>A IDH1 NP_005887.2:p.R132H","name":"IDH1 R132H","synonyms":["IDH1 NP_005887.2:p.Arg132His","IDH c.395G>A","IDH1 p.R132H","IDH1 NM_005896.3:c.395_396GT>AC","Cytosolic NADP-Isocitrate Dehydrogenase Protein Arg132His","Isocitrate Dehydrogenase [NADP] Cytoplasmic R132H","Cytosolic NADP-Isocitrate Dehydrogenase Protein R132H","Isocitrate Dehydrogenase [NADP] Cytoplasmic Arg132His","Isocitrate Dehydrogenase 1 (NADP(+)), Cytosolic c.395_396GT>AC","NP_005887.2:p.Arg132His","IDH1 NP_005887.2:p.R132H","NM_005896.3:c.395_396delGTinsAC","IDH1 NM_005896.3:c.395_396delGTinsAC","IDH1 NM_005896.3:c.395G>A","NM_005896.3:c.395G>A","IDH1 c.395_396GT>AC","IDH1 c.395G>A","NM_005896.3:c.395_396GT>AC","IDH1 Arg132His","Isocitrate Dehydrogenase 1 (NADP+), Soluble c.395_396GT>AC","IDH1 c.395_396delGTinsAC","Isocitrate Dehydrogenase 1 (NADP+), Soluble c.395G>A","Isocitrate Dehydrogenase 1 (NADP(+)), Cytosolic c.395G>A","NP_005887.2:p.R132H","IDH1 p.Arg132His","G395A","IDH c.395_396GT>AC"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128900:C128826:C128827","eligibility_criterion":"inclusion"}]"
NCT02193152,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KDR Gene Mutation","name":"KDR Gene Mutation","synonyms":["CD309 Gene Mutation","Kinase Insert Domain Receptor Gene Mutation","VEGFR-2 Gene Mutation","Vascular Endothelial Growth Factor Receptor 2 Gene Mutation","FLK1 Gene Mutation","VEGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129628","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Fusion Positive","name":"RET Fusion","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Fusion Positive","RET Fusion Positive","Proto-Oncogene c-Ret Fusion Positive","Ret Proto-Oncogene Fusion Positive","RET/PTC Fusion Positive","Tyrosine-Protein Kinase Receptor RET Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131069","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT4 Gene Mutation","name":"FLT4 Gene Mutation","synonyms":["PCL Gene Mutation","FMS Related Tyrosine Kinase 4 Gene Mutation","VEGFR-3 Gene Mutation","Vascular Endothelial Growth Factor Receptor 3 Gene Mutation","VEGFR3 Gene Mutation","VGR3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129629","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Mutation","name":"PDGFRB Gene Mutation","synonyms":["Platelet Derived Growth Factor Receptor Beta Gene Mutation","CD140b Gene Mutation","JTK12 Gene Mutation","PDGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET/PTC Rearrangement","name":"RET Rearrangement","synonyms":["Ret Proto-Oncogene Rearrangement","RET-PTC Gene Rearrangement","RET/PTC Gene Rearrangement","RET Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT1 Gene Mutation","name":"FLT1 Gene Mutation","synonyms":["VEGFR-1 Gene Mutation","FMS-Related Tyrosine Kinase 1 Gene Mutation","FLT Gene Mutation","Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor Gene Mutation","FLT-1 Gene Mutation","Fms Related Tyrosine Kinase 1 Gene Mutation","Vascular Endothelial Growth Factor Receptor 1 Gene Mutation","FRT Gene Mutation","VEGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129625","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"}]"
NCT02192359,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"UGT1A1*28 Allele Negative","name":"UGT1A1*28 Allele Negative","synonyms":["UGT1A1*28 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141408","eligibility_criterion":"inclusion"}]"
NCT02186509,24,"null"
NCT02186470,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02184533,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Two","name":"PSA Level Less Than Two","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136415","eligibility_criterion":"inclusion"}]"
NCT02181478,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"inv(3)","name":"inv(3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C111789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"i(17q)","name":"i(17q)","synonyms":["Isochromosome 17q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36477","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Peripheral Blood White Cells","name":"Blasts Under 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41399","eligibility_criterion":"inclusion"}]"
NCT02180217,137,"null"
NCT02177578,60,"null"
NCT02171221,36,"null"
NCT02168140,14,"null"
NCT02167958,50,"null"
NCT02163356,42,"null"
NCT02163317,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal Ten","name":"PSA Level Ten or Less","synonyms":["PSA Level Less than or Equal 10","PSA Level 10 or Less","PSA Level Less than or Equal Ten"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138945","eligibility_criterion":"inclusion"}]"
NCT02161705,70,"null"
NCT02160925,160,"null"
NCT02159989,57,"null"
NCT02159872,80,"null"
NCT02159703,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02159495,60,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Interleukin-3 Receptor Subunit Alpha Positive","name":"IL3RA Positive","synonyms":["IL3R-Alpha Positive","CD123 Positive","IL-3R-Alpha Positive","IL-3R Subunit Alpha Positive","Interleukin-3 Receptor Subunit Alpha Positive","CD123 Antigen Positive","IL-3 Receptor Subunit Alpha Positive","Interleukin 3 Receptor Alpha Chain Positive","Interleukin 3 Receptor Positive","Interleukin 3 Receptor Alpha Positive","IL-3RA Positive","IL3R Positive","IL3RX Positive","Low Affinity Interleukin 3 Receptor Alpha Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132655","eligibility_criterion":"inclusion"}]"
NCT02158234,21,"null"
NCT02157051,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02154737,36,"null"
NCT02153905,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A1 Positive Cells Present","name":"HLA-A*01 Positive","synonyms":["HLA-A*01 Positive Cells Present","HLA-A1 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69407","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA3 Positive","name":"MAGEA3 Positive","synonyms":["Melanoma-Associated Antigen 3 Positive","HYPD Positive","MAGE-3 Positive","HIP8 Positive","MAGE3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135575","eligibility_criterion":"inclusion"}]"
NCT02153580,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02153450,20,"null"
NCT02152995,35,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02151864,18,"null"
NCT02151448,168,"null"
NCT02146924,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02141919,16,"null"
NCT02141906,20,"null"
NCT02141451,30,"null"
NCT02139397,38,"null"
NCT02138214,140,"null"
NCT02136797,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02135874,60,"null"
NCT02132754,92,"null"
NCT02132598,54,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02131597,100,"null"
NCT02129582,78,"null"
NCT02128958,78,"null"
NCT02126553,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"}]"
NCT02125786,99,"null"
NCT02124902,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02122081,45,"null"
NCT02120807,34,"null"
NCT02120677,15,"null"
NCT02120287,40,"null"
NCT02115295,308,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Peripheral Blood White Cells","name":"Blasts 10 Percent or More of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138056","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT02113878,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"}]"
NCT02112656,550,"null"
NCT02112617,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Catecholamine Metabolites","name":"Elevated Catecholamine Metabolites","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142091","eligibility_criterion":"inclusion"}]"
NCT02112565,19,"null"
NCT02112552,17,"null"
NCT02112032,32,"null"
NCT02111850,107,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MAGEA3 Positive","name":"MAGEA3 Positive","synonyms":["Melanoma-Associated Antigen 3 Positive","HYPD Positive","MAGE-3 Positive","HIP8 Positive","MAGE3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135575","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-DP4 Positive Cells Present","name":"HLA-DP4 Positive Cells Present","synonyms":["HLA-DP4 Antigen Positive","HLA-DP4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142096","eligibility_criterion":"inclusion"}]"
NCT02109627,24,"null"
NCT02108522,50,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Herpes virus 6 Positive","name":"HHV-6 Positive","synonyms":["Human Herpes Virus 6 Positive","Human Herpesvirus 6 Positive","Human Herpes Virus-6 Positive","Human Herpesvirus-6 Positive","HHV6 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141401","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Adenovirus Positive","name":"Adenovirus Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141278","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BK Virus Positive","name":"BK Virus Positive","synonyms":["BKV Papovavirus Positive","Polyomavirus BK Positive","BK Polyomavirus Positive","BKV Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141400","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"JC Virus Positive","name":"JC Virus Positive","synonyms":["JC Polyomavirus Virus Positive","Polyomavirus JC Positive","JCV Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141402","eligibility_criterion":"inclusion"}]"
NCT02106988,40,"null"
NCT02100930,125,"null"
NCT02098161,40,"null"
NCT02097225,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02096055,120,"null"
NCT02094794,87,"null"
NCT02090114,90,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02089230,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02086552,43,"null"
NCT02085070,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02083250,72,"null"
NCT02079740,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02078609,86,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Wild Type","name":"FLT3 Wild Type","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02078102,127,"null"
NCT02072356,100,"null"
NCT02068794,51,"null"
NCT02068586,150,"null"
NCT02064673,608,"null"
NCT02064582,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02064036,29,"null"
NCT02062827,36,"null"
NCT02054689,25,"null"
NCT02054520,100,"null"
NCT02053545,30,"null"
NCT02047474,46,"null"
NCT02044861,56,"null"
NCT02041260,40,"null"
NCT02040142,50,"null"
NCT02038478,50,"null"
NCT02037230,36,"null"
NCT02030847,24,"null"
NCT02030834,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02023905,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT02022644,24,"null"
NCT02013778,70,"null"
NCT02013492,35,"null"
NCT02013336,30,"null"
NCT02009436,36,"null"
NCT02006485,140,"null"
NCT02003625,100,"null"
NCT02002598,34,"null"
NCT02002182,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT01998529,30,"null"
NCT01996202,24,"null"
NCT01995669,72,"null"
NCT01992705,20,"null"
NCT01992250,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01991457,20,"null"
NCT01991379,92,"null"
NCT01988090,184,"null"
NCT01980823,40,"null"
NCT01978184,90,"null"
NCT01976585,30,"null"
NCT01976520,30,"null"
NCT01967823,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT01966289,32,"null"
NCT01959698,73,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01958580,18,"null"
NCT01955460,15,"null"
NCT01954992,480,"null"
NCT01954316,48,"null"
NCT01954173,41,"null"
NCT01950351,200,"null"
NCT01946854,30,"null"
NCT01941316,112,"null"
NCT01936948,1020,"null"
NCT01925573,32,"null"
NCT01923766,18,"null"
NCT01919619,40,"null"
NCT01918644,36,"null"
NCT01912612,132,"null"
NCT01906385,30,"null"
NCT01904903,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT01904136,45,"null"
NCT01903330,84,"null"
NCT01902381,20,"null"
NCT01900691,130,"null"
NCT01898793,140,"null"
NCT01897454,50,"null"
NCT01897441,132,"null"
NCT01896999,189,"null"
NCT01896271,33,"null"
NCT01892371,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT01891318,45,"null"
NCT01890590,44,"null"
NCT01890213,20,"null"
NCT01880567,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND2 Positive","name":"CCND2 Positive","synonyms":["Cyclin D2 Positive","Cyclin-D2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141300","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND3 Positive","name":"CCND3 Positive","synonyms":["Cyclin D3 Positive","Cyclin-D3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141301","eligibility_criterion":"inclusion"}]"
NCT01879085,67,"null"
NCT01876641,134,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01873833,40,"null"
NCT01873495,45,"null"
NCT01871571,43,"null"
NCT01869764,60,"null"
NCT01869114,83,"null"
NCT01865617,189,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01861106,144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GATA2 Gene Mutation","name":"GATA2 Gene Mutation","synonyms":["GATA Binding Protein 2 Gene Mutation","NFE1B Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129705","eligibility_criterion":"inclusion"}]"
NCT01859026,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01857934,210,"null"
NCT01856855,25,"null"
NCT01854684,12,"null"
NCT01853631,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01850888,250,"null"
NCT01850563,22,"null"
NCT01847326,61,"null"
NCT01843413,40,"null"
NCT01839838,57,"null"
NCT01838317,25,"null"
NCT01837602,24,"null"
NCT01827137,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"}]"
NCT01826864,380,"null"
NCT01823198,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Peripheral Blood White Cells","name":"Blasts Under 20 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36220","eligibility_criterion":"inclusion"}]"
NCT01822275,47,"null"
NCT01819480,85,"null"
NCT01818986,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.2","name":"PSA Level 0.2 or Greater","synonyms":["PSA Level Greater than or Equal to 0.2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138952","eligibility_criterion":"inclusion"}]"
NCT01818492,32,"null"
NCT01817751,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PDGFRA Positive","name":"PDGFRA Positive","synonyms":["PDGFRalpha Positive","Platelet Derived Growth Factor Receptor Alpha Positive","PDGFR-2 Positive","PDGFR2 Positive","RHEPDGFRA Positive","Platelet-Derived Growth Factor Receptor Alpha Positive","CD140A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131460","eligibility_criterion":"inclusion"}]"
NCT01811992,18,"null"
NCT01811368,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01807611,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 25 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 25 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137701","eligibility_criterion":"inclusion"}]"
NCT01804634,39,"null"
NCT01801046,35,"null"
NCT01800422,60,"null"
NCT01795313,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01794793,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Negative","name":"BRAF Negative","synonyms":["RAFB1 Negative","v-raf Murine Sarcoma Viral Oncogene Homolog B Negative","Serine/Threonine-Protein Kinase B-Raf Negative","KRAB Negative","B-RAF1 Negative","B-RAF Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142836","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Negative","name":"NRAS Negative","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Negative","N-Ras Negative","p21 N-Ras Negative","NRAS Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142837","eligibility_criterion":"inclusion"}]"
NCT01794117,30,"null"
NCT01787487,125,"null"
NCT01787474,22,"null"
NCT01786343,100,"null"
NCT01783535,100,"null"
NCT01782131,600,"null"
NCT01781728,120,"null"
NCT01774019,294,"null"
NCT01766297,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01766219,40,"null"
NCT01760655,50,"null"
NCT01757626,224,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Catecholamine Metabolites","name":"Elevated Catecholamine Metabolites","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142091","eligibility_criterion":"inclusion"}]"
NCT01754857,36,"null"
NCT01754402,56,"null"
NCT01751425,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01750567,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 11q","name":"11q Deletion","synonyms":["del11q","Loss of Chromosome 11q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C37312","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT01747499,70,"null"
NCT01744171,20,"null"
NCT01740557,15,"null"
NCT01738139,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"C-KIT Tyrosine Kinase Protein Overexpression","name":"C-KIT Tyrosine Kinase Protein Overexpression","synonyms":["KIT Tyrosine Kinase Protein Overexpression","KIT Protein Overexpression","Proto-Oncogene c-Kit Protein Overexpression","CD117 Antigen Protein Overexpression","Tyrosine-Protein Kinase Kit Protein Overexpression","Proto-Oncogene Tyrosine-Protein Kinase Kit Protein Overexpression","CD117 Protein Overexpression","Stem Cell Factor Receptor Protein Overexpression","c-KIT Protein Overexpression","Mast/Stem Cell Growth Factor Receptor Kit Protein Overexpression","CD117 Tyrosine Kinase Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39711","eligibility_criterion":"inclusion"}]"
NCT01737502,47,"null"
NCT01732120,80,"null"
NCT01729091,60,"null"
NCT01728207,100,"null"
NCT01712308,60,"null"
NCT01703949,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01701986,80,"null"
NCT01700673,75,"null"
NCT01697527,8,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01696734,200,"null"
NCT01676818,30,"null"
NCT01676753,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01676259,80,"null"
NCT01664910,30,"null"
NCT01661088,31,"null"
NCT01659606,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NOP10 Gene Mutation","name":"NOP10 Gene Mutation","synonyms":["Nucleolar Protein Family A, Member 3 Gene Mutation","NOP10P Gene Mutation","NOP10 Ribonucleoprotein Gene Mutation","NOLA3 Gene Mutation","DKCB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152081","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TERC Gene Mutation","name":"TERC Gene Mutation","synonyms":["TR Gene Mutation","hTR Gene Mutation","Small Cajal Body-Specific RNA 19 Gene Mutation","SCARNA19 Gene Mutation","DKCA1 Gene Mutation","TRC3 Gene Mutation","Telomerase RNA Component Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152080","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TCAB1 gene mutation","name":"TCAB1 gene mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TERT Gene Mutation","name":"TERT Gene Mutation","synonyms":["DKCA2 Gene Mutation","Telomerase Reverse Transcriptase Gene Mutation","TRT Gene Mutation","TP2 Gene Mutation","DKCB4 Gene Mutation","TCS1 Gene Mutation","EST2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131104","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PARN Gene Mutation","name":"PARN Gene Mutation","synonyms":["DKCB6 Gene Mutation","DAN Gene Mutation","Poly(A)-Specific Ribonuclease Gene Mutation","Deadenylation Nuclease Gene Mutation","Poly(A)-Specific Ribonuclease (Deadenylation Nuclease) Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152086","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RTEL1 Gene Mutation","name":"RTEL1 Gene Mutation","synonyms":["NHL Gene Mutation","C20orf41 Gene Mutation","Regulator of Telomere Elongation Helicase 1 Gene Mutation","DKCA4 Gene Mutation","DKCB5 Gene Mutation","RTEL Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152087","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TINF2 Gene Mutation","name":"TINF2 Gene Mutation","synonyms":["DKCA3 Gene Mutation","TERF1 Interacting Nuclear Factor 2 Gene Mutation","TIN2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152084","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NHP2 Gene Mutation","name":"NHP2 Gene Mutation","synonyms":["DKCB2 Gene Mutation","Nucleolar Protein Family A, Member 2 Gene Mutation","NOLA2 Gene Mutation","NHP2P Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152082","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DKC1 Gene Mutation","name":"DKC1 Gene Mutation","synonyms":["NAP57 Gene Mutation","CBF5 Gene Mutation","XAP101 Gene Mutation","Dyskerin Pseudouridine Synthase 1 Gene Mutation","DKC Gene Mutation","DKCX Gene Mutation","NOLA4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152079","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ACD Gene Mutation","name":"ACD Gene Mutation","synonyms":["TPP1 Gene Mutation","PTOP Gene Mutation","Adrenocortical Dysplasia Homolog (Mouse) Gene Mutation","ACD, Shelterin Complex Subunit and Telomerase Recruitment Factor Gene Mutation","PIP1 Gene Mutation","TINT1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152088","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTC1 Gene Mutation","name":"CTC1 Gene Mutation","synonyms":["AAF132 Gene Mutation","AAF-132 Gene Mutation","CST Telomere Replication Complex Component 1 Gene Mutation","C17orf68 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C152085","eligibility_criterion":"inclusion"}]"
NCT01655745,30,"null"
NCT01640301,55,"null"
NCT01633541,52,"null"
NCT01631617,113,"null"
NCT01629498,100,"null"
NCT01627275,42,"null"
NCT01624805,100,"null"
NCT01624090,57,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ABCB4 Positive","name":"ABCB4 Positive","synonyms":["P Glycoprotein 3 Positive","ATP Binding Cassette Subfamily B Member 4 Positive","ABC21 Positive","Multidrug Resistance Protein 3 Positive","ATP-Binding Cassette Subfamily B Member 4 Positive","PGY3 Positive","MDR3 Positive"],"hugo_biomarker_code":"45","nci_thesaurus_concept_id":"C141305","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ABCB11 Positive","name":"ABCB11 Positive","synonyms":["ATP-Binding Cassette Subfamily B Member 11 Positive","PGY4 Positive","ABC16 Positive","P Glycoprotein 4 Positive","ATP Binding Cassette Subfamily B Member 11 Positive","Bile Salt Export Pump Positive","BSEP Positive","SPGP Positive","BRIC2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141302","eligibility_criterion":"exclusion"}]"
NCT01620216,24,"null"
NCT01618357,24,"null"
NCT01609816,30,"null"
NCT01600040,22,"null"
NCT01599559,540,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01598025,21,"null"
NCT01592968,100,"null"
NCT01591577,60,"null"
NCT01591356,60,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EPHA2 Protein Overexpression","name":"EphA2 Protein Overexpression","synonyms":["Ephrin Type-A Receptor 2 Protein Overexpression","EphA2 Overexpression","EPH Receptor A2 Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131065","eligibility_criterion":"inclusion"}]"
NCT01590628,20,"null"
NCT01586767,90,"null"
NCT01585194,39,"null"
NCT01582191,200,"null"
NCT01561586,590,"null"
NCT01555892,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01554410,48,"null"
NCT01554371,58,"null"
NCT01552434,300,"null"
NCT01532687,80,"null"
NCT01531361,183,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01529593,104,"null"
NCT01526096,30,"null"
NCT01525069,42,"null"
NCT01515527,160,"null"
NCT01512589,180,"null"
NCT01502917,64,"null"
NCT01498484,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01498445,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT01495598,40,"null"
NCT01489865,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PALB2 Gene Mutation","name":"Deleterious PALB2 Gene Mutation","synonyms":["Deleterious Partner and Localizer of BRCA2 Gene Mutation","Deleterious FANCN Gene Mutation","Deleterious Fanconi Anemia, Complementation Group N Gene Mutation","Deleterious PNCA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131775","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01485055,44,"null"
NCT01476839,22,"null"
NCT01473784,600,"null"
NCT01473628,130,"null"
NCT01473485,10,"null"
NCT01466686,49,"null"
NCT01454596,107,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR variant III","name":"EGFRvIII","synonyms":["C101140","Epidermal Growth Factor Receptor variant III","C101139"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101139:C101140","eligibility_criterion":"inclusion"}]"
NCT01449149,50,"null"
NCT01441063,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"}]"
NCT01437709,76,"null"
NCT01434602,118,"null"
NCT01434472,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01433965,24,"null"
NCT01430390,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01424982,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome","name":"t(9;22)(q34;q11)","synonyms":["Philadelphia Translocation","t(9;22)(q34.1;q11.2)","Philadelphia chromosome","t(9;22)(q34;q11.2)","Philadelphia Chromosome","Ph"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C28452","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT01419834,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT01409200,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Twenty-Five","name":"PSA Level Twenty Five or Greater","synonyms":["PSA Level Greater than or Equal to Twenty Five","PSA Level Greater than or Equal to Twenty-Five","PSA Level Twenty-Five or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137708","eligibility_criterion":"inclusion"}]"
NCT01409161,100,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PML Gene RARA Gene Chromosomal mutation","name":"PML-RAR alpha mutation","synonyms":["PML/RAR Alpha Fusion","PML/RARA Fusion","PML/RAR","C24686:C21571:C0948447","PML-RARA Fusion","PML-RAR Alpha Fusion","PML-RAR","PML/RARalpha"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C53622:C99186","eligibility_criterion":"inclusion"}]"
NCT01384513,40,"null"
NCT01376505,81,"null"
NCT01371630,256,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"}]"
NCT01367301,18,"null"
NCT01360606,18,"null"
NCT01358058,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosomes 1p/19q","name":"1p/19q Codeletion","synonyms":["Loss of Chromosomes 1p/19q","1p/19q Co-deletion","del(1p/19q)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C79099","eligibility_criterion":"inclusion"}]"
NCT01357525,50,"null"
NCT01349101,81,"null"
NCT01345851,45,"null"
NCT01345136,25,"null"
NCT01342367,70,"null"
NCT01331018,10,"null"
NCT01315132,50,"null"
NCT01281514,24,"null"
NCT01270742,28,"null"
NCT01252797,36,"null"
NCT01247701,20,"null"
NCT01245712,200,"null"
NCT01244789,240,"null"
NCT01239134,71,"null"
NCT01203722,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLL Gene Rearrangement","name":"MLL Gene Rearrangement","synonyms":["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila) Gene Rearrangement","Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement","KMT2A Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122623","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(6;9)","name":"t(6;9)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 7q","name":"7q Deletion","synonyms":["del(7q)","Loss of Chromosome 7q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 11q","name":"11q Deletion","synonyms":["del11q","Loss of Chromosome 11q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C37312","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"inv(3)","name":"inv(3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C111789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 3 Chromosomal Translocation","name":"t(3;3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128647","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Less Than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36209","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 1 Chromosome 19 Chromosomal Translocation","name":"t(1;19)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128654","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 4 Chromosome 11 Chromosomal Translocation","name":"t(4;11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128652","eligibility_criterion":"inclusion"}]"
NCT01192464,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01189786,74,"null"
NCT01176604,230,"null"
NCT01176006,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DOCK8 Deficiency","name":"DOCK8 Deficiency","synonyms":["Dedicator of Cytokinesis 8 Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C126343","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DOCK8 Gene Mutation","name":"DOCK8 Gene Muatation","synonyms":["Dedicator of Cytokinesis 8 Gene Mutation","DOCK8 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128819","eligibility_criterion":"inclusion"}]"
NCT01174108,117,"null"
NCT01163357,27,"null"
NCT01130077,84,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01119066,400,"null"
NCT01117844,50,"null"
NCT01099644,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"}]"
NCT01089374,50,"null"
NCT01088789,72,"null"
NCT01088750,200,"null"
NCT01087294,150,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Greater than 5 Percent of Peripheral Blood White Cells","Blasts Over 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146656","eligibility_criterion":"exclusion"}]"
NCT01071941,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 1 Positive","name":"HSV-1 Positive","synonyms":["HHV-1 Positive","Herpes Simplex Virus Type 1 Positive","Human Herpes Virus 1 Positive","Human Alphaherpesvirus 1 Positive","Human Herpes Virus-1 Positive","Human Herpesvirus 1 Positive","HHV1 Positive","Human Herpesvirus-1 Positive","HSV1 Positive","Herpes Simplex Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141249","eligibility_criterion":"inclusion"}]"
NCT01061788,100,"null"
NCT01061515,48,"null"
NCT01059786,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CD25 Negative","name":"CD25 Negative","synonyms":["Interleukin 2 Receptor, Alpha Negative","IL2R, Alpha Chain Negative","Interleukin-2 Receptor Alpha Chain Negative","IL2R Negative","CD25 Antigen Negative","Interleukin-2 Receptor Subunit Alpha Negative","IDDM10 Negative","TCGFR Negative","IL2RA Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD11c Positive","name":"ITGAX Positive","synonyms":["Axb2 Positive","CD11c Antigen Positive","p150 95 Integrin Alpha Chain Positive","Leukocyte Adhesion Glycoprotein P150,95, Alpha Chain Positive","Integrin Alpha X Positive","Leukocyte Surface Antigen P150, 95 Positive","Integrin Alpha-X Positive","Leu M5 Positive","CD11 Antigen-Like Family Member C Positive","Antigen Cd11c (P150), Alpha Polypeptide Positive","Leukocyte Adhesion Receptor P150,95 Positive","Cr4 Positive","ITGAX Positive","Alphax Integrin Chain Positive","Myeloid Membrane Antigen, Alpha Subunit Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133812","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"IGHV4-34 Positive","name":"IGHV4-34 Positive","synonyms":["Ig Heavy Chain V-II Region ARH-77 Positive","Immunoglobulin Heavy Variable 4-34 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133813","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD103 Negative","name":"CD103 Negative","synonyms":["HUMINAE Negative","ITGAE Negative","Integrin Alpha-E Negative","Integrin, Alpha E (Antigen CD103, Human Mucosal Lymphocyte Antigen 1 Negative","Mucosal Lymphocyte 1 Antigen Negative","HML-1 Antigen Negative","Integrin, Alpha-E Negative","Alpha Polypeptide Negative","Human Mucosal Lymphocyte Antigen 1, Alpha Subunit Negative","CD103 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133816","eligibility_criterion":"inclusion"}]"
NCT01059513,40,"null"
NCT01045226,262,"null"
NCT01041027,25,"null"
NCT01028716,50,"null"
NCT01008462,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hypoploidy","name":"Hypoploidy","synonyms":["Hypodiploidy","hypodiploidy"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128304","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(4;14)","name":"t(4;14)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C95145","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(14;16)","name":"t(14;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C95146","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT01003769,60,"null"
NCT00986661,66,"null"
NCT00977860,111,"null"
NCT00971737,60,"null"
NCT00936936,67,"null"
NCT00936364,88,"null"
NCT00931931,30,"null"
NCT00911560,215,"null"
NCT00909909,150,"null"
NCT00902044,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00896493,40,"null"
NCT00887432,103,"null"
NCT00882895,12,"null"
NCT00856037,24,"null"
NCT00855803,55,"null"
NCT00809991,108,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PSA Level Ten to Fifty","name":"PSA Level Ten to Fifty","synonyms":["PSA Level 10 to 50"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C124830","eligibility_criterion":"exclusion"}]"
NCT00801489,200,"null"
NCT00796068,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT00756639,30,"null"
NCT00739141,80,"null"
NCT00707473,45,"null"
NCT00679536,30,"null"
NCT00670046,50,"null"
NCT00630565,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"inclusion"}]"
NCT00630253,25,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts 30 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 30 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141297","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Greater than 5 Percent of Peripheral Blood White Cells","Blasts Over 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146656","eligibility_criterion":"exclusion"}]"
NCT00628238,80,"null"
NCT00619879,200,"null"
NCT00612716,15,"null"
NCT00590187,300,"null"
NCT00550992,445,"null"
NCT00532740,1000,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"}]"
NCT00530010,250,"null"
NCT00501826,100,"null"
NCT00489281,25,"null"
NCT00473564,40,"null"
NCT00466531,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT00458484,32,"null"
NCT00432094,25,"null"
NCT00412594,150,"null"
NCT00368355,87,"null"
NCT00357565,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT00352976,50,"null"
NCT00338377,1500,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT00309842,300,"null"
NCT00305682,320,"null"
NCT00303849,43,"null"
NCT00282100,40,"null"
NCT00246727,300,"null"
NCT00107289,120,"null"
NCT00089245,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD276 Antigen Positive","name":"CD276 Positive","synonyms":["B7-H3 Positive","B7H3 Positive","B7RP-2 Positive","PSEC0249 Positive","CD276 Antigen Positive","M8H9 Antigen Positive","CD276 Molecule Positive","B7 Homolog 3 Positive","4Ig-B7-H3 Positive","Antigen CD276 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131770","eligibility_criterion":"inclusion"}]"
NCT00075387,60,"null"
NCT00006436,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT00002663,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT00001379,90,"null"
NCT00001337,348,"null"
NCT03597581,60,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"SLC6a8 Positive","name":"SLC6a8 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03576131,188,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03564340,264,"null"
NCT03543813,150,"null"
NCT03536728,52,"null"
NCT03522298,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT03522246,1012,"null"
NCT03522142,93,"null"
NCT03520686,388,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03515837,480,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Resistant Mutation","name":"EGFR Tyrosine Kinase Inhibitor Resistant Mutation","synonyms":["EGFR-TKI Resistant Mutation","EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96862","eligibility_criterion":"inclusion"}]"
NCT03509012,300,"null"
NCT03504397,550,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CLDN18.2 Positive","name":"CLDN18.2 Positive","synonyms":["Claudin 18 Isoform A2 Positive","Claudin-18 Isoform A2 Positive","Claudin 18.2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153150","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03490838,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03489343,48,"null"
NCT03473743,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"}]"
NCT03458728,130,"null"
NCT03457896,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation Negative","name":"BRAF Gene Mutation Negative","synonyms":["BRAF Wildtype","BRAF Mutation Negative","B-RAF1 Gene Mutation Negative","BRAF wt","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation Negative","B-RAF Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148089","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation Negative","name":"KRAS Gene Mutation Negative","synonyms":["c-K-ras Gene Mutation Negative","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation Negative","KRAS2 Gene Mutation Negative","KRAS-2 Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142879","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation Negative","name":"NRAS Gene Mutation Negative","synonyms":["N-RAS Gene Mutation Negative","Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation Negative","NRAS Wildtype","NRAS wt","NRAS Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148093","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation Negative","name":"ERBB2 Gene Mutation Negative","synonyms":["ERBB2 wt","HER2 Gene Mutation Negative","HER2 wt","v-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 Gene Mutation Negative","Erb-B2 Receptor Tyrosine Kinase Gene Mutation Negative","ERBB2 Wildtype","HER2 Wildtype","HER2/neu Gene Mutation Negative","HER-2 Gene Mutation Negative","NEU Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153091","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation Negative","name":"PIK3CA Gene Mutation Negative","synonyms":["PI3KCA Mutation Negative","PIK3CA Gene Mutation Negative","PIK3CA wt","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation Negative","p110-alpha Gene Mutation Negative","PIK3CA Mutation Negative","PIK3CA Wildtype"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148081","eligibility_criterion":"inclusion"}]"
NCT03455270,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03447314,54,"null"
NCT03441360,30,"null"
NCT03440437,51,"null"
NCT03439293,60,"null"
NCT03432741,26,"null"
NCT03432364,6,"null"
NCT03431350,60,"null"
NCT03430843,450,"null"
NCT03429101,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03418038,151,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT03417882,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0202 Positive Cells Present","name":"HLA-A*0202 Positive Cells Present","synonyms":["HLA-A*02:02 Positive Cells Present","HLA-A0202 Positive","HLA-A*02:02 Positive","HLA-A*0202 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147058","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03416179,720,"null"
NCT03415126,110,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HRAS Gene Mutation","name":"HRAS Gene Mutation","synonyms":["HRas Proto-Oncogene, GTPase Gene Mutation","Ha-ras Gene Mutation","RASH1 Gene Mutation","C-HA-RAS1 Gene Mutation","v-Ha-ras Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","C-H-RAS Gene Mutation","H-ras Gene Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","HRAS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45934","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT03414450,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 30 Percent or Less of Peripheral Blood White Cells","name":"Blasts 30 Percent or Less of Peripheral Blood White Cells","synonyms":["Blasts Less than or Equal to 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146673","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Peripheral Blood White Cells","name":"Blasts 10 Percent or More of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138056","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 30 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 30 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150453","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less Than 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138057","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Peripheral Blood White Cells","name":"Blasts Under 30 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C143154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or Less of Peripheral Blood White Cells","name":"Blasts 20 Percent or Less of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"}]"
NCT03410693,400,"null"
NCT03404726,120,"null"
NCT03399539,71,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT03384654,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03379051,30,"null"
NCT03364400,70,"null"
NCT03360890,46,"null"
NCT03348748,57,"null"
NCT03347396,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"C3D Positive","name":"C3D Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03340766,86,"null"
NCT03332589,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MEK Family Gene Mutation","name":"MEK Family Gene Mutation","synonyms":["MEK Family Mutation","Mitogen-Activated Protein Kinase Kinase Family Gene Mutation","MAP2K Family Gene Mutation","MAPKK Family Gene Mutation","MEK Mutation","Mutant MEK","Mutant MEK Family Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136422","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT03329950,105,"null"
NCT03327857,24,"null"
NCT03327727,200,"null"
NCT03321981,120,"null"
NCT03314974,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Peripheral Blood White Cells","name":"Blasts 5 Percent or Less of Peripheral Blood White Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 25 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 25 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137701","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT03303950,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 5 Rearrangement","name":"Chromosome 5 Rearrangement","synonyms":["Rearrangement of Chromosome 5"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150478","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 7 Rearrangement","name":"Chromosome 7 Rearrangement","synonyms":["Rearrangement of Chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150479","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EZH2 Gene Mutation","name":"EZH2 Gene Mutation","synonyms":["ENX1 Gene Mutation","ENX-1 Gene Mutation","KMT6 Gene Mutation","Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene Mutation","EZH2b Gene Mutation","Enhancer of Zeste 2 Gene Mutation","KTM6A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C97311","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SRSF2 Gene Mutation","name":"SRSF2 Gene Mutation","synonyms":["Splicing Factor, Arginine/Serine-Rich 2 Gene Mutation","SC35 Gene Mutation","SFRS2 Gene Mutation","Serine/Arginine-Rich Splicing Factor 2 Gene Mutation","Serine and Arginine Rich Splicing Factor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ASXL1 Gene Mutation","name":"ASXL1 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03301896,200,"null"
NCT03285178,88,"null"
NCT03279133,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"inclusion"}]"
NCT03277482,32,"null"
NCT03275454,16,"null"
NCT03275285,300,"null"
NCT03265717,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03265080,48,"null"
NCT03259035,58,"null"
NCT03257163,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Protein Deficient","synonyms":["MMR Protein Deficiency","MMR Protein Deficient","Mismatch Repair Protein Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137827","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT03250338,322,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 NP_004110.2:p.D835X","name":"FLT3 D835 Mutation","synonyms":["Fms-Related Tyrosine Kinase 3 D835X","Stem Cell Tyrosine Kinase 1 Asp835Xxx","FLT3 NP_004110.2:p.D835X","Flt-3 Receptor D835X","CD135 Antigen Asp835Xxx","Receptor-Type Tyrosine-Protein Kinase FLT3 D835X","CD135 Antigen D835X","Stem Cell Tyrosine Kinase 1 D835X","NP_004110.2:p.D835X","FLT3 Asp835 Mutation","FLT3  NP_004110.2:p.Asp835Xxx","Fetal Liver Kinase-2 Asp835Xxx","NP_004110.2:p.Asp835Xxx","FLT3-D835","FLT3 D835X","FLT3 p.Asp835Xxx","Flt-3 Receptor Asp835Xxx","FLT3 p.D835X","FLT3 Asp835Xxx","Fetal Liver Kinase-2 D835X","Receptor-Type Tyrosine-Protein Kinase FLT3 Asp835Xxx","Fms-Related Tyrosine Kinase 3 Asp835Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128921","eligibility_criterion":"inclusion"}]"
NCT03245736,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"F3 Positive","name":"F3 Positive","synonyms":["Tissue Factor Positive","Coagulation Factor III Positive","Factor III Positive","CD142 Positive","CD142 Antigen Positive","TF Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150554","eligibility_criterion":"inclusion"}]"
NCT03245489,20,"null"
NCT03239340,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT03234465,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT03229278,27,"null"
NCT03228667,105,"null"
NCT03228186,37,"null"
NCT03218826,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RAF1 Gene Mutation","name":"RAF1 Gene Mutation","synonyms":["NS5 Gene Mutation","c-Raf Gene Mutation","RAF Gene Mutation","RAF-1 Gene Mutation","v-RAF-1 Murine Leukemia Viral Oncogene Homolog 1 Gene Mutation","cRAF Gene Mutation","Raf-1 Proto-Oncogene, Serine/Threonine Kinase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133676","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CB Gain","name":"PIK3CB Gain","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"exclusion"}]"
NCT03205176,60,"null"
NCT03200340,84,"null"
NCT03194867,105,"null"
NCT03173092,160,"null"
NCT03162562,10,"null"
NCT03145558,134,"null"
NCT03136185,15,"null"
NCT03109301,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation Negative","name":"KIT Gene Mutation Negative","synonyms":["KIT wt","CD117 Gene Mutation Negative","c-KIT Gene Mutation Negative","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation Negative","KIT Wild Type","KIT Wildtype","KIT Mutation Negative","Wild-type KIT"," v-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"}]"
NCT03102047,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT03099174,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03089645,204,"null"
NCT03073525,25,"null"
NCT03071094,30,"null"
NCT03054909,28,"null"
NCT03045406,1168,"null"
NCT03044353,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATTR wild type","name":"ATTR wild type","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TTR mutation","name":"TTR mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03038230,50,"null"
NCT03025698,60,"null"
NCT02988440,50,"null"
NCT02980341,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB3 Positive","name":"ERBB3 Positive","synonyms":["c-erbB-3 Positive","c-erbB3 Positive","ErbB-3 Positive","HER3 Positive","Receptor Tyrosine-Protein Kinase erbB-3 Positive","HER-3 Positive","ERBB3 Receptor Protein-Tyrosine Kinase Positive","Tyrosine Kinase-Type Cell Surface Receptor HER3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02979522,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02973399,5,"null"
NCT02972034,96,"null"
NCT02953340,218,"null"
NCT02923466,93,"null"
NCT02914327,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BTK Gene Mutation","name":"BTK Gene Mutation","synonyms":["XLA Gene Mutation","AGMX1 Gene Mutation","Bruton Tyrosine Kinase Gene Mutation","IMD1 Gene Mutation","Bruton Agammaglobulinemia Tyrosine Kinase Gene Mutation","BPK Gene Mutation","PSCTK1 Gene Mutation","AT Gene Mutation","ATK Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132254","eligibility_criterion":"inclusion"}]"
NCT02882282,250,"null"
NCT02881242,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02859324,21,"null"
NCT02829099,114,"null"
NCT02815982,66,"null"
NCT02795429,87,"null"
NCT02768363,156,"null"
NCT02751918,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT02737306,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Peripheral Blood White Cells","name":"Blasts Under 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41399","eligibility_criterion":"inclusion"}]"
NCT02678338,40,"null"
NCT02676986,235,"null"
NCT02663908,900,"null"
NCT02659540,18,"null"
NCT02593045,60,"null"
NCT02584933,150,"null"
NCT02540330,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02536300,240,"null"
NCT02531425,10,"null"
NCT02525692,76,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"IDH1 NP_005887.2:p.R132X","name":"IDH1 R132X Mutation","synonyms":["DH1 Arg132Xxx","IDH1 p.Arg132Xxx","Cytosolic NADP-Isocitrate Dehydrogenase Protein R132X","Isocitrate Dehydrogenase [NADP] Cytoplasmic Arg132Xxx","NP_005887.2:p.Arg132Xxx","NP_005887.2:p.R132X","IDH1 R132X","IDH1 NP_005887.2:p.Arg132Xxx","Isocitrate Dehydrogenase [NADP] Cytoplasmic R132X","IDH1 p.R132X","Cytosolic NADP-Isocitrate Dehydrogenase Protein Arg132Xxx","IDH1 NP_005887.2:p.R132X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117280","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"H3 K27M Mutation","name":"Histone 3 K27M Mutation","synonyms":["Histone H3 K28M","H3 K28M Mutation","H3 Lys28Met","H3 K27M","Histone H3 Lys27Met","H3 K28M","Histone H3 Lys28Met","H3 Lys27Met","Histone H3 K27M","H3 p.Lys28Met","H3 K27M Mutation","H3 p.K28M"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129310","eligibility_criterion":"inclusion"}]"
NCT02519270,62,"null"
NCT02516696,320,"null"
NCT02508441,91,"null"
NCT02494258,125,"null"
NCT02458638,725,"null"
NCT02448589,80,"null"
NCT02446093,44,"null"
NCT02442414,30,"null"
NCT02391727,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"}]"
NCT02340156,26,"null"
NCT02260804,174,"null"
NCT02224599,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TAPA Positive","name":"TAPA Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02207179,40,"null"
NCT02202993,24,"null"
NCT02199665,100,"null"
NCT02134067,74,"null"
NCT02130700,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02124148,205,"null"
NCT02052128,60,"null"
NCT02047344,60,"null"
NCT02041299,300,"null"
NCT02000934,182,"null"
NCT01975701,26,"null"
NCT01893801,25,"null"
NCT01855750,800,"null"
NCT01789281,52,"null"
NCT01767636,39,"null"
NCT01742299,250,"null"
NCT01739634,10,"null"
NCT01738594,48,"null"
NCT01735955,300,"null"
NCT01695590,40,"null"
NCT01690468,36,"null"
NCT01672463,31,"null"
NCT01644591,49,"null"
NCT01630733,700,"null"
NCT01619761,13,"null"
NCT01605318,104,"null"
NCT01584258,1716,"null"
NCT01573468,580,"null"
NCT01551693,50,"null"
NCT01543607,10,"null"
NCT01524991,36,"null"
NCT01501604,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT01470131,300,"null"
NCT01459666,50,"null"
NCT01455389,57,"null"
NCT01361711,60,"null"
NCT01296243,57,"null"
NCT01280565,200,"null"
NCT01221870,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01221753,60,"null"
NCT01215877,33,"null"
NCT01199718,22,"null"
NCT01053013,60,"null"
NCT00981578,50,"null"
NCT00959140,30,"null"
NCT00956787,25,"null"
NCT00914628,170,"null"
NCT00891280,55,"null"
NCT00821301,30,"null"
NCT00814073,200,"null"
NCT00812240,222,"null"
NCT00777244,200,"null"
NCT00709215,44,"null"
NCT00706862,1100,"null"
NCT00701987,12,"null"
NCT00685204,90,"null"
NCT00669747,45,"null"
NCT00651677,128,"null"
NCT00565708,1200,"null"
NCT00441818,59,"null"
NCT00419731,120,"null"
NCT00394628,60,"null"
NCT00364143,40,"null"
NCT00271063,34,"null"
NCT00147056,10,"null"
NCT01804686,700,"null"
NCT02646839,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIR2DL1 Polymorphism Positive","name":"KIR2DL1 Polymorphism Positive","synonyms":["KIR2DL1 Polymorphism Present","CD158A Polymorphism Positive","Killer Cell Immunoglobulin Like Receptor, Two Ig Domains and Long Cytoplasmic Tail 1 Gene Polymorphism Positive","KIR2DS5 Polymorphism Positive","NKAT-1 Polymorphism Positive","NKAT Polymorphism Positive","NKAT1 Polymorphism Positive","KIR221 Polymorphism Positive","KIR2DL1 Gene Polymorphism Positive","KIR-K64 Polymorphism Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146646","eligibility_criterion":"inclusion"}]"
NCT03441113,200,"null"
NCT02955940,150,"null"
NCT02362464,40,"null"
NCT02049515,150,"null"
NCT03145337,224,"null"
NCT02510261,228,"null"
NCT02370082,150,"null"
NCT00832871,6,"null"
NCT00194714,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT03334344,80,"null"
NCT02354612,50,"null"
NCT02243124,18,"null"
NCT02065973,18,"null"
NCT01109069,200,"null"
NCT03416816,90,"null"
NCT03326102,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03604991,278,"null"
NCT03602586,23,"null"
NCT03598257,300,"null"
NCT03598244,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Fusion Gene Positive","name":"MET Gene Fusion Positive","synonyms":["MET Gene Fusion","Hepatocyte Growth Factor Receptor Gene Fusion Positive","HGFR Gene Fusion Positive","MET Proto-Oncogene, Receptor Tyrosine Kinase Fusion Gene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 7 gain","name":"Chromosome 7 gain","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03595124,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TFE3 Positive","name":"TFE3 Positive","synonyms":["Transcription Factor E3 Positive","Transcription Factor Binding to IGHM Enhancer 3 Positive","TFEA Positive","RCCX1 Positive","bHLHe33 Positive","RCCP2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132234","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TFEB Gene Translocation","name":"TFEB Gene Translocation","synonyms":["BHLHE35 Gene Translocation","Transcription Factor EB Gene Translocation","TCFEB Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153273","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TFE3 Gene Translocation","name":"TFE3 Gene Translocation","synonyms":["TFEA Gene Translocation","RCCX1 Gene Translocation","bHLHe33 Gene Translocation","Transcription Factor Binding to IGHM Enhancer 3 Gene Translocation","RCCP2 Gene Translocation","Transcription Factor E3 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153272","eligibility_criterion":"inclusion"}]"
NCT03592641,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Wild Type","name":"BRAF V600 Wild Type","synonyms":["BRAF V600V","BRAF p.V600V","BRAF V600 wt","B-RAF1 V600 Wild Type","Serine/Threonine-Protein Kinase B-raf V600 Wild Type","B-RAF V600 Wild Type"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134468","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03581292,115,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRAF V600E Mutation Negative","name":"BRAF V600E Mutation Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"H3 K27M Mutation Negative","name":"H3 K27M Mutation Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03571828,85,"null"
NCT03565991,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT03518320,25,"null"
NCT03515551,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"LAGE-1A Positive","name":"LAGE-1A Positive","synonyms":["Isoform LAGE-1A Positive","CT6.2a Positive","L Antigen Family Member 1 Isoform A Positive","LAGE-1S Positive","Cancer/Testis Antigen 6.2a Positive","Cancer/Testis Antigen 2 Isoform LAGE-1A Positive","LAGE-1a Protein Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153126","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT03513952,54,"null"
NCT03484819,99,"null"
NCT03419403,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT03416335,44,"null"
NCT03348631,43,"null"
NCT03289299,83,"null"
NCT03253679,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCNE1 Gene Amplification","name":"CCNE1 Gene Amplification","synonyms":["Cyclin E1 Gene Amplification","CCNE1 Amplification","CCNE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36682","eligibility_criterion":"inclusion"}]"
NCT03199885,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02842125,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Positive","name":"TP53 Positive","synonyms":["TRP53 Positive","Cellular Tumor Antigen p53 Positive","p53 Positive","Transformation-Related Protein 53 Positive","Antigen NY-CO-13 Positive","Tumor Protein p53 Positive","Tumor Suppressor p53 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146668","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 wt Allele","name":"TP53 wt Allele","synonyms":["Tumor Protein p53 wt Allele","Tumor Protein P53 (Li-Fraumeni Syndrome) wt Allele","TRP53","P53","LFS1","p53 wild type","BCC7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52271","eligibility_criterion":"inclusion"}]"
NCT03605719,62,"null"
NCT03582033,65,"null"
NCT03579771,34,"null"
NCT03579758,264,"null"
NCT03575234,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03574779,40,"null"
NCT03572764,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146669","eligibility_criterion":"inclusion"}]"
NCT03570476,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Monoallelic Inactivation","name":"ATM Monoallelic Inactivation","synonyms":["ATM Serine/Threonine Kinase Monoallelic Gene Inactivation","AT Mutated Monoallelic Gene Inactivation","Ataxia Telangiectasia Mutated Monoallelic Gene Inactivation","ATM Monoallelic Gene Inactivation","A-T Mutated Monoallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150584","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Biallelic Inactivation","name":"BRCA1 Biallelic Inactivation","synonyms":["Breast Cancer Type 1 Susceptibility Biallelic Gene Inactivation","BRCA1 Biallelic Gene Inactivation","BROVCA1 Biallelic Gene Inactivation","Breast Cancer 1 Biallelic Gene Inactivation","Breast Cancer 1, Early Onset Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142121","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Biallelic Inactivation","name":"ATM Biallelic Inactivation","synonyms":["AT Mutated Biallelic Gene Inactivation","Ataxia Telangiectasia Mutated Biallelic Gene Inactivation","ATM Serine/Threonine Kinase Biallelic Gene Inactivation","ATM Biallelic Gene Inactivation","A-T Mutated Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142120","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Biallelic Inactivation","name":"BRCA2 Biallelic Inactivation","synonyms":["Breast Cancer Type 2 Susceptibility Biallelic Gene Inactivation","BRCA2 Biallelic Gene Inactivation","BROVCA2 Biallelic Gene Inactivation","Breast Cancer 2, Early Onset Biallelic Gene Inactivation","BRCC2 Biallelic Gene Inactivation","Breast Cancer 2 Biallelic Gene Inactivation","FANCD1 Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142122","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Biallelic Inactivation","name":"PALB2 Biallelic Inactivation","synonyms":["PALB2 Biallelic Gene Inactivation","Fanconi Anemia, Complementation Group N Biallelic Gene Inactivation","Partner and Localizer of BRCA2 Biallelic Gene Inactivation","FANCN Biallelic Gene Inactivation","PNCA3 Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150582","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCA Biallelic Inactivation","name":"FANCA Biallelic Inactivation","synonyms":["FACA Biallelic Gene Inactivation","FANCA Biallelic Gene Inactivation","FA1 Biallelic Gene Inactivation","FAH Biallelic Gene Inactivation","FA-H Biallelic Gene Inactivation","FAA Biallelic Gene Inactivation","FA Biallelic Gene Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150583","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"}]"
NCT03557970,100,"null"
NCT03552796,36,"null"
NCT03552029,156,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT03549338,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Anti-EGFR Monoclonal Antibody","name":"Anti-EGFR Monoclonal Antibody","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03546361,36,"null"
NCT03544281,90,"null"
NCT03539744,244,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"}]"
NCT03537599,30,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT03534180,20,"null"
NCT03531918,72,"null"
NCT03520959,248,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT03517956,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Gene Mutation","name":"FGFR Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor Family Gene Mutation","FGFR Mutation","FGF Receptor Gene Mutation","FGFR Family Mutation","FGF Receptor Gene Family Mutation","Fibroblast Growth Factor Receptor Gene Mutation","FGFR Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146713","eligibility_criterion":"inclusion"}]"
NCT03516981,192,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating BRAF Mutation","name":"Activating BRAF Mutation","synonyms":["B-RAF1 Activating Mutation","B-RAF Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Activating Mutation","B-Raf Proto-Oncogene, Serine/Threonine Kinase Activating Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B Activating Mutation","BRAF Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139795","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT03516812,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"}]"
NCT03515629,585,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"exclusion"}]"
NCT03513562,28,"null"
NCT03512405,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03499353,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Germline BRCA2 Gene Mutation","name":"Germline BRCA2 Gene Mutation","synonyms":["Germline FANCD1 Gene Mutation","Germline Breast Cancer Type 2 Susceptibility Gene Mutation","Germline BRCA2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150630","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Germline BRCA1 Gene Mutation","name":"Germline BRCA1 Gene Mutation","synonyms":["Germline BROVCA1 Gene Mutation","Germline Breast Cancer Type 1 Susceptibility Gene Mutation","Germline BRCA1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150629","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03495921,140,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ewing's Sarcoma Gene translocation mutation","name":"EWS translocation mutation","synonyms":["Ewing Sarcoma Breakpoint Region 1","Ewing's Sarcoma Gene translocation mutation","RNA Binding Protein EWS","EWSR1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128648","eligibility_criterion":"inclusion"}]"
NCT03484923,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Wild Type","name":"BRAF V600 Wild Type","synonyms":["BRAF V600V","BRAF p.V600V","BRAF V600 wt","B-RAF1 V600 Wild Type","Serine/Threonine-Protein Kinase B-raf V600 Wild Type","B-RAF V600 Wild Type"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134468","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT03484520,44,"null"
NCT03454243,42,"null"
NCT03445663,120,"null"
NCT03442556,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Repair Biallelic Inactivation","name":"Homologous Recombination Repair Biallelic Inactivation","synonyms":["Recombination Repair Biallelic Inactivation","HRR Biallelic Inactivation","HHR Biallelic Inactivation","Homologous Recombination Pathway Biallelic Inactivation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150641","eligibility_criterion":"inclusion"}]"
NCT03441100,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA Positive","name":"HLA Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03435848,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR-ABL1 Translocation","name":"BCR-ABL1 Translocation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Peripheral Blood White Cells","name":"Blasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36213","eligibility_criterion":"inclusion"}]"
NCT03435796,191,"null"
NCT03411070,50,"null"
NCT03370159,58,"null"
NCT03346135,34,"null"
NCT03332667,24,"null"
NCT03317405,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT03274479,18,"null"
NCT03272633,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2 Gene Mutation","name":"JAK2 Gene Mutation","synonyms":["JAK2 Mutation","JAK2 Gene Variant","Janus Kinase 2 Gene Variant","Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT03266627,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T-Lymphocyte","name":"T Cell","synonyms":["T Lymphocyte","T-Cell","Thymus-Dependent Lymphocytes","Thymus Derived Lymphocyte","T-Lymphocyte"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C12476","eligibility_criterion":"inclusion"}]"
NCT03260504,27,"null"
NCT03258931,510,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 NP_004110.2:p.D835X","name":"FLT3 D835 Mutation","synonyms":["Fms-Related Tyrosine Kinase 3 D835X","Stem Cell Tyrosine Kinase 1 Asp835Xxx","FLT3 NP_004110.2:p.D835X","Flt-3 Receptor D835X","CD135 Antigen Asp835Xxx","Receptor-Type Tyrosine-Protein Kinase FLT3 D835X","CD135 Antigen D835X","Stem Cell Tyrosine Kinase 1 D835X","NP_004110.2:p.D835X","FLT3 Asp835 Mutation","FLT3  NP_004110.2:p.Asp835Xxx","Fetal Liver Kinase-2 Asp835Xxx","NP_004110.2:p.Asp835Xxx","FLT3-D835","FLT3 D835X","FLT3 p.Asp835Xxx","Flt-3 Receptor Asp835Xxx","FLT3 p.D835X","FLT3 Asp835Xxx","Fetal Liver Kinase-2 D835X","Receptor-Type Tyrosine-Protein Kinase FLT3 Asp835Xxx","Fms-Related Tyrosine Kinase 3 Asp835Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128921","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT03238703,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03196180,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT03068832,10,"null"
NCT02885649,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02847949,62,"null"
NCT02836470,120,"null"
NCT02587871,34,"null"
NCT02487459,40,"null"
NCT02472626,64,"null"
NCT02451865,30,"null"
NCT02258243,3,"null"
NCT01915472,50,"null"
NCT01858181,9,"null"
NCT02379416,24,"null"
NCT02211755,35,"null"
NCT03516279,40,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02582697,500,"null"
NCT01019850,42,"null"
NCT03603223,26,"null"
NCT03579927,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03579888,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","name":"Blasts More Than 5 Percent of Peripheral Blood White Cells","synonyms":["Blasts Greater than 5 Percent of Peripheral Blood White Cells","Blasts Over 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146656","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Anti-Mouse Antibodies Negative","name":"HAMA Negative","synonyms":["Human Anti-Mouse Antibodies Absent","Human Anti-Mouse Antibodies Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128838","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT03579316,70,"null"
NCT03565783,22,"null"
NCT03554044,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03541850,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.03","name":"PSA Level Greater than 0.03","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141369","eligibility_criterion":"inclusion"}]"
NCT03531645,15,"null"
NCT03525873,398,"null"
NCT03516617,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IGH/CCND1 Fusion Negative","name":"IGH/CCND1 Fusion Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03515941,40,"null"
NCT03514927,32,"null"
NCT03513484,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Translocation 11q23","name":"11q23 translocation","synonyms":["t(V;11)(v;q23)","t(v;11q23)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36517","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fibroblast Growth Factor Basic Form Measurement","name":"FGF2","synonyms":["fibroblast growth factor 2 (basic)","basic fibroblast growth factor","FGFB","bFGF"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C18569","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HOXA9 Positive","name":"HOXA9 Positive","synonyms":["Hox-1G Positive","Homeobox 1G Positive","Hox-1.7 Positive","HOX1.7 Positive","HOX1G Positive","Homeobox A9 Positive","Hox-A9 Positive","Homeo Box A9 Positive","Homeobox 1.7 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150643","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HOXA10 Positive","name":"HOXA10 Positive","synonyms":["Homeo Box A10 Positive","Hox-1.8 Positive","HOX1.8 Positive","HOX1H Positive","Hox-A10 Positive","Hox-1H Positive","Homeobox 1.8 Positive","Homeobox 1H Positive","Homeobox A10 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150642","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLL Partial Tandem Duplication","name":"MLL-PTD","synonyms":["MLL Partial Tandem Duplication","Partial Tandem Duplication of MLL"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C113507","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT03511222,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT03508570,58,"null"
NCT03507491,24,"null"
NCT03506373,47,"null"
NCT03506139,40,"null"
NCT03506048,30,"null"
NCT03503344,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Two","name":"PSA Level Greater than Two","synonyms":["PSA Level Greater than 2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138948","eligibility_criterion":"inclusion"}]"
NCT03496662,50,"null"
NCT03496519,44,"null"
NCT03486197,20,"null"
NCT03485950,100,"null"
NCT03479268,30,"null"
NCT03477864,24,"null"
NCT03475004,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"exclusion"}]"
NCT03473730,30,"null"
NCT03471364,80,"null"
NCT03469284,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT03468218,53,"null"
NCT03467516,56,"null"
NCT03455556,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT03452930,128,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT03452332,18,"null"
NCT03450122,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT03446157,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03439085,77,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-18 Positive","name":"HPV-18 Positive","synonyms":["Human Papilloma Virus 18 Positive","HPV18 Positive","Human Papillomavirus-18 Positive","Human Papilloma Virus-18 Positive","Human Papillomavirus 18 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131711","eligibility_criterion":"inclusion"}]"
NCT03435952,18,"null"
NCT03432676,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Deletion","name":"ATM Gene Deletion","synonyms":["ATM Serine/Threonine Kinase Gene Amplification","Ataxia Telangiectasia Mutated Gene Amplification","AT Mutated Gene Amplification","A-T Mutated Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133680","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT03422094,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT03420963,32,"null"
NCT03419130,60,"null"
NCT03417284,90,"null"
NCT03417154,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03399773,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03376659,54,"null"
NCT03374852,33,"null"
NCT03373305,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT03367546,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ABCD1 Gene Mutation","name":"ABCD1 Gene Mutation","synonyms":["ATP-Binding Cassette, Subfamily D, Member 1 Gene Mutation","ALDP Gene Mutation","AMN Gene Mutation","ABC42 Gene Mutation","ATP Binding Cassette Subfamily D Member 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147902","eligibility_criterion":"inclusion"}]"
NCT03365661,43,"null"
NCT03361436,16,"null"
NCT03360708,20,"null"
NCT03359460,20,"null"
NCT03344211,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT03337087,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Homologous Recombination Deficiency","name":"HRD","synonyms":["Homologous Recombination Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT03331341,30,"null"
NCT03326310,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Peripheral Blood White Cells","name":"Blasts 5 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141299","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT03325465,44,"null"
NCT03318900,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"COL6A3 Positive","name":"COL6A3 Positive","synonyms":["Type VI Collagen Alpha 3 Chain Positive","Collagen Alpha-3(VI) Chain Positive","Collagen Type VI Alpha 3 Chain Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150668","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PRAME Positive","name":"PRAME Positive","synonyms":["Cancer/Testis Antigen 130 Positive","CT130 Positive","Preferentially Expressed Antigen in Melanoma Positive","MAPE Positive","Melanoma Antigen Preferentially Expressed in Tumors Positive","OIP-4 Positive","OIP4 Positive","Opa-Interacting Protein 4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133814","eligibility_criterion":"inclusion"}]"
NCT03299088,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT03285607,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03283761,39,"null"
NCT03267680,80,"null"
NCT03259503,30,"null"
NCT03257761,90,"null"
NCT03232307,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT03219047,50,"null"
NCT03207542,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"}]"
NCT03207529,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Positive","name":"PTEN Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03203525,52,"null"
NCT03140670,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PALB2 Gene Mutation","name":"Deleterious PALB2 Gene Mutation","synonyms":["Deleterious Partner and Localizer of BRCA2 Gene Mutation","Deleterious FANCN Gene Mutation","Deleterious Fanconi Anemia, Complementation Group N Gene Mutation","Deleterious PNCA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131775","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT03126461,24,"null"
NCT03123978,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03122444,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03122301,20,"null"
NCT03121677,10,"null"
NCT03111069,28,"null"
NCT03087071,84,"[{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NRAS Exon 3 Mutation","name":"NRAS Exon 3 Mutation","synonyms":["N-RAS Exon 3 Mutation","Neuroblastoma RAS Viral Oncogene Homolog Exon 3 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135719","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR S492R Gene Mutation","name":"EGFR S492R Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Exon 4 Mutation","name":"KRAS Exon 4 Mutation","synonyms":["KRAS2 Exon 4 Mutation","c-K-ras Exon 4 Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 4 Mutation","KRAS-2 Exon 4 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135717","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Exon 3 Mutation","name":"KRAS Exon 3 Mutation","synonyms":["KRAS-2 Exon 3 Mutation","c-K-ras Exon 3 Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 3 Mutation","KRAS2 Exon 3 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135716","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NRAS Exon 2 Mutation","name":"NRAS Exon 2 Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Exon 2 Mutation","N-RAS Exon 2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135718","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS Exon 2 Mutation","name":"KRAS Exon 2 Mutation","synonyms":["v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 2 Mutation","c-K-ras Exon 2 Mutation","KRAS2 Exon 2 Mutation","KRAS-2 Exon 2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135715","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"NRAS Exon 4 Mutation","name":"NRAS Exon 4 Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Exon 4 Mutation","N-RAS Exon 4 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135720","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRAF Codon 600 Mutation","name":"BRAF Codon 600 Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT03058939,60,"null"
NCT03011671,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MGMT Gene Promoter Hypermethylation","name":"MGMT Gene Promoter Hypermethylation","synonyms":["Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation","O-6-Methylguanine-DNA Methyltransferase Gene Promoter Hypermethylation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139588","eligibility_criterion":"inclusion"}]"
NCT03003546,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02962661,72,"null"
NCT02948101,15,"null"
NCT02905591,46,"null"
NCT02757391,40,"null"
NCT02756130,17,"null"
NCT02718755,20,"null"
NCT02699853,218,"null"
NCT02699723,5,"null"
NCT02615574,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02538926,71,"null"
NCT02530034,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02521090,57,"null"
NCT02413853,100,"null"
NCT02353026,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02298595,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02259725,48,"null"
NCT02211027,37,"null"
NCT01904123,33,"null"
NCT01871311,22,"null"
NCT01835288,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NPM1 Gene Mutation","name":"NPM1 Gene Mutation","synonyms":["Mutation of the Nucleophosmin Gene","Nucleophosmin Gene Mutation","NPM1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82429","eligibility_criterion":"inclusion"}]"
NCT02037529,910,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03213665,49,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Loss of INI 1 Protein Expression","name":"Loss of INI1 Protein Expression","synonyms":["Loss of BAF47 Protein Expression","Loss of SMARCB1 Protein Expression","Loss of INI1 Protein Expression","Loss of SNF5 Homolog Protein Expression","Loss of SWI/SNF-Related Matrix-Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121966","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Loss of BRG1 Protein Expression","name":"Loss of BRG1 Protein Expression","synonyms":["Loss of SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 4 Protein Expression","Loss of Protein Brahma Homolog 1 Protein Expression","Loss of Brahma Protein Homolog 1 Protein Expression","Loss of Possible Global Transcription Activator SNF2L4 Protein Expression","Loss of BRG-1 Protein Expression","Loss of BAF190A Protein Expression","Loss of  ATP-Dependent Helicase SMARCA4 Protein Expression","Loss of SNF2-Beta Protein Expression","Loss of SMARCA4 Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129500","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"EZH2 Gain of Function","name":"EZH2 Gain of Function","synonyms":["KTM6A Gain of Function Mutation","EZH2 Gain of Function Mutation","Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene Gain of Function Mutation","ENX-1 Gain of Function Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142125","eligibility_criterion":"inclusion"}]"
NCT02546102,414,"null"
NCT03196401,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"}]"
NCT03164057,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells","name":"Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36229","eligibility_criterion":"inclusion"}]"
NCT03093922,62,"null"
NCT02291055,66,"null"
NCT03250299,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02892318,40,"null"
NCT02523014,69,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"PTCH1 Gene Mutation","name":"PTCH1 Gene Mutation","synonyms":["PTCH Gene Mutation","PTC Gene Mutation","Patched Homolog (Drosophila) Gene Mutation","Patched Homolog 1 Gene Mutation","PTC1 Gene Mutation","Patched 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133669","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"SMO Gene Mutation","name":"SMO Gene Mutation","synonyms":["Smoothened Homolog (Drosophila) Gene Mutation","Smoothened Homolog Gene Mutation","Smoothened, Frizzled Class Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C124793","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"}]"
NCT02085408,747,"null"
NCT01935934,72,"null"
NCT03031730,40,"null"
NCT02921256,348,"null"
NCT03061188,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51 Gene Mutation","name":"RAD51 Gene Mutation","synonyms":["HRAD51 Gene Mutation","FANCR Gene Mutation","BRCC5 Gene Mutation","HsRad51 Gene Mutation","RAD51A Gene Mutation","RAD51, S. cerevisiae, Homolog of A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131795","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCE Gene Mutation","name":"FANCE Gene Mutation","synonyms":["Fanconi Anemia, Complementation Group E Gene Mutation","FACE Gene Mutation","FAE Gene Mutation","Fanconi Anemia Complementation Group E Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131791","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATR Gene Mutation","name":"ATR Gene Mutation","synonyms":["FRP1 Gene Mutation","ATR Serine/Threonine Kinase Gene Mutation","Ataxia Telangiectasia and Rad3 Related Gene Mutation","MEC1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131479","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCA Gene Amplification","name":"FANCA Gene Amplification","synonyms":["FANCH Gene Amplification","Fanconi Anemia, Complementation Group A Gene Amplification","Fanconi Anemia Complementation Group A Gene Amplification","FA Gene Amplification","FAA Gene Amplification","FACA Gene Amplification","FA-H Gene Amplification","Fanconi Anemia, Complementation Group H Gene Amplification","Fanconi Anemia, Type 1 Gene Amplification","FAH Gene Amplification","FA1 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131457","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCD2 Gene Amplification","name":"FANCD2 Gene Amplification","synonyms":["FAD Gene Amplification","FACD Gene Amplification","FA-D2 Gene Amplification","FA4 Gene Amplification","FANCD Gene Amplification","Fanconi Anemia, Complementation Group D2 Gene Amplification","Fanconi Anemia Complementation Group D2 Gene Amplification","FAD2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERCC2 Gene Mutation","name":"ERCC2 Gene Mutation","synonyms":["CXPD Gene Mutation","MAG Gene Mutation","TTD Gene Mutation","XPDC Gene Mutation","Excision-Repair, Complementing Defective, In Chinese Hamster, 2 Gene Mutation","XP4 Gene Mutation","EM9 Gene Mutation","Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 Gene Mutation","TTD1 Gene Mutation","XPD Gene Mutation","ERCC Excision Repair 2, TFIIH Core Complex Helicase Subunit Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131800","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"POLQ Gene Mutation","name":"POLQ Gene Mutation","synonyms":["Polymerase (DNA Directed), Theta Gene Mutation","Polymerase, DNA, Theta Gene Mutation","Polymerase (DNA) Theta Gene","DNA Polymerase Theta Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131804","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK1 Gene Mutation","name":"CHEK1 Gene Mutation","synonyms":["CHK1 Gene Mutation","CHK1 Checkpoint Homolog (S. pombe) Gene Mutation","Checkpoint Kinase 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BARD1 Gene Mutation","name":"BARD1 Gene Mutation","synonyms":["BARD-1 Gene Mutation","BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK2 Gene Mutation","name":"CHEK2 Gene Mutation","synonyms":["LFS2 Gene Mutation","CHK2 Gene Mutation","CHK2 Checkpoint Homolog (S. pombe) Gene Mutation","CDS1 Gene Mutation","Checkpoint Kinase 2 Gene Mutation","hCds1 Gene Mutation","RAD53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BAP1 Gene Mutation","name":"BAP1 Gene Mutation","synonyms":["UCHL2 Gene Mutation","BRCA1 Associated Protein 1 Gene Mutation","BAP1 Mutation","BRCA1-Associated Protein 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128813","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NBN Gene Mutation","name":"NBN Gene Mutation","synonyms":["AT-V2 Gene Mutation","P95 Gene Mutation","AT-V1 Gene Mutation","Nijmegen Breakage Syndrome 1 Gene Mutation","ATV Gene Mutation","NBS1 Gene Mutation","NBS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131806","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EMSY Gene Amplification","name":"EMSY Gene Amplification","synonyms":["GL002 Gene Amplification","EMSY, BRCA2 Interacting Transcriptional Repressor Gene Amplification","C11orf30 Gene Amplification","EMSY, BRCA2-Interacting Transcriptional Repressor Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131453","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PRKDC Gene Mutation","name":"PRKDC Gene Mutation","synonyms":["DNA-PKcs Gene Mutation","Protein Kinase, DNA-Activated, Catalytic Polypeptide Gene Mutation","HYRC1 Gene Mutation","p350 Gene Mutation","Hyperradiosensitivity Complementing 1, Mouse, Homolog of Gene Mutation","Hyper-Radiosensitivity of Murine SCID Mutation, Complementing 1 Gene Mutation","XRCC7 Gene Mutation","DNAPK Gene Mutation","DNPK1 Gene Mutation","HYRC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131799","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"POLD1 Gene Mutation","name":"POLD1 Gene Mutation","synonyms":["Polymerase (DNA Directed), Delta 1, Catalytic Subunit (125kD) Gene Mutation","CRCS10 Gene Mutation","POLD Gene Mutation","MDPL Gene Mutation","CDC2 Homolog (S. cerevisiae) Gene Mutation","DNA Polymerase Delta 1, Catalytic Subunit Gene Mutation","Polymerase (DNA) Delta 1, Catalytic Subunit Gene Mutation","Polymerase (DNA Directed), Delta 1, Catalytic Subunit Gene Mutation","CDC2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131798","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCC Gene Amplification","name":"FANCC Gene Amplification","synonyms":["Fanconi Anemia Complementation Group C Gene Amplification","FA3 Gene Amplification","FAC Gene Amplification","FACC Gene Amplification","Fanconi Anemia, Complementation Group C Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131456","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"POLE Gene Mutation","name":"POLE Gene Mutation","synonyms":["POLE1 Exonuclease Gene Mutation","DNA Polymerase Epsilon, Catalytic Subunit Exonuclease Gene Mutation","DNA Polymerase Epsilon Catalytic Subunit A Exonuclease Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131797","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCC Gene Mutation","name":"FANCC Gene Mutation","synonyms":["Fanconi Anemia Complementation Group C Gene Mutation","Fanconi Anemia, Complementation Group C Gene Mutation","FACC Gene Mutation","FAC Gene Mutation","FA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131792","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDK12 Gene Mutation","name":"CDK12 Gene Mutation","synonyms":["Cyclin-Dependent Kinase 1 Gene Mutation","CRK7 Gene Mutation","CRKR Gene Mutation","Cdc2-Related Kinase, Arginine/Serine-Rich Gene Mutation","CDC2 Related Protein Kinase 7 Gene Mutation","CRKRS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131796","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD50 Gene Mutation","name":"RAD50 Gene Mutation","synonyms":["RAD50-2 Gene Mutation","RAD502 Gene Mutation","RAD50 Homolog, Double Strand Break Repair Protein Gene Mutation","RAD50 Double Strand Break Repair Protein Gene Mutation","RAD50 (S. cerevisiae) Homolog Gene Mutation","RAD50, S. cerevisiae, Homolog of Gene Mutation","RAD50 Homolog (S. cerevisiae) Gene Mutation","hRad50 Gene Mutation","NBSLD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131793","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCA Gene Mutation","name":"FANCA Gene Mutation","synonyms":["FA Gene Mutation","FA1 Gene Mutation","Fanconi Anemia, Complementation Group H Gene Mutation","Fanconi Anemia, Complementation Group A Gene Mutation","FACA Gene Mutation","FA-H Gene Mutation","FAA Gene Mutation","Fanconi Anemia Complementation Group A Gene Mutation","FAH Gene Mutation","Fanconi Anemia, Type 1 Gene Mutation","FANCH Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131794","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MRE11 Gene Mutation","name":"MRE11 Gene Mutation","synonyms":["MRE11A Gene Mutation","MRE11 Homolog A, Double Strand Break Repair Nuclease Gene Mutation","Meiotic Recombination (S. cerevisiae) 11 Homolog A Gene Mutation","MRE11B Gene Mutation","HNGS1 Gene Mutation","ATLD Gene Mutation","MRE11 Meiotic Recombination 11 Homolog A (S. cerevisiae) Gene Mutation","MRE11 Homolog, Double Strand Break Repair Nuclease Gene Mutation","Meiotic Recombination 11, S. cerevisiae, Homolog of, A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131805","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCE Gene Amplification","name":"FANCE Gene Amplification","synonyms":["FACE Gene Amplification","Fanconi Anemia, Complementation Group E Gene Amplification","Fanconi Anemia Complementation Group E Gene Amplification","FAE Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCD2 Gene Mutation","name":"FANCD2 Gene Mutation","synonyms":["FANCD Gene Mutation","FAD Gene Mutation","Fanconi Anemia, Complementation Group D2 Gene Mutation","Fanconi Anemia Complementation Group D2 Gene Mutation","FA4 Gene Mutation","FAD2 Gene Mutation","FA-D2 Gene Mutation","FACD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131790","eligibility_criterion":"inclusion"}]"
NCT02484443,44,"null"
NCT02382614,200,"null"
NCT02339571,400,"null"
NCT00983398,55,"null"
NCT03258554,523,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene","name":"CDKN2A","synonyms":["p16","Cyclin-Dependent Kinase Inhibitor 2A, Isoforms 1/2/3","P16(INK4A)","Cyclin-Dependent Kinase Inhibitor 2A, Isoform 4","p16-INK4","p19Arf","CDK4I","Cyclin-Dependent Kinase Inhibitor 2A","Multiple Tumor Suppressor 1","TP16","p16INK4a","Cyclin-Dependent Kinase Inhibitor p12","P16","CMM2","P16INK4A","CDK4 Inhibitor","INK4","ARF","P16INK4","Cyclin-Dependent Kinase Inhibitor p16","INK4A","P14","Cell Cycle Negative Regulator Beta","p19(ARF)","CDKN2","P19ARF","p16(INK4)","MTS1","P19","p14","INK4a","MLM","MTS-1","p16(INK4a)","P16-INK4A","CDK2NA","p14Arf","p19","P14ARF","cyclin-dependent kinase inhibitor 2A","p14(ARF)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C18022","eligibility_criterion":"inclusion"}]"
NCT03206047,78,"null"
NCT03200847,30,"null"
NCT03179943,53,"null"
NCT03043599,52,"null"
NCT02981628,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02923778,40,"null"
NCT02839343,124,"null"
NCT02775812,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Negative","name":"p16 Negative","synonyms":["Cyclin-Dependent Kinase 4 Inhibitor A Negative","p16INK4 Negative","CDKN2A-p16 Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative","p16(INK4a) Negative","p16-INK4 Negative","CDKN2A-p16(INK4a) Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132226","eligibility_criterion":"inclusion"}]"
NCT02749903,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02715011,60,"null"
NCT02610062,110,"null"
NCT02508870,100,"null"
NCT02489448,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02429466,15,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"}]"
NCT02390752,47,"null"
NCT02372240,70,"null"
NCT02173093,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT02112916,1400,"null"
NCT01869803,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD33 Positive","name":"CD33 Positive","synonyms":["CD33 Molecule Positive","gp67 Positive","p67 Positive","CD33 Antigen Positive","Myeloid Cell Surface Antigen CD33 Positive","SIGLEC3 Positive","SIGLEC-3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132228","eligibility_criterion":"inclusion"}]"
NCT01846091,30,"null"
NCT01844076,35,"null"
NCT01827384,700,"null"
NCT01810913,660,"null"
NCT01628640,110,"null"
NCT01602666,275,"null"
NCT01503177,36,"null"
NCT01474681,35,"null"
NCT01366144,276,"null"
NCT00651976,200,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03366103,79,"null"
NCT03302247,22,"null"
NCT03238495,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03223103,20,"null"
NCT03217669,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT03217253,48,"null"
NCT03212274,145,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT03172754,98,"null"
NCT03162731,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Negative","name":"Human Papillomavirus-16 Negative","synonyms":["HPV-16 Negative","HPV16 Negative","Human Papilloma Virus 16 Negative","Human Papillomavirus 16 Negative","Human Papilloma Virus-16 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146716","eligibility_criterion":"inclusion"}]"
NCT03143985,18,"null"
NCT03135171,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03106415,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT03063944,43,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(15;17)(q22;q12)","name":"t(15;17)(q24;q21)","synonyms":["t(15;17)(q22;q12)","t(15;17)(q22;q21)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27758","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PML Gene RARA Gene Chromosomal mutation","name":"PML-RAR alpha mutation","synonyms":["PML/RAR Alpha Fusion","PML/RARA Fusion","PML/RAR","C24686:C21571:C0948447","PML-RARA Fusion","PML-RAR Alpha Fusion","PML-RAR","PML/RARalpha"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C53622:C99186","eligibility_criterion":"exclusion"}]"
NCT03041181,64,"null"
NCT03040986,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NM_004985.3:c.34G>C KRAS NP_004976.2:p.G12R","name":"KRAS G12R Mutation","synonyms":["KRAS NM_004985.3:c.34G>C","KRAS p.G12R","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34G>C","KRAS NP_004976.2:p.Gly12Arg","KRAS1 c.34G>C"," GTPase KRas G12R","KI-RAS c.34G>C","C-K-RAS c.34G>C","KRAS G12R","K-Ras 2 G12R","KRAS2 c.34G>C","KRAS NP_004976.2:p.G12R","Ki-Ras G12R c-K-ras G12R","KRAS p.Gly12Arg","KRAS Gly12Arg","NM_004985.3:c.34G>C","KRAS c.34G>C"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98387:C98386","eligibility_criterion":"inclusion"}]"
NCT03038477,120,"null"
NCT02992015,10,"null"
NCT02946008,38,"null"
NCT02943733,33,"null"
NCT02925533,12,"null"
NCT02899728,132,"null"
NCT02890758,54,"null"
NCT02859415,100,"null"
NCT02829931,26,"null"
NCT02728258,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02671890,74,"null"
NCT02661815,54,"null"
NCT02658487,41,"null"
NCT02642965,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02631733,48,"null"
NCT02627443,150,"null"
NCT02620865,43,"null"
NCT02595879,64,"null"
NCT02581930,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02569320,72,"null"
NCT02535247,27,"null"
NCT02526329,12,"null"
NCT02502266,680,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT02492750,120,"null"
NCT02460835,25,"null"
NCT02428192,37,"null"
NCT02420314,42,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02407171,60,"null"
NCT02378922,5,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT02327390,24,"null"
NCT02323607,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"}]"
NCT02298959,36,"null"
NCT02287428,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02281760,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT02267863,60,"null"
NCT02204462,30,"null"
NCT02177838,27,"null"
NCT02168725,54,"null"
NCT02137837,825,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02123966,31,"null"
NCT02118285,20,"null"
NCT02117336,36,"null"
NCT02075034,36,"null"
NCT02020707,36,"null"
NCT02005614,132,"null"
NCT01970358,20,"null"
NCT01934335,80,"null"
NCT01933815,92,"null"
NCT01722305,34,"null"
NCT01720836,30,"null"
NCT01705548,24,"null"
NCT01660607,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01618851,70,"null"
NCT01574274,240,"null"
NCT01570348,12,"null"
NCT01562873,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Phosphorylated Signal Transducer and Activator of Transcription 3 Positive","name":"pSTAT3 Positive","synonyms":["Phospho-Signal Transducer and Activator of Transcription 3 Positive","Phospho-STAT3 Positive","Phosphorylated Signal Transducer and Activator of Transcription 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141274","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01537107,42,"null"
NCT01532960,40,"null"
NCT01441947,75,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01207765,14,"null"
NCT01012817,102,"null"
NCT00909948,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Exclusion","long_name":"Circulating Tumor Cells Positive","name":"Circulating Tumor Cells Positive","synonyms":["Circulating Tumor Cells Present","CTC Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146691","eligibility_criterion":"exclusion"}]"
NCT00832780,43,"null"
NCT00799110,60,"null"
NCT00392327,400,"null"
NCT00390299,40,"null"
NCT01982448,187,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02142530,34,"null"
NCT01711554,62,"null"
NCT01170650,640,"null"
NCT02748564,65,"null"
NCT02322190,450,"null"
NCT03297463,40,"null"
NCT02621398,30,"null"
NCT02203526,52,"null"
NCT01051635,74,"null"
NCT00915694,31,"null"
NCT03113487,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Overexpression Positive","name":"TP53 Overexpression Positive","synonyms":["TP53 Overexpression","Transformation-Related Protein 53 Overexpression","Tumor Protein p53 Overexpression","Tumor Suppressor p53 Overexpression","TRP53 Overexpression","Antigen NY-CO-13 Overexpression","p53 Overexpression","Cellular Tumor Antigen p53 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146952","eligibility_criterion":"inclusion"}]"
NCT03093428,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02886065,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02191761,25,"null"
NCT02190695,120,"null"
NCT02129075,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02054104,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01841463,100,"null"
NCT01779336,70,"null"
NCT01762410,60,"null"
NCT01623349,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT00911248,25,"null"
NCT00827203,30,"null"
NCT00789633,320,"null"
NCT00499499,40,"null"
NCT02526498,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02785913,59,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Stratification Factor, Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02147990,225,"null"
NCT01881867,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01274338,1500,"null"
NCT02880228,41,"null"
NCT02300610,24,"null"
NCT01946789,12,"null"
NCT01858922,40,"null"
NCT01231906,693,"null"
NCT00499330,1297,"null"
NCT00336024,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SMARCB1 Negative","name":"SMARCB1 Negative","synonyms":["SNF5 Negative","SWI/SNF-Related Matrix-Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 Negative","INI1 Negative","BAF47 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150645","eligibility_criterion":"inclusion"}]"
NCT02948283,24,"null"
NCT02502864,52,"null"
NCT02395692,66,"null"
NCT02338037,8,"null"
NCT02147301,51,"null"
NCT02112045,176,"null"
NCT02053376,37,"null"
NCT01976169,17,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01961063,3,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT01896869,92,"null"
NCT01688401,5,"null"
NCT01497626,40,"null"
NCT00554788,60,"null"
NCT00303719,300,"null"
NCT03211117,25,"null"
NCT03042780,28,"null"
NCT02988843,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02986919,24,"null"
NCT02965378,42,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Mutation","name":"FGFR2 Gene Mutation","synonyms":["CD332 Gene Mutation","BEK Gene Mutation","KGFR Gene Mutation","ECT1 Gene Mutation","FGFR-2 Gene Mutation","K-SAM Gene Mutation","Fibroblast Growth Factor Receptor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107579","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Mutation","name":"FGFR1 Gene Mutation","synonyms":["FGFR-1 Gene Mutation","BFGFR Gene Mutation","FLG Gene Mutation","CEK Gene Mutation","CD331 Gene Mutation","N-SAM Gene Mutation","FMS-Like Tyrosine Kinase 2 Gene Mutation","FGFBR Gene Mutation","Fibroblast Growth Factor Receptor 1 Gene Mutation","KAL2 Gene Mutation","FLT2 Gene Mutation","FLT-2 Gene Mutation","OGD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129632","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Amplification","name":"FGFR3 Amplification","synonyms":["FGFR-3 Gene Amplification","JKT4 Gene Amplification","FGFR3 Gene Amplification","CD333 Gene Amplification","Fibroblast Growth Factor Receptor 3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129621","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"}]"
NCT02875067,29,"null"
NCT02852564,12,"null"
NCT02839681,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT02785939,42,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND1 Gene Amplification","name":"CCND1 Gene Amplification","synonyms":["Cyclin D1 Gene Activation","BCL1 Gene Amplification","PRAD1 Gene Amplification","BCL-1 Gene Amplification","Cyclin D1 Gene Amplification","CCND1 Gene Activation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36652","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND3 Gene Amplification","name":"CCND3 Gene Amplification","synonyms":["Cyclin D3 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131784","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CDK4 Gene Amplification","name":"CDK4 Gene Amplification","synonyms":["Cell Division Kinase 4 Gene Amplification","Cyclin Dependent Kinase 4 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131786","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"CCND2 Gene Amplification","name":"CCND2 Gene Amplification","synonyms":["Cyclin D2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131785","eligibility_criterion":"inclusion"}]"
NCT02729194,16,"null"
NCT02717949,21,"null"
NCT02716896,30,"null"
NCT02631746,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD4 Positive","name":"CD4 Positive","synonyms":["OKT4 Antigen Positive","T4/Leu-3 Positive","T-Cell Surface Glycoprotein CD4 Positive","CD4 Molecule Positive","T-Cell Antigen T4/Leu3 Positive","CD4-Positive","CD4 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153220","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HTLV-1 Positive","name":"HTLV-1 Positive","synonyms":["HTLV-I Positive","Human T-Lymphotropic Virus 1 Positive","Human T-Cell Lymphotropic Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142127","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD3 Positive","name":"CD3 Positive","synonyms":["T3 Complex Positive","CD3 Complex Positive","T-Cell Surface Glycoprotein CD3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131386","eligibility_criterion":"inclusion"}]"
NCT02614508,66,"null"
NCT02586675,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02581839,20,"null"
NCT02573363,27,"null"
NCT02566421,5000,"null"
NCT02491411,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02463994,18,"null"
NCT02452554,114,"null"
NCT02432963,19,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02419755,66,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"MLL Gene Rearrangement","name":"MLL Gene Rearrangement","synonyms":["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila) Gene Rearrangement","Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement","KMT2A Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122623","eligibility_criterion":"inclusion"}]"
NCT02414724,55,"null"
NCT02403310,21,"null"
NCT02402764,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02395822,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less Than 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138057","eligibility_criterion":"inclusion"}]"
NCT02381535,36,"null"
NCT02379247,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02357121,12,"null"
NCT02337985,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT02337426,23,"null"
NCT02328807,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT02283190,18,"null"
NCT02280252,150,"null"
NCT02277184,24,"null"
NCT02269670,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02257528,25,"null"
NCT02254278,296,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02220608,18,"null"
NCT02218164,30,"null"
NCT02215967,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 30 Percent or Less of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 30 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Neoplastic Plasma Cells Less than or Equal to 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138182","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF17 Positive","name":"TNFRSF17 Positive","synonyms":["CD269 Antigen Positive","BCMA Positive","CD269 Positive"],"hugo_biomarker_code":"11913","nci_thesaurus_concept_id":"C128845","eligibility_criterion":"inclusion"}]"
NCT02194829,133,"null"
NCT02188264,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT02187822,46,"null"
NCT02186847,168,"null"
NCT02171260,94,"null"
NCT02166255,22,"null"
NCT02164838,51,"null"
NCT02155088,39,"null"
NCT02145403,55,"null"
NCT02142803,23,"null"
NCT02139358,49,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02138383,38,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02116777,148,"null"
NCT02107963,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT02097732,40,"null"
NCT02087657,20,"null"
NCT02075112,25,"null"
NCT02070458,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"}]"
NCT02061449,30,"null"
NCT02059265,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Negative","name":"WT1 Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02057640,31,"null"
NCT02042430,12,"null"
NCT02017964,42,"null"
NCT02015819,33,"null"
NCT02015117,33,"null"
NCT02015104,54,"null"
NCT02003209,312,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01999985,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT01989598,74,"null"
NCT01989546,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT01961115,12,"null"
NCT01947023,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01940809,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"exclusion"}]"
NCT01935973,148,"null"
NCT01935921,18,"null"
NCT01921751,346,"null"
NCT01903811,140,"null"
NCT01897012,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Positive","name":"Myc Positive","synonyms":["c-MYC Positive","Myc Proto-Oncogene Positive","Proto-Oncogene c-Myc Positive","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131061","eligibility_criterion":"inclusion"}]"
NCT01894477,100,"null"
NCT01885897,61,"null"
NCT01885689,77,"null"
NCT01882946,60,"null"
NCT01861340,20,"null"
NCT01861314,30,"null"
NCT01856920,34,"null"
NCT01842646,35,"null"
NCT01835145,69,"null"
NCT01833832,30,"null"
NCT01822652,28,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Anti-Mouse Antibodies Negative","name":"HAMA Negative","synonyms":["Human Anti-Mouse Antibodies Absent","Human Anti-Mouse Antibodies Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128838","eligibility_criterion":"inclusion"}]"
NCT01814046,57,"null"
NCT01813227,55,"null"
NCT01813214,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01807065,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01790568,37,"null"
NCT01783756,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01781741,33,"null"
NCT01775423,90,"null"
NCT01768897,40,"null"
NCT01763931,64,"null"
NCT01760226,12,"null"
NCT01758731,24,"null"
NCT01739439,25,"null"
NCT01737151,160,"null"
NCT01720264,74,"null"
NCT01711697,18,"null"
NCT01711541,110,"null"
NCT01711515,28,"null"
NCT01708941,88,"null"
NCT01702064,24,"null"
NCT01701674,20,"null"
NCT01700036,40,"null"
NCT01687673,28,"null"
NCT01678443,52,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"PTPRC Positive","name":"CD45 Positive","synonyms":["PTPRC Positive","T200 Positive","Leukocyte Common Antigen Positive","Receptor-Type Tyrosine-Protein Phosphatase C Positive","CD45 Antigen Positive","L-CA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134500","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Human Anti-Mouse Antibodies Positive","name":"Human Anti-Mouse Antibodies Positive","synonyms":["Human Anti-Mouse Antibodies Present","HAMA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139787","eligibility_criterion":"exclusion"}]"
NCT01672892,281,"null"
NCT01663259,36,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT01660971,24,"null"
NCT01659151,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600D","name":"BRAF V600D Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98340","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01657591,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01627041,180,"null"
NCT01607554,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ISG15 Positive","name":"ISG15 Positive","synonyms":["IP17 Positive","Ubiquitin Cross-Reactive Protein Positive","G1P2 Positive","IFI15 Positive","hUCRP Positive","UCRP Positive","Ubiquitin-Like Protein ISG15 Positive","ISG15 Ubiquitin-Like Modifier Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150648","eligibility_criterion":"inclusion"}]"
NCT01606878,50,"null"
NCT01593696,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01585688,30,"null"
NCT01580410,116,"null"
NCT01578564,23,"null"
NCT01560923,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01557517,40,"null"
NCT01553851,20,"null"
NCT01552356,54,"null"
NCT01547806,70,"null"
NCT01526928,605,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01507428,138,"null"
NCT01490749,83,"null"
NCT01480154,62,"null"
NCT01470209,51,"null"
NCT01468896,47,"null"
NCT01468311,95,"null"
NCT01463072,40,"null"
NCT01439711,115,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01436214,60,"null"
NCT01434303,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01433172,70,"null"
NCT01399372,89,"null"
NCT01372618,24,"null"
NCT01351909,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01326871,90,"null"
NCT01303341,36,"null"
NCT01289353,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01287104,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Peripheral Blood White Cells","name":"Blasts Under 10 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less Than 10 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41241","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT01286272,130,"null"
NCT01283789,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01266083,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"}]"
NCT01260506,75,"null"
NCT01239368,86,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41028","eligibility_criterion":"inclusion"}]"
NCT01236547,121,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PSA Level Less Than One","name":"PSA Level Less Than One","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT01222754,30,"null"
NCT01218542,30,"null"
NCT01217437,120,"null"
NCT01204684,60,"null"
NCT01196390,591,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01193842,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Negative","name":"CD20 Negative","synonyms":["Leu-16 Negative","MS4A1 Negative","CD20 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137690","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01176474,85,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PMEL positive","name":"PMEL positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLANA Positive","name":"MLANA Positive","synonyms":["Antigen LB39-AA Positive","Antigen SK29-AA Positive","Melanoma Antigen Recognized by T Cells 1 Positive","Melanoma Antigen Recognized by T-Cells 1 Positive","Melan A Positive","MART-1 Positive","MART1 Positive","MART-1 Antigen Positive","Melan-A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134491","eligibility_criterion":"inclusion"}]"
NCT01176461,175,"null"
NCT01164228,85,"null"
NCT01145430,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01126476,120,"null"
NCT01093573,50,"null"
NCT01064648,116,"null"
NCT00992446,20,"null"
NCT00989651,474,"null"
NCT00979212,97,"null"
NCT00956930,258,"null"
NCT00939770,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Fusion Protein Expression","name":"ALK Fusion Protein Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Protein Expression","ALK Fusion Protein Expression","CD246 Antigen Fusion Protein Expression","ALK Fusion Protein Positive","Anaplastic Lymphoma Kinase Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81946","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Amplification","name":"ALK Gene Amplification","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Amplification","Anaplastic Lymphoma Kinase Receptor Gene Amplification","CD246 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131136","eligibility_criterion":"inclusion"}]"
NCT00924170,37,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"IL2RA Positive","name":"IL2RA Positive","synonyms":["IL-2R Subunit Alpha Positive","IL-2 Receptor Subunit Alpha Positive","Interleukin-2 Receptor Subunit Alpha Positive","IL-2R Positive","IL-2 Receptor Positive","IL-2-RA Positive","Interleukin 2 Receptor Subunit Alpha Positive","IL2-RA Positive","CD25 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129706","eligibility_criterion":"inclusion"}]"
NCT00911079,24,"null"
NCT00904345,50,"null"
NCT00889954,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00860171,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPRC Positive","name":"CD45 Positive","synonyms":["PTPRC Positive","T200 Positive","Leukocyte Common Antigen Positive","Receptor-Type Tyrosine-Protein Phosphatase C Positive","CD45 Antigen Positive","L-CA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134500","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Human Anti-Mouse Antibodies Positive","name":"Human Anti-Mouse Antibodies Positive","synonyms":["Human Anti-Mouse Antibodies Present","HAMA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139787","eligibility_criterion":"exclusion"}]"
NCT00733408,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT00669162,25,"null"
NCT00586391,18,"null"
NCT00573989,40,"null"
NCT00553098,50,"null"
NCT00345865,425,"null"
NCT00321555,27,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"IL2RA Positive","name":"IL2RA Positive","synonyms":["IL-2R Subunit Alpha Positive","IL-2 Receptor Subunit Alpha Positive","Interleukin-2 Receptor Subunit Alpha Positive","IL-2R Positive","IL-2 Receptor Positive","IL-2-RA Positive","Interleukin 2 Receptor Subunit Alpha Positive","IL2-RA Positive","CD25 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129706","eligibility_criterion":"inclusion"}]"
NCT00074490,510,"null"
NCT01208662,1450,"null"
NCT01259817,188,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"JAK2.p.V617F","name":"JAK2 V617F mutation","synonyms":["JAK2 Val617Phe","JAK2 NM_004972.3:c.1848_1849TG>CT","JTK10 c.1849G>T","NP_004963.1:p.V617F","Janus Kinase 2 Val617Phe","NM_004972.3:c.1848_1849TG>CT","JAK2 c.1848_1849delTGinsCT","JAK2 V617F","Janus Kinase- 2 V617F","Janus Kinase-2 Val617Phe","Janus Kinase 2 c.1848_1849TG>CT","JAK2 NM_004972.3:c.1849G>T","JAK2 NP_004963.1:p.V617F","JTK10 c.1848_1849TG>CT","Janus Kinase-2 V617F Mutation","NM_004972.3:c.1848_1849delTGinsCT","JAK-2 c.1849G>T","JAK2 c.1849G>T","JAK2 c.1848_1849TG>CT","NM_004972.3:c.1849G>T","Janus Kinase 2 V617F","JAK2 p.Val617Phe","NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 Val617Phe","Janus Kinase 2 c.1849G>T","JAK2 NM_004972.3:c.1848_1849delTGinsCT","JAK2 NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 V617F","JAK-2 c.1848_1849TG>CT","JAK2 p.V617F"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105909:C105910:C105908","eligibility_criterion":"inclusion"}]"
NCT02438722,223,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT01790295,86,"null"
NCT01272037,10000,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01259856,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2.p.V617F","name":"JAK2 V617F mutation","synonyms":["JAK2 Val617Phe","JAK2 NM_004972.3:c.1848_1849TG>CT","JTK10 c.1849G>T","NP_004963.1:p.V617F","Janus Kinase 2 Val617Phe","NM_004972.3:c.1848_1849TG>CT","JAK2 c.1848_1849delTGinsCT","JAK2 V617F","Janus Kinase- 2 V617F","Janus Kinase-2 Val617Phe","Janus Kinase 2 c.1848_1849TG>CT","JAK2 NM_004972.3:c.1849G>T","JAK2 NP_004963.1:p.V617F","JTK10 c.1848_1849TG>CT","Janus Kinase-2 V617F Mutation","NM_004972.3:c.1848_1849delTGinsCT","JAK-2 c.1849G>T","JAK2 c.1849G>T","JAK2 c.1848_1849TG>CT","NM_004972.3:c.1849G>T","Janus Kinase 2 V617F","JAK2 p.Val617Phe","NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 Val617Phe","Janus Kinase 2 c.1849G>T","JAK2 NM_004972.3:c.1848_1849delTGinsCT","JAK2 NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 V617F","JAK-2 c.1848_1849TG>CT","JAK2 p.V617F"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105909:C105910:C105908","eligibility_criterion":"inclusion"}]"
NCT02470585,1140,"null"
NCT02120157,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hypoploidy","name":"Hypoploidy","synonyms":["Hypodiploidy","hypodiploidy"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128304","eligibility_criterion":"inclusion"}]"
NCT03068455,2000,"null"
NCT02874742,224,"null"
NCT02773849,150,"null"
NCT02631876,333,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT02526017,295,"null"
NCT01367002,110,"null"
NCT02563002,308,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT01873326,88,"null"
NCT01624285,356,"null"
NCT02785952,350,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"}]"
NCT02601937,82,"null"
NCT02421939,371,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT02336815,202,"null"
NCT02263508,713,"null"
NCT01809691,1304,"null"
NCT01808573,621,"null"
NCT00565851,1038,"null"
NCT02899195,55,"null"
NCT02814669,45,"null"
NCT02684006,888,"null"
NCT02320058,119,"null"
NCT02285062,570,"null"
NCT02039726,367,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3-ITD Activating Mutation","name":"FLT3-ITD Activating Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01620190,29,"null"
NCT01169337,180,"null"
NCT00697632,180,"null"
NCT02982954,200,"null"
NCT02674568,339,"null"
NCT02655016,620,"null"
NCT02563548,81,"null"
NCT02514551,245,"null"
NCT02426086,107,"null"
NCT02412371,48,"null"
NCT02177695,230,"null"
NCT02060188,340,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT01908101,60,"null"
NCT03377556,64,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRIP1 Gene Mutation","name":"BRIP1 Gene Mutation","synonyms":["BRCA1 Interacting Protein C-Terminal Helicase 1 Gene Mutation","BACH1 Gene Mutation","FANCJ Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132002","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51 Gene Mutation","name":"RAD51 Gene Mutation","synonyms":["HRAD51 Gene Mutation","FANCR Gene Mutation","BRCC5 Gene Mutation","HsRad51 Gene Mutation","RAD51A Gene Mutation","RAD51, S. cerevisiae, Homolog of A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131795","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BARD1 Gene Mutation","name":"BARD1 Gene Mutation","synonyms":["BARD-1 Gene Mutation","BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RPA1 Gene Mutation","name":"RPA1 Gene Mutation","synonyms":["RF-A Gene Mutation","Replication Protein A1 Gene Mutation","RP-A Gene Mutation","RPA70 Gene Mutation","Replication Protein A1, 70kDa Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132007","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCC Gene Mutation","name":"FANCC Gene Mutation","synonyms":["Fanconi Anemia Complementation Group C Gene Mutation","Fanconi Anemia, Complementation Group C Gene Mutation","FACC Gene Mutation","FAC Gene Mutation","FA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131792","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATR Gene Mutation","name":"ATR Gene Mutation","synonyms":["FRP1 Gene Mutation","ATR Serine/Threonine Kinase Gene Mutation","Ataxia Telangiectasia and Rad3 Related Gene Mutation","MEC1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131479","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCD2 Gene Mutation","name":"FANCD2 Gene Mutation","synonyms":["FANCD Gene Mutation","FAD Gene Mutation","Fanconi Anemia, Complementation Group D2 Gene Mutation","Fanconi Anemia Complementation Group D2 Gene Mutation","FA4 Gene Mutation","FAD2 Gene Mutation","FA-D2 Gene Mutation","FACD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131790","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK2 Gene Mutation","name":"CHEK2 Gene Mutation","synonyms":["LFS2 Gene Mutation","CHK2 Gene Mutation","CHK2 Checkpoint Homolog (S. pombe) Gene Mutation","CDS1 Gene Mutation","Checkpoint Kinase 2 Gene Mutation","hCds1 Gene Mutation","RAD53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCA Gene Mutation","name":"FANCA Gene Mutation","synonyms":["FA Gene Mutation","FA1 Gene Mutation","Fanconi Anemia, Complementation Group H Gene Mutation","Fanconi Anemia, Complementation Group A Gene Mutation","FACA Gene Mutation","FA-H Gene Mutation","FAA Gene Mutation","Fanconi Anemia Complementation Group A Gene Mutation","FAH Gene Mutation","Fanconi Anemia, Type 1 Gene Mutation","FANCH Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131794","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CHEK1 Gene Mutation","name":"CHEK1 Gene Mutation","synonyms":["CHK1 Gene Mutation","CHK1 Checkpoint Homolog (S. pombe) Gene Mutation","Checkpoint Kinase 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NBN Gene Mutation","name":"NBN Gene Mutation","synonyms":["AT-V2 Gene Mutation","P95 Gene Mutation","AT-V1 Gene Mutation","Nijmegen Breakage Syndrome 1 Gene Mutation","ATV Gene Mutation","NBS1 Gene Mutation","NBS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131806","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCM Gene Mutation","name":"FANCM Gene Mutation","synonyms":["Fanconi Anemia, Complementation Group M Gene Mutation","Fanconi Anemia Complementation Group M Gene Mutation","FAAP250 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132004","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD54L Gene Mutation","name":"RAD54L Gene Mutation","synonyms":["HR54 Gene Mutation","RAD54 Homolog Gene Mutation","RAD54-like (S. cerevisiae) Gene Mutation","HRAD54 Gene Mutation","RAD54A Gene Mutation","hHR54 Gene Mutation","RAD54L Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51B Gene Mutation","name":"RAD51B Gene Mutation","synonyms":["REC2 Gene Mutation","R51H2 Gene Mutation","RAD51L1 Gene Mutation","RAD51 Paralog B Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132005","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FANCF Gene Mutation","name":"FANCF Gene Mutation","synonyms":["Fanconi Anemia, Complementation Group F Gene Mutation","Fanconi Anemia Complementation Group F Gene Mutation","FAF Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132003","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"}]"
NCT02823574,400,"null"
NCT02702401,408,"null"
NCT02544633,68,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Activating MET Mutation","name":"Activating MET Mutation","synonyms":["Activating HGFR Mutation","Activating Hepatocyte Growth Factor Receptor Mutation","Activating MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Activating Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Mutation","MET Activating Mutation","Activating c-Met Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129701","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT02538965,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02449239,134,"null"
NCT02445976,197,"null"
NCT02335918,175,"null"
NCT02111577,1170,"null"
NCT02074839,266,"null"
NCT02027428,426,"null"
NCT01746251,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"}]"
NCT01359592,155,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01307267,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01079780,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT03078751,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03053440,210,"null"
NCT02953678,71,"null"
NCT02861573,180,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02764151,17,"null"
NCT02702141,44,"null"
NCT02665650,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02659059,507,"null"
NCT02650752,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02579863,640,"null"
NCT02494583,764,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02383212,398,"null"
NCT02327078,309,"null"
NCT02319837,1860,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to One","name":"PSA Level Greater than or Equal to One","synonyms":["PSA Level Greater than or Equal to 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136574","eligibility_criterion":"inclusion"}]"
NCT02318329,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2IIIb Positive","name":"FGFR2IIIb Positive","synonyms":["FGFR2 IIIb Positive","FGFR2IIIb Positive","FGFR2-IIIb Positive","FGFR-2 IIIb Positive","FGFR2b Positive","FGFR2(IIIb) Positive","Fibroblast Growth Factor Receptor 2 Isoform IIIb Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142105","eligibility_criterion":"inclusion"}]"
NCT02261220,380,"null"
NCT02178722,444,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02163694,513,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02076191,40,"null"
NCT02065869,193,"null"
NCT02035137,105,"null"
NCT02030964,30,"null"
NCT01970865,367,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT01945775,430,"null"
NCT01919086,28,"null"
NCT01772004,1758,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating EGFR Gene Mutation Negative","name":"Activating EGFR Gene Mutation Negative","synonyms":["EGFR Activating Mutation Negative","Activating c-erbB1 Mutation Negative","Activating EGFR Mutation Negative","Epidermal Growth Factor Receptor Activating Mutation Negative","Activating HER1 Mutation Negative","Activating ERBB Mutation Negative","Activating ERBB1 Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Translocation Negative","name":"ALK Gene Translocation Negative","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation Negative","Anaplastic Lymphoma Kinase Gene Translocation Negative","CD246 Gene Translocation Negative","ALK Translocation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134488","eligibility_criterion":"inclusion"}]"
NCT01727336,174,"null"
NCT01714739,650,"null"
NCT01661972,62,"null"
NCT01610206,148,"null"
NCT01414608,900,"null"
NCT01348490,66,"null"
NCT03358472,625,"null"
NCT03066778,430,"null"
NCT02915523,140,"null"
NCT02853305,990,"null"
NCT02752074,706,"null"
NCT02726399,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02718417,998,"null"
NCT02711137,136,"null"
NCT02675231,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02657889,121,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02625610,499,"null"
NCT02609984,88,"null"
NCT02576990,80,"null"
NCT02555657,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02536339,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02506153,1378,"null"
NCT02481154,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT02354586,500,"null"
NCT02252172,744,"null"
NCT02228096,67,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02203773,212,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"}]"
NCT02167854,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02134197,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"LYPD3 Positive","name":"LYPD3 Positive","synonyms":["LY6/PLAUR Domain-Containing 3 Positive","C4.4a Positive","LY6/PLAUR Domain Containing 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132243","eligibility_criterion":"inclusion"}]"
NCT02052648,160,"null"
NCT02013219,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT01928394,1150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01908426,760,"null"
NCT01633970,240,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01575548,128,"null"
NCT03205046,25,"null"
NCT02954796,27,"null"
NCT02907385,736,"null"
NCT02807454,37,"null"
NCT02806947,150,"null"
NCT02642042,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.Q61X","name":"KRAS Q61 Mutation","synonyms":["NP_004976.2:p.Gln61Xxx","KRAS Gln61Xxx","K-Ras 2 Q61X","KRAS NP_004976.2:p.Gln61Xxx","KRAS Q61X","KRAS p.Q61X","Ki-Ras Q61X","KRAS NP_004976.2:p.Q61X","KRAS p.Gln61Xxx","c-K-ras Q61X","GTPase KRas Q61X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107478","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"inclusion"}]"
NCT02631070,229,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 5q","name":"5q Deletion","synonyms":["del(5q)","5q-","Loss of Chromosome 5q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27712","eligibility_criterion":"exclusion"}]"
NCT02588092,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IL2RA Positive","name":"IL2RA Positive","synonyms":["IL-2R Subunit Alpha Positive","IL-2 Receptor Subunit Alpha Positive","Interleukin-2 Receptor Subunit Alpha Positive","IL-2R Positive","IL-2 Receptor Positive","IL-2-RA Positive","Interleukin 2 Receptor Subunit Alpha Positive","IL2-RA Positive","CD25 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129706","eligibility_criterion":"inclusion"}]"
NCT02586987,58,"null"
NCT02580058,566,"null"
NCT02576977,300,"null"
NCT02572167,93,"null"
NCT02477696,533,"null"
NCT02475681,535,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02445248,116,"null"
NCT02437318,572,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02426125,466,"null"
NCT02409342,572,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Fusion Gene Positive","name":"ALK Fusion Gene Positive","synonyms":["Anaplastic Lymphoma Kinase Fusion Gene Positive","CD246 Fusion Gene Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Fusion Gene Alteration Positive","ALK Fusion Gene Present","ALK Fusion Oncogene Positive","Anaplastic Lymphoma Kinase Fusion Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142114","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02387125,79,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02324257,185,"null"
NCT02309177,118,"null"
NCT02283177,48,"null"
NCT02281084,66,"null"
NCT02219724,174,"null"
NCT02101788,250,"null"
NCT02071862,205,"null"
NCT02065687,540,"null"
NCT02044120,29,"null"
NCT01975519,111,"null"
NCT01962792,102,"null"
NCT01953692,207,"null"
NCT01864746,1250,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01814813,165,"null"
NCT01391143,179,"null"
NCT01387932,520,"null"
NCT01386385,162,"null"
NCT01120249,1537,"null"
NCT02959437,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Stable","name":"Microsatellite Stable","synonyms":["MSS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131459","eligibility_criterion":"inclusion"}]"
NCT02923531,20,"null"
NCT02853344,255,"null"
NCT02844439,40,"null"
NCT02766543,115,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"}]"
NCT02766335,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"exclusion"}]"
NCT02705105,114,"null"
NCT02685826,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(14;16)","name":"t(14;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C95146","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(4;14)","name":"t(4;14)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C95145","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Gain of Chromosome 1q","name":"1q Amplification","synonyms":["Gain of Chromosome 1q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36482","eligibility_criterion":"inclusion"}]"
NCT02669264,60,"null"
NCT02657369,76,"null"
NCT02607228,31,"null"
NCT02598960,310,"null"
NCT02586857,52,"null"
NCT02583165,40,"null"
NCT02578680,646,"null"
NCT02575807,126,"null"
NCT02562716,150,"null"
NCT02500043,506,"null"
NCT02482441,50,"null"
NCT02463032,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02435849,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02425891,900,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02410512,610,"null"
NCT02362035,159,"null"
NCT02327169,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Exon 2 Mutation","name":"KRAS Exon 2 Mutation","synonyms":["v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 2 Mutation","c-K-ras Exon 2 Mutation","KRAS2 Exon 2 Mutation","KRAS-2 Exon 2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT02306291,91,"null"
NCT02289690,221,"null"
NCT02283775,89,"null"
NCT02279433,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Gene Rearrangement","name":"NTRK3 Gene Rearrangement","synonyms":["Neurotrophic Tyrosine Kinase Receptor Type 3 Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 3 Gene Rearrangement","NTRK3 Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 3 Gene Rearrangement","TRKC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131325","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Gene Rearrangement","name":"NTRK2 Gene Rearrangement","synonyms":["TRKB Tyrosine Kinase Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor 2 Gene Rearrangement","Tropomyosin-Related Kinase B Gene Rearrangement","Neurotrophic Tyrosine Kinase Receptor Type 2 Gene Rearrangement","NTRK2 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131321","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Rearrangement","name":"NTRK1 Gene Rearrangement","synonyms":["TRK1 Gene Rearrangement","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Rearrangement","MTC Gene Rearrangement","TRKA Gene Rearrangement","Neurotrophic Receptor Tyrosine Kinase 1 Gene Rearrangement","Trk-A Gene Rearrangement","TRK Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C46006","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Rearrangement","name":"ROS1 Gene Rearrangement","synonyms":["ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Rearrangement","ROS Gene Rearrangement","c-ros-1 Gene Rearrangement","MCF3 Gene Rearrangement","ROS1 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C130236","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT02259231,102,"null"
NCT02258451,283,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02211131,150,"null"
NCT02122861,47,"null"
NCT02101775,100,"null"
NCT02097810,125,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Gene Alteration Positive","name":"NTRK2 Gene Alteration Positive","synonyms":["Tropomyosin-Related Kinase B Gene Alteration Positive","TRKB Gene Alteration Positive","Neurotrophic Tyrosine Kinase Receptor 2 Gene Alteration Positive","Neurotrophic Tyrosine Kinase Receptor Type 2 Gene Alteration Positive","TRKB Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134453","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Alteration Positive","name":"ALK Gene Alteration Positive","synonyms":["CD246 Gene Alteration Positive","Anaplastic Lymphoma Kinase Gene Alteration Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134458","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Gene Alteration Positive","name":"NTRK1 Gene Alteration Positive","synonyms":["TRK1 Gene Alteration Positive","TRKA Gene Alteration Positive","Neurotrophic Tyrosine Kinase Receptor 1 Gene Alteration Positive","Trk-A Gene Alteration Positive","Neurotrophic Tyrosine Kinase, Receptor, Type 1 Gene Alteration Positive","p140-TrkA Gene Alteration Positive","TRK Gene Alteration Positive","MTC Gene Alteration Positive Neurotrophic Receptor Tyrosine Kinase 1 Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134452","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Alteration Positive","name":"ROS1 Gene Alteration Positive","synonyms":["ROS Gene Alteration Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Alteration Positive","c-ros-1 Gene Alteration Positive","MCF3 Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Gene Alteration Positive","name":"NTRK3 Gene Alteration Positive","synonyms":["Neurotrophic Tyrosine Kinase Receptor Type 3 Gene Alteration Positive","Neurotrophic Tyrosine Kinase Receptor 3 Gene Alteration Positive","Neurotrophic Tyrosine Kinase, Receptor, Type 3 Gene Alteration Positive","TRKC Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134456","eligibility_criterion":"inclusion"}]"
NCT02043665,90,"null"
NCT02017704,165,"null"
NCT02000947,459,"null"
NCT01999972,52,"null"
NCT01997333,327,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01971515,101,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"AKT2 Gene Mutation","name":"AKT2 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 2 Gene Mutation","PRKBB Gene Mutation","PKBBETA Gene Mutation","PKBB Gene Mutation","HIHGHH Gene Mutation","AKT Serine/Threonine Kinase 2 Gene Mutation","RAC-PK-Beta Gene Mutation","RAC-BETA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141362","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01963052,93,"null"
NCT01877811,143,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"}]"
NCT01846611,585,"null"
NCT01834235,81,"null"
NCT01799889,326,"null"
NCT01757535,472,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"}]"
NCT01566695,217,"null"
NCT01535157,40,"null"
NCT01533207,216,"null"
NCT01525589,111,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT01517451,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Ten to Twenty","name":"PSA Level Ten to Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137687","eligibility_criterion":"inclusion"}]"
NCT01408563,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 20 Percent or Less of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 20 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Neoplastic Plasma Cells Less than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150709","eligibility_criterion":"inclusion"}]"
NCT01013649,545,"null"
NCT00956007,700,"null"
NCT03351231,289,"null"
NCT03207906,150,"null"
NCT03122548,79,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03028103,28,"null"
NCT02981342,231,"null"
NCT02944396,25,"null"
NCT02924883,202,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02910583,289,"null"
NCT02899299,600,"null"
NCT02899052,42,"null"
NCT02890355,143,"null"
NCT02880410,45,"null"
NCT02853331,862,"null"
NCT02775903,213,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"}]"
NCT02759016,7,"null"
NCT02745743,74,"null"
NCT02717611,60,"null"
NCT02713529,116,"null"
NCT02677896,1150,"null"
NCT02657928,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02654132,157,"null"
NCT02616640,114,"null"
NCT02616393,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02611960,230,"null"
NCT02593227,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02576509,726,"null"
NCT02574078,342,"null"
NCT02567656,58,"null"
NCT02564263,720,"null"
NCT02561962,41,"null"
NCT02541604,90,"null"
NCT02530619,24,"null"
NCT02514174,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02511132,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ewing's Sarcoma Gene translocation mutation","name":"EWS translocation mutation","synonyms":["Ewing Sarcoma Breakpoint Region 1","Ewing's Sarcoma Gene translocation mutation","RNA Binding Protein EWS","EWSR1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128648","eligibility_criterion":"inclusion"}]"
NCT02501473,51,"null"
NCT02420821,915,"null"
NCT02404220,30,"null"
NCT02393755,48,"null"
NCT02366143,1202,"null"
NCT02349633,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02346747,91,"null"
NCT02316509,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02311933,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02302339,134,"null"
NCT02293980,107,"null"
NCT02282020,266,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02272790,96,"null"
NCT02258464,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02220842,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02200614,1502,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Two","name":"PSA Level Greater than Two","synonyms":["PSA Level Greater than 2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138948","eligibility_criterion":"inclusion"}]"
NCT02174172,158,"null"
NCT02157792,205,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02155647,204,"null"
NCT02120469,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02110355,31,"null"
NCT02014636,248,"null"
NCT02009449,350,"null"
NCT02003924,1401,"null"
NCT01998971,240,"null"
NCT01959139,172,"null"
NCT01950390,168,"null"
NCT01946477,162,"null"
NCT01856192,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01823835,152,"null"
NCT01803282,236,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Driver Mutation Negative","name":"EGFR Driver Mutation Negative","synonyms":["c-erbB1 Driver Mutation Negative","ERBB1 Driver Mutation Negative","Epidermal Growth Factor Receptor Driver Mutation Negative","HER1 Driver Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129575","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"}]"
NCT01717053,37,"null"
NCT01695005,237,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01691898,230,"null"
NCT01658878,620,"null"
NCT01656642,67,"null"
NCT01631552,250,"null"
NCT01587703,195,"null"
NCT01586455,43,"null"
NCT01431209,90,"null"
NCT01375842,661,"null"
NCT01150045,2500,"null"
NCT01092182,153,"null"
NCT01025089,28,"null"
NCT01004224,208,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR2 Gene Amplification","name":"FGFR2 Amplification","synonyms":["FGFR-2 Gene Amplification","K-SAM Gene Amplification","CD332 Gene Mutation","BEK Gene Amplification","ECT1 Gene Amplification","FGFR2 Gene Activation","Fibroblast Growth Factor Receptor 2 Gene Amplification","FGFR2 Gene Amplification","Fibroblast Growth Factor Receptor 2 Gene Activation","KGFR Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"}]"
NCT00843882,252,"null"
NCT00840177,110,"null"
NCT00576654,36,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT00397813,144,"null"
NCT03329846,72,"null"
NCT03056040,197,"null"
NCT03023878,47,"null"
NCT02978716,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02963090,98,"null"
NCT02939651,21,"null"
NCT02934568,17,"null"
NCT02874664,46,"null"
NCT02860286,67,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BAP1 Loss of Function Mutation","name":"BAP1 Loss of Function Gene Mutation","synonyms":["Inactivating UCHL2 Gene Mutation","Inactivating BRCA1 Associated Protein 1 Gene Mutation","Inactivating BAP1 Gene Mutation","Inactivating BAP1 Mutation","Inactivating BRCA1-Associated Protein 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150448","eligibility_criterion":"inclusion"}]"
NCT02837991,16,"null"
NCT02826486,37,"null"
NCT02783599,40,"null"
NCT02768558,13,"null"
NCT02737501,275,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02713867,620,"null"
NCT02713828,13,"null"
NCT02669017,200,"null"
NCT02664077,34,"null"
NCT02648932,180,"null"
NCT02646319,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF2 Gene Rearrangement","name":"NF2 Gene Rearrangement","synonyms":["BANF Gene Rearrangement","Neurofibromin 2 Gene Rearrangement","SCH Gene Rearrangement","NF-2 Gene Rearrangement","ACN Gene Rearrangement","Merlin Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150714","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"STK11 Gene Rearrangement","name":"STK11 Gene Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC1 Gene Rearrangement","name":"TSC1 Gene Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MTOR Gene Rearrangement","name":"MTOR Gene Rearrangement","synonyms":["Mechanistic Target of Rapamycin Gene Rearrangement","Mammalian Target of Rapamycin Gene Rearrangement","FRAP1 Gene Rearrangement","FK506 Binding Protein 12-Rapamycin Associated Protein 1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150705","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Rearrangement","name":"PIK3CA Gene Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Rearrangement","name":"NF1 Gene Rearrangement","synonyms":["NF-1 Gene Rearrangement","NFNS Gene Rearrangement","Neurofibromin Gene Rearrangement","Neurofibromin 1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Rearrangement","name":"AKT1 Gene Rearrangement","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Rearrangement","PKB Gene Rearrangement","RAC-ALPHA Gene Rearrangement","AKT Gene Rearrangement","RAC-PK-Alpha Gene Rearrangement","PRKBA Gene Rearrangement","RAC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150441","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RHEB Gene Rearrangement","name":"RHEB Gene Rearrangement","synonyms":[],"hugo_biomarker_code":"10011","nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC2 Gene Rearrangement","name":"TSC2 Gene Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02643667,40,"null"
NCT02639910,24,"null"
NCT02627963,322,"null"
NCT02612311,600,"null"
NCT02603419,33,"null"
NCT02588612,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTAG2 Positive","name":"CTAG2 Positive","synonyms":["LAGE1 Positive","ESO2 Positive","Cancer/Testis Antigen 2 Positive","LAGE-1 Positive","NY-ESO-2 Positive","LAGE 1 Positive","L Antigen Family Member 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138947","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02561455,130,"null"
NCT02559674,8,"null"
NCT02551159,823,"null"
NCT02548962,235,"null"
NCT02545504,432,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02511678,65,"null"
NCT02511405,252,"null"
NCT02499770,110,"null"
NCT02499120,120,"null"
NCT02489318,1052,"null"
NCT02457598,197,"null"
NCT02453282,1118,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02452424,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK wt Allele","name":"ALK wt Allele","synonyms":["CD246","Anaplastic Lymphoma Receptor Tyrosine Kinase wt Allele","Anaplastic Lymphoma Kinase (Ki-1) wt Allele","NBLST3"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51738","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"}]"
NCT02447003,285,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02443324,155,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02432326,150,"null"
NCT02400242,81,"null"
NCT02399813,55,"null"
NCT02399215,30,"null"
NCT02399137,88,"null"
NCT02399085,81,"null"
NCT02395601,41,"null"
NCT02389985,40,"null"
NCT02388906,800,"null"
NCT02381886,166,"null"
NCT02381314,59,"null"
NCT02370238,156,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02369874,736,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lack of Expression of PD-L1","name":"PD-L1 Negative","synonyms":["CD274 Molecule Negative","PDCD1L1 Negative","Programmed Cell Death 1 Ligand 1 Negative","PDL1 Negative","CD274 Antigen Negative","B7H1 Negative","B7-H Negative","CD274 Negative","PDCD1LG1 Negative","B7 Homolog 1 Negative","Lack of Expression of PD-L1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122809","eligibility_criterion":"inclusion"}]"
NCT02343536,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Positive","name":"BCL2 Positive","synonyms":["B-Cell Leukemia/Lymphoma 2 Positive","Apoptosis Regulator Bcl-2 Positive","BCL-2 Positive","B-Cell CLL/Lymphoma 2 Positive","BCL2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134463","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Positive","name":"Myc Positive","synonyms":["c-MYC Positive","Myc Proto-Oncogene Positive","Proto-Oncogene c-Myc Positive","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131061","eligibility_criterion":"inclusion"}]"
NCT02341625,407,"null"
NCT02340221,631,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02336165,159,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02330562,130,"null"
NCT02322814,169,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02298387,71,"null"
NCT02265510,80,"null"
NCT02234986,29,"null"
NCT02231723,250,"null"
NCT02223052,89,"null"
NCT02216409,88,"null"
NCT02210559,37,"null"
NCT02202447,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02181738,338,"null"
NCT02160015,28,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Human Anti-Chimeric Antibody Positive","name":"Human Anti-Chimeric Antibody Positive","synonyms":["HACA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150631","eligibility_criterion":"exclusion"}]"
NCT02152982,440,"null"
NCT02124746,105,"null"
NCT02124707,38,"null"
NCT02108964,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02091960,103,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"}]"
NCT02091063,80,"null"
NCT02086604,48,"null"
NCT02077881,157,"null"
NCT02073123,132,"null"
NCT02048384,22,"null"
NCT02036502,84,"null"
NCT02032277,634,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02023333,37,"null"
NCT01981850,98,"null"
NCT01949883,64,"null"
NCT01946074,80,"null"
NCT01926587,45,"null"
NCT01911507,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"}]"
NCT01897714,75,"null"
NCT01860937,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01858025,25,"null"
NCT01857193,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01844765,70,"null"
NCT01830777,28,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01816230,40,"null"
NCT01806064,168,"null"
NCT01757288,98,"null"
NCT01742286,83,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Alteration Positive","name":"ALK Gene Alteration Positive","synonyms":["CD246 Gene Alteration Positive","Anaplastic Lymphoma Kinase Gene Alteration Positive","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134458","eligibility_criterion":"inclusion"}]"
NCT01711658,142,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Negative","name":"p16 Negative","synonyms":["Cyclin-Dependent Kinase 4 Inhibitor A Negative","p16INK4 Negative","CDKN2A-p16 Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative","p16(INK4a) Negative","p16-INK4 Negative","CDKN2A-p16(INK4a) Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132226","eligibility_criterion":"inclusion"}]"
NCT01668719,130,"null"
NCT01578954,26,"null"
NCT01556490,526,"null"
NCT01546038,255,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10-19 Percent of Bone Marrow Nucleated Cells","name":"Blasts 10-19 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41401","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"exclusion"}]"
NCT01535053,384,"null"
NCT01451515,72,"null"
NCT01437449,27,"null"
NCT01421524,254,"null"
NCT01316523,30,"null"
NCT01267812,36,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT01252667,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT01190930,9483,"null"
NCT01023737,70,"null"
NCT00730158,130,"null"
NCT03374488,648,"null"
NCT03361865,650,"null"
NCT03361228,5,"null"
NCT03274687,282,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Two","name":"PSA Level Less Than Two","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136415","eligibility_criterion":"inclusion"}]"
NCT03260894,630,"null"
NCT03175172,35,"null"
NCT03098550,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03081481,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"}]"
NCT03074513,160,"null"
NCT03029780,118,"null"
NCT03018249,50,"null"
NCT03011034,34,"null"
NCT02998476,60,"null"
NCT02990338,300,"null"
NCT02988986,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02985957,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02983604,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02971397,40,"null"
NCT02970981,25,"null"
NCT02961283,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"}]"
NCT02946463,246,"null"
NCT02923739,121,"null"
NCT02908672,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02871219,60,"null"
NCT02864381,144,"null"
NCT02848651,150,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR sensitizing mutation","name":"EGFR sensitizing mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02833233,6,"null"
NCT02824042,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02776683,123,"null"
NCT02765165,120,"null"
NCT02755597,291,"null"
NCT02745769,45,"null"
NCT02734160,37,"null"
NCT02733042,107,"null"
NCT02724020,96,"null"
NCT02717624,48,"null"
NCT02716805,6,"null"
NCT02714218,483,"null"
NCT02711553,300,"null"
NCT02702414,150,"null"
NCT02686164,22,"null"
NCT02674061,325,"null"
NCT02669914,138,"null"
NCT02658812,35,"null"
NCT02643420,405,"null"
NCT02642016,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Positive","name":"KIT Positive","synonyms":["CD117 Positive","v-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Positive","c-KIT Positive","KIT Proto-Oncogene Tyrosine Protein Kinase Positive","Mast/Stem Cell Growth Factor Receptor Kit Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138942","eligibility_criterion":"inclusion"}]"
NCT02631577,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02626130,30,"null"
NCT02614612,31,"null"
NCT02613390,10,"null"
NCT02612779,95,"null"
NCT02610777,120,"null"
NCT02609386,105,"null"
NCT02607124,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT02603445,20,"null"
NCT02596971,91,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02584634,41,"null"
NCT02582749,204,"null"
NCT02570919,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT02569242,390,"null"
NCT02560298,90,"null"
NCT02557516,22,"null"
NCT02538510,50,"null"
NCT02527434,64,"null"
NCT02519452,78,"null"
NCT02518555,42,"null"
NCT02510950,20,"null"
NCT02498600,96,"null"
NCT02490488,68,"null"
NCT02482311,97,"null"
NCT02471846,158,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02467361,120,"null"
NCT02454270,59,"null"
NCT02453087,66,"null"
NCT02450539,159,"null"
NCT02446444,802,"null"
NCT02441088,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT02436668,430,"null"
NCT02435680,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02432846,88,"null"
NCT02429375,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02425683,24,"null"
NCT02423902,40,"null"
NCT02422615,725,"null"
NCT02421354,40,"null"
NCT02415608,26,"null"
NCT02412670,60,"null"
NCT02411786,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02407990,451,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02399917,64,"null"
NCT02395627,87,"null"
NCT02392507,50,"null"
NCT02380677,42,"null"
NCT02367794,1021,"null"
NCT02367781,724,"null"
NCT02365818,66,"null"
NCT02357992,130,"null"
NCT02357147,108,"null"
NCT02351739,75,"null"
NCT02345629,67,"null"
NCT02338349,57,"null"
NCT02336984,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02335983,107,"null"
NCT02333188,51,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"UGT1A1 wt Allele","name":"UGT1A1*1","synonyms":["UGT1A1 Wild-Type Allele","UGT1A1 wt Allele","Polypeptide A1 wt Allele","UGT1A1 *1","Polypeptide A1*1 Allele","UDP Glycosyltransferase 1 Family","UGT1A1 Gene Allele 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51018","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"UGT1A1*28 Allele","name":"UGT1A1*28","synonyms":["UGT1A1 Variant Allele (TA)7"," NM_000463.2:c.-55_-54dupAT","UGT1A1 (TA)7 Allele","UGT1A1*28 Allele","UGT1A1 TATA Element ins TA Allele","UGT1A1, 2-BP ins, TA, TATAA Element Allele","UDP Glycosyltransferase 1 Family, Polypeptide A1*28 Allele","UGT1A1 c.-55_-54dupAT","UGT1A1 NM_000463.2:c.-55_-54insAT","UGT1A1 A(TA)7TAA Allele","UGT1A1 c.-55_-54insAT","NM_000463.2:c.-55_-54insAT","UGT1A1 Variant (TA)7 Allele","UGT1A1 NM_000463.2:c.-55_-54dupAT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564","eligibility_criterion":"inclusion"}]"
NCT02331706,24,"null"
NCT02325557,51,"null"
NCT02324543,54,"null"
NCT02322281,149,"null"
NCT02316964,10,"null"
NCT02316106,120,"null"
NCT02314117,645,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02313272,32,"null"
NCT02311920,42,"null"
NCT02308488,104,"null"
NCT02297438,339,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02293005,58,"null"
NCT02286726,55,"null"
NCT02282358,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CREBBP Gene Mutation","name":"CREBBP Gene Mutation","synonyms":["RSTS Gene Mutation","CBP Gene Mutation","KAT3A Gene Mutation","CREB Binding Protein Gene Mutation","CREB-Binding Protein Gene Mutation","Rubinstein-Taybi Syndrome Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132227","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EP300 Gene Mutation","name":"EP300 Gene Mutation","synonyms":["E1A Binding Protein p300 Gene Mutation","p300 Gene Mutation"],"hugo_biomarker_code":"3373","nci_thesaurus_concept_id":"C150502","eligibility_criterion":"inclusion"}]"
NCT02282345,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT02280525,44,"null"
NCT02278120,672,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02277522,10,"null"
NCT02275416,12,"null"
NCT02272413,672,"null"
NCT02264639,15,"null"
NCT02260440,40,"null"
NCT02257541,74,"null"
NCT02249949,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"DDIT3 Gene Rearrangement","name":"DDIT3 Gene Rearrangement","synonyms":["CHOP-10 Gene Rearrangement","CHOP10 Gene Rearrangement","GADD153 Gene Rearrangement","DNA Damage Inducible Transcript 3 Gene Rearrangement","DNA-Damage-Inducible Transcript 3 Gene Rearrangement","CEBPZ Gene Rearrangement","C/EBPzeta Gene Rearrangement","DDIT3 Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141403","eligibility_criterion":"inclusion"}]"
NCT02247349,172,"null"
NCT02246621,493,"null"
NCT02244918,278,"null"
NCT02232243,18,"null"
NCT02228681,74,"null"
NCT02228369,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02225925,45,"null"
NCT02225405,45,"null"
NCT02225366,54,"null"
NCT02206334,84,"null"
NCT02204072,117,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Five","name":"PSA Level Five or Greater","synonyms":["PSA Level Greater than or Equal to 5","PSA Level Greater than or Equal to Five","PSA Level 5 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139792","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02202746,178,"null"
NCT02196857,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT02180698,17,"null"
NCT02178709,48,"null"
NCT02177812,38,"null"
NCT02175004,135,"null"
NCT02164916,163,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02162719,124,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02159716,24,"null"
NCT02159066,140,"null"
NCT02158507,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"}]"
NCT02152631,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"inclusion"}]"
NCT02144649,45,"null"
NCT02142738,305,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"}]"
NCT02138292,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02136134,499,"null"
NCT02131064,444,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02116894,50,"null"
NCT02115048,44,"null"
NCT02113813,133,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02099539,18,"null"
NCT02089685,293,"null"
NCT02079636,150,"null"
NCT02076074,55,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02075840,303,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02070406,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02067156,40,"null"
NCT02066636,1380,"null"
NCT02061423,15,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02057770,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT02055820,267,"null"
NCT02047747,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT02044796,199,"null"
NCT02042989,56,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02039674,267,"null"
NCT02034916,86,"null"
NCT02032810,36,"null"
NCT02025803,60,"null"
NCT02023463,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Ten","name":"PSA Level Ten or Greater","synonyms":["PSA Level 10 or Greater","PSA Level Ten or Greater","PSA Level Greater than or Equal to Ten","PSA Level Greater than or Equal to 10"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136534","eligibility_criterion":"inclusion"}]"
NCT02018861,88,"null"
NCT02012920,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02007044,208,"null"
NCT02001623,170,"null"
NCT01999738,93,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Positive","name":"Folate Receptor Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01970527,40,"null"
NCT01969838,432,"null"
NCT01968213,564,"null"
NCT01942135,521,"null"
NCT01938001,358,"null"
NCT01928290,67,"null"
NCT01921387,44,"null"
NCT01905657,1061,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT01905592,306,"null"
NCT01895842,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2 Gene Mutation","name":"JAK2 Gene Mutation","synonyms":["JAK2 Mutation","JAK2 Gene Variant","Janus Kinase 2 Gene Variant","Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84255","eligibility_criterion":"inclusion"}]"
NCT01891344,493,"null"
NCT01886872,523,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT01876212,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"exclusion"}]"
NCT01852890,20,"null"
NCT01839799,50,"null"
NCT01819233,90,"null"
NCT01807598,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01807182,20,"null"
NCT01804712,18,"null"
NCT01768338,18,"null"
NCT01767194,74,"null"
NCT01766739,34,"null"
NCT01761266,954,"null"
NCT01742988,88,"null"
NCT01740427,666,"null"
NCT01740297,217,"null"
NCT01736943,30,"null"
NCT01712490,1334,"null"
NCT01695941,24,"null"
NCT01688999,71,"null"
NCT01671904,84,"null"
NCT01667419,475,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01666730,43,"null"
NCT01655836,42,"null"
NCT01625260,52,"null"
NCT01624766,147,"null"
NCT01610284,1200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01598831,814,"null"
NCT01593254,288,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT01580969,26,"null"
NCT01546571,1059,"null"
NCT01516307,349,"null"
NCT01503242,20,"null"
NCT01491841,36,"null"
NCT01447056,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01421017,60,"null"
NCT01415752,372,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT01413178,205,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Bence Jones Protein Present","name":"Bence Jones Protein Present","synonyms":["Bence-Jones Protein Positive","Bence-Jones Protein Present","Bence Jones Protein Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150451","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Monoclonal Protein, Electrophoresis, Serum","name":"M-Protein Present","synonyms":["M Spike Present","Monoclonal Band","M-Band Present","M Protein Present","M-Protein","Paraprotein Present","M-Spike","M-Band","Monoclonal Spike","M-Spike Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C113808","eligibility_criterion":"exclusion"}]"
NCT01371981,1750,"null"
NCT01358877,4804,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01319981,65,"null"
NCT01316146,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01226576,8,"null"
NCT01206530,25,"null"
NCT01140568,32,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PDGFR Positive","name":"PDGFR Positive","synonyms":["Platelet Derived Growth Factor Receptor Positive","PDGFR Family Positive","Platelet-Derived Growth Factor Receptor Positive","PDGF Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138941","eligibility_criterion":"inclusion"}]"
NCT01140373,18,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01076231,74,"null"
NCT01074970,135,"null"
NCT00981656,37,"null"
NCT00980460,253,"null"
NCT00936390,1520,"null"
NCT00910650,22,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"MLANA Positive","name":"MLANA Positive","synonyms":["Antigen LB39-AA Positive","Antigen SK29-AA Positive","Melanoma Antigen Recognized by T Cells 1 Positive","Melanoma Antigen Recognized by T-Cells 1 Positive","Melan A Positive","MART-1 Positive","MART1 Positive","MART-1 Antigen Positive","Melan-A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134491","eligibility_criterion":"inclusion"}]"
NCT00879437,56,"null"
NCT00877110,36,"null"
NCT00876395,719,"null"
NCT00874614,81,"null"
NCT00788307,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT00723099,76,"null"
NCT00703326,1144,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT00680901,545,"null"
NCT00592293,70,"null"
NCT00591838,75,"null"
NCT00570323,60,"null"
NCT00549848,531,"null"
NCT00493870,1296,"null"
NCT00206518,120,"null"
NCT00177047,250,"null"
NCT03384316,32,"null"
NCT03357952,10,"null"
NCT03279237,25,"null"
NCT03187756,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137695","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT03170869,50,"null"
NCT03168906,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Transthyretin Gene Mutation","name":"Transthyretin Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03158688,466,"null"
NCT03158103,40,"null"
NCT03149575,180,"null"
NCT03068624,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*24:02 Positive Cells Present","name":"HLA-A*24:02 Positive Cells Present","synonyms":["HLA-A2402 Positive","HLA-A2402 Positive Cells Present","HLA-A*24:02 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142110","eligibility_criterion":"inclusion"}]"
NCT03064867,18,"null"
NCT03044730,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03041311,105,"null"
NCT03032406,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Disseminated Tumor Cells Positive","name":"Disseminated Tumor Cells Positive","synonyms":["DTC Positive","Disseminated Tumor Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146678","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03030183,8,"null"
NCT03023423,100,"null"
NCT03008408,76,"null"
NCT03003520,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02995655,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts less than 10,000 of Peripheral Blood White Cells","name":"Blasts less than 10,000 of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02992977,20,"null"
NCT02967133,200,"null"
NCT02921269,22,"null"
NCT02915666,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02906696,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 30 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less Than 30 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138057","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Peripheral Blood White Cells","name":"Blasts Under 30 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C143154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 15 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 15 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 15 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C143153","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 15 Percent of Peripheral Blood White Cells","name":"Blasts Under 15 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 15 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C143152","eligibility_criterion":"inclusion"}]"
NCT02903381,30,"null"
NCT02898116,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02896907,8,"null"
NCT02873962,38,"null"
NCT02873195,135,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Dihydropyrimidine Dehydrogenase Deficiency","name":"Dihydropyrimidine Dehydrogenase Deficiency","synonyms":["DPD Deficiency","DYPD Deficiency"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84672","eligibility_criterion":"exclusion"}]"
NCT02871323,10,"null"
NCT02869295,40,"null"
NCT02868632,36,"null"
NCT02865811,26,"null"
NCT02860676,75,"null"
NCT02859454,40,"null"
NCT02841891,730,"null"
NCT02835833,18,"null"
NCT02831257,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"}]"
NCT02819804,22,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome","name":"t(9;22)(q34;q11)","synonyms":["Philadelphia Translocation","t(9;22)(q34.1;q11.2)","Philadelphia chromosome","t(9;22)(q34;q11.2)","Philadelphia Chromosome","Ph"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C28452","eligibility_criterion":"inclusion"}]"
NCT02801578,12,"null"
NCT02795819,51,"null"
NCT02789345,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02788279,363,"null"
NCT02787369,56,"null"
NCT02784496,14,"null"
NCT02781792,30,"null"
NCT02780869,412,"null"
NCT02780310,32,"null"
NCT02768701,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02764333,40,"null"
NCT02756247,60,"null"
NCT02747004,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02744898,23,"null"
NCT02737787,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"}]"
NCT02735356,10,"null"
NCT02730130,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02729896,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02728531,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Positive","name":"t(11;14) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142136","eligibility_criterion":"inclusion"}]"
NCT02720484,33,"null"
NCT02711852,500,"null"
NCT02700529,46,"null"
NCT02698189,9,"null"
NCT02697383,14,"null"
NCT02690948,26,"null"
NCT02685267,9,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02680587,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level 0.5 to 50","name":"PSA Level 0.5 to 50","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137707","eligibility_criterion":"inclusion"}]"
NCT02657330,72,"null"
NCT02650635,20,"null"
NCT02649439,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Thirty","name":"PSA Level Less than or Equal to Thirty","synonyms":["PSA Level 30 or Less","PSA Level Thirty or Less","PSA Level Less than or Equal to 30"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142129","eligibility_criterion":"inclusion"}]"
NCT02648711,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02640508,40,"null"
NCT02640053,46,"null"
NCT02639091,36,"null"
NCT02634827,26,"[{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"}]"
NCT02630251,5,"null"
NCT02625857,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02623582,15,"null"
NCT02620800,13,"null"
NCT02620423,11,"null"
NCT02610140,248,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT02609737,20,"null"
NCT02604511,33,"null"
NCT02603887,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","name":"Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41031","eligibility_criterion":"inclusion"}]"
NCT02599714,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02599649,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137695","eligibility_criterion":"inclusion"}]"
NCT02588443,23,"null"
NCT02583269,30,"null"
NCT02582931,10,"null"
NCT02579811,40,"null"
NCT02579421,70,"null"
NCT02575339,118,"null"
NCT02575300,56,"null"
NCT02572687,114,"null"
NCT02569801,71,"null"
NCT02569723,6,"null"
NCT02568449,55,"null"
NCT02563925,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02563561,1869,"null"
NCT02562898,50,"null"
NCT02561273,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02559687,121,"null"
NCT02550210,50,"null"
NCT02546986,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"exclusion"}]"
NCT02538471,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02537444,76,"null"
NCT02532257,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02530515,40,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02530502,50,"null"
NCT02530125,150,"null"
NCT02530047,21,"null"
NCT02529852,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02528643,165,"null"
NCT02525757,40,"null"
NCT02519322,40,"null"
NCT02514824,34,"null"
NCT02514447,120,"null"
NCT02513498,50,"null"
NCT02508636,53,"null"
NCT02508246,18,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02493751,55,"null"
NCT02493361,42,"null"
NCT02491359,20,"null"
NCT02489357,12,"null"
NCT02487277,36,"null"
NCT02485652,162,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02485535,45,"null"
NCT02483247,200,"null"
NCT02481830,568,"null"
NCT02481297,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 11q","name":"11q Deletion","synonyms":["del11q","Loss of Chromosome 11q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C37312","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IGHV Wildtype","name":"IGHV Wildtype","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02480374,15,"null"
NCT02472275,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Ten","name":"PSA Level Ten or Greater","synonyms":["PSA Level 10 or Greater","PSA Level Ten or Greater","PSA Level Greater than or Equal to Ten","PSA Level Greater than or Equal to 10"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136534","eligibility_criterion":"inclusion"}]"
NCT02470091,90,"null"
NCT02465957,24,"null"
NCT02464137,60,"null"
NCT02464007,36,"null"
NCT02462200,550,"null"
NCT02460198,124,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Deficiency","name":"Mismatch Repair Deficiency","synonyms":["MMR Deficiency","Mismatch Repair Deficient","dMMR","Deficient DNA Mismatch Repair","Mismatch Repair Deficiency","MMR Deficient"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT02458716,50,"null"
NCT02458235,67,"null"
NCT02455557,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A24 Positive Cells Present","name":"HLA-A*024 Positive","synonyms":["HLA-A24 Positive Cells Present","HLA-A*024 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69410","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A11 Positive Cells Present","name":"HLA-A*011 Positive","synonyms":["HLA-A11 Positive Cells Present","HLA-A*011 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131871","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A3 Positive Cells Present","name":"HLA-A*03 Positive","synonyms":["HLA-A3 Positive Cells Present","HLA-A*03 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69409","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Survivin Positive","name":"Survivin Positive","synonyms":["Baculoviral IAP Repeat-Containing 5 Positive","BIRC5 Positive","Survivin Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131872","eligibility_criterion":"inclusion"}]"
NCT02454933,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02454179,74,"null"
NCT02453737,168,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"}]"
NCT02453594,211,"null"
NCT02452970,30,"null"
NCT02451943,460,"null"
NCT02451930,75,"null"
NCT02448771,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02448537,60,"null"
NCT02448303,74,"null"
NCT02446457,40,"null"
NCT02446405,1125,"null"
NCT02444546,21,"null"
NCT02443883,164,"null"
NCT02441686,46,"null"
NCT02440425,40,"null"
NCT02439138,30,"null"
NCT02437071,48,"null"
NCT02431559,53,"null"
NCT02429843,18,"null"
NCT02429570,30,"null"
NCT02428855,19,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT02427451,68,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BTK NP_000052.1:pC481X","name":"BTK C481X Mutation","synonyms":["Bruton Tyrosine Kinase Cys481Xxx","BPK Cys481Xxx","Cysteine-481 BTK Mutation","B-Cell Progenitor Kinase C481X","BTK NP_000052.1:pCys481Xxx","BPK C481X","ATK Cys481Xxx","BTK Cys481Xxx Mutation","BTK NP_000052.1:pC481X","ATK C481X","BTK p.Cys481Xxx","Bruton Tyrosine Kinase C481X","Tyrosine-Protein Kinase BTK Cys481Xxx","NP_000052.1:pC481X","BTK C481X Mutation","B-Cell Progenitor Kinase Cys481Xxx","Agammaglobulinaemia Tyrosine Kinase C481X","Tyrosine-Protein Kinase BTK C481X","Agammaglobulinaemia Tyrosine Kinase Cys481Xxx","NP_000052.1:pCys481Xxx","BTK p.C481X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134490","eligibility_criterion":"exclusion"}]"
NCT02426892,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT02423915,47,"null"
NCT02422979,24,"null"
NCT02421588,443,"null"
NCT02420795,60,"null"
NCT02420691,20,"null"
NCT02420652,66,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02417753,15,"null"
NCT02416908,52,"null"
NCT02415153,42,"null"
NCT02414646,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02412878,478,"null"
NCT02408016,20,"[{"assay_purpose":"Treatment Assignment, Response Assessment, Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02407080,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2.p.V617F","name":"JAK2 V617F mutation","synonyms":["JAK2 Val617Phe","JAK2 NM_004972.3:c.1848_1849TG>CT","JTK10 c.1849G>T","NP_004963.1:p.V617F","Janus Kinase 2 Val617Phe","NM_004972.3:c.1848_1849TG>CT","JAK2 c.1848_1849delTGinsCT","JAK2 V617F","Janus Kinase- 2 V617F","Janus Kinase-2 Val617Phe","Janus Kinase 2 c.1848_1849TG>CT","JAK2 NM_004972.3:c.1849G>T","JAK2 NP_004963.1:p.V617F","JTK10 c.1848_1849TG>CT","Janus Kinase-2 V617F Mutation","NM_004972.3:c.1848_1849delTGinsCT","JAK-2 c.1849G>T","JAK2 c.1849G>T","JAK2 c.1848_1849TG>CT","NM_004972.3:c.1849G>T","Janus Kinase 2 V617F","JAK2 p.Val617Phe","NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 Val617Phe","Janus Kinase 2 c.1849G>T","JAK2 NM_004972.3:c.1848_1849delTGinsCT","JAK2 NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 V617F","JAK-2 c.1848_1849TG>CT","JAK2 p.V617F"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105909:C105910:C105908","eligibility_criterion":"inclusion"}]"
NCT02406521,30,"null"
NCT02403778,60,"null"
NCT02401048,109,"null"
NCT02400437,27,"null"
NCT02400281,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Activation Loop Mutation","name":"FLT3-ALM","synonyms":["FLT3 Activation Loop Mutation","FLT3 A-Loop Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120063","eligibility_criterion":"inclusion"}]"
NCT02399371,65,"null"
NCT02392637,60,"null"
NCT02389751,40,"null"
NCT02387996,386,"null"
NCT02386501,12,"null"
NCT02385214,400,"null"
NCT02384382,23,"null"
NCT02383433,40,"null"
NCT02375880,51,"null"
NCT02375672,30,"null"
NCT02375555,41,"null"
NCT02371369,120,"null"
NCT02370498,592,"null"
NCT02369016,25,"null"
NCT02368886,123,"null"
NCT02366949,75,"null"
NCT02366728,180,"null"
NCT02366195,112,"null"
NCT02366130,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02362594,1019,"null"
NCT02362048,73,"null"
NCT02361086,21,"null"
NCT02359851,29,"null"
NCT02358200,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT02358031,825,"null"
NCT02353832,45,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"}]"
NCT02352948,597,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"}]"
NCT02352844,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC1 Gene Mutation","name":"TSC1 Gene Mutation","synonyms":["TSC1 Mutation","Tuberous Sclerosis 1 Gene Mutation","TSC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118398","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TSC2 Gene Mutation","name":"TSC2 Gene Mutation","synonyms":["Tuberous Sclerosis 2 Gene Mutation","TSC2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118399","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"STK11 Gene Mutation","name":"STK11 Gene Mutation","synonyms":["Liver Kinase B1 Gene Mutation","Serine/Threonine Kinase 11 Gene Mutation","LKB1 Gene Mutation","STK11 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128825","eligibility_criterion":"inclusion"}]"
NCT02352831,48,"null"
NCT02352558,200,"null"
NCT02348489,815,"null"
NCT02348008,61,"null"
NCT02345460,32,"null"
NCT02345408,54,"null"
NCT02345265,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT02343952,93,"null"
NCT02342379,33,"null"
NCT02342353,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02341014,30,"null"
NCT02340676,25,"null"
NCT02339558,40,"null"
NCT02337686,20,"null"
NCT02337491,82,"null"
NCT02335424,374,"null"
NCT02335411,316,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02329847,141,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 11q","name":"11q Deletion","synonyms":["del11q","Loss of Chromosome 11q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C37312","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02329717,50,"null"
NCT02326441,29,"null"
NCT02321540,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Mutation","name":"ERBB2 Gene Mutation","synonyms":["HER2/neu Gene Mutation","HER2 Gene Mutation","NEU Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96866","eligibility_criterion":"inclusion"}]"
NCT02320487,102,"null"
NCT02320305,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLANA Positive","name":"MLANA Positive","synonyms":["Antigen LB39-AA Positive","Antigen SK29-AA Positive","Melanoma Antigen Recognized by T Cells 1 Positive","Melanoma Antigen Recognized by T-Cells 1 Positive","Melan A Positive","MART-1 Positive","MART1 Positive","MART-1 Antigen Positive","Melan-A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134491","eligibility_criterion":"inclusion"}]"
NCT02319044,267,"null"
NCT02319018,30,"null"
NCT02318771,40,"null"
NCT02318589,22,"null"
NCT02318082,21,"null"
NCT02316002,42,"null"
NCT02315534,60,"null"
NCT02315430,34,"null"
NCT02314169,37,"null"
NCT02312934,40,"null"
NCT02312622,27,"null"
NCT02312557,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02308241,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02302807,931,"null"
NCT02301364,21,"null"
NCT02301156,120,"null"
NCT02296801,306,"null"
NCT02296125,674,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02292758,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Exon 3 Mutation","name":"KRAS Exon 3 Mutation","synonyms":["KRAS-2 Exon 3 Mutation","c-K-ras Exon 3 Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 3 Mutation","KRAS2 Exon 3 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135716","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Exon 4 Mutation","name":"KRAS Exon 4 Mutation","synonyms":["KRAS2 Exon 4 Mutation","c-K-ras Exon 4 Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 4 Mutation","KRAS-2 Exon 4 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135717","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Exon 2 Mutation","name":"KRAS Exon 2 Mutation","synonyms":["v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Exon 2 Mutation","c-K-ras Exon 2 Mutation","KRAS2 Exon 2 Mutation","KRAS-2 Exon 2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135715","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Exon 4 Mutation","name":"NRAS Exon 4 Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Exon 4 Mutation","N-RAS Exon 4 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135720","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Exon 2 Mutation","name":"NRAS Exon 2 Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Exon 2 Mutation","N-RAS Exon 2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135718","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Exon 3 Mutation","name":"NRAS Exon 3 Mutation","synonyms":["N-RAS Exon 3 Mutation","Neuroblastoma RAS Viral Oncogene Homolog Exon 3 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135719","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"}]"
NCT02292550,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02289833,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02289222,48,"null"
NCT02287233,94,"null"
NCT02286687,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ATM Gene Mutation","name":"ATM Gene Mutation","synonyms":["ATM Serine/Threonine Kinase Gene Mutation","A-T Mutated Gene Mutation","Ataxia Telangiectasia Mutated Gene Mutation","AT Mutated Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40459","eligibility_criterion":"inclusion"}]"
NCT02285855,70,"null"
NCT02283658,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02283372,35,"null"
NCT02282371,18,"null"
NCT02280356,45,"null"
NCT02279394,82,"null"
NCT02278965,20,"null"
NCT02278510,24,"null"
NCT02277197,22,"null"
NCT02274987,40,"null"
NCT02273219,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GNA11 Gene Mutation","name":"GNA11 Gene Mutation","synonyms":["G Protein Subunit Alpha 11 Gene Mutation","Guanine Nucleotide-Binding Protein, Alpha-11 Gene Mutation","GNA-11 Gene Mutation","GA11 Gene Mutation","Guanine Nucleotide Binding Protein (G Protein), Alpha 11 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C89714","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GNAQ Gene Mutation","name":"GNAQ Gene Mutation","synonyms":["G Protein Subunit Alpha q Gene Mutation","GAQ Gene Mutation","SWS Gene Mutation","CMC1 Gene Mutation","Guanine Nucleotide Binding Protein (G Protein), Q Polypeptide Gene Mutation","G-ALPHA-q Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C89713","eligibility_criterion":"inclusion"}]"
NCT02272855,46,"null"
NCT02272270,38,"null"
NCT02270606,20,"null"
NCT02269293,72,"null"
NCT02269267,173,"null"
NCT02269085,35,"null"
NCT02268851,60,"null"
NCT02268825,134,"null"
NCT02268175,75,"null"
NCT02267603,50,"null"
NCT02265341,30,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"FGFR2 Fusion Positive","name":"FGFR2 Fusion Positive","synonyms":["KGFR Fusion Positive","FGFR-2 Fusion Positive","Fibroblast Growth Factor Receptor 2 Fusion Positive","BEK Fusion Positive","Keratinocyte Growth Factor Receptor Fusion Positive","K-SAM Fusion Positive","ECT1 Fusion Positive","CD332 Fusion Positive","CD332 Antigen Fusion Positive","FGFR2 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150616","eligibility_criterion":"inclusion"}]"
NCT02264990,595,"null"
NCT02264574,212,"null"
NCT02258659,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT02257736,983,"null"
NCT02256436,542,"null"
NCT02255162,56,"null"
NCT02255097,172,"null"
NCT02252887,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02252042,495,"null"
NCT02250326,240,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating EML4/ALK Gene Mutation","name":"Activating EML4/ALK Gene Mutation","synonyms":["Activating EML4-ALK Gene Mutation","Activating EML4/ALK Mutation","Activating EML4-ALK Mutation","Activating EML4/ALK Fusion Gene Mutation","Activating EML4-ALK Fusion Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150436","eligibility_criterion":"exclusion"}]"
NCT02250014,20,"null"
NCT02248090,45,"null"
NCT02245867,72,"null"
NCT02243371,94,"null"
NCT02242942,445,"null"
NCT02240719,21,"null"
NCT02240537,4,"null"
NCT02238496,22,"null"
NCT02236572,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02234596,32,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02234180,105,"null"
NCT02231749,1407,"null"
NCT02229422,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT02228382,163,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02226965,61,"null"
NCT02224729,37,"null"
NCT02221960,39,"null"
NCT02220855,27,"null"
NCT02219789,12,"null"
NCT02215512,29,"null"
NCT02213926,124,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14)(q13;q32)","name":"t(11;14)(q13;q32)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27490","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"}]"
NCT02213861,60,"null"
NCT02213042,42,"null"
NCT02208375,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA Gene Mutation","name":"Deleterious BRCA Mutation","synonyms":["Deleterious BRCA Family Mutation","Deleterious BRCA Gene Family Mutation","Deleterious BRCA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141233","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02207530,112,"null"
NCT02207504,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02202772,24,"null"
NCT02199197,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02197572,44,"null"
NCT02197234,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02195869,45,"null"
NCT02195479,706,"null"
NCT02186834,47,"null"
NCT02181829,15,"null"
NCT02181413,656,"null"
NCT02180724,106,"null"
NCT02178436,49,"null"
NCT02178241,21,"null"
NCT02176213,35,"null"
NCT02175433,85,"null"
NCT02172846,26,"null"
NCT02168270,21,"null"
NCT02165397,181,"null"
NCT02164461,25,"null"
NCT02164240,35,"null"
NCT02164006,14,"null"
NCT02159755,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"}]"
NCT02158520,112,"null"
NCT02158091,32,"null"
NCT02157324,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02153918,27,"null"
NCT02152254,1362,"null"
NCT02151981,419,"null"
NCT02146222,60,"null"
NCT02145286,47,"null"
NCT02145143,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02142049,56,"null"
NCT02141282,127,"null"
NCT02139280,44,"null"
NCT02138929,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GLI1 Positive","name":"GLI1 Positive","synonyms":["GLI Positive","Zinc Finger Protein GLI1 Positive","GLI Family Zinc Finger 1 Positive","Glioma Associated Oncogene Homolog 1 Positive","Glioma-Associated Oncogene Family Zinc Finger 1 Positive","Glioma-Associated Oncogene 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134862","eligibility_criterion":"inclusion"}]"
NCT02136290,184,"null"
NCT02135133,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11;14) Negative","name":"t(11;14) Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131064","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cyclin D1 Protein Overexpression","name":"Cyclin D1 Protein Overexpression","synonyms":["B-Cell Lymphoma 1 Protein Overexpression","BCL-1 Protein Overexpression","CCND1 Protein Overexpression","BCL1 Protein Overexpression","Cyclin D1 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36485","eligibility_criterion":"inclusion"}]"
NCT02133742,52,"null"
NCT02132949,401,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02130557,535,"null"
NCT02129101,78,"null"
NCT02127710,111,"null"
NCT02126969,72,"null"
NCT02125461,713,"null"
NCT02123758,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02121990,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02120222,26,"null"
NCT02119468,37,"null"
NCT02117024,123,"null"
NCT02116959,36,"null"
NCT02115542,39,"null"
NCT02113657,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02112526,20,"null"
NCT02111941,22,"null"
NCT02108652,310,"null"
NCT02107755,32,"null"
NCT02107703,669,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02106546,970,"null"
NCT02106507,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02105636,506,"null"
NCT02103478,113,"null"
NCT02102490,132,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02101580,21,"null"
NCT02101268,156,"null"
NCT02100423,35,"null"
NCT02099864,36,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02098538,38,"null"
NCT02096588,90,"null"
NCT02096471,19,"null"
NCT02096354,57,"null"
NCT02095834,49,"null"
NCT02095054,83,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"}]"
NCT02094573,222,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02094261,210,"null"
NCT02093403,42,"null"
NCT02092298,30,"null"
NCT02091531,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02088112,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02087423,446,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02077959,53,"null"
NCT02077933,79,"null"
NCT02076997,50,"null"
NCT02076009,569,"null"
NCT02073994,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"}]"
NCT02072486,30,"null"
NCT02066181,83,"null"
NCT02065362,14,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT02064725,8,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02063958,19,"null"
NCT02062749,30,"null"
NCT02060370,60,"null"
NCT02059213,95,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Five","name":"PSA Level Five or Greater","synonyms":["PSA Level Greater than or Equal to 5","PSA Level Greater than or Equal to Five","PSA Level 5 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139792","eligibility_criterion":"inclusion"}]"
NCT02058849,50,"null"
NCT02058706,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Four","name":"PSA Level Four or Greater","synonyms":["PSA Level Greater than or Equal to Four"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137705","eligibility_criterion":"inclusion"}]"
NCT02058680,48,"null"
NCT02054806,477,"null"
NCT02051257,51,"null"
NCT02050919,20,"null"
NCT02049593,30,"null"
NCT02049541,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cyclin D1 Protein Overexpression","name":"Cyclin D1 Protein Overexpression","synonyms":["B-Cell Lymphoma 1 Protein Overexpression","BCL-1 Protein Overexpression","CCND1 Protein Overexpression","BCL1 Protein Overexpression","Cyclin D1 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36485","eligibility_criterion":"inclusion"}]"
NCT02049489,20,"null"
NCT02048813,519,"null"
NCT02047253,28,"null"
NCT02046421,22,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02046174,120,"null"
NCT02046122,60,"null"
NCT02045446,36,"null"
NCT02045433,21,"null"
NCT02043678,806,"null"
NCT02041533,1325,"null"
NCT02041429,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02040857,165,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02038946,116,"null"
NCT02038933,161,"null"
NCT02038647,178,"null"
NCT02038153,48,"null"
NCT02038010,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02036476,12,"null"
NCT02035358,18,"null"
NCT02034552,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT02031458,659,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PD-L1 Positive","name":"PD-L1 Positive","synonyms":["CD274 Molecule Positive","PDCD1L1 Positive","CD274 Positive","PDCD1LG1 Positive","B7-H Positive","PDL1 Positive","B7H1 Positive","CD274 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128554","eligibility_criterion":"inclusion"}]"
NCT02030860,15,"null"
NCT02029950,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5-19 Percent of Peripheral Blood White Cells","name":"Blasts 5-19 Percent of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41400","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than 10 Percent of Bone Marrow Nucleated Cells","Blasts Over 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150457","eligibility_criterion":"inclusion"}]"
NCT02029690,85,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ASS1 Gene Deficiency","name":"ASS1 Gene Deficiency","synonyms":["Argininosuccinate Synthase 1 Low","Argininosuccinate Synthase 1 Gene Deficiency","ASS1 Low Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138072","eligibility_criterion":"inclusion"}]"
NCT02029443,286,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02028988,64,"null"
NCT02027935,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SLC45A2 Positive","name":"SLC45A2 Positive","synonyms":["Melanoma Antigen AIM1 Positive","AIM-1 Positive","AIM1 Positive","SHEP5 Positive","Solute Carrier Family 45 Member 2 Positive","MATP Positive","OCA4 Positive"],"hugo_biomarker_code":"16472","nci_thesaurus_concept_id":"C141404","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLANA Positive","name":"MLANA Positive","synonyms":["Antigen LB39-AA Positive","Antigen SK29-AA Positive","Melanoma Antigen Recognized by T Cells 1 Positive","Melanoma Antigen Recognized by T-Cells 1 Positive","Melan A Positive","MART-1 Positive","MART1 Positive","MART-1 Antigen Positive","Melan-A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134491","eligibility_criterion":"inclusion"}]"
NCT02026063,71,"null"
NCT02025192,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02025010,60,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02024607,609,"null"
NCT02023697,391,"null"
NCT02022982,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT02020941,35,"null"
NCT02020226,40,"null"
NCT02020070,53,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02019069,33,"null"
NCT02017717,626,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Unmethylated MGMT Promoter","name":"Unmethylated MGMT Promoter","synonyms":["Unmethylated Methylguanine-DNA Methyltransferase Gene Promoter","Unmethylated O-6-Methylguanine-DNA Methyltransferase Gene Promoter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132892","eligibility_criterion":"inclusion"}]"
NCT02015728,24,"null"
NCT02015065,27,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"exclusion"}]"
NCT02014116,50,"null"
NCT02011945,69,"null"
NCT02010645,50,"null"
NCT02010567,71,"null"
NCT02010203,110,"null"
NCT02005471,389,"null"
NCT02004522,300,"null"
NCT02004028,38,"null"
NCT02000622,302,"null"
NCT02000596,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01999335,33,"null"
NCT01998035,89,"null"
NCT01997840,101,"null"
NCT01995513,509,"null"
NCT01992653,85,"null"
NCT01990352,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT01988896,153,"null"
NCT01985763,24,"null"
NCT01984502,48,"null"
NCT01983501,57,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01982682,41,"null"
NCT01977677,29,"null"
NCT01977651,424,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01975831,106,"null"
NCT01975766,9,"null"
NCT01974440,403,"null"
NCT01972217,159,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01969448,94,"null"
NCT01967576,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHB Gene Mutation","name":"SDHB Gene Mutation","synonyms":["SDH1 Gene Mutation","SDHIP Gene Mutation","SDH2 Gene Mutation","Succinate Dehydrogenase Complex Iron Sulfur Subunit B Gene Mutation","IP Gene Mutation","SDH Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48302","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"VHL Gene Mutation","name":"VHL Gene Mutation","synonyms":["HRCA1 Gene Mutation","Von Hippel-Lindau Tumor Supressor Gene Mutation","VHL Mutation","VHL1 Gene Mutation","Von Hippel-Lindau Syndrome Gene Mutation","RCA1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118400","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHD Gene Mutation","name":"SDHD Gene Mutation","synonyms":["Succinate Dehydrogenase Complex Subunit D Gene Mutation","SDH4 Gene Mutation","cybS Gene Mutation","CII-4 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48304","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SDHC Gene Mutation","name":"SDHC Gene Mutation","synonyms":["cybL Gene Mutation","SDH3 Gene Mutation","CYB560 Gene Mutation","Succinate Dehydrogenase Complex Subunit C Gene Mutation","QPS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48303","eligibility_criterion":"inclusion"}]"
NCT01967095,89,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01966471,1846,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01965353,28,"null"
NCT01964924,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01964430,866,"null"
NCT01964300,52,"null"
NCT01962948,74,"null"
NCT01962103,107,"null"
NCT01961843,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01960023,22,"null"
NCT01959672,66,"null"
NCT01958112,35,"null"
NCT01958021,668,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01957956,25,"null"
NCT01957787,134,"null"
NCT01955499,34,"null"
NCT01955434,27,"null"
NCT01952054,35,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"exclusion"}]"
NCT01949337,1224,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01946529,47,"null"
NCT01946204,1207,"null"
NCT01946152,55,"null"
NCT01943461,57,"null"
NCT01942837,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01940276,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01938729,28,"null"
NCT01935336,100,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"RET Positive","name":"RET Positive","synonyms":["Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret Positive","Tyrosine-Protein Kinase Receptor RET Positive","Ret Proto-Oncogene Positive","Proto-Oncogene c-Ret Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141317","eligibility_criterion":"inclusion"}]"
NCT01933932,510,"null"
NCT01932697,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT01931787,20,"null"
NCT01931098,66,"null"
NCT01927744,100,"null"
NCT01927627,42,"null"
NCT01924260,34,"null"
NCT01923506,34,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Two","name":"PSA Level Less Than Two","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136415","eligibility_criterion":"inclusion"}]"
NCT01923337,42,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"UGT1A1*28 Allele","name":"UGT1A1*28","synonyms":["UGT1A1 Variant Allele (TA)7"," NM_000463.2:c.-55_-54dupAT","UGT1A1 (TA)7 Allele","UGT1A1*28 Allele","UGT1A1 TATA Element ins TA Allele","UGT1A1, 2-BP ins, TA, TATAA Element Allele","UDP Glycosyltransferase 1 Family, Polypeptide A1*28 Allele","UGT1A1 c.-55_-54dupAT","UGT1A1 NM_000463.2:c.-55_-54insAT","UGT1A1 A(TA)7TAA Allele","UGT1A1 c.-55_-54insAT","NM_000463.2:c.-55_-54insAT","UGT1A1 Variant (TA)7 Allele","UGT1A1 NM_000463.2:c.-55_-54dupAT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564","eligibility_criterion":"exclusion"}]"
NCT01922921,30,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01921335,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01920932,77,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01915498,357,"null"
NCT01913951,38,"null"
NCT01912963,93,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01910012,43,"null"
NCT01909453,921,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01907802,122,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01907165,21,"null"
NCT01907100,545,"null"
NCT01905813,121,"null"
NCT01902173,97,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01900002,40,"null"
NCT01899053,152,"null"
NCT01898494,515,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT01898130,27,"null"
NCT01897116,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01893372,46,"null"
NCT01893320,84,"null"
NCT01892397,21,"null"
NCT01886859,40,"null"
NCT01885949,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01882985,25,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01882816,25,"null"
NCT01882803,129,"null"
NCT01881789,134,"null"
NCT01880749,21,"null"
NCT01876446,38,"null"
NCT01875250,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01874353,295,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT01874054,55,"null"
NCT01871116,80,"null"
NCT01870505,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01867333,76,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01859858,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"UGT1A1*28 Allele","name":"UGT1A1*28","synonyms":["UGT1A1 Variant Allele (TA)7"," NM_000463.2:c.-55_-54dupAT","UGT1A1 (TA)7 Allele","UGT1A1*28 Allele","UGT1A1 TATA Element ins TA Allele","UGT1A1, 2-BP ins, TA, TATAA Element Allele","UDP Glycosyltransferase 1 Family, Polypeptide A1*28 Allele","UGT1A1 c.-55_-54dupAT","UGT1A1 NM_000463.2:c.-55_-54insAT","UGT1A1 A(TA)7TAA Allele","UGT1A1 c.-55_-54insAT","NM_000463.2:c.-55_-54insAT","UGT1A1 Variant (TA)7 Allele","UGT1A1 NM_000463.2:c.-55_-54dupAT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564","eligibility_criterion":"exclusion"}]"
NCT01858740,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Less than or Equal to 10000/mm3","name":"Blasts Less than or Equal to 10000/mm3","synonyms":["Blasts Less than or Equal to 10000/Cubic mm","Blasts Less than or Equal to 10,000/mm3","Blasts Less than or Equal to 10,000 per Cubic Millimeter","Blasts Less than or Equal to 10000 per Cubic mm","Blasts Less than or Equal to 10000 per Cubic Millimeter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150456","eligibility_criterion":"inclusion"}]"
NCT01855828,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01854567,240,"null"
NCT01854554,90,"null"
NCT01854034,29,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"inclusion"}]"
NCT01853748,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01853618,90,"null"
NCT01851733,40,"null"
NCT01850524,701,"null"
NCT01849874,360,"null"
NCT01849783,41,"null"
NCT01849588,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"inclusion"}]"
NCT01849276,28,"null"
NCT01847001,20,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01846624,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"}]"
NCT01844986,450,"null"
NCT01844505,1296,"null"
NCT01843062,233,"null"
NCT01842308,68,"null"
NCT01841736,165,"null"
NCT01840592,30,"null"
NCT01840566,24,"null"
NCT01839981,13,"null"
NCT01839916,80,"null"
NCT01839487,279,"null"
NCT01839240,50,"null"
NCT01838551,90,"null"
NCT01837095,54,"null"
NCT01836432,302,"null"
NCT01836029,175,"null"
NCT01835223,49,"null"
NCT01835041,18,"null"
NCT01833520,15,"null"
NCT01832727,128,"null"
NCT01832259,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Twenty","name":"PSA Level Twenty or Greater","synonyms":["PSA Level Greater than or Equal to Twenty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137702","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Ten","name":"PSA Level Greater Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137686","eligibility_criterion":"inclusion"}]"
NCT01829711,80,"null"
NCT01829503,39,"null"
NCT01829217,35,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PDGFRB Gene Mutation","name":"PDGFRB Gene Mutation","synonyms":["Platelet Derived Growth Factor Receptor Beta Gene Mutation","CD140b Gene Mutation","JTK12 Gene Mutation","PDGFR1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128172","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01828554,10,"null"
NCT01828112,231,"null"
NCT01828034,47,"null"
NCT01827787,90,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01827111,64,"null"
NCT01826877,18,"null"
NCT01824875,145,"null"
NCT01823978,19,"null"
NCT01822015,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 20 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than 20 Percent of Bone Marrow Nucleated Cells","Blasts Over 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150460","eligibility_criterion":"inclusion"}]"
NCT01821729,50,"null"
NCT01820754,30,"null"
NCT01820299,26,"null"
NCT01818063,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01816984,30,"null"
NCT01816971,70,"null"
NCT01806571,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Overexpression Positive","name":"KIT Overexpression Positive","synonyms":["Mast/Stem Cell Growth Factor Receptor Kit Positive","c-KIT Positive","CD117 Antigen Positive","CD117 Positive","Proto-Oncogene c-Kit Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147076","eligibility_criterion":"inclusion"}]"
NCT01802632,603,"null"
NCT01797523,64,"null"
NCT01796197,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01794507,66,"null"
NCT01792687,6,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01792050,169,"null"
NCT01791478,76,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01790503,65,"null"
NCT01790126,90,"null"
NCT01787500,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G12X","name":"KRAS G12 Mutation","synonyms":["KRAS Codon 12 Mutation","NP_004976.2:p.Gly12Xxx","c-K-ras G12X","KRAS p.Gly12Xxx","KRAS G12X","K-Ras 2 G12X","KRAS p.G12X","KRAS NP_004976.2:p.G12X","KRAS NP_004976.2:p.Gly12Xxx","KRAS Gly12Xxx","Ki-Ras G12X","GTPase KRas G12X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117180","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS NP_004976.2:p.G13X","name":"KRAS G13 Mutation","synonyms":["KRAS G13X","c-K-ras G13X","KRAS NP_004976.2:p.G13X","KRAS NP_004976.2:p.Gly13Xxx","KRAS p.Gly13Xxx","NP_004976.2:p.Gly13Xxx","KRAS p.G13X","KRAS Codon 13 Mutation","Ki-Ras G13X","KRAS Gly13Xxx","GTPase KRas G13X","K-Ras 2 G13X"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117177","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"exclusion"}]"
NCT01784861,71,"null"
NCT01784640,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01781455,350,"null"
NCT01781429,125,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MEK Family Gene Mutation","name":"MEK Family Gene Mutation","synonyms":["MEK Family Mutation","Mitogen-Activated Protein Kinase Kinase Family Gene Mutation","MAP2K Family Gene Mutation","MAPKK Family Gene Mutation","MEK Mutation","Mutant MEK","Mutant MEK Family Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136422","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERK Family Gene Mutation","name":"ERK Family Gene Mutation","synonyms":["MAP Kinase Family Gene Mutation","ERK Family Mutation","Mitogen-Activated Protein Kinase Family Gene Mutation","ERK Mutation","Mutant ERK","Extracellular Signal-Regulated Kinase Family Gene Mutation","MAPK Family Gene Mutation","Mutant ERK Family Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136423","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01780662,72,"null"
NCT01779050,50,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Presence of ERBB2 Overexpressing Disseminated Tumor Cells","name":"Presence of ERBB2 Overexpressing Disseminated Tumor Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01777152,452,"null"
NCT01776723,53,"null"
NCT01776307,150,"null"
NCT01775501,40,"null"
NCT01774786,780,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01774578,135,"null"
NCT01774344,573,"null"
NCT01773109,37,"null"
NCT01772472,1487,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01770132,12,"null"
NCT01767792,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"}]"
NCT01767766,90,"null"
NCT01763164,402,"null"
NCT01760525,51,"null"
NCT01758328,26,"null"
NCT01755975,67,"null"
NCT01754389,144,"null"
NCT01752920,109,"null"
NCT01752491,20,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT01752036,35,"null"
NCT01751451,120,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01751438,180,"null"
NCT01751412,40,"null"
NCT01750983,115,"null"
NCT01750918,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01750281,212,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation Negative","name":"KRAS Gene Mutation Negative","synonyms":["c-K-ras Gene Mutation Negative","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation Negative","KRAS2 Gene Mutation Negative","KRAS-2 Gene Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142879","eligibility_criterion":"inclusion"}]"
NCT01749969,60,"null"
NCT01749397,102,"null"
NCT01747486,32,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01746238,24,"null"
NCT01745588,72,"null"
NCT01744665,59,"null"
NCT01744652,176,"null"
NCT01740648,30,"null"
NCT01738152,108,"null"
NCT01734928,559,"null"
NCT01730950,178,"null"
NCT01730729,20,"null"
NCT01729260,33,"null"
NCT01729104,68,"null"
NCT01728805,372,"null"
NCT01728779,42,"null"
NCT01728259,40,"null"
NCT01726738,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Glucose-6-Phosphate Dehydrogenase Deficiency","name":"G6PD Deficiency","synonyms":["Glucose-6-Phosphate Dehydrogenase Deficiency","G-6-PD Variant Enzyme Deficiency Anemia"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98933","eligibility_criterion":"exclusion"}]"
NCT01725165,94,"null"
NCT01724346,232,"null"
NCT01723202,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01721876,666,"null"
NCT01721746,631,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"}]"
NCT01720225,120,"null"
NCT01719380,150,"null"
NCT01718743,88,"null"
NCT01717391,40,"null"
NCT01716416,33,"null"
NCT01716208,36,"null"
NCT01715233,130,"null"
NCT01711970,38,"null"
NCT01711632,36,"null"
NCT01709734,126,"null"
NCT01707264,69,"null"
NCT01706939,365,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT01706458,30,"null"
NCT01702844,42,"null"
NCT01702155,60,"null"
NCT01701323,15,"null"
NCT01698918,202,"null"
NCT01698905,163,"null"
NCT01697800,40,"null"
NCT01696084,309,"null"
NCT01693601,58,"null"
NCT01693562,1022,"null"
NCT01690520,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT01688492,57,"null"
NCT01688466,35,"null"
NCT01687413,496,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT01687400,125,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"}]"
NCT01685892,82,"null"
NCT01685762,15,"null"
NCT01685008,120,"null"
NCT01683994,81,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01682226,101,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT01682213,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01682083,852,"null"
NCT01681537,37,"null"
NCT01680965,50,"null"
NCT01678352,40,"null"
NCT01677559,39,"null"
NCT01676831,20,"null"
NCT01675765,60,"null"
NCT01673867,792,"null"
NCT01672229,16,"null"
NCT01668784,1068,"null"
NCT01664754,8,"null"
NCT01664182,78,"null"
NCT01662804,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT01661283,25,"null"
NCT01660711,21,"null"
NCT01660529,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01660451,227,"null"
NCT01657682,70,"null"
NCT01657331,71,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01654497,60,"null"
NCT01654068,26,"null"
NCT01652196,70,"null"
NCT01652079,84,"null"
NCT01650506,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01649947,40,"null"
NCT01644955,42,"null"
NCT01644773,58,"null"
NCT01643850,36,"null"
NCT01643603,30,"null"
NCT01643499,79,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"UGT1A1 wt Allele","name":"UGT1A1*1","synonyms":["UGT1A1 Wild-Type Allele","UGT1A1 wt Allele","Polypeptide A1 wt Allele","UGT1A1 *1","Polypeptide A1*1 Allele","UDP Glycosyltransferase 1 Family","UGT1A1 Gene Allele 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51018","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"UGT1A1*28 Allele","name":"UGT1A1*28","synonyms":["UGT1A1 Variant Allele (TA)7"," NM_000463.2:c.-55_-54dupAT","UGT1A1 (TA)7 Allele","UGT1A1*28 Allele","UGT1A1 TATA Element ins TA Allele","UGT1A1, 2-BP ins, TA, TATAA Element Allele","UDP Glycosyltransferase 1 Family, Polypeptide A1*28 Allele","UGT1A1 c.-55_-54dupAT","UGT1A1 NM_000463.2:c.-55_-54insAT","UGT1A1 A(TA)7TAA Allele","UGT1A1 c.-55_-54insAT","NM_000463.2:c.-55_-54insAT","UGT1A1 Variant (TA)7 Allele","UGT1A1 NM_000463.2:c.-55_-54dupAT"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564","eligibility_criterion":"inclusion"}]"
NCT01639690,10,"null"
NCT01638936,64,"null"
NCT01636934,40,"null"
NCT01636622,96,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01636609,96,"null"
NCT01634685,18,"null"
NCT01634217,32,"null"
NCT01630590,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than One","name":"PSA Level Greater than One","synonyms":["PSA Level Greater than 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138949","eligibility_criterion":"inclusion"}]"
NCT01628536,44,"null"
NCT01627288,24,"null"
NCT01625351,24,"null"
NCT01624220,57,"null"
NCT01622933,30,"null"
NCT01621568,58,"null"
NCT01615029,45,"null"
NCT01612351,40,"null"
NCT01611090,579,"null"
NCT01609556,205,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT01608594,30,"null"
NCT01601535,44,"null"
NCT01597908,704,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01596751,85,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01596257,72,"null"
NCT01596140,114,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"}]"
NCT01595048,640,"null"
NCT01594229,60,"null"
NCT01593748,90,"null"
NCT01591733,50,"null"
NCT01590732,18,"null"
NCT01590069,70,"null"
NCT01589094,46,"null"
NCT01588821,38,"null"
NCT01587352,40,"null"
NCT01587040,150,"null"
NCT01583283,38,"null"
NCT01582269,180,"null"
NCT01578967,43,"null"
NCT01578499,131,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01578239,231,"null"
NCT01578109,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"}]"
NCT01576172,148,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01575925,25,"null"
NCT01573702,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT01572662,200,"null"
NCT01572493,52,"null"
NCT01567891,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CTAG1B Positive","name":"CTAG1B Positive","synonyms":["NY-ESO-1B Positive","Cancer/Testis Antigen 1B Positive","LAGE2B Positive","LAGE-2B Positive","CT6.1B Positive","ESO1B Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142102","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0206 Positive Cells Present","name":"HLA-A*02:06 Positive","synonyms":["HLA-A*0206 Positive","HLA-A*0206 Positive Cells Present","HLA-A0206 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0205 Positive Cells Present","name":"HLA-A*0205 Positive Cells Present","synonyms":["HLA-A0205 Positive","HLA-A*02:05 Positive Cells Present","HLA-A*0205 Positive","HLA-A*02:05 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131443","eligibility_criterion":"inclusion"}]"
NCT01567462,160,"null"
NCT01564537,722,"null"
NCT01560949,33,"null"
NCT01560416,71,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01558921,920,"null"
NCT01557790,56,"null"
NCT01555541,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01553149,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"inclusion"}]"
NCT01548807,33,"null"
NCT01548144,364,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"c-MET Gene Amplification","name":"MET Gene Amplification","synonyms":["HGFR Gene Amplification","c-Met Gene Amplification","Hepatocyte Growth Factor Receptor Gene Amplification","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43532","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Amplification","name":"ALK Gene Amplification","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Amplification","Anaplastic Lymphoma Kinase Receptor Gene Amplification","CD246 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131136","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Gene Mutation","name":"MET Gene Mutation","synonyms":["c-met Gene Mutation","MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Mutation","Hepatocyte Growth Factor Receptor Gene Mutation","Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Mutation","HGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39788","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Kinase Overexpression","name":"ALK Kinase Overexpression","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Gene Translocation","name":"ROS1 Translocation","synonyms":["ROS Gene Translocation","c-ros-1 Gene Translocation","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Translocation","MCF3 Gene Translocation","ROS1 Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"}]"
NCT01543776,72,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01543763,60,"null"
NCT01542918,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01542021,60,"null"
NCT01537744,39,"null"
NCT01536743,30,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT01535924,41,"null"
NCT01532089,112,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT01527149,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clonal CCND1 Gene Rearrangement","name":"CCND1 Gene Rearrangement","synonyms":["Bcl-1 Rearrangement","Cyclin D1 Gene Rearrangement","Clonal BCL-1 Gene Rearrangement","Clonal Cyclin D1 Gene Rearrangement","Clonal CCND1 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27714","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"CCND1 Positive","name":"CCND1 Positive","synonyms":["BCL1 Positive","Cyclin D1 Positive","Cyclin-D1 Positive","BCL-1 Positive","PRAD1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128832","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clonal Immunoglobulin Heavy Chain Gene Rearrangement","name":"IGH Gene Rearrangement","synonyms":["Clonal IGH Gene Rearrangement","Clonal Immunoglobulin Heavy Chain Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36444","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(11,14)(CLL,IGH) gene translocation","name":"t(11;14)","synonyms":["C0808176"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Negative","name":"FCER2 Negative","synonyms":["CD23 Antigen Negative","Low Affinity Immunoglobulin Epsilon Fc Receptor Negative","CD23 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131487","eligibility_criterion":"inclusion"}]"
NCT01526473,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01525082,30,"null"
NCT01523977,24,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 14 Chromosomal Translocation","name":"t(8;14)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128649","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(2;8)","name":"t(2;8)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131808","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"t(8;22)","name":"t(8;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131810","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Lymphoblasts with Surface Immunoglobulin Present","name":"Lymphoblasts with Surface Immunoglobulin Present","synonyms":["Lymphoblasts with Surface Ig","Surface Immunoglobulin Positive Lymphoblasts Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150656","eligibility_criterion":"exclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 25 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 25 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C140330","eligibility_criterion":"inclusion"}]"
NCT01523223,18,"null"
NCT01522989,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Positive","name":"RB Positive","synonyms":["Retinoblastoma Positive","RB1 Positive","Retinoblastoma 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128842","eligibility_criterion":"inclusion"}]"
NCT01522872,98,"null"
NCT01520558,12,"null"
NCT01519869,28,"null"
NCT01517802,32,"null"
NCT01516580,482,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD20 Negative","name":"CD20 Negative","synonyms":["Leu-16 Negative","MS4A1 Negative","CD20 Antigen Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137690","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lactate Dehydrogenase","name":"LDH","synonyms":["lactate dehydrogenase"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C25184","eligibility_criterion":"inclusion"}]"
NCT01516216,140,"null"
NCT01512810,200,"null"
NCT01511562,110,"null"
NCT01509911,99,"null"
NCT01506856,654,"null"
NCT01506609,294,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT01504126,25,"null"
NCT01502800,60,"null"
NCT01498978,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"}]"
NCT01497925,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01497808,40,"null"
NCT01496976,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT01496313,81,"null"
NCT01494662,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01494155,50,"null"
NCT01492673,29,"null"
NCT01491893,110,"null"
NCT01491737,258,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01490723,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01485744,45,"null"
NCT01484275,87,"null"
NCT01483144,171,"null"
NCT01482715,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT01478438,60,"null"
NCT01478321,77,"null"
NCT01476787,255,"null"
NCT01476410,48,"null"
NCT01473940,28,"null"
NCT01473004,48,"null"
NCT01472562,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MME Negative","name":"MME Negative","synonyms":["Skin Fibroblast Elastase Negative","CD10 Negative","Common ALL Antigen Negative","CALLA Negative","SFE Negative","Membrane Metalloendopeptidase Negative","Neprilysin Negative","Common Acute Lymphoblastic Leukemia Antigen Negative","NEP Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141363","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cyclin D1 Protein Overexpression","name":"Cyclin D1 Protein Overexpression","synonyms":["B-Cell Lymphoma 1 Protein Overexpression","BCL-1 Protein Overexpression","CCND1 Protein Overexpression","BCL1 Protein Overexpression","Cyclin D1 Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36485","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND2 Protein Overexpression","name":"CCND2 Protein Overexpression","synonyms":["Cyclin-D2 Protein Overexpression","G1/S-Specific Cyclin D2 Protein Overexpression","G1/S-Specific Cyclin-D2 Protein Overexpression","Cyclin D2 Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141364","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CCND3 Protein Overexpression","name":"CCND3 Protein Overexpression","synonyms":["G1/S-Specific Cyclin-D3 Protein Overexpression","Cyclin D3 Protein Overexpression","G1/S-Specific Cyclin D3 Protein Overexpression","Cyclin-D3 Protein Overexpression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141368","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Negative","name":"FCER2 Negative","synonyms":["CD23 Antigen Negative","Low Affinity Immunoglobulin Epsilon Fc Receptor Negative","CD23 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131487","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT01472081,175,"null"
NCT01471964,35,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT01471444,250,"null"
NCT01470365,24,"null"
NCT01469247,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"exclusion"}]"
NCT01468818,35,"null"
NCT01466972,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01466660,319,"null"
NCT01466036,70,"null"
NCT01463046,22,"null"
NCT01460472,1082,"null"
NCT01458366,36,"null"
NCT01456689,79,"null"
NCT01454102,472,"null"
NCT01449864,24,"null"
NCT01449279,25,"null"
NCT01446809,21,"null"
NCT01446159,188,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01444742,80,"null"
NCT01444716,34,"null"
NCT01440582,54,"null"
NCT01439152,147,"null"
NCT01436227,40,"null"
NCT01431794,52,"null"
NCT01430416,153,"null"
NCT01430351,144,"null"
NCT01425008,149,"null"
NCT01423851,77,"null"
NCT01420874,24,"null"
NCT01420250,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Twenty","name":"PSA Level Twenty or Greater","synonyms":["PSA Level Greater than or Equal to Twenty"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137702","eligibility_criterion":"inclusion"}]"
NCT01419067,140,"null"
NCT01416974,18,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01416428,364,"null"
NCT01415882,144,"null"
NCT01414738,102,"null"
NCT01410344,18,"null"
NCT01407562,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01407198,29,"null"
NCT01404949,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PML/RARA Fusion Positive","name":"PML/RARA Fusion Positive","synonyms":["PML-RARA Positive","PML-RAR Alpha Fusion Positive","PML-RAR Alpha Positive","PML-RARA Fusion Positive","PML/RAR Alpha Fusion Positive","PML/RAR Alpha Positive","PML/RARA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128836","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"inclusion"}]"
NCT01400672,20,"null"
NCT01399918,54,"null"
NCT01399658,100,"null"
NCT01397734,18,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BCR/ABL Translocation","name":"BCR/ABL Translocation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01394016,220,"null"
NCT01393509,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2 Gene Mutation","name":"JAK2 Gene Mutation","synonyms":["JAK2 Mutation","JAK2 Gene Variant","Janus Kinase 2 Gene Variant","Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C84255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MPL Gene Mutation","name":"MPL Gene Mutation","synonyms":["CD110 Gene Mutation","Myeloproliferative Leukemia Virus Oncogene Gene Mutation","c-MPL Gene Mutation","TPOR Gene Mutation","MPL Proto-Oncogene, Thrombopoietin Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C126821","eligibility_criterion":"inclusion"}]"
NCT01392989,44,"null"
NCT01392209,42,"null"
NCT01392183,90,"null"
NCT01385423,43,"null"
NCT01380106,80,"null"
NCT01372774,192,"null"
NCT01372540,76,"null"
NCT01370213,43,"null"
NCT01365156,600,"null"
NCT01363128,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"exclusion"}]"
NCT01362374,123,"null"
NCT01361113,39,"null"
NCT01353625,119,"null"
NCT01352520,84,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01350401,4,"null"
NCT01349660,88,"null"
NCT01346124,64,"null"
NCT01342354,24,"null"
NCT01341652,106,"null"
NCT01340495,96,"null"
NCT01339039,46,"null"
NCT01339000,50,"null"
NCT01338987,118,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 7","name":"Monosomy 7","synonyms":["-7","Deletion of chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 3q","name":"Loss of Chromosome 3q","synonyms":["del(3q)","3q Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45859","eligibility_criterion":"inclusion"}]"
NCT01336634,174,"null"
NCT01332968,1401,"null"
NCT01329900,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01328626,222,"null"
NCT01328535,75,"null"
NCT01328249,81,"null"
NCT01324908,203,"null"
NCT01321541,260,"null"
NCT01321437,32,"null"
NCT01320592,30,"null"
NCT01317875,69,"null"
NCT01308567,1168,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01307956,23,"null"
NCT01305941,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01304797,75,"null"
NCT01301807,46,"null"
NCT01301391,30,"null"
NCT01300962,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01300572,30,"null"
NCT01298570,180,"null"
NCT01295645,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BK Virus Positive","name":"BK Virus Positive","synonyms":["BKV Papovavirus Positive","Polyomavirus BK Positive","BK Polyomavirus Positive","BKV Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141400","eligibility_criterion":"inclusion"}]"
NCT01286675,18,"null"
NCT01286038,57,"null"
NCT01285557,500,"null"
NCT01274624,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT01273610,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01273168,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01270321,90,"null"
NCT01266460,67,"null"
NCT01266057,224,"null"
NCT01265576,20,"null"
NCT01262664,39,"null"
NCT01261247,41,"null"
NCT01253642,30,"null"
NCT01253460,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"del(11q22q23)","name":"11q22-23 Deletion","synonyms":["del(11q22-q23)","del(11)(q22q23)","11q22-q23 Deletion","del(11q22q23)","del(11)(q22-q23)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36422","eligibility_criterion":"inclusion"}]"
NCT01248962,150,"null"
NCT01248247,200,"null"
NCT01246986,235,"null"
NCT01243190,44,"null"
NCT01242800,368,"null"
NCT01239797,761,"null"
NCT01238172,464,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT01231594,221,"null"
NCT01231412,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT01224665,620,"null"
NCT01223248,300,"null"
NCT01222260,40,"null"
NCT01212991,1735,"null"
NCT01211691,120,"null"
NCT01209871,12,"null"
NCT01207921,28,"null"
NCT01207440,449,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT01202409,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT01199575,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"}]"
NCT01197170,281,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01189643,15,"null"
NCT01187199,278,"null"
NCT01186978,62,"null"
NCT01185639,95,"null"
NCT01184326,51,"null"
NCT01182350,100,"null"
NCT01182285,25,"null"
NCT01180049,101,"null"
NCT01178411,60,"null"
NCT01171898,127,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01163786,20,"null"
NCT01162200,75,"null"
NCT01160211,364,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01159028,60,"null"
NCT01155583,44,"null"
NCT01149850,50,"null"
NCT01146834,180,"null"
NCT01142232,62,"null"
NCT01132014,35,"null"
NCT01131169,77,"null"
NCT01124695,240,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01121588,44,"null"
NCT01120639,30,"null"
NCT01118026,100,"null"
NCT01116648,162,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01113476,183,"null"
NCT01112527,58,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT01107522,100,"null"
NCT01106833,151,"null"
NCT01104350,20,"null"
NCT01102088,71,"null"
NCT01100502,329,"null"
NCT01096602,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blast Cells Present","name":"Blast Cells Present","synonyms":["Circulating Blasts"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C35880","eligibility_criterion":"exclusion"}]"
NCT01094860,35,"null"
NCT01088802,60,"null"
NCT01087554,249,"null"
NCT01085630,94,"null"
NCT01077518,346,"null"
NCT01075113,15,"null"
NCT01067287,63,"null"
NCT01064921,38,"null"
NCT01064479,120,"null"
NCT01063114,90,"null"
NCT01061840,100,"null"
NCT01059630,396,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01059552,30,"null"
NCT01058707,116,"null"
NCT01049230,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Fetoprotein","name":"Elevated AFP","synonyms":["Elevated Alpha-Fetoprotein"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136630","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Human Chorionic Gonadotropin","name":"Elevated HCG","synonyms":["Elevated Human Chorionic Gonadotropin"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136631","eligibility_criterion":"inclusion"}]"
NCT01044069,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT01038778,45,"null"
NCT01036087,40,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT01035463,114,"null"
NCT01030900,52,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"exclusion"}]"
NCT01027416,50,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Alpha Positive","name":"Estrogen Receptor Alpha Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"exclusion"}]"
NCT01013441,20,"null"
NCT01011439,60,"null"
NCT01004861,150,"null"
NCT01000051,64,"null"
NCT00983619,136,"null"
NCT00978458,540,"null"
NCT00978250,165,"null"
NCT00970203,12,"null"
NCT00960752,71,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT00950001,132,"null"
NCT00942877,73,"null"
NCT00929214,75,"null"
NCT00924326,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"}]"
NCT00923936,26,"null"
NCT00915018,479,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00910910,450,"null"
NCT00903968,85,"null"
NCT00892190,24,"null"
NCT00887068,246,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLL Gene Rearrangement","name":"MLL Gene Rearrangement","synonyms":["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila) Gene Rearrangement","Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement","KMT2A Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C122623","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 5","name":"Monosomy 5","synonyms":["-5","Deletion of chromosome 5"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36523","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 7","name":"Monosomy 7","synonyms":["-7","Deletion of chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36411","eligibility_criterion":"inclusion"}]"
NCT00878709,2840,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00857389,60,"null"
NCT00849745,20,"null"
NCT00840853,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT00828919,52,"null"
NCT00807599,62,"null"
NCT00789776,40,"null"
NCT00788671,70,"null"
NCT00777101,233,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00777036,145,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT00774345,317,"null"
NCT00772317,117,"null"
NCT00759798,300,"null"
NCT00748189,447,"null"
NCT00741260,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT00706030,92,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00703820,270,"null"
NCT00700882,87,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"}]"
NCT00669669,24,"null"
NCT00636168,1211,"null"
NCT00634231,12,"null"
NCT00626990,1367,"null"
NCT00626483,64,"null"
NCT00625378,206,"null"
NCT00620633,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"}]"
NCT00618657,120,"null"
NCT00614211,636,"null"
NCT00602667,315,"null"
NCT00589316,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Human Anti-Mouse Antibodies Positive","name":"Human Anti-Mouse Antibodies Positive","synonyms":["Human Anti-Mouse Antibodies Present","HAMA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139787","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPRC Positive","name":"CD45 Positive","synonyms":["PTPRC Positive","T200 Positive","Leukocyte Common Antigen Positive","Receptor-Type Tyrosine-Protein Phosphatase C Positive","CD45 Antigen Positive","L-CA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134500","eligibility_criterion":"inclusion"}]"
NCT00520130,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 8 Chromosome 14 Chromosomal Translocation","name":"t(8;14)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128649","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 13q","name":"13q Deletion","synonyms":["del(13q)","Loss of Chromosome 13q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Translocation 11q23","name":"11q23 translocation","synonyms":["t(V;11)(v;q23)","t(v;11q23)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36517","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 6 Chromosome 11 Chromosomal Translocation","name":"t(6;11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128651","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"11q Translocation","name":"11q Translocation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133693","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Trisomy Chromosome 8","name":"Trisomy 8","synonyms":["+8","Trisomy of Chromosome 8"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mutation Abnormality BCR/ABL1 Fusion Gene","name":"BCR-ABL fusion mutation","synonyms":["BCR-ABL Oncogene","BCR/ABL Oncogene","C45576:C94600","BCR-ABL","BCR-ABL1 Fusion","BCR/ABL1 fusion mutation","BCR/ABL1 Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C16325:C94600","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 3 Chromosomal Translocation","name":"t(3;3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128647","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"inv(3)","name":"inv(3)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C111789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 4 Chromosome 11 Chromosomal Translocation","name":"t(4;11)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128652","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(6;9)","name":"t(6;9)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128650","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 1 Chromosome 19 Chromosomal Translocation","name":"t(1;19)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128654","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"t(9;22)","name":"t(9;22)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C117116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Deletion","name":"TP53 Deletion","synonyms":["TP53 Gene Deletion","p53 Gene Deletion","p53 Deletion","Tumor Protein p53 Gene Deleltion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133694","eligibility_criterion":"inclusion"}]"
NCT00515411,120,"null"
NCT00498316,125,"null"
NCT00494234,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT00487305,40,"null"
NCT00481832,30,"null"
NCT00481091,60,"null"
NCT00450814,85,"null"
NCT00445965,130,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT00430183,788,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than One Hundred","name":"PSA Level Less Than One Hundred","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT00426764,131,"null"
NCT00410761,437,"null"
NCT00396019,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NF1 Positive","name":"NF1 Positive","synonyms":["Neurofibromin Positive","NF-1 Positive","Neurofibromin 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150713","eligibility_criterion":"inclusion"}]"
NCT00378482,37,"null"
NCT00365157,132,"null"
NCT00363649,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL Rearrangement","name":"BCR-ABL Rearrangement","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT00129740,150,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT00114738,80,"null"
NCT00104858,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT00096161,80,"null"
NCT00045968,348,"null"
NCT00005803,80,"null"
NCT02592876,81,"null"
NCT02312206,260,"null"
NCT02680951,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"inclusion"}]"
NCT02785900,240,"null"
NCT02732938,22,"null"
NCT02588261,530,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02298153,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Fusion Positive","name":"ALK Fusion Positive","synonyms":["ALK Tyrosine Kinase Receptor Fusion Positive","CD246 Antigen Fusion Positive","Anaplastic Lymphoma Kinase Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142135","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious EGFR Gene Mutation","name":"EGFR Driver Mutation","synonyms":["Deleterious EGFR Mutation","Deleterious ERBB1 Gene Mutation","Deleterious EGFR Gene Mutation","Deleterious HER1 Gene Mutation","Deleterious Epidermal Growth Factor Receptor Gene Mutation","Deleterious ERBB Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150500","eligibility_criterion":"inclusion"}]"
NCT02978235,11,"null"
NCT02748161,170,"null"
NCT02411084,36,"null"
NCT02337309,4,"null"
NCT01804530,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TRK Receptor Family Fusion Positive","name":"NTRK Fusion Positive","synonyms":["TRK Receptor Fusion","TRK Receptor Family Fusion","TRK Fusion","TRK Receptor Family Fusion Positive","NTRK Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138156","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating NTRK Family Point Mutation","name":"Activating NTRK Family Point Mutation","synonyms":["Activating NTRK Point Mutation","Activating TRK Receptor Family Gene Point Mutation","Activating TRK Receptor Gene Point Mutation","Activating TRK Family Gene Point Mutation","Activating TRK Gene Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150439","eligibility_criterion":"inclusion"}]"
NCT03154047,80,"null"
NCT02543645,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02349139,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02205307,330,"null"
NCT01907815,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT02993783,17,"null"
NCT02855359,24,"null"
NCT02848248,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Interleukin-3 Receptor Subunit Alpha Positive","name":"IL3RA Positive","synonyms":["IL3R-Alpha Positive","CD123 Positive","IL-3R-Alpha Positive","IL-3R Subunit Alpha Positive","Interleukin-3 Receptor Subunit Alpha Positive","CD123 Antigen Positive","IL-3 Receptor Subunit Alpha Positive","Interleukin 3 Receptor Alpha Chain Positive","Interleukin 3 Receptor Positive","Interleukin 3 Receptor Alpha Positive","IL-3RA Positive","IL3R Positive","IL3RX Positive","Low Affinity Interleukin 3 Receptor Alpha Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132655","eligibility_criterion":"inclusion"}]"
NCT02781467,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 30 Percent of Peripheral Blood White Cells","name":"Blasts Under 30 Percent of Peripheral Blood White Cells","synonyms":["Blasts Less than 30 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C143154","eligibility_criterion":"inclusion"}]"
NCT02745756,16,"null"
NCT02706899,19,"null"
NCT02538614,2,"null"
NCT02499952,20,"null"
NCT02462525,74,"null"
NCT02444793,24,"null"
NCT02413489,36,"null"
NCT02368691,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Androgen Receptor Positive","name":"Androgen Receptor Positive","synonyms":["AR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C94297","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02365662,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02346955,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT02326844,28,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02245412,25,"null"
NCT01582672,462,"null"
NCT01555489,35,"null"
NCT00622895,20,"null"
NCT03253185,7,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT03146039,37,"null"
NCT03125200,21,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03070964,60,"null"
NCT03029000,1,"null"
NCT02954653,8,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 15 Chromosome 17 Chromosomal Translocation","name":"t(15;17)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128656","eligibility_criterion":"exclusion"}]"
NCT02919449,4,"null"
NCT02812693,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Amplification","name":"KIT Gene Amplification","synonyms":["V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Amplification","c-KIT Gene Amplification","CD117 Gene Amplification","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133678","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"}]"
NCT02731742,14,"null"
NCT02662296,50,"null"
NCT02647190,12,"null"
NCT02641639,91,"null"
NCT02623920,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02606123,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02605083,66,"null"
NCT02581059,10,"null"
NCT02569957,48,"null"
NCT02568046,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT02535364,82,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02519712,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT02518750,40,"null"
NCT02511184,9,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02460991,2,"null"
NCT02360111,18,"null"
NCT02335814,51,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"}]"
NCT02316548,185,"null"
NCT02261805,22,"null"
NCT02243917,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02242409,31,"null"
NCT02226172,21,"null"
NCT02225496,150,"null"
NCT02225223,36,"null"
NCT02213744,113,"null"
NCT02186301,100,"null"
NCT02169505,20,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02117479,321,"null"
NCT02093962,265,"null"
NCT02034123,29,"null"
NCT01991938,75,"null"
NCT01980875,57,"null"
NCT01954784,12,"null"
NCT01937715,18,"null"
NCT01910428,14,"null"
NCT01857752,11,"null"
NCT01769209,25,"null"
NCT01732913,295,"null"
NCT01588951,80,"null"
NCT01483690,23,"null"
NCT01322815,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT01077154,4509,"null"
NCT00981799,23,"null"
NCT00926640,44,"null"
NCT00863122,26,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"NF2 Gene Mutation","name":"NF2 Gene Mutation","synonyms":["Merlin Gene Mutation","Neurofibromin 2 Gene Mutation","NF2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45669","eligibility_criterion":"inclusion"}]"
NCT03386838,1,"null"
NCT03318562,4,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03182257,1,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK2 Fusion Positive","name":"NTRK2 Fusion Positive","synonyms":["NTRK2 Fusion","BDNF/NT-3 Growth Factors Receptor Fusion Positive","TRKB Tyrosine Kinase Fusion Positive","TrkB Fusion Positive","Tropomyosin-Related Kinase B Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132235","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK1 Fusion Positive","name":"NTRK1 Fusion","synonyms":["NTRK1 Fusion Positive","TRKA Fusion Positive","High Affinity Nerve Growth Factor Receptor Fusion Positive","Tropomyosin-Related Kinase A Fusion Positive","Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive","Trk-A Fusion Positive","TRK1 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131070","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NTRK3 Fusion Positive","name":"NTRK3 Fusion Positive","synonyms":["TRKC Tyrosine Kinase Fusion Positive","TrkC Fusion Positive","Neurotrophic Tyrosine Kinase Receptor Type 3 Fusion Positive","NTRK3 Fusion","NT-3 Growth Factor Receptor Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132236","eligibility_criterion":"inclusion"}]"
NCT03130764,30,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement Negative","name":"ALK Gene Rearrangement Negative","synonyms":["ALK Rearrangement Negative","Anaplastic Lymphoma Kinase Gene Rearrangement Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative","CD246 Gene Rearrangement Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134487","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"exclusion"}]"
NCT03100877,63,"null"
NCT03082300,3,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT03023904,47,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT03000452,18,"null"
NCT02963610,44,"null"
NCT02956122,1,"null"
NCT02947152,9,"null"
NCT02826161,4,"null"
NCT02815059,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 20 Percent or more of Bone Marrow Nucleated Cells","name":"Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Lymphoblasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146661","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Lymphoblasts 20 Percent or More of Peripheral Blood White Cells","name":"Lymphoblasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Lymphoblasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146662","eligibility_criterion":"inclusion"}]"
NCT02763644,7,"null"
NCT02748889,1,"null"
NCT02737072,45,"null"
NCT02732327,2,"null"
NCT02720510,6,"null"
NCT02709083,100,"null"
NCT02702960,6,"null"
NCT02700022,24,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT02698176,13,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02673736,11,"null"
NCT02671955,12,"null"
NCT02661659,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02654639,45,"null"
NCT02651727,13,"null"
NCT02639767,18,"null"
NCT02635074,18,"null"
NCT02633540,30,"null"
NCT02614560,14,"null"
NCT02613182,40,"null"
NCT02612285,1,"null"
NCT02570711,3,"null"
NCT02553330,90,"null"
NCT02551055,32,"null"
NCT02548468,18,"null"
NCT02548390,70,"null"
NCT02546427,35,"null"
NCT02540356,2,"null"
NCT02538627,5,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IGF1 Positive","name":"IGF1 Positive","synonyms":["IGF I Positive","Insulin-Like Growth Factor 1 Positive","Somatomedin C Positive","Insulin-Like Growth Factor I Positive","IGF-I Positive","IGF-1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138950","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Heregulin Positive","name":"Heregulin Positive","synonyms":["Neuregulin Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138951","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"}]"
NCT02508077,25,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRAF Wild Type","name":"BRAF Wild Type","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"}]"
NCT02504892,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLCN Gene Mutation","name":"FLCN Gene Mutation","synonyms":["Birt Hogg Dube Gene Mutation","Folliculin Gene Mutation","Birt-Hogg-Dube Gene Mutation","BHD Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51150","eligibility_criterion":"inclusion"}]"
NCT02504099,3,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"inclusion"}]"
NCT02495233,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02485834,162,"null"
NCT02479178,73,"null"
NCT02470559,20,"null"
NCT02469415,40,"null"
NCT02468557,16,"null"
NCT02461134,1,"null"
NCT02456675,8,"null"
NCT02455297,4,"null"
NCT02454842,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"}]"
NCT02449681,60,"null"
NCT02448810,115,"null"
NCT02447887,49,"null"
NCT02443337,31,"null"
NCT02441517,4,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02439346,15,"null"
NCT02438007,953,"null"
NCT02437916,30,"null"
NCT02436460,4,"null"
NCT02427893,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02425072,34,"null"
NCT02421575,30,"null"
NCT02420873,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NCAM1 Positive","name":"NCAM1 Positive","synonyms":["CD56 Positive","CD56 Antigen Positive","Neural Cell Adhesion Molecule 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129251","eligibility_criterion":"inclusion"}]"
NCT02420210,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02419469,100,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Philadelphia Chromosome","name":"t(9;22)(q34;q11)","synonyms":["Philadelphia Translocation","t(9;22)(q34.1;q11.2)","Philadelphia chromosome","t(9;22)(q34;q11.2)","Philadelphia Chromosome","Ph"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C28452","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02418000,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Gene Mutant","name":"FLT3 Gene Mutation","synonyms":["CD135 Gene Mutation","FLK2 Gene Mutation","FLT3 Gene Mutant","FMS-Related Tyrosine Kinase 3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128919","eligibility_criterion":"inclusion"}]"
NCT02413827,9,"null"
NCT02411565,20,"null"
NCT02410551,40,"null"
NCT02405585,10,"null"
NCT02403895,11,"null"
NCT02393209,14,"null"
NCT02392377,50,"null"
NCT02389764,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02388932,24,"null"
NCT02386111,17,"null"
NCT02381548,30,"null"
NCT02378038,5,"null"
NCT02372227,21,"null"
NCT02369029,8,"null"
NCT02368951,20,"null"
NCT02366663,158,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02354417,3,"null"
NCT02351037,36,"null"
NCT02350777,47,"null"
NCT02346370,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NPM1/ALK Fusion Protein","name":"t(2;5)(p23;q35)","synonyms":["NPM1/ALK Fusion","NPM1-ALK fusion","NPM-ALK fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99362","eligibility_criterion":"inclusion"}]"
NCT02345330,4,"null"
NCT02338050,1,"null"
NCT02334319,15,"null"
NCT02323906,12,"null"
NCT02318368,10,"null"
NCT02317419,15,"null"
NCT02314052,72,"null"
NCT02313012,19,"null"
NCT02303041,40,"null"
NCT02302846,40,"null"
NCT02299635,19,"null"
NCT02295540,45,"null"
NCT02292225,3,"null"
NCT02283359,33,"null"
NCT02278783,31,"null"
NCT02277457,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT02274012,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02273752,26,"null"
NCT02272686,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Amplification","name":"BCL2 Gene Amplification","synonyms":["B-Cell CLL-Lymphoma 2 Gene Amplification","B-Cell CLL/Lymphoma 2 Gene Amplification","Bcl-2 Gene Amplification","BCL2, Apoptosis Regulator Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132021","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Rearrangement","name":"BCL6 Gene Rearrangement","synonyms":["BCL5 Gene Rearrangement","B-Cell CLL/Lymphoma 6 Gene Rearrangement","LAZ3 Gene Rearrangement","Bcl-6 Gene Rearrangement","ZNF51 Gene Rearrangement","ZBTB27 Gene Rearrangement","Zinc Finger Protein 51 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132020","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL6 Gene Amplification","name":"BCL6 Gene Amplification","synonyms":["LAZ3 Gene Amplification","Zinc Finger Protein 51 Gene Amplification","Bcl-6 Gene Amplification","BCL5 Gene Amplification","B-Cell CLL/Lymphoma 6 Gene Amplification","ZBTB27 Gene Amplification","ZNF51 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132022","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCL2 Gene Rearrangement","name":"BCL2 Gene Rearrangement","synonyms":["BCL2, Apoptosis Regulator Gene Rearrangement","Bcl-2 Gene Rearrangement","B-Cell CLL/Lymphoma 2 Gene Rearrangement","B-Cell CLL-Lymphoma 2 Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132019","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Rearrangement","name":"MYC Gene Rearrangement","synonyms":["MYCC Gene Rearrangement","MRTL Gene Rearrangement","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Rearrangement","bHLHe39 Gene Rearrangement","C-MYC Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132018","eligibility_criterion":"inclusion"}]"
NCT02267707,1,"null"
NCT02258607,21,"null"
NCT02257619,9,"null"
NCT02254954,30,"null"
NCT02254772,27,"null"
NCT02241720,41,"null"
NCT02234037,20,"null"
NCT02231710,1,"null"
NCT02231164,12,"null"
NCT02228811,44,"null"
NCT02227108,37,"null"
NCT02225574,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"}]"
NCT02223819,34,"null"
NCT02223598,120,"null"
NCT02221505,3,"null"
NCT02218242,78,"null"
NCT02215876,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02213133,45,"null"
NCT02206763,11,"null"
NCT02205398,13,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT02205333,48,"null"
NCT02204982,13,"null"
NCT02204020,35,"null"
NCT02202785,43,"null"
NCT02202759,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GUCY2C Positive","name":"GUCY2C Positive","synonyms":["STAR Positive","GC-C Positive","Guanylate Cyclase 2C Positive","Heat-Stable Enterotoxin Receptor Positive","Guanylyl Cyclase C Positive","hSTAR Positive","Intestinal Guanylate Cyclase Positive","Heat Stable Enterotoxin Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138955","eligibility_criterion":"inclusion"}]"
NCT02202044,50,"null"
NCT02200562,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT02200380,36,"null"
NCT02200042,182,"null"
NCT02199223,42,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"}]"
NCT02196168,6,"null"
NCT02192541,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"}]"
NCT02189174,31,"null"
NCT02170389,10,"null"
NCT02169284,45,"null"
NCT02168907,14,"null"
NCT02168777,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02161419,142,"null"
NCT02159950,60,"null"
NCT02159040,1,"null"
NCT02158975,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"}]"
NCT02158936,356,"null"
NCT02154529,17,"null"
NCT02147873,118,"null"
NCT02146833,20,"null"
NCT02145078,150,"null"
NCT02141477,66,"null"
NCT02138786,26,"null"
NCT02138578,110,"null"
NCT02137564,20,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT02134886,48,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"}]"
NCT02134015,145,"null"
NCT02132884,110,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating ALK Gene Mutation","name":"Activating ALK Gene Mutation","synonyms":["Activating Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","Activating CD246 Gene Mutation","Activating ALK Gene Mutation Activating ALK Receptor Tyrosine Kinase Gene Mutation","Activating Anaplastic Lymphoma Kinase Receptor Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146722","eligibility_criterion":"exclusion"}]"
NCT02132845,200,"null"
NCT02129062,3,"null"
NCT02122146,31,"null"
NCT02120417,149,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02119676,396,"null"
NCT02119663,86,"null"
NCT02119650,76,"null"
NCT02115828,16,"null"
NCT02113007,2,"null"
NCT02111863,35,"null"
NCT02110953,30,"null"
NCT02110563,50,"null"
NCT02109224,72,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT02106559,8,"null"
NCT02105116,50,"null"
NCT02101021,25,"null"
NCT02100007,46,"null"
NCT02087241,22,"null"
NCT02083679,15,"null"
NCT02082977,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Five","name":"PSA Level Five or Greater","synonyms":["PSA Level Greater than or Equal to 5","PSA Level Greater than or Equal to Five","PSA Level 5 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139792","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EZH2 Gene Mutation","name":"EZH2 Gene Mutation","synonyms":["ENX1 Gene Mutation","ENX-1 Gene Mutation","KMT6 Gene Mutation","Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Gene Mutation","EZH2b Gene Mutation","Enhancer of Zeste 2 Gene Mutation","KTM6A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C97311","eligibility_criterion":"inclusion"}]"
NCT02082522,28,"null"
NCT02080416,10,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"}]"
NCT02080195,25,"null"
NCT02074878,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02068157,19,"null"
NCT02062359,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02058667,18,"null"
NCT02055781,300,"null"
NCT02049801,19,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTPN11 Gene Mutation","name":"PTPN11 Gene Mutation","synonyms":["SHP-2 Gene Mutation","Protein Tyrosine Phosphatase, Non-Receptor Type 11 Gene Mutation","PTP-1D Gene Mutation","BPTP3 Gene Mutation","PTP2C Gene Mutation","SHP2 Gene Mutation","SH-PTP2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82612","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Peripheral Blood White Cells","name":"Blasts 20 Percent or More of Peripheral Blood White Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Peripheral Blood White Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36213","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02047500,19,"null"
NCT02047214,17,"null"
NCT02046928,5,"null"
NCT02044822,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT02042950,60,"null"
NCT02040558,44,"null"
NCT02034227,6,"null"
NCT02031965,24,"null"
NCT02030405,16,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NPM1 Gene Mutation","name":"NPM1 Gene Mutation","synonyms":["Mutation of the Nucleophosmin Gene","Nucleophosmin Gene Mutation","NPM1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82429","eligibility_criterion":"inclusion"}]"
NCT02029417,60,"null"
NCT02016534,60,"null"
NCT02013167,405,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts More than 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Over 5 Percent of Bone Marrow Nucleated Cells","Blasts Greater than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142112","eligibility_criterion":"inclusion"}]"
NCT02010021,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01990287,38,"null"
NCT01986218,36,"null"
NCT01983709,21,"null"
NCT01965002,30,"null"
NCT01958372,24,"null"
NCT01956812,334,"null"
NCT01943188,14,"null"
NCT01939223,25,"null"
NCT01935947,165,"null"
NCT01928485,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal Ten","name":"PSA Level Ten or Less","synonyms":["PSA Level Less than or Equal 10","PSA Level 10 or Less","PSA Level Less than or Equal Ten"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138945","eligibility_criterion":"inclusion"}]"
NCT01925612,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01916109,38,"null"
NCT01911273,3,"null"
NCT01904643,30,"null"
NCT01893294,18,"null"
NCT01892293,6,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT01891981,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD22 Positive","name":"CD22 Positive","synonyms":["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive","SIGLEC-2 Positive","CD22 Molecule Positive","BL-CAM Positive","B-Cell Receptor CD22 Positive","T-Cell Surface Antigen Leu-14 Positive","SIGLEC2 Positive","B-Lymphocyte Cell Adhesion Molecule Positive","CD22 Antigen Positive","Sialic Acid-Binding Ig-Like Lectin 2 Positive","B-Cell Antigen CD22 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131066","eligibility_criterion":"inclusion"}]"
NCT01891669,26,"null"
NCT01889797,32,"null"
NCT01887717,36,"null"
NCT01876251,30,"null"
NCT01875653,250,"null"
NCT01875601,51,"null"
NCT01875237,35,"null"
NCT01870726,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Loss","name":"PTEN Loss","synonyms":["PTEN1 Gene Deletion","TEP1 Gene Deletion","Mutated in Multiple Advanced Cancers 1 Gene Deletion","Phosphatase and Tensin Homolog Gene Deletion","PTEN Gene Deletion","MMAC1 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96270","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Negative","name":"PTEN Negative","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01870609,344,"null"
NCT01868503,22,"null"
NCT01864538,11,"null"
NCT01857817,35,"null"
NCT01856023,29,"null"
NCT01852292,158,"null"
NCT01849744,48,"null"
NCT01841021,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"}]"
NCT01839955,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROS1 Fusion Positive","name":"ROS1 Fusion","synonyms":["ROS1 Fusion Positive","Proto-Oncogene Tyrosine-Protein Kinase ROS Fusion Positive","ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Fusion Positive","Proto-Oncogene c-Ros Fusion Positive","MCF3 Fusion Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131071","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EML4-ALK translocation mutation","name":"EML4-ALK translocation mutation","synonyms":["C25756:C45576:C2002015","EML4/ALK"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99733:C99724","eligibility_criterion":"inclusion"}]"
NCT01838642,31,"null"
NCT01835171,73,"null"
NCT01829971,155,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01822496,234,"null"
NCT01820624,24,"null"
NCT01810016,27,"null"
NCT01798485,696,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Gene Translocation","name":"ALK Translocation","synonyms":["Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Translocation","ALK Gene Translocation","CD246 Gene Translocation","Anaplastic Lymphoma Kinase Gene Translocation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129703","eligibility_criterion":"exclusion"}]"
NCT01795924,13,"null"
NCT01783054,12,"null"
NCT01776008,87,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01773785,30,"null"
NCT01767935,15,"null"
NCT01767857,643,"null"
NCT01765582,280,"null"
NCT01759303,12,"null"
NCT01758588,8,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"JAK2.p.V617F","name":"JAK2 V617F mutation","synonyms":["JAK2 Val617Phe","JAK2 NM_004972.3:c.1848_1849TG>CT","JTK10 c.1849G>T","NP_004963.1:p.V617F","Janus Kinase 2 Val617Phe","NM_004972.3:c.1848_1849TG>CT","JAK2 c.1848_1849delTGinsCT","JAK2 V617F","Janus Kinase- 2 V617F","Janus Kinase-2 Val617Phe","Janus Kinase 2 c.1848_1849TG>CT","JAK2 NM_004972.3:c.1849G>T","JAK2 NP_004963.1:p.V617F","JTK10 c.1848_1849TG>CT","Janus Kinase-2 V617F Mutation","NM_004972.3:c.1848_1849delTGinsCT","JAK-2 c.1849G>T","JAK2 c.1849G>T","JAK2 c.1848_1849TG>CT","NM_004972.3:c.1849G>T","Janus Kinase 2 V617F","JAK2 p.Val617Phe","NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 Val617Phe","Janus Kinase 2 c.1849G>T","JAK2 NM_004972.3:c.1848_1849delTGinsCT","JAK2 NP_004963.1:p.Val617Phe","Tyrosine-Protein Kinase JAK2 V617F","JAK-2 c.1848_1849TG>CT","JAK2 p.V617F"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105909:C105910:C105908","eligibility_criterion":"inclusion"}]"
NCT01758458,16,"null"
NCT01756729,13,"null"
NCT01754519,82,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01745354,18,"null"
NCT01731704,120,"null"
NCT01729923,43,"null"
NCT01705106,48,"null"
NCT01703065,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01681433,72,"null"
NCT01677988,30,"null"
NCT01672736,19,"null"
NCT01671488,11,"null"
NCT01670994,6,"null"
NCT01669720,10,"null"
NCT01656252,15,"null"
NCT01646125,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT01621243,128,"null"
NCT01605396,80,"null"
NCT01604031,15,"null"
NCT01602315,179,"null"
NCT01596127,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01579318,2,"null"
NCT01578551,60,"null"
NCT01572987,12,"null"
NCT01534260,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 7","name":"Monosomy 7","synonyms":["-7","Deletion of chromosome 7"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36411","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Monosomy 5","name":"Monosomy 5","synonyms":["-5","Deletion of chromosome 5"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36523","eligibility_criterion":"inclusion"}]"
NCT01519323,6,"null"
NCT01499251,75,"null"
NCT01498588,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01495988,10,"null"
NCT01482949,2,"null"
NCT01450696,296,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01442415,10,"null"
NCT01420679,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD8 Positive","name":"CD8 Positive","synonyms":["T-Cell Surface Glycoprotein CD8 Positive","CD8 Antigen Positive","CD8 Co-Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Negative","name":"ALK Negative","synonyms":["Anaplastic Lymphoma Kinase Receptor Negative","CD246 Antigen Negative","CD246 Negative","ALK Receptor Tyrosine Kinase Negative","ALK Tyrosine Kinase Receptor Negative","Anaplastic Lymphoma Kinase Negative","Anaplastic Lymphoma Receptor Tyrosine Kinase Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133707","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"exclusion"}]"
NCT01411098,15,"null"
NCT01409174,64,"null"
NCT01408043,70,"null"
NCT01383148,222,"null"
NCT01362790,75,"null"
NCT01357655,70,"null"
NCT01352962,42,"null"
NCT01352312,39,"null"
NCT01345669,617,"null"
NCT01341496,80,"null"
NCT01332630,69,"null"
NCT01316692,56,"null"
NCT01313416,2,"null"
NCT01309126,217,"null"
NCT01306045,600,"[{"assay_purpose":"Treatment Assignment, Research, Eligibility Criterion - Inclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"KIT Gene Mutation","name":"KIT Gene Mutation","synonyms":["CD117 Mutation","C-KIT Mutation","c-KIT Gene Mutation","CD117 Gene Mutation","KIT Proto-Oncogene Tyrosine Protein Kinase Gene Mutation","V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39712","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Mutation","name":"PDGFRA Gene Mutation","synonyms":["CD140A Gene Mutation","PDGFRalpha Gene Mutation","PDGFR-2 Gene Mutation","Platelet-Derived Growth Factor Receptor Alpha Gene Mutation","RHEPDGFRA Gene Mutation","PDGFR2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39718","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"PDGFRA Gene Amplification","name":"PDGFRA Amplification","synonyms":["CD140A Gene Amplification","PDGFRalpha Gene Amplification","PDGFRA Gene Amplification","RHEPDGFRA Gene Amplification","Platelet-Derived Growth Factor Receptor Alpha Gene Amplification","PDGFR2 Gene Amplification","PDGFR-2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96868","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"AKT1 Gene Mutation","name":"AKT1 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 1 Gene Mutation","AKT Gene Mutation","PKB Gene Mutation","RAC Gene Mutation","RAC-PK-Alpha Gene Mutation","PRKBA Gene Mutation","RAC-ALPHA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98304","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"HRAS Gene Mutation","name":"HRAS Gene Mutation","synonyms":["HRas Proto-Oncogene, GTPase Gene Mutation","Ha-ras Gene Mutation","RASH1 Gene Mutation","C-HA-RAS1 Gene Mutation","v-Ha-ras Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","C-H-RAS Gene Mutation","H-ras Gene Mutation","Harvey Rat Sarcoma Viral Oncogene Homolog Gene Mutation","HRAS1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C45934","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"AKT2 Gene Mutation","name":"AKT2 Gene Mutation","synonyms":["v-akt Murine Thymoma Viral Oncogene Homolog 2 Gene Mutation","PRKBB Gene Mutation","PKBBETA Gene Mutation","PKBB Gene Mutation","HIHGHH Gene Mutation","AKT Serine/Threonine Kinase 2 Gene Mutation","RAC-PK-Beta Gene Mutation","RAC-BETA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141362","eligibility_criterion":"inclusion"}]"
NCT01283178,15,"null"
NCT01242748,288,"null"
NCT01240629,55,"null"
NCT01239875,26,"null"
NCT01218867,118,"null"
NCT01181258,17,"null"
NCT01177683,26,"null"
NCT01174199,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01147016,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01093092,42,"null"
NCT01067066,21,"null"
NCT01032148,45,"null"
NCT00942409,28,"null"
NCT00790842,62,"null"
NCT00686556,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT00671112,36,"null"
NCT00536991,89,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT00414076,9,"null"
NCT00253721,15,"null"
NCT00110149,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02254421,60,"null"
NCT01273155,80,"null"
NCT02254408,189,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Rous Sarcoma Virus Positive","name":"RSV Positive","synonyms":["Rous Sarcoma Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142092","eligibility_criterion":"inclusion"}]"
NCT02701634,65,"null"
NCT02649894,119,"null"
NCT02518113,36,"null"
NCT02157636,30,"null"
NCT02115243,30,"null"
NCT02092363,37,"null"
NCT02728895,24,"null"
NCT02515630,41,"null"
NCT02478125,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02336230,55,"null"
NCT02318394,56,"null"
NCT02309515,58,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD2 Positive","name":"CD2 Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"CD3 Positive","name":"CD3 Positive","synonyms":["T3 Complex Positive","CD3 Complex Positive","T-Cell Surface Glycoprotein CD3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131386","eligibility_criterion":"exclusion"}]"
NCT02301130,64,"null"
NCT02138812,69,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02088541,171,"null"
NCT02049957,118,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01924689,24,"null"
NCT01923168,340,"null"
NCT01594918,57,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT02736123,66,"null"
NCT02632786,129,"null"
NCT02553317,145,"null"
NCT02483858,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating PIK3CA Gene Mutation","name":"Activating PIK3CA Gene Mutation","synonyms":["Activating p110-alpha Gene Mutation","Activating Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation","PIK3CA Activating Mutation","Activating PI3KCA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142116","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02431260,69,"null"
NCT02326584,116,"null"
NCT02301988,151,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02259582,81,"null"
NCT02216890,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD70 Positive","name":"CD70 Positive","synonyms":["Tumor Necrosis Factor Ligand Superfamily, Member 7 Positive","CD70 Molecule Positive","CD27 Ligand Positive","CD27LG Positive"," Ki-24 Antigen Positive","TNFSF7 Positive","CD27L Positive","CD70 Antigen Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132239","eligibility_criterion":"inclusion"}]"
NCT02204761,20,"null"
NCT02190721,50,"null"
NCT02146313,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MUC16 positive","name":"MUC16 positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02082210,100,"null"
NCT02073682,1050,"null"
NCT02038673,86,"null"
NCT01991678,25,"null"
NCT01987362,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MYC Gene Amplification","name":"MYC Gene Amplification","synonyms":["v-MYC Myelocytomatosis Viral Oncogene Homolog (Avian) Gene Amplification","c-MYC Gene Amplification","MYCC Gene Amplification","v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Gene Amplification","MRTL Gene Amplification","MYC Amplification","bHLHe39 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36641","eligibility_criterion":"inclusion"}]"
NCT01961765,24,"null"
NCT01690624,30,"null"
NCT01629511,30,"null"
NCT01396148,6,"null"
NCT03045393,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT03042910,38,"null"
NCT02944357,20,"null"
NCT02760797,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02732184,29,"null"
NCT02696356,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02669511,21,"null"
NCT02644278,15,"null"
NCT02639117,12,"null"
NCT02631252,36,"null"
NCT02626234,32,"null"
NCT02594163,25,"null"
NCT02529553,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR3 Gene Mutation","name":"FGFR3 Gene Mutation","synonyms":["Fibroblast Growth Factor Receptor 3 Gene Mutation","FGFR-3 Gene Mutation","JKT4 Gene Mutation","CD333 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C39877","eligibility_criterion":"inclusion"}]"
NCT02487979,38,"null"
NCT02457793,27,"null"
NCT02441946,224,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02433483,19,"null"
NCT02432690,13,"null"
NCT02409355,8,"null"
NCT02391194,27,"null"
NCT02363283,35,"null"
NCT02313857,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02308761,26,"null"
NCT02300987,10,"null"
NCT02296242,53,"null"
NCT02286219,30,"null"
NCT02273973,334,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02266147,29,"null"
NCT02262741,71,"null"
NCT02262455,32,"null"
NCT02257476,45,"null"
NCT02243007,112,"null"
NCT02213263,394,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02209532,180,"null"
NCT02198859,18,"null"
NCT02191878,43,"null"
NCT02151903,5,"null"
NCT02151149,143,"null"
NCT02130869,36,"null"
NCT02092909,31,"null"
NCT02092792,42,"null"
NCT02087306,201,"null"
NCT02083692,50,"null"
NCT02071927,43,"null"
NCT02050178,26,"null"
NCT02048059,72,"null"
NCT02037555,425,"null"
NCT02016729,36,"null"
NCT02005315,30,"null"
NCT01980654,80,"null"
NCT01900509,30,"null"
NCT01888978,20,"null"
NCT01871805,127,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Rearrangement","name":"ALK Gene Rearrangement","synonyms":["Anaplastic Lymphoma Kinase Gene Rearrangement"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129574","eligibility_criterion":"inclusion"}]"
NCT01868477,23,"null"
NCT01847274,597,"null"
NCT01831089,69,"null"
NCT01783171,54,"null"
NCT01696045,14,"null"
NCT01670175,18,"null"
NCT01647828,217,"null"
NCT01641939,415,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01621542,64,"null"
NCT01615042,18,"null"
NCT01596400,19,"null"
NCT01545141,50,"null"
NCT01525602,74,"null"
NCT01524978,208,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01496742,259,"null"
NCT01471067,50,"null"
NCT01457118,27,"null"
NCT01346358,72,"null"
NCT01321346,30,"null"
NCT01293539,20,"null"
NCT01289457,304,"null"
NCT01282424,125,"null"
NCT01269346,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01265849,928,"null"
NCT01102426,250,"null"
NCT00988559,132,"null"
NCT00968968,280,"null"
NCT00721409,177,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT00628498,1206,"null"
NCT03042702,2,"null"
NCT03029832,5,"null"
NCT03002623,50,"null"
NCT02944565,28,"null"
NCT02935790,1,"null"
NCT02925104,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT02913443,18,"null"
NCT02847000,12,"null"
NCT02796352,45,"null"
NCT02771340,10,"null"
NCT02758132,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02722954,29,"null"
NCT02705469,44,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02702921,201,"null"
NCT02700841,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02644122,29,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3R5 Gene Mutation","name":"PIK3R5 Gene Mutation","synonyms":["p101 Gene Mutation","FOAP-2 Gene Mutation","Phosphoinositide-3-Kinase, Regulatory Subunit 5 Gene Mutation","P101-PI3K Gene Mutation","Phosphoinositide-3-Kinase Regulatory Subunit 5 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146728","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CG Gene Mutation","name":"PIK3CG Gene Mutation","synonyms":["PI3CG Gene Mutation","p110gamma Gene Mutation","PI3Kgamma Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146727","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT Family Gene Mutation","name":"AKT Family Gene Mutation","synonyms":["AKT Serine/Threonine Kinase Family Gene Mutation","v-akt Murine Thymoma Viral Oncogene Homolog Gene Family Mutation","AKT Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96865","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MTOR Gene Mutation","name":"MTOR Gene Mutation","synonyms":["Rapamycin and FKBP12 Target 1 Gene Mutation","FRAP1 Gene Mutation","FRAP Gene Mutation","FK506 Binding Protein 12-Rapamycin Associated Protein 1 Gene Mutation","Mechanistic Target of Rapamycin Gene Mutation","Mammalian Target of Rapamycin Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133686","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3R1 Gene Mutation","name":"PIK3R1 Gene Mutation","synonyms":["Phosphoinositide-3-Kinase Regulatory Subunit 1 Gene Mutation","p85-ALPHA Gene Mutation","GRB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132894","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PTEN Gene Mutation","name":"PTEN Gene Mutation","synonyms":["TEP1 Gene Mutation","PTEN1 Gene Mutation","Phosphatase and Tensin Homolog Gene Mutation","MMAC1 Gene Mutation","Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C121369","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3AP1 Gene Mutation","name":"PIK3AP1 Gene Mutation","synonyms":["Phosphoinositide-3-Kinase Adaptor Protein 1 Gene Mutation","BCAP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C147052","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"}]"
NCT02633020,28,"null"
NCT02626338,72,"null"
NCT02614456,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02598427,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02593708,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating ERBB2 Mutation","name":"Activating ERBB2 Mutation","synonyms":["CD340 Activating Mutation","Activating HER2 Mutation","HER2/Neu Activating Mutation","HER-2 Activating Mutation","c-erbB2 Activating Mutation","ERBB2 Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129700","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02590003,72,"null"
NCT02583477,23,"null"
NCT02580708,7,"null"
NCT02576548,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02568683,10,"null"
NCT02564614,9,"null"
NCT02561832,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT02558894,65,"null"
NCT02552121,24,"null"
NCT02536469,15,"null"
NCT02532114,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02520752,37,"null"
NCT02514213,62,"null"
NCT02507583,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IGF1R Positive","name":"IGF1R Positive","synonyms":["IGFR Positive","Insulin Like Growth Factor 1 Receptor Positive","CD221 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128840","eligibility_criterion":"inclusion"}]"
NCT02501759,512,"null"
NCT02495636,40,"null"
NCT02494206,22,"null"
NCT02492737,46,"null"
NCT02485353,20,"null"
NCT02483871,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02473731,12,"null"
NCT02472145,326,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PML Gene RARA Gene Chromosomal mutation","name":"PML-RAR alpha mutation","synonyms":["PML/RAR Alpha Fusion","PML/RARA Fusion","PML/RAR","C24686:C21571:C0948447","PML-RARA Fusion","PML-RAR Alpha Fusion","PML-RAR","PML/RARalpha"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C53622:C99186","eligibility_criterion":"exclusion"}]"
NCT02469974,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41397","eligibility_criterion":"inclusion"}]"
NCT02461550,10,"null"
NCT02456883,6,"null"
NCT02456701,7,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02450591,5,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Exon Insertion Mutation Twenty","name":"EGFR Exon 20 Insertion","synonyms":["ERBB Exon 20 Insertion Mutation","ERBB Exon 20 Insertion","Epidermal Growth Factor Receptor Exon 20 Insertion","ERBB1 Exon 20 Insertion Mutation","Epidermal Growth Factor Receptor Exon 20 Insertion Mutation","mENA Exon 20 Insertion Mutation","mENA Exon 20 Insertion","ERBB1 Exon 20 Insertion","PIG61 Exon 20 Insertion","PIG61 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion (ERBB Exon 20 Insertion","HER1 Exon 20 Insertion","HER1 Exon 20 Insertion Mutation","EGFR Exon 20 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125605","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Exon 19 Insertion Mutation","name":"EGFR Exon 19 Insertion","synonyms":["EGFR Exon 19 Insertion Mutation","Epidermal Growth Factor Receptor Gene Exon 19 Insertion Mutation","ERBB1 Exon 19 Insertion Mutation","ERBB Exon 19 Insertion Mutation","HER1 Exon 19 Insertion Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134465","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NM_005228.3:c.2303G>T EGFR NP_005219.2:p.S768I","name":"EGFR S768I","synonyms":["ERBB c.2303G>T","EGFR Ser768Ile","EGFR p.Ser768Ile","ERBB1 c.2303G>T","EGFR NP_005219.2:p.Ser768Ile","Proto-Oncogene c-ErbB-1 S768I","Epidermal Growth Factor Receptor S768I","EGFR p.S768I","Epidermal Growth Factor Receptor Gene c.2303G>T","EGFR NM_005228.3:c.2303G>T","NP_005219.2:p.Ser768Ile","HER1 c.2303G>T","EGFR NP_005219.2:p.S768I","Receptor Tyrosine-Protein Kinase erbB-1 S768I","NM_005228.3:c.2303G>T","EGFR c.2303G>T"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C125209:C125210","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NM_005228.3:c.2156G>C EGFR NP_005219.2:p.G719A","name":"EGFR G719A","synonyms":["EGFR NP_005219.2:p.G719A","EGFR NP_005219.2:p.Gly719Ala","EGFR p.Gly719Ala","EGFR Gly719Ala","ERBB1 c.2156G>C","Receptor Tyrosine-Protein Kinase erbB-1 G719A","Epidermal Growth Factor Receptor G719A","NM_005228.3:c.2156G>C","HER1 c.2156G>C","EGFR p.G719A","ERBB c.2156G>C","Proto-Oncogene c-ErbB-1 G719A","EGFR c.2156G>C","Epidermal Growth Factor Receptor Gene c.2156G>C","EGFR G719A","EGFR NM_005228.3:c.2156G>C","NP_005219.2:p.Gly719Ala"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98521:C98520","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"}]"
NCT02436135,10,"null"
NCT02404480,31,"null"
NCT02403271,124,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02401295,25,"null"
NCT02392611,33,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02391545,55,"null"
NCT02383368,165,"null"
NCT02379390,8,"null"
NCT02376933,25,"null"
NCT02376166,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"exclusion"}]"
NCT02374099,97,"null"
NCT02372877,59,"null"
NCT02363439,5,"null"
NCT02358473,13,"null"
NCT02351505,46,"null"
NCT02348255,20,"null"
NCT02345382,42,"null"
NCT02338492,81,"null"
NCT02331368,50,"null"
NCT02326168,25,"null"
NCT02319889,15,"null"
NCT02319824,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*24:02 Positive Cells Present","name":"HLA-A*24:02 Positive Cells Present","synonyms":["HLA-A2402 Positive","HLA-A2402 Positive Cells Present","HLA-A*24:02 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142110","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02305758,130,"null"
NCT02303262,20,"null"
NCT02301143,107,"null"
NCT02301104,24,"null"
NCT02299518,43,"null"
NCT02298946,25,"null"
NCT02289898,207,"null"
NCT02289456,40,"null"
NCT02283320,69,"null"
NCT02280811,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*0201 Positive Cells Present","name":"HLA-A*0201 Positive","synonyms":["HLA-A*02:01 Positive Cells Present","HLA-A*0201 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69178","eligibility_criterion":"inclusion"}]"
NCT02279732,344,"null"
NCT02279602,7,"null"
NCT02278133,20,"null"
NCT02277093,38,"null"
NCT02276560,51,"null"
NCT02275039,9,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT02273960,52,"null"
NCT02273739,21,"null"
NCT02271945,10,"null"
NCT02271906,20,"null"
NCT02270788,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MPO Positive","name":"MPO Positive","synonyms":["Myeloperoxidase Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150694","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"}]"
NCT02270372,22,"null"
NCT02269943,36,"null"
NCT02267278,25,"null"
NCT02267083,22,"null"
NCT02264886,35,"null"
NCT02260661,20,"null"
NCT02259348,18,"null"
NCT02256982,48,"null"
NCT02252263,44,"null"
NCT02252146,6,"null"
NCT02243579,24,"null"
NCT02241551,40,"null"
NCT02238925,26,"null"
NCT02236195,17,"null"
NCT02223247,180,"null"
NCT02221882,45,"null"
NCT02219737,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT02215161,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02214147,36,"null"
NCT02203825,12,"null"
NCT02199041,49,"null"
NCT02197169,37,"null"
NCT02191891,32,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR T790M Mutation Negative","name":"EGFR T790M Mutation Negative","synonyms":["EGFR Thr790Met Negative","EFGR p.T790M Mutation Negative","Proto-Oncogene c-ErbB-1 T790M Negative","Receptor Tyrosine-Protein Kinase erbB-1 T790M Negative","EGFR NP_005219.2:p.Thr790Met Negative","EGFR NP_005219.2:p.T790M Negative","Epidermal Growth Factor Receptor T790M Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131326","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT02187861,164,"null"
NCT02187783,106,"null"
NCT02187302,115,"null"
NCT02186821,47,"null"
NCT02181634,74,"null"
NCT02179918,23,"null"
NCT02179515,38,"null"
NCT02178956,714,"null"
NCT02172911,10,"null"
NCT02160041,85,"null"
NCT02159898,60,"null"
NCT02157103,13,"null"
NCT02155465,43,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"}]"
NCT02150733,29,"null"
NCT02149108,768,"null"
NCT02144038,20,"null"
NCT02141828,18,"null"
NCT02141295,200,"null"
NCT02134912,114,"[{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02132468,18,"null"
NCT02129205,40,"null"
NCT02124850,15,"null"
NCT02122770,51,"null"
NCT02121652,58,"null"
NCT02121418,30,"null"
NCT02116803,12,"null"
NCT02115373,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT02111187,40,"null"
NCT02110082,66,"null"
NCT02109016,18,"null"
NCT02103335,38,"null"
NCT02101918,41,"null"
NCT02101593,8,"null"
NCT02098967,68,"null"
NCT02098109,100,"null"
NCT02097238,19,"null"
NCT02097134,50,"null"
NCT02096042,61,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02094872,96,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"}]"
NCT02092922,154,"null"
NCT02088684,70,"null"
NCT02083653,254,"null"
NCT02082665,6,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Activating RAS Mutation","name":"Activating RAS Mutation","synonyms":["Activating RAS Family Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128901","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02078752,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02078648,74,"null"
NCT02076451,32,"null"
NCT02075021,45,"null"
NCT02071888,25,"null"
NCT02069145,10,"null"
NCT02065063,28,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Wild Type","name":"BRAF V600 Wild Type","synonyms":["BRAF V600V","BRAF p.V600V","BRAF V600 wt","B-RAF1 V600 Wild Type","Serine/Threonine-Protein Kinase B-raf V600 Wild Type","B-RAF V600 Wild Type"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134468","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS wt Allele","name":"NRAS wt Allele","synonyms":["NCMS","N-RAS","CMNS","ALPS4","Neuroblastoma RAS Viral Oncogene Homolog","Neuroblastoma RAS Viral (v-Ras) Oncogene Homolog","V-Ras Neuroblastoma RAS Viral Oncogene Homolog","NRAS1","NS6"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52549","eligibility_criterion":"inclusion"}]"
NCT02060253,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02057445,1,"null"
NCT02057380,13,"null"
NCT02049905,433,"null"
NCT02046070,148,"null"
NCT02045095,119,"null"
NCT02041481,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT02039947,126,"null"
NCT02038218,27,"null"
NCT02035657,10,"null"
NCT02029729,11,"null"
NCT02029638,6,"null"
NCT02027961,68,"[{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Treatment Assignment, Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT02024087,20,"null"
NCT02018926,18,"null"
NCT02014909,64,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"}]"
NCT02014844,28,"null"
NCT02014558,258,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"exclusion"}]"
NCT02014441,61,"null"
NCT02014337,37,"null"
NCT02013804,58,"null"
NCT02013050,111,"null"
NCT02008877,20,"null"
NCT02004262,303,"null"
NCT02004106,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Carcinoembryonic Antigen Positive","name":"Carcinoembryonic Antigen Positive","synonyms":["CEA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128808","eligibility_criterion":"inclusion"}]"
NCT02001051,66,"null"
NCT02000427,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Positive","name":"Philadelphia Chromosome Positive","synonyms":["Ph Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128843","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136411","eligibility_criterion":"inclusion"}]"
NCT01999673,582,"null"
NCT01999491,40,"null"
NCT01998126,62,"null"
NCT01995188,41,"null"
NCT01994889,441,"null"
NCT01989325,77,"null"
NCT01987232,32,"null"
NCT01986829,36,"null"
NCT01986166,23,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"inclusion"}]"
NCT01985256,17,"null"
NCT01985191,26,"null"
NCT01984255,24,"null"
NCT01983969,60,"null"
NCT01983683,631,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clostridium difficile Positive","name":"Clostridium difficile Positive","synonyms":["C. diff. Positive","C. difficile Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146650","eligibility_criterion":"inclusion"}]"
NCT01980628,63,"null"
NCT01979523,60,"null"
NCT01978964,90,"null"
NCT01978236,30,"null"
NCT01976143,33,"null"
NCT01974752,152,"null"
NCT01973868,42,"null"
NCT01973309,37,"null"
NCT01972516,60,"null"
NCT01969435,50,"null"
NCT01967043,34,"null"
NCT01966445,29,"null"
NCT01960348,225,"null"
NCT01959490,70,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01957007,34,"null"
NCT01954576,30,"null"
NCT01952249,20,"null"
NCT01951690,55,"null"
NCT01951586,226,"null"
NCT01951157,69,"null"
NCT01948843,15,"null"
NCT01948141,67,"null"
NCT01945619,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Adenovirus Positive","name":"Adenovirus Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141278","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Epstein-Barr Virus Positive","name":"EBV Positive","synonyms":["Epstein Barr Virus Positive","Human Herpesvirus 4 Positive","Epstein-Barr Virus Positive","HHV-4 Positive","HHV4 Positive","Human Herpesvirus-4 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129454","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"66 kDa Phosphoprotein Antibody Positive","name":"Anti-pp65 Antibody Positive","synonyms":["Anti-CMV pp65 Antibody Positive","66 kDa Phosphoprotein Antibody Positive","CMV 66 kDa Phosphoprotein Antibody Positive","Anti-CMV 66 kDa Phosphoprotein Antibody Positive","pp65 Antibody Positive","Phosphoprotein UL83 Antibody Positive","Anti-Phosphoprotein UL83 Antibody Positive","CMV pp65 Antibody Positive","Anti-66 kDa Phosphoprotein Antibody Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141280","eligibility_criterion":"inclusion"}]"
NCT01943422,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01942993,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01938833,47,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01938638,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01938573,45,"null"
NCT01936363,65,"null"
NCT01934361,35,"null"
NCT01928459,62,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR Family Alteration Positive","name":"FGFR Family Alteration Positive","synonyms":["FGFR Family Alteration Positive","FGFR Alteration","Fibroblast Growth Factor Receptor Alteration Positive","Fibroblast Growth Factor Receptor Alteration","Fibroblast Growth Factor Receptor Family Alteration","Fibroblast Growth Factor Receptor Family Alteration Positive","FGFR Alteration Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133705","eligibility_criterion":"inclusion"}]"
NCT01927965,45,"null"
NCT01927718,17,"null"
NCT01927120,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137698","eligibility_criterion":"inclusion"}]"
NCT01926665,30,"null"
NCT01922752,32,"null"
NCT01916447,65,"null"
NCT01915576,79,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT1 NP_001014431.1:p.E17K","name":"AKT1 NP_001014431.1:p.E17K","synonyms":["AKT1 p.Glu17Lys","RAC-alpha Serine/Threonine-Protein Kinase E17K","NP_001014431.1:p.Glu17Lys","RAC-alpha Serine/Threonine-Protein Kinase","AKT1 Glu17Lys","RAC-alpha Serine/Threonine-Protein Kinase p.E17K","Glu17Lys","AKT1 E17K Mutation","AKT1 E17K (G49A) Mutation","AKT1 E17K","RAC-alpha Serine/Threonine-Protein Kinase p.Glu17Lys","AKT1 NP_001014431.1:p.Glu17Lys","AKT1 p.E17K"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98306","eligibility_criterion":"inclusion"}]"
NCT01911598,24,"null"
NCT01910545,32,"null"
NCT01902329,195,"null"
NCT01901653,82,"null"
NCT01900496,35,"null"
NCT01898715,63,"null"
NCT01896505,54,"null"
NCT01895361,198,"null"
NCT01892930,15,"null"
NCT01892046,18,"null"
NCT01891968,40,"null"
NCT01890746,148,"null"
NCT01889420,42,"null"
NCT01888302,13,"null"
NCT01887886,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT01881230,191,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT01878708,11,"null"
NCT01877083,25,"null"
NCT01876953,52,"null"
NCT01874288,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01873573,60,"null"
NCT01868893,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01868022,65,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FGFR1 Gene Amplification","name":"FGFR1 Amplification","synonyms":["Fibroblast Growth Factor Receptor 1 Gene Amplification","OGD Gene Amplification","CD331 Gene Amplification","FLT-2 Gene Amplification","FGFR-1 Gene Amplification","Fibroblast Growth Factor Receptor 1 Gene Activation","N-SAM Gene Amplification","FLG Gene Amplification","FGFR1 Gene Activation","FMS-Like Tyrosine Kinase 2 Gene Amplification","KAL2 Gene Amplification","FGFR1 Gene Amplification","FGFBR Gene Amplification","CEK Gene Amplification","BFGFR Gene Amplification","FLT2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36650","eligibility_criterion":"inclusion"}]"
NCT01866293,73,"null"
NCT01862328,64,"null"
NCT01862081,80,"null"
NCT01859741,145,"null"
NCT01858883,55,"null"
NCT01854606,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating CD79B Gene Mutation","name":"Activating CD79B Gene Mutation","synonyms":["Activating CD79b Antigen Gene Mutation","Activating CD79B Mutation","Activating IGB Gene Mutation","Activating CD79b Molecule Gene Mutation","Activating AGM6 Gene Mutation","Activating B29 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150435","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Activating CD79A Gene Mutation","name":"Activating CD79A Gene Mutation","synonyms":["Activating CD79A Mutation","Activating CD79a Molecule, Immunoglobulin-Associated Alpha Gene Mutation","Activating CD79a Molecule Gene Mutation","Activating MB-1 Gene Mutation","Activating MB1 Gene Mutation","Activating IGA Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150434","eligibility_criterion":"inclusion"}]"
NCT01853306,71,"null"
NCT01853046,24,"null"
NCT01845792,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT01839097,23,"null"
NCT01838395,42,"null"
NCT01837667,29,"null"
NCT01835587,31,"null"
NCT01833351,66,"null"
NCT01831505,12,"null"
NCT01831388,36,"null"
NCT01830816,41,"null"
NCT01828476,53,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT01828021,25,"null"
NCT01824693,145,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NF1 Gene Mutation","name":"NF1 Gene Mutation","synonyms":["Neurofibromin 1 Gene Mutation","NF1 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118388","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"PTPN11 Gene Mutation","name":"PTPN11 Gene Mutation","synonyms":["SHP-2 Gene Mutation","Protein Tyrosine Phosphatase, Non-Receptor Type 11 Gene Mutation","PTP-1D Gene Mutation","BPTP3 Gene Mutation","PTP2C Gene Mutation","SHP2 Gene Mutation","SH-PTP2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C82612","eligibility_criterion":"exclusion"}]"
NCT01823107,25,"null"
NCT01822613,48,"null"
NCT01818752,955,"null"
NCT01816035,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01815840,229,"null"
NCT01814826,64,"null"
NCT01812005,50,"null"
NCT01808040,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01804101,90,"null"
NCT01802333,784,"null"
NCT01802320,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"AKT Family Gene Mutation","name":"AKT Family Gene Mutation","synonyms":["AKT Serine/Threonine Kinase Family Gene Mutation","v-akt Murine Thymoma Viral Oncogene Homolog Gene Family Mutation","AKT Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96865","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PIK3CA Gene Mutation","name":"PIK3CA Gene Mutation","synonyms":["PI3K Gene Mutation","Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96271","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"KRAS wt Allele","name":"KRAS Wildtype","synonyms":["K-RAS2B","K-RAS2A","v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog wt Allele","K-Ras 2A","RASK2","KRAS wt Allele","C-K-RAS","KRAS2","KI-RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C52546","eligibility_criterion":"inclusion"}]"
NCT01801111,138,"null"
NCT01800695,202,"null"
NCT01799993,725,"null"
NCT01799278,60,"null"
NCT01797120,131,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01794702,92,"null"
NCT01794039,82,"null"
NCT01789242,32,"null"
NCT01787331,42,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01786135,64,"null"
NCT01786096,92,"null"
NCT01781572,102,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT01780545,200,"null"
NCT01778439,48,"null"
NCT01775631,47,"null"
NCT01775553,36,"null"
NCT01773408,122,"null"
NCT01769768,114,"null"
NCT01769170,458,"null"
NCT01767454,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01767155,511,"null"
NCT01765790,68,"null"
NCT01764477,20,"null"
NCT01757717,20,"null"
NCT01757639,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT01757171,85,"null"
NCT01755767,383,"null"
NCT01754480,325,"null"
NCT01751308,39,"null"
NCT01745120,18,"null"
NCT01743859,37,"null"
NCT01741727,57,"null"
NCT01737814,388,"null"
NCT01736683,74,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Loss of Chromosome 5q","name":"5q Deletion","synonyms":["del(5q)","5q-","Loss of Chromosome 5q"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C27712","eligibility_criterion":"exclusion"}]"
NCT01733953,27,"null"
NCT01733004,42,"null"
NCT01731951,81,"null"
NCT01731912,25,"null"
NCT01730586,35,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High CpG Island Methylator Phenotype","name":"CIMP-High Phenotype Positive","synonyms":["CIMP-High","High CpG Island Methylator Phenotype","CIMP High","CIMP-High Phenotype Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150486","eligibility_criterion":"inclusion"}]"
NCT01729845,52,"null"
NCT01729806,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01729338,35,"null"
NCT01727076,30,"null"
NCT01723020,107,"null"
NCT01722162,36,"null"
NCT01712217,220,"null"
NCT01711671,8,"null"
NCT01711528,60,"null"
NCT01708174,22,"null"
NCT01707004,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 20 Percent or More of Bone Marrow Nucleated Cells","synonyms":["Blasts Greater than or Equal to 20 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36214","eligibility_criterion":"inclusion"}]"
NCT01703572,24,"null"
NCT01703481,188,"null"
NCT01699152,30,"null"
NCT01697579,240,"null"
NCT01696461,128,"null"
NCT01695473,24,"null"
NCT01693614,72,"null"
NCT01686165,43,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01684150,51,"null"
NCT01677780,11,"null"
NCT01676714,35,"null"
NCT01672775,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ENPP3 Positive","name":"ENPP3 Positive","synonyms":["PD-Ibeta Positive","CD203c Positive","PDNP3 Positive","Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 Positive","Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146756","eligibility_criterion":"inclusion"}]"
NCT01670799,21,"null"
NCT01665183,8,"null"
NCT01664000,48,"null"
NCT01663857,81,"null"
NCT01662869,564,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT01661101,1754,"null"
NCT01660750,29,"null"
NCT01655719,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PAX8/PPARG Fusion Gene Mutation Abnormality","name":"PAX8/PPAR gamma fusion mutation","synonyms":["PAX8/PPARG Fusion","PAX8-PPAR gamma Fusion","PAX8-PPARgamma Fusion","PAX8/PPARgammA2 Fusion","PAX8-PPARgammA2 Fusion","C99365:C45576","PAX8-PPARG Fusion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C99366:C99365","eligibility_criterion":"inclusion"}]"
NCT01653470,141,"null"
NCT01651039,27,"null"
NCT01650194,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01649336,36,"null"
NCT01648348,113,"null"
NCT01647711,35,"null"
NCT01646762,30,"null"
NCT01644877,111,"null"
NCT01643278,39,"null"
NCT01642251,168,"null"
NCT01639248,41,"null"
NCT01636882,16,"null"
NCT01636479,77,"null"
NCT01635712,10,"null"
NCT01633060,432,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01632852,30,"null"
NCT01627535,10,"null"
NCT01625156,48,"null"
NCT01621477,39,"null"
NCT01620593,94,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Five","name":"PSA Level Five or Greater","synonyms":["PSA Level Greater than or Equal to 5","PSA Level Greater than or Equal to Five","PSA Level 5 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139792","eligibility_criterion":"inclusion"}]"
NCT01613768,29,"null"
NCT01611675,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT01610479,120,"null"
NCT01607905,189,"null"
NCT01607892,285,"null"
NCT01606787,210,"null"
NCT01606579,49,"null"
NCT01602406,64,"null"
NCT01593228,37,"null"
NCT01592383,39,"null"
NCT01590017,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT01585428,73,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-18 Positive","name":"HPV-18 Positive","synonyms":["Human Papilloma Virus 18 Positive","HPV18 Positive","Human Papillomavirus-18 Positive","Human Papilloma Virus-18 Positive","Human Papillomavirus 18 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131711","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT01585415,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600K Chromosomal mutation","name":"BRAF V600K Mutation","synonyms":["BRAF p.Val600Lys","BRAF NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf V600K","NP_004324.2:p.Val600Lys","Serine/Threonine-Protein Kinase B-raf Val600Lys","BRAF NP_004324.2:p.V600K","BRAF p.V600K","B-RAF1 c.1798_1799GT>AA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98348:C98347","eligibility_criterion":"inclusion"}]"
NCT01582009,48,"null"
NCT01579929,30,"null"
NCT01579812,100,"null"
NCT01577745,58,"null"
NCT01577173,122,"null"
NCT01568866,929,"null"
NCT01567709,60,"null"
NCT01565928,23,"null"
NCT01565083,213,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01564784,327,"null"
NCT01564251,104,"null"
NCT01563302,64,"null"
NCT01553188,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01550224,43,"null"
NCT01543672,60,"null"
NCT01542736,10,"null"
NCT01539291,160,"null"
NCT01534715,49,"null"
NCT01532011,74,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719C","name":"EGFR G719C","synonyms":["HER1 c.2154_2155GG>TT","EGFR c.2154_2155GG>TT","NM_005228.3:c.2154_2155GG>TT","Receptor Tyrosine-Protein Kinase erbB-1 G719C","EGFR NP_005219.2:p.Gly719Cys","Epidermal Growth Factor Receptor Gene c.2154_2155GG>TT","EGFR c.2155G>T","NP_005219.2:p.Gly719Cys","ERBB1 c.2155G>T","NM_005228.3:c.2154_2155delGGinsTT","EGFR p.G719C","EGFR c.2154_2155delGGinsTT","EGFR NM_005228.3:c.2154_2155delGGinsTT","Proto-Oncogene c-ErbB-1 G719C","ERBB c.2155G>T","EGFR p.Gly719Cys","EGFR NP_005219.2:p.G719C","Epidermal Growth Factor Receptor G719C","EGFR NM_005228.3:c.2155G>T","EGFR Gly719Cys","HER1 c.2155G>T","ERBB c.2154_2155GG>TT","ERBB1 c.2154_2155GG>TT","Epidermal Growth Factor Receptor Gene c.2155G>T","NM_005228.3:c.2155G>T"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98522","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR E746-A750 Gene Mutation","name":"EGFR E746-A750 Gene Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01531894,9,"null"
NCT01528345,97,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01525446,15,"null"
NCT01520922,99,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD19 Positive","name":"CD19 Positive","synonyms":["CD19 Antigen Positive","CD19 Molecule Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129255","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FCER2 Positive","name":"FCER2 Positive","synonyms":["CD23 Antigen Positive","CD23 Positive","Fc-Epsilon-RII Positive","Low Affinity Immunoglobulin Epsilon Fc Receptor Positive","Antigen CD23 Positive","Immunoglobulin E-Binding Factor Positive","Fc Fragment of IgE Receptor I Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132231","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD5 Positive","name":"CD5 Positive","synonyms":["CD5 Antigen Positive","Lymphocyte Antigen CD5 Positive","LEU1 Positive","CD5 Molecule Positive","Lymphocyte Antigen T1/Leu-1 Positive","T-Cell Surface Glycoprotein CD5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131063","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD79B Positive","name":"CD79B Positive","synonyms":["Ig-Beta Positive","IGB Positive","B29 Positive","CD79b Molecule Positive","CD79b Antigen Positive","B-Cell Antigen Receptor Complex-Associated Protein Beta Chain Positive","AGM6 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132230","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01520389,112,"null"
NCT01517464,13,"null"
NCT01515189,831,"null"
NCT01514201,66,"null"
NCT01511081,100,"null"
NCT01509547,158,"null"
NCT01503229,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01502293,51,"null"
NCT01497821,37,"null"
NCT01497444,48,"null"
NCT01493843,501,"null"
NCT01492088,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01488318,37,"null"
NCT01485835,54,"null"
NCT01478178,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MGMT Methylation","name":"MGMT Methylation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT01473901,38,"null"
NCT01473095,120,"null"
NCT01472887,61,"null"
NCT01471210,124,"null"
NCT01470794,58,"null"
NCT01469793,71,"null"
NCT01460940,25,"null"
NCT01460134,90,"null"
NCT01458067,30,"null"
NCT01456325,494,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MET Positive","name":"MET Positive","synonyms":["MET Proto-Oncogene, Receptor Tyrosine Kinase Positive","c-met Positive","Hepatocyte Growth Factor Receptor Positive","HGFR Positive","Met Proto-Oncogene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131068","eligibility_criterion":"inclusion"}]"
NCT01453205,187,"null"
NCT01450761,1351,"null"
NCT01449370,125,"null"
NCT01449058,139,"null"
NCT01441765,44,"null"
NCT01437566,318,"null"
NCT01435395,18,"null"
NCT01419587,10,"null"
NCT01419483,10,"null"
NCT01417000,93,"null"
NCT01416038,19,"null"
NCT01413568,38,"null"
NCT01409811,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT01406119,14,"null"
NCT01405391,42,"null"
NCT01400555,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01400503,60,"null"
NCT01398462,69,"null"
NCT01395407,54,"null"
NCT01394978,444,"null"
NCT01393964,35,"null"
NCT01393717,57,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT01383928,64,"null"
NCT01376310,250,"null"
NCT01369433,225,"null"
NCT01363947,87,"null"
NCT01363817,42,"null"
NCT01351415,485,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"exclusion"}]"
NCT01349049,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FLT3 Internal Tandem Duplication Positive","name":"FLT3 Internal Tandem Duplication Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150626","eligibility_criterion":"inclusion"}]"
NCT01345682,483,"null"
NCT01343277,579,"null"
NCT01342289,140,"null"
NCT01339871,174,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT01335685,61,"null"
NCT01334502,37,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01330966,47,"null"
NCT01327885,452,"null"
NCT01325558,30,"null"
NCT01324570,41,"null"
NCT01324479,131,"null"
NCT01324180,24,"null"
NCT01323751,120,"null"
NCT01323517,39,"null"
NCT01322490,1298,"null"
NCT01311687,455,"null"
NCT01309789,39,"null"
NCT01306643,18,"null"
NCT01306058,44,"null"
NCT01305512,36,"null"
NCT01304303,30,"null"
NCT01297452,52,"null"
NCT01296932,37,"null"
NCT01294579,49,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01292655,94,"null"
NCT01287546,117,"null"
NCT01285037,190,"null"
NCT01283516,304,"null"
NCT01283373,84,"null"
NCT01276210,23,"null"
NCT01274377,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT01273493,15,"null"
NCT01271504,102,"null"
NCT01265433,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"WT1 Positive","name":"WT1 Positive","synonyms":["Wilms Tumor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129453","eligibility_criterion":"inclusion"}]"
NCT01261299,40,"null"
NCT01258855,105,"null"
NCT01258608,101,"null"
NCT01253707,111,"null"
NCT01252251,25,"null"
NCT01249443,26,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT01248949,162,"null"
NCT01248923,55,"null"
NCT01246063,60,"null"
NCT01240590,70,"null"
NCT01237236,156,"null"
NCT01234402,153,"null"
NCT01233687,61,"null"
NCT01232452,172,"null"
NCT01231620,626,"null"
NCT01226485,86,"null"
NCT01218555,45,"null"
NCT01216176,59,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01211262,84,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01207323,66,"null"
NCT01204164,120,"null"
NCT01200589,516,"null"
NCT01194869,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT01188109,45,"null"
NCT01175356,105,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NMYC Gene Amplification","name":"MYCN Amplification","synonyms":["N-myc Gene Amplification","V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification","Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification","NMYC Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36673","eligibility_criterion":"inclusion"}]"
NCT01169636,102,"null"
NCT01162785,7,"null"
NCT01162551,17,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","name":"Blasts 10 Percent or More of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136648","eligibility_criterion":"inclusion"}]"
NCT01160744,280,"null"
NCT01156584,54,"null"
NCT01153763,92,"null"
NCT01146795,45,"null"
NCT01110226,15,"null"
NCT01108094,90,"null"
NCT01107665,60,"null"
NCT01090414,202,"null"
NCT01090128,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01080391,792,"null"
NCT01077544,15,"null"
NCT01072175,430,"null"
NCT01067599,278,"null"
NCT01051063,17,"null"
NCT01051037,20,"null"
NCT01048008,18,"null"
NCT01046669,450,"null"
NCT01040000,94,"null"
NCT01034631,154,"null"
NCT01023477,12,"null"
NCT01021059,39,"null"
NCT01010217,337,"null"
NCT01010061,787,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT01006369,43,"null"
NCT00999713,43,"null"
NCT00990249,150,"null"
NCT00988208,1059,"null"
NCT00985777,45,"null"
NCT00968630,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT00962611,57,"null"
NCT00960960,71,"null"
NCT00952380,38,"null"
NCT00940602,224,"null"
NCT00932893,347,"null"
NCT00923845,54,"null"
NCT00923520,73,"null"
NCT00923351,102,"null"
NCT00912340,34,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT00908167,60,"null"
NCT00892385,78,"null"
NCT00890305,171,"null"
NCT00887198,1088,"null"
NCT00877006,447,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CD20 Positive","name":"CD20 Positive","synonyms":["CD20 Expressing","CD20 Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128631","eligibility_criterion":"inclusion"}]"
NCT00871533,60,"null"
NCT00866047,58,"null"
NCT00832338,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT00826085,17,"null"
NCT00823797,61,"null"
NCT00823459,60,"null"
NCT00820222,546,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00806819,718,"null"
NCT00790816,500,"null"
NCT00782067,116,"null"
NCT00781911,43,"null"
NCT00767286,null,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"}]"
NCT00761722,31,"null"
NCT00761644,285,"null"
NCT00761267,69,"null"
NCT00756340,24,"null"
NCT00754910,105,"null"
NCT00752206,46,"null"
NCT00748553,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT00743496,78,"null"
NCT00742560,101,"null"
NCT00727506,151,"null"
NCT00725283,34,"null"
NCT00724503,532,"null"
NCT00709761,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ERBB2 Gene Amplification","name":"HER2 Amplification","synonyms":["ERBB2 Gene Amplification","HER2/Neu Amplification","c-erbB2 Gene Amplification","HER-2 Gene Amplification","ERBB2 Amplification","c-erbB2 Gene Activation","HER2 Gene Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36638","eligibility_criterion":"inclusion"}]"
NCT00689936,1623,"null"
NCT00683670,12,"null"
NCT00683306,94,"null"
NCT00680992,536,"null"
NCT00672139,156,"null"
NCT00658658,31,"null"
NCT00641147,50,"null"
NCT00611208,32,"null"
NCT00589875,52,"null"
NCT00582816,12,"null"
NCT00577993,210,"null"
NCT00545532,228,"null"
NCT00532675,46,"null"
NCT00510718,140,"null"
NCT00509002,37,"null"
NCT00501215,15,"null"
NCT00490529,59,"null"
NCT00458601,82,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR variant III","name":"EGFRvIII","synonyms":["C101140","Epidermal Growth Factor Receptor variant III","C101139"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101139:C101140","eligibility_criterion":"inclusion"}]"
NCT00450372,38,"null"
NCT00449137,13,"null"
NCT00426101,368,"null"
NCT00387205,188,"null"
NCT00385788,70,"null"
NCT00375674,674,"null"
NCT00326417,97,"null"
NCT00300781,136,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT00085735,510,"null"
NCT00026312,1660,"null"
NCT03220009,0,"null"
NCT02785068,0,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRAF Gene Mutation","name":"BRAF Gene Mutation","synonyms":["B-RAF Gene Mutation","v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C40430","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"exclusion"}]"
NCT02763761,0,"null"
NCT02406508,0,"null"
NCT02276820,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Adenovirus Positive","name":"Adenovirus Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141278","eligibility_criterion":"inclusion"}]"
NCT02269579,0,"null"
NCT03430687,30,"null"
NCT03369964,0,"null"
NCT03343977,32,"null"
NCT03342352,0,"null"
NCT03288818,68,"null"
NCT03238664,20,"null"
NCT03168152,100,"null"
NCT03166254,20,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"exclusion"}]"
NCT03149159,36,"null"
NCT03130348,40,"null"
NCT03117855,16,"null"
NCT03081234,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03042013,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Activating Mutation","name":"Activating EGFR Gene Mutation","synonyms":["EGFR Activating Mutation","Epidermal Growth Factor Receptor Activating Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C92172","eligibility_criterion":"inclusion"}]"
NCT03035357,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Testosterone","name":"Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C2299","eligibility_criterion":"inclusion"}]"
NCT03007771,40,"null"
NCT02971410,35,"null"
NCT02966587,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Microsatellite Instability","name":"Microsatellite Instability","synonyms":["Microsatellite Instability Present","MSI","Microsatellite Mutator Phenotype","Microsatellite Instability Positive","MSI Present","MSI Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36318","eligibility_criterion":"inclusion"}]"
NCT02961816,75,"null"
NCT02950038,25,"null"
NCT02943603,44,"null"
NCT02924233,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Amplification","name":"EGFR Gene Amplification","synonyms":["ERBB1 Gene Amplification","EGFR Gene Activation","Epidermal Growth Factor Receptor Gene Amplification","HER1 Gene Amplification","Epidermal Growth Factor Receptor Gene Activation","c-erbB1 Gene Amplification","EGFR Amplification"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36649","eligibility_criterion":"inclusion"}]"
NCT02915172,46,"null"
NCT02861040,18,"null"
NCT02856568,47,"null"
NCT02839694,46,"null"
NCT02833506,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NY-ESO-1 Positive","name":"NY-ESO-1 Positive","synonyms":["LAGE-2 Positive","LAGE2 Positive","CT6.1 Positive","CTAG1 Positive","Cancer/Testis Antigen 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131557","eligibility_criterion":"inclusion"}]"
NCT02831179,20,"null"
NCT02829840,132,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"FLT3 Activation Loop Mutation","name":"FLT3-ALM","synonyms":["FLT3 Activation Loop Mutation","FLT3 A-Loop Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C120063","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Fms-Related Tyrosine Kinase 3 Mutation","name":"FLT3-ITD Mutation","synonyms":["internal tandem duplications of FLT3","FLT3/ITD","C26202:C0026882"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67494","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"FLT3 Tyrosine Kinase Domain Point Mutation","name":"FLT3-TKD Mutation","synonyms":["FLT3/TKD Mutation","FLT3 Tyrosine Kinase Domain Mutation","FLT3 Tyrosine Kinase Domain Point Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C67495","eligibility_criterion":"inclusion"}]"
NCT02812056,44,"null"
NCT02805868,12,"null"
NCT02791919,36,"null"
NCT02719015,36,"null"
NCT02718742,37,"null"
NCT02705339,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"T790M EGFR Gene Mutation","name":"EGFR T790M","synonyms":["T790M EGFR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98504:C98503","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT02674555,0,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"}]"
NCT02653989,0,"null"
NCT02649530,20,"null"
NCT02645591,100,"null"
NCT02640833,0,"null"
NCT02639234,0,"null"
NCT02628704,0,"null"
NCT02627430,40,"null"
NCT02575508,78,"null"
NCT02573220,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"UGT1A1 wt Allele","name":"UGT1A1*1","synonyms":["UGT1A1 Wild-Type Allele","UGT1A1 wt Allele","Polypeptide A1 wt Allele","UGT1A1 *1","Polypeptide A1*1 Allele","UDP Glycosyltransferase 1 Family","UGT1A1 Gene Allele 1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51018","eligibility_criterion":"inclusion"},{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"UGT1A1*28 Allele UGT1A1 wt Allele","name":"UGT1A1 *1*/*28","synonyms":["UGT1A1 wt Allele/UGT1A1*28 Allele"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C72564:C51018","eligibility_criterion":"inclusion"}]"
NCT02567396,105,"null"
NCT02564536,24,"null"
NCT02536495,52,"null"
NCT02532192,40,"null"
NCT02520245,0,"null"
NCT02489266,20,"null"
NCT02447055,10,"null"
NCT02425813,24,"null"
NCT02420938,24,"null"
NCT02390739,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Thyroglobulin","name":"TG","synonyms":["Tg","AITD3","Thyroglobulin","TGN"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C2304","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain","name":"HLA-A*0201","synonyms":["HLA-A 0201","C69178"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128306","eligibility_criterion":"inclusion"}]"
NCT02389543,0,"null"
NCT02370342,20,"null"
NCT02348398,40,"null"
NCT02343679,24,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"ALK Positive","name":"ALK Positive","synonyms":["Anaplastic Lymphoma Kinase Positive","ALK-Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128831","eligibility_criterion":"inclusion"}]"
NCT02315157,12,"null"
NCT02307474,22,"null"
NCT02296671,200,"null"
NCT02287727,80,"null"
NCT02281279,56,"null"
NCT02263898,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02250378,22,"null"
NCT02206971,0,"null"
NCT02194374,48,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ROR1 Positive","name":"ROR1 Positive","synonyms":["Receptor Tyrosine Kinase-Like Orphan Receptor 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142123","eligibility_criterion":"inclusion"}]"
NCT02119728,57,"null"
NCT02109653,0,"null"
NCT02108782,63,"null"
NCT02079155,74,"null"
NCT02068079,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"}]"
NCT02065466,59,"null"
NCT02059850,12,"null"
NCT01972867,0,"null"
NCT01971489,44,"null"
NCT01924351,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01765556,0,"null"
NCT01677949,10,"null"
NCT01561482,37,"null"
NCT01539174,61,"null"
NCT01528865,30,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human endogenous retrovirus K","name":"HERV-K","synonyms":["Human endogenous retrovirus K"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128305","eligibility_criterion":"inclusion"}]"
NCT01245543,0,"null"
NCT01824836,1000,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03414970,880,"null"
NCT03087708,204,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Driver Mutation Negative","name":"EGFR Driver Mutation Negative","synonyms":["c-erbB1 Driver Mutation Negative","ERBB1 Driver Mutation Negative","Epidermal Growth Factor Receptor Driver Mutation Negative","HER1 Driver Mutation Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129575","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EML4/ALK Fusion Negative","name":"EML4/ALK Fusion Negative","synonyms":["EML4-ALK Negative","EML4/ALK Negative","EML4-ALK Fusion Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129576","eligibility_criterion":"inclusion"}]"
NCT03180294,234,"null"
NCT03367572,800,"null"
NCT02856581,783,"null"
NCT01781468,330,"null"
NCT02490878,130,"null"
NCT02822573,276,"null"
NCT02613364,720,"null"
NCT03190291,90,"null"
NCT01806129,612,"null"
NCT02308085,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT01503632,608,"null"
NCT01649089,600,"null"
NCT02054741,700,"null"
NCT03418961,817,"null"
NCT03291587,1114,"null"
NCT03375489,1250,"null"
NCT03227068,1000,"null"
NCT01503086,71,"null"
NCT03180502,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH1 Gene Mutation","name":"IDH1 Gene Mutation","synonyms":["IDH1 Mutation","Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118389","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH2 Gene Mutation","name":"IDH2 Gene Mutation","synonyms":["Isocitrate Dehydrogenase 1 (NADP+), Mitochondrial Gene Mutation","Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation","IDH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118390","eligibility_criterion":"inclusion"}]"
NCT03137121,30,"null"
NCT02682316,686,"null"
NCT02157610,350,"null"
NCT01982058,3124,"null"
NCT02887521,194,"null"
NCT02638298,160,"null"
NCT02496585,68,"null"
NCT03422003,400,"null"
NCT02063828,75,"null"
NCT03572374,420,"null"
NCT03351348,140,"null"
NCT03158519,60,"null"
NCT02979574,360,"null"
NCT02923544,40,"null"
NCT02702453,128,"null"
NCT02698891,125,"null"
NCT02163226,300,"null"
NCT01829958,200,"null"
NCT02908061,160,"null"
NCT02871752,400,"null"
NCT02745353,60,"null"
NCT02627079,35,"null"
NCT02499497,135,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than 0.1","name":"PSA Level Less than 0.1","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138071","eligibility_criterion":"inclusion"}]"
NCT02253238,566,"null"
NCT02243748,385,"null"
NCT01603316,600,"null"
NCT01407263,2300,"null"
NCT03157323,50,"null"
NCT03137537,60,"null"
NCT03116997,202,"null"
NCT03078855,210,"null"
NCT03070236,1200,"null"
NCT02989974,300,"null"
NCT02779725,780,"null"
NCT02707471,480,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02517034,700,"null"
NCT02328313,100,"null"
NCT02027948,36,"null"
NCT03539991,89,"null"
NCT03454295,60,"null"
NCT03397160,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"}]"
NCT03337399,480,"null"
NCT03285633,35,"null"
NCT03183050,105,"null"
NCT03178617,276,"null"
NCT03089125,200,"null"
NCT02975869,160,"null"
NCT02944344,400,"null"
NCT02816697,440,"null"
NCT02430467,572,"null"
NCT02414672,700,"null"
NCT02409485,60,"null"
NCT02278055,63,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01833806,70,"null"
NCT01802346,120,"null"
NCT03465813,75,"null"
NCT03392090,50,"null"
NCT03367156,201,"null"
NCT03292328,40,"null"
NCT03217201,248,"null"
NCT03184038,90,"null"
NCT03183037,75,"null"
NCT03157947,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level 0.1 to 50","name":"PSA Level 0.1 to 50","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138321","eligibility_criterion":"inclusion"}]"
NCT03119363,200,"null"
NCT03035773,375,"null"
NCT03025139,360,"null"
NCT03016741,150,"null"
NCT02986152,1000,"null"
NCT02964325,556,"null"
NCT02832154,60,"null"
NCT02787993,100,"null"
NCT02783495,20,"null"
NCT02763228,320,"null"
NCT02759146,363,"null"
NCT02688192,108,"null"
NCT02626637,44,"null"
NCT02613923,75,"null"
NCT02578888,180,"null"
NCT02452710,120,"null"
NCT02442635,100,"null"
NCT02406599,440,"null"
NCT02281864,600,"null"
NCT02278185,56,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"exclusion"}]"
NCT02256111,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.01","name":"PSA Level Greater than or Equal to 0.01","synonyms":["PSA Level 0.01 or Greater"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142094","eligibility_criterion":"inclusion"}]"
NCT02215070,40,"null"
NCT02193191,39,"null"
NCT02191969,40,"null"
NCT02118987,10,"null"
NCT02090582,182,"null"
NCT02074631,192,"null"
NCT02074436,100,"null"
NCT02070250,60,"null"
NCT02046694,35,"null"
NCT01951885,100,"null"
NCT01905397,138,"null"
NCT01873794,200,"null"
NCT01870947,26,"null"
NCT01828775,480,"null"
NCT01821833,60,"null"
NCT01536392,150,"null"
NCT01140282,100,"null"
NCT03578432,16,"null"
NCT03575832,96,"null"
NCT03574792,60,"null"
NCT03573557,150,"null"
NCT03573375,200,"null"
NCT03568526,68,"null"
NCT03564678,78,"null"
NCT03564587,96,"null"
NCT03557515,20,"null"
NCT03537963,80,"null"
NCT03532997,50,"null"
NCT03531814,30,"null"
NCT03528863,60,"null"
NCT03524716,48,"null"
NCT03523195,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03514680,222,"null"
NCT03502512,110,"null"
NCT03471546,50,"null"
NCT03469258,67,"null"
NCT03462667,100,"null"
NCT03461965,100,"null"
NCT03446105,80,"null"
NCT03443908,20,"null"
NCT03442452,50,"null"
NCT03432247,100,"null"
NCT03429907,140,"null"
NCT03424837,490,"null"
NCT03423264,46,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT03418025,60,"null"
NCT03413332,141,"null"
NCT03408314,400,"null"
NCT03396510,450,"null"
NCT03387527,48,"null"
NCT03378089,50,"null"
NCT03376035,82,"null"
NCT03372720,40,"null"
NCT03372291,60,"null"
NCT03367923,60,"null"
NCT03367260,300,"null"
NCT03367247,40,"null"
NCT03364673,168,"null"
NCT03360695,120,"null"
NCT03360214,60,"null"
NCT03354728,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT03352414,128,"null"
NCT03349034,40,"null"
NCT03340038,112,"null"
NCT03331458,25,"null"
NCT03331406,20,"null"
NCT03329131,65,"null"
NCT03328663,100,"null"
NCT03328091,450,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.2","name":"PSA Level 0.2 or Greater","synonyms":["PSA Level Greater than or Equal to 0.2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138952","eligibility_criterion":"inclusion"}]"
NCT03323450,30,"null"
NCT03322007,20,"null"
NCT03317730,50,"null"
NCT03310918,320,"null"
NCT03304587,34,"null"
NCT03299465,20,"null"
NCT03291730,62,"null"
NCT03290430,150,"null"
NCT03287492,292,"null"
NCT03284346,100,"null"
NCT03279055,25,"null"
NCT03272880,20,"null"
NCT03267524,80,"null"
NCT03262831,30,"null"
NCT03261180,330,"null"
NCT03258892,50,"null"
NCT03257007,120,"null"
NCT03254394,38,"null"
NCT03253627,40,"null"
NCT03252145,80,"null"
NCT03246113,15,"null"
NCT03244995,100,"null"
NCT03243734,50,"null"
NCT03238976,100,"null"
NCT03234933,30,"null"
NCT03233555,535,"null"
NCT03229512,20,"null"
NCT03220945,50,"null"
NCT03214510,96,"null"
NCT03213249,24,"null"
NCT03212261,55,"null"
NCT03211806,85,"null"
NCT03210376,100,"null"
NCT03207360,72,"null"
NCT03204266,46,"null"
NCT03198754,24,"null"
NCT03197896,240,"null"
NCT03194906,50,"null"
NCT03187977,77,"null"
NCT03187951,128,"null"
NCT03187275,15,"null"
NCT03186937,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03174626,20,"null"
NCT03162718,30,"null"
NCT03158467,100,"null"
NCT03155672,80,"null"
NCT03150758,7,"null"
NCT03146806,25,"null"
NCT03144206,180,"null"
NCT03144128,56,"null"
NCT03143894,45,"null"
NCT03138967,50,"null"
NCT03125070,1300,"null"
NCT03122886,40,"null"
NCT03114501,100,"null"
NCT03112668,30,"null"
NCT03109847,60,"null"
NCT03108911,120,"null"
NCT03106090,110,"null"
NCT03102866,44,"null"
NCT03101371,250,"null"
NCT03097588,43,"null"
NCT03091647,124,"null"
NCT03085927,368,"null"
NCT03084536,160,"null"
NCT03076255,24,"null"
NCT03072849,40,"null"
NCT03071744,15,"null"
NCT03069742,32100,"null"
NCT03067766,40,"null"
NCT03049397,99,"null"
NCT03042897,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT03040726,42,"null"
NCT03039140,20,"null"
NCT03035409,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CRP Level Greater than or Equal to 3 mg/L","name":"CRP Level Greater than or Equal to 3 mg/L","synonyms":["CRP Level Greater than or Equal to 3 Milligrams/Liter","CRP Level Greater than or Equal to 3 Milligrams per Liter","CRP Level Greater than or Equal to Three","CRP Level Greater than or Equal to 3","C-Reactive Protein Level Greater than or Equal to 3 Milligrams/Liter","C-Reactive Protein Level Greater than or Equal to 3 Milligrams per Liter"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150492","eligibility_criterion":"inclusion"}]"
NCT03028948,450,"null"
NCT03027063,30,"null"
NCT03021486,54,"null"
NCT03012399,50,"null"
NCT03011736,60,"null"
NCT03011684,144,"null"
NCT03010163,224,"null"
NCT03008213,50,"null"
NCT02998086,75,"null"
NCT02992171,105,"null"
NCT02987881,15,"null"
NCT02982902,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02980601,100,"null"
NCT02970617,240,"null"
NCT02970344,230,"null"
NCT02969577,150,"null"
NCT02965976,50,"null"
NCT02965521,50,"null"
NCT02957981,375,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Protein Variant","name":"BRCA1 Protein Variant","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Protein Variant","name":"BRCA2 Protein Variant","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02955043,48,"null"
NCT02949947,50,"null"
NCT02944617,20,"null"
NCT02939755,900,"null"
NCT02939040,50,"null"
NCT02932332,36,"null"
NCT02928185,33,"null"
NCT02924441,500,"null"
NCT02923037,40,"null"
NCT02922790,50,"null"
NCT02916472,20,"null"
NCT02897635,70,"null"
NCT02895841,220,"null"
NCT02893397,30,"null"
NCT02891759,180,"null"
NCT02887235,180,"null"
NCT02871115,80,"null"
NCT02868112,85,"null"
NCT02866994,64,"null"
NCT02864355,140,"null"
NCT02831582,200,"null"
NCT02817607,15,"null"
NCT02810652,160,"null"
NCT02803593,330,"null"
NCT02796755,120,"null"
NCT02793921,350,"null"
NCT02792270,60,"null"
NCT02791737,30,"null"
NCT02791646,350,"null"
NCT02786524,180,"null"
NCT02781051,50,"null"
NCT02780271,250,"null"
NCT02773329,126,"null"
NCT02770781,60,"null"
NCT02766478,24,"null"
NCT02759731,31,"null"
NCT02757859,845,"null"
NCT02756390,50,"null"
NCT02754752,109,"null"
NCT02740127,104,"null"
NCT02737839,144,"null"
NCT02732015,91,"null"
NCT02730858,135,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02726763,16,"null"
NCT02724956,50,"null"
NCT02724540,194,"null"
NCT02719613,21,"null"
NCT02715856,72,"null"
NCT02712229,672,"null"
NCT02706561,310,"null"
NCT02706301,80,"null"
NCT02704377,140,"null"
NCT02699996,168,"null"
NCT02699983,70,"null"
NCT02699697,158,"null"
NCT02697357,32,"null"
NCT02693665,260,"null"
NCT02682836,30,"null"
NCT02681796,150,"null"
NCT02681601,60,"null"
NCT02677389,100,"null"
NCT02671448,30,"null"
NCT02667626,196,"null"
NCT02666183,385,"null"
NCT02662907,300,"null"
NCT02662036,104,"null"
NCT02657993,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02650583,48,"null"
NCT02639208,110,"null"
NCT02624388,50,"null"
NCT02620033,30,"null"
NCT02617979,225,"null"
NCT02613273,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02601027,128,"null"
NCT02598726,40,"null"
NCT02597491,1000,"null"
NCT02596490,200,"null"
NCT02574507,60,"null"
NCT02573766,99,"null"
NCT02558946,160,"null"
NCT02556931,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Philadelphia Chromosome Negative","name":"Philadelphia Chromosome Negative","synonyms":["Ph Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128844","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"}]"
NCT02550925,100,"null"
NCT02525029,88,"null"
NCT02523443,240,"null"
NCT02518308,38,"null"
NCT02501460,150,"null"
NCT02491632,70,"null"
NCT02489422,60,"null"
NCT02480114,150,"null"
NCT02473042,176,"null"
NCT02471339,90,"null"
NCT02465892,180,"null"
NCT02465541,40,"null"
NCT02464696,366,"null"
NCT02457715,40,"null"
NCT02454777,60,"null"
NCT02454517,200,"null"
NCT02452463,99,"null"
NCT02442583,45,"null"
NCT02442323,50,"null"
NCT02439437,60,"null"
NCT02435472,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Ten to Fifteen","name":"PSA Level Ten to Fifteen","synonyms":["PSA Level Between Ten and Fifteen","PSA Level 10 to 15","PSA Level Between 10 and 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142106","eligibility_criterion":"inclusion"}]"
NCT02429063,55,"null"
NCT02423876,110,"null"
NCT02415387,240,"null"
NCT02412241,120,"null"
NCT02409121,20,"null"
NCT02394951,35,"null"
NCT02387905,80,"null"
NCT02369835,170,"null"
NCT02363933,71,"null"
NCT02359838,540,"null"
NCT02357134,50,"null"
NCT02356471,38,"null"
NCT02332928,142,"null"
NCT02305979,52,"null"
NCT02300961,35,"null"
NCT02285738,42,"null"
NCT02277548,20,"null"
NCT02276885,284,"null"
NCT02266017,180,"null"
NCT02227797,60,"null"
NCT02222337,373,"null"
NCT02221700,90,"null"
NCT02218151,90,"null"
NCT02193568,80,"null"
NCT02178644,24,"null"
NCT02165839,180,"null"
NCT02159157,120,"null"
NCT02153957,60,"null"
NCT02153619,119,"null"
NCT02151513,40,"null"
NCT02131376,40,"null"
NCT02129517,1262,"null"
NCT02117011,80,"null"
NCT02086773,90,"null"
NCT02079662,160,"null"
NCT02071901,31,"null"
NCT02046291,20,"null"
NCT01984671,80,"null"
NCT01984138,44,"null"
NCT01980368,53,"null"
NCT01970306,86,"null"
NCT01947166,90,"null"
NCT01943695,160,"null"
NCT01927731,60,"null"
NCT01909440,32,"null"
NCT01902745,66,"null"
NCT01870752,10,"null"
NCT01868750,53,"null"
NCT01848457,24,"null"
NCT01836068,20,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"}]"
NCT01811862,60,"null"
NCT01746849,78,"null"
NCT01725022,90,"null"
NCT01709344,72,"null"
NCT01701284,50,"null"
NCT01653327,10,"null"
NCT01646645,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT01644136,100,"null"
NCT01516684,40,"null"
NCT01450826,136,"null"
NCT01347723,200,"null"
NCT01186367,174,"null"
NCT00984321,126,"null"
NCT00726934,164,"null"
NCT03561272,20,"null"
NCT03535701,15,"null"
NCT03414905,40,"null"
NCT03374995,26,"null"
NCT03316170,80,"null"
NCT03293940,40,"null"
NCT03107156,375,"null"
NCT02970435,628,"null"
NCT02597478,30,"null"
NCT02481349,80,"null"
NCT02361125,36,"null"
NCT03233581,50,"null"
NCT03195010,12,"null"
NCT03531281,36,"null"
NCT03520283,30,"null"
NCT03505762,80,"null"
NCT03505671,24,"null"
NCT03172832,184,"null"
NCT03580499,40,"null"
NCT03579446,86,"null"
NCT03567850,100,"null"
NCT03525106,30,"null"
NCT03445572,90,"null"
NCT03438344,108,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT03436680,20,"null"
NCT03407716,48,"null"
NCT03379376,15,"null"
NCT03319342,130,"null"
NCT03177681,40,"null"
NCT03177252,200,"null"
NCT03175289,70,"null"
NCT03128281,240,"null"
NCT03082612,80,"null"
NCT03049358,120,"null"
NCT03032250,40,"null"
NCT03030859,98,"null"
NCT02988271,30,"null"
NCT02837887,150,"null"
NCT02439060,110,"null"
NCT02438852,90,"null"
NCT02492100,50,"null"
NCT02891993,150,"null"
NCT02309944,200,"null"
NCT02167932,150,"null"
NCT03313193,390,"null"
NCT03179995,80,"null"
NCT03139227,12,"null"
NCT03070145,40,"null"
NCT02948712,50,"null"
NCT02919670,285,"null"
NCT02408406,516,"null"
NCT02396134,115,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02179762,30,"null"
NCT02659800,75,"null"
NCT01824745,100,"null"
NCT00922974,395,"null"
NCT02432950,20,"null"
NCT02057991,300,"null"
NCT01823991,40,"null"
NCT01649258,40,"null"
NCT01307579,575,"null"
NCT03161665,40,"null"
NCT03063918,10,"null"
NCT02942524,450,"null"
NCT02877862,106,"null"
NCT02648880,30,"null"
NCT02559557,50,"null"
NCT02531906,60,"null"
NCT02511821,24,"null"
NCT02510430,60,"null"
NCT02506933,115,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02490930,5,"null"
NCT02485470,180,"null"
NCT02451735,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02445378,50,"null"
NCT02306252,82,"null"
NCT02288416,20,"null"
NCT02109809,40,"null"
NCT02036281,28,"null"
NCT02015936,20,"null"
NCT01986140,235,"null"
NCT01951807,401,"null"
NCT01900418,80,"null"
NCT01846520,200,"null"
NCT01817075,450,"null"
NCT01797159,125,"null"
NCT01687738,496,"null"
NCT01645852,110,"null"
NCT01614990,26,"null"
NCT01599520,375,"null"
NCT01503515,590,"null"
NCT01450020,145,"null"
NCT01445158,20,"null"
NCT01381718,143,"null"
NCT01371656,740,"null"
NCT01351376,150,"null"
NCT01347970,250,"null"
NCT01230346,475,"null"
NCT01201850,10,"null"
NCT01058746,330,"null"
NCT02107443,1056,"null"
NCT01743131,180,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"}]"
NCT02783755,44,"null"
NCT02740114,200,"null"
NCT02145871,320,"null"
NCT01573442,224,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02508389,200,"null"
NCT02360215,510,"null"
NCT01711944,629,"null"
NCT01598298,294,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03301857,85,"null"
NCT03061175,140,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"}]"
NCT02517502,50,"null"
NCT02287519,75,"null"
NCT02058745,420,"null"
NCT02054598,420,"null"
NCT01927081,80,"null"
NCT01557608,600,"null"
NCT03437161,30,"null"
NCT02842047,20,"null"
NCT02729883,80,"null"
NCT02722434,50,"null"
NCT02677883,128,"null"
NCT02647216,60,"null"
NCT02613728,32,"null"
NCT02606396,15,"null"
NCT02600533,82,"null"
NCT02575898,20,"null"
NCT02574897,180,"null"
NCT02564458,60,"null"
NCT02558998,140,"null"
NCT02517268,138,"null"
NCT02491957,15,"null"
NCT02483832,760,"null"
NCT02440737,140,"null"
NCT02370264,150,"null"
NCT02360917,50,"null"
NCT02204124,60,"null"
NCT02156518,20,"null"
NCT02131584,60,"null"
NCT02111174,40,"null"
NCT02081612,55,"null"
NCT02053350,188,"[{"assay_purpose":"Research, Response Assessment, Eligibility Criterion - Inclusion","long_name":"Clostridium difficile Positive","name":"Clostridium difficile Positive","synonyms":["C. diff. Positive","C. difficile Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146650","eligibility_criterion":"inclusion"}]"
NCT01987596,30,"null"
NCT01941784,20,"null"
NCT01923298,20,"null"
NCT01911039,41,"null"
NCT01790035,120,"null"
NCT01764802,100,"null"
NCT01641068,30,"null"
NCT01202851,700,"null"
NCT03239587,304,"null"
NCT03228147,80,"null"
NCT03220100,30,"null"
NCT03198286,63,"null"
NCT03170648,26,"null"
NCT03169023,120,"null"
NCT03130751,26,"null"
NCT03109873,50,"null"
NCT03042884,100,"null"
NCT03042715,10,"null"
NCT03035448,110,"null"
NCT02976103,149,"null"
NCT02961790,150,"null"
NCT02940223,96,"null"
NCT02924324,50,"null"
NCT02895880,50,"null"
NCT02848989,21,"null"
NCT02846870,60,"null"
NCT02833246,80,"null"
NCT02774759,75,"null"
NCT02733744,13,"null"
NCT02723656,600,"null"
NCT02721147,110,"null"
NCT02719821,18,"null"
NCT02716623,5,"null"
NCT02611544,93,"null"
NCT02592447,48,"null"
NCT02585713,315,"null"
NCT02583815,40,"null"
NCT02577237,24,"null"
NCT02575872,30,"null"
NCT02566408,60,"null"
NCT02543541,160,"null"
NCT02531997,97,"null"
NCT02521961,50,"null"
NCT02515487,24,"null"
NCT02514252,30,"null"
NCT02474095,30,"null"
NCT02470936,76,"null"
NCT02462226,120,"null"
NCT02459964,84,"null"
NCT02442336,80,"null"
NCT02429414,80,"null"
NCT02422329,200,"null"
NCT02400060,64,"null"
NCT02379988,10,"null"
NCT02374255,280,"null"
NCT02373722,192,"null"
NCT02367508,60,"null"
NCT02364726,135,"null"
NCT02355886,44,"null"
NCT02351479,100,"null"
NCT02349412,700,"null"
NCT02349217,60,"null"
NCT02348710,68,"null"
NCT02340884,100,"null"
NCT02336282,55,"null"
NCT02305498,40,"null"
NCT02297412,46,"null"
NCT02295956,70,"null"
NCT02292368,50,"null"
NCT02286713,550,"null"
NCT02286466,156,"null"
NCT02274623,24,"null"
NCT02259699,229,"null"
NCT02248350,90,"null"
NCT02229539,234,"null"
NCT02224924,552,"null"
NCT02224482,735,"null"
NCT02207322,320,"null"
NCT02198131,10,"null"
NCT02196844,100,"null"
NCT02192333,455,"null"
NCT02191982,150,"null"
NCT02186457,164,"null"
NCT02177175,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02168062,100,"null"
NCT02165605,30,"null"
NCT02162329,140,"null"
NCT02157519,220,"null"
NCT02144701,68,"null"
NCT02137252,300,"null"
NCT02129686,60,"null"
NCT02123511,36,"null"
NCT02108457,10,"null"
NCT02099097,72,"null"
NCT02086578,130,"null"
NCT02065154,48,"null"
NCT02063698,40,"null"
NCT02058550,72,"null"
NCT02055963,130,"null"
NCT02052882,85,"null"
NCT02050451,60,"null"
NCT02037568,450,"null"
NCT02015559,66,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02002806,150,"null"
NCT01993550,120,"null"
NCT01985945,48,"null"
NCT01977612,162,"null"
NCT01973452,335,"null"
NCT01955395,96,"null"
NCT01954420,160,"null"
NCT01952847,180,"null"
NCT01951664,50,"null"
NCT01949662,100,"null"
NCT01941810,30,"null"
NCT01940796,40,"null"
NCT01937468,25,"null"
NCT01906008,166,"null"
NCT01867606,100,"null"
NCT01856114,25,"null"
NCT01840163,550,"null"
NCT01832402,25,"null"
NCT01793051,88,"null"
NCT01790789,80,"null"
NCT01785810,37,"null"
NCT01779063,120,"null"
NCT01775085,105,"null"
NCT01763606,40,"null"
NCT01742143,600,"null"
NCT01736345,1500,"null"
NCT01725633,72,"null"
NCT01700959,987,"null"
NCT01700751,36,"null"
NCT01695382,240,"null"
NCT01693523,121,"null"
NCT01676961,14,"null"
NCT01670097,40,"null"
NCT01656044,264,"null"
NCT01628029,64,"null"
NCT01596634,18,"null"
NCT01596218,35,"null"
NCT01556256,198,"null"
NCT01553916,26,"null"
NCT01535066,228,"null"
NCT01502072,96,"null"
NCT01428635,39,"null"
NCT01422408,35,"null"
NCT01416688,140,"null"
NCT01410942,175,"null"
NCT01401907,351,"null"
NCT01375114,158,"null"
NCT01370278,40,"null"
NCT01346267,240,"null"
NCT01345019,1718,"null"
NCT01340300,200,"null"
NCT01266044,435,"null"
NCT01121120,75,"null"
NCT01009918,468,"null"
NCT01821443,45,"null"
NCT02590107,98,"null"
NCT02529150,10,"null"
NCT02434146,24,"null"
NCT02412124,30,"null"
NCT02203578,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT01924169,35,"null"
NCT01481753,380,"null"
NCT00858364,2549,"null"
NCT03096431,76,"null"
NCT03086252,25,"null"
NCT02712437,30,"null"
NCT02623959,250,"null"
NCT02443103,15,"null"
NCT02410564,29,"null"
NCT02410382,80,"null"
NCT02360059,42,"null"
NCT02334332,20,"null"
NCT02246907,30,"null"
NCT02230917,20,"null"
NCT02170350,36,"null"
NCT02163187,76,"null"
NCT02118324,35,"null"
NCT02073045,30,"null"
NCT02065232,52,"null"
NCT02017925,50,"null"
NCT01996852,144,"null"
NCT01931462,20,"null"
NCT01928030,23,"null"
NCT01900730,76,"null"
NCT01815346,54,"null"
NCT01603303,472,"null"
NCT01550185,36,"null"
NCT01284075,10,"null"
NCT01228864,30,"null"
NCT00618917,45,"null"
NCT02002533,70,"null"
NCT02282215,163,"null"
NCT02454036,30,"null"
NCT02324335,61,"null"
NCT02869412,120,"null"
NCT02805075,15,"null"
NCT02659345,50,"null"
NCT02642510,70,"null"
NCT02637297,40,"null"
NCT02401321,64,"null"
NCT01803516,44,"null"
NCT01721343,516,"null"
NCT01674101,35,"null"
NCT01613651,312,"null"
NCT03068637,165,"null"
NCT03002896,200,"null"
NCT02966054,49,"null"
NCT02926573,120,"null"
NCT02770469,86,"null"
NCT02760524,41,"null"
NCT02662335,30,"null"
NCT02658708,22,"null"
NCT02611219,30,"null"
NCT02608879,40,"null"
NCT02603367,40,"null"
NCT02601794,270,"null"
NCT02601638,50,"null"
NCT02564835,60,"null"
NCT02556632,180,"null"
NCT02495155,45,"null"
NCT02476162,60,"null"
NCT02473523,24,"null"
NCT02444195,130,"null"
NCT02423720,64,"null"
NCT02357251,110,"null"
NCT02352779,75,"null"
NCT02345798,80,"null"
NCT02339870,100,"null"
NCT02323854,15,"null"
NCT02274493,15,"null"
NCT02272335,114,"null"
NCT02241005,264,"null"
NCT02203565,20,"null"
NCT02200133,495,"null"
NCT02170272,55,"null"
NCT02135562,20,"null"
NCT02129218,72,"null"
NCT02104076,90,"null"
NCT02096783,30,"null"
NCT02086513,34,"null"
NCT02082470,20,"null"
NCT02078089,15,"null"
NCT02066103,20,"null"
NCT02054715,392,"null"
NCT02043184,322,"null"
NCT01932710,50,"null"
NCT01931150,40,"null"
NCT01930435,20,"null"
NCT01926678,72,"null"
NCT01921426,30,"null"
NCT01901835,66,"null"
NCT01893892,26,"null"
NCT01856543,143,"null"
NCT01855607,60,"null"
NCT01748942,84,"null"
NCT01706081,92,"null"
NCT01705288,112,"null"
NCT01695993,242,"null"
NCT01635413,481,"null"
NCT01602211,1600,"null"
NCT01570283,43,"null"
NCT01525407,60,"null"
NCT01523821,24,"null"
NCT01506453,80,"null"
NCT01484314,24,"null"
NCT01461265,29,"null"
NCT01441492,570,"null"
NCT01438476,200,"null"
NCT01310075,398,"null"
NCT01200485,55,"null"
NCT01200355,114,"null"
NCT01200316,80,"null"
NCT00925600,769,"null"
NCT02968446,28,"null"
NCT02878980,10,"null"
NCT02621684,30,"null"
NCT02528877,30,"null"
NCT02511600,48,"null"
NCT02429544,100,"null"
NCT02382068,60,"null"
NCT02252393,190,"null"
NCT02174263,42,"null"
NCT02168894,120,"null"
NCT02130947,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT02118311,18,"null"
NCT02069340,100,"null"
NCT01545687,148,"null"
NCT01508273,1000,"null"
NCT01473290,140,"null"
NCT01000623,100,"null"
NCT02194738,8300,"null"
NCT03155620,1500,"null"
NCT03233191,164946,"null"
NCT01850654,13068,"null"
NCT02029937,1300,"null"
NCT03435380,291,"null"
NCT03303846,650,"null"
NCT02816879,375,"null"
NCT02993068,3000,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PALB2 Gene Mutation","name":"PALB2 Gene Mutation","synonyms":["FANCN Gene Mutation","PNCA3 Gene Mutation","Fanconi Anemia, Complementation Group N Gene Mutation","Partner and Localizer of BRCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C101641","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MSH2 Gene Mutation","name":"MSH2 Gene Mutation","synonyms":["MutS, E. coli, Homolog of, 2 Gene Mutation","COCA1 Gene Mutation","MutS Homolog 2 Gene Mutation","HNPCC1 Gene Mutation","HNPCC Gene Mutation","MSH2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128821","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MSH6 Gene Mutation","name":"MSH6 Gene Mutation","synonyms":["MutS Homolog 6 Gene Mutation","MSH6 Mutation","MutS, E. coli, Homolog of, 6 Gene Mutation","HNPCC5 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118395","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51D Gene Mutation","name":"RAD51D Gene Mutation","synonyms":["R51H3 Gene Mutation","RAD51L3 Gene Mutation","BROVCA4 Gene Mutation","TRAD Gene Mutation","RAD51-Like 3 Gene Mutation","RAD51 Homolog D Gene Mutation","RAD51 Paralog D Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131481","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PMS2 Gene Mutation","name":"PMS2 Gene Mutation","synonyms":["HNPCC4 Gene Mutation","Postmeiotic Segregation Increased 2 Gene Mutation","PMS2CL Gene Mutation","PMS1 Homolog 2, Mismatch Repair System Component Gene Mutation","Postmeiotic Segregation Increased (S. cerevisiae) 2 Gene Mutation","MLH4 Gene Mutation","PMSL2 Gene Mutation","PMS2 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118397","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MLH1 Gene Mutation","name":"MLH1 Gene Mutation","synonyms":["COCA2 Gene Mutation","HNPCC2 Gene Mutation","MLH1 Mutation","MutL Homolog 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118394","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRIP1 Gene Mutation","name":"BRIP1 Gene Mutation","synonyms":["BRCA1 Interacting Protein C-Terminal Helicase 1 Gene Mutation","BACH1 Gene Mutation","FANCJ Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132002","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAD51C Gene Mutation","name":"RAD51C Gene Mutation","synonyms":["RAD51L2 Gene Mutation","FANCO Gene Mutation","RAD51 Paralog C Gene Mutation","BROVCA3 Gene Mutation","RAD51 Homolog C Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131480","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BARD1 Gene Mutation","name":"BARD1 Gene Mutation","synonyms":["BARD-1 Gene Mutation","BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131789","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT02620852,100000,"null"
NCT02538406,400,"null"
NCT02441140,10,"null"
NCT02018367,100,"null"
NCT03505372,30,"null"
NCT03495115,910,"null"
NCT03482557,96,"null"
NCT03473587,356,"null"
NCT03471650,160,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Two to Ten","name":"PSA Level Two to Ten","synonyms":["PSA Level 2 to 10","PSA Level Between Two and Ten","PSA Level Between 2 and 10"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148266","eligibility_criterion":"inclusion"}]"
NCT03407001,150,"null"
NCT03324945,48,"null"
NCT03287453,200,"null"
NCT02870049,648,"null"
NCT02823847,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT02795104,1058,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Polymorphism Positive","name":"BRCA2 Polymorphism Positive","synonyms":["BRCA2 Gene Polymorphism Present","BRCA2 Polymorphism Present","FANCD1 Gene Polymorphism Present","BROVCA2 Gene Polymorphism Present","Breast Cancer Type 2 Susceptibility Gene Polymorphism Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146649","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Polymorphism Positive","name":"BRCA1 Polymorphism Positive","synonyms":["Breast Cancer Type 1 Susceptibility Gene Polymorphism Present","BRCA1 Gene Polymorphism Present","BRCA1 Polymorphism Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146648","eligibility_criterion":"exclusion"}]"
NCT02767726,40,"null"
NCT02758054,340,"null"
NCT02651883,870,"null"
NCT02643966,6200,"null"
NCT02614703,104,"null"
NCT02597452,1000,"null"
NCT02590458,200,"null"
NCT02462460,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02310698,800,"null"
NCT01210027,70,"null"
NCT00540540,780,"null"
NCT00291096,4000,"null"
NCT03288792,2625,"null"
NCT03161600,25,"null"
NCT02419846,400,"null"
NCT02666378,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03078361,124,"null"
NCT01992016,40,"null"
NCT01441687,240,"null"
NCT01296672,500,"null"
NCT01662609,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02933489,1450,"null"
NCT02549534,40,"null"
NCT02485561,420,"null"
NCT02460237,110,"null"
NCT02377232,500,"null"
NCT02202109,700,"null"
NCT02174406,1500,"null"
NCT01299493,1800,"null"
NCT02100189,310,"null"
NCT01694966,1249,"null"
NCT03135444,165,"null"
NCT02451124,120,"null"
NCT02384005,225,"null"
NCT02226107,130,"null"
NCT02006407,80,"null"
NCT01742065,62155,"null"
NCT01716247,1000,"null"
NCT01550783,2000,"null"
NCT00719303,1070,"null"
NCT01349881,491,"null"
NCT02717507,250,"null"
NCT03223753,384,"null"
NCT02791581,1000,"null"
NCT02135419,5058,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Positive","name":"CDKN2A-p16 Positive","synonyms":["CDKN2A-p16 Positive","CDKN2A-p16(INK4a) Positive","p16INK4 Positive","p16(INK4a) Positive","p16-INK4 Positive","p16 Positive","Cyclin-Dependent Kinase Inhibitor 2A Positive","Cyclin-Dependent Kinase 4 Inhibitor A Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129258","eligibility_criterion":"inclusion"}]"
NCT01905046,128,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02851407,400,"null"
NCT02369653,500,"null"
NCT02345850,345,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT02743351,70,"null"
NCT03080883,370,"null"
NCT02195232,618,"null"
NCT01479283,600,"null"
NCT02860039,200,"null"
NCT02679144,258,"null"
NCT02351258,10000,"null"
NCT02961374,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"APC Gene Mutation","name":"APC Gene Mutation","synonyms":["FPC Gene Mutation","BTPS2 Gene Mutation","PPP1R46 Gene Mutation","APC, WNT Signaling Pathway Regulator Gene Mutation","Adenomatosis Polyposis Gene Mutation","FAP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134473","eligibility_criterion":"inclusion"}]"
NCT02943590,300,"null"
NCT02760849,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PMS2 Gene Mutation","name":"Deleterious PMS2 Gene Mutation","synonyms":["Deleterious MLH4 Gene Mutation","Deleterious PMS1 Homolog 2, Mismatch Repair System Component Gene Mutation","Deleterious Postmeiotic Segregation Increased (S. cerevisiae) 2 Gene Mutation","Deleterious PMSL2 Gene Mutation","Deleterious PMS2CL Gene Mutation","Deleterious HNPCC4 Gene Mutation","Deleterious Postmeiotic Segregation Increased 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131780","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious RAD51D Gene Mutation","name":"Deleterious RAD51D Gene Mutation","synonyms":["Deleterious RAD51 Homolog D Gene Mutation","Deleterious R51H3 Gene Mutation","Deleterious BROVCA4 Gene Mutation","Deleterious TRAD Gene Mutation","Deleterious RAD51L3 Gene Mutation","Deleterious RAD51-Like 3 Gene Mutation","Deleterious RAD51 Paralog D Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131782","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious RAD51C Gene Mutation","name":"Deleterious RAD51C Gene Mutation","synonyms":["Deleterious BROVCA3 Gene Mutation","Deleterious FANCO Gene Mutation","Deleterious RAD51 Paralog C Gene Mutation","Deleterious RAD51L2 Gene Mutation","Deleterious RAD51 Homolog C Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131781","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BARD1 Gene Mutation","name":"Deleterious BARD1 Gene Mutation","synonyms":["Deleterious BARD-1 Gene Mutation","Deleterious BRCA1 Associated RING Domain 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131776","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious MSH2 Gene Mutation","name":"Deleterious MSH2 Gene Mutation","synonyms":["Deleterious MutS, E. coli, Homolog of, 2 Gene Mutation","Deleterious COCA1 Gene Mutation","Deleterious HNPCC Gene Mutation","Deleterious HNPCC1 Gene Mutation","Deleterious MutS Homolog 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131777","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PALB2 Gene Mutation","name":"Deleterious PALB2 Gene Mutation","synonyms":["Deleterious Partner and Localizer of BRCA2 Gene Mutation","Deleterious FANCN Gene Mutation","Deleterious Fanconi Anemia, Complementation Group N Gene Mutation","Deleterious PNCA3 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131775","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRIP1 Gene Mutation","name":"Deleterious BRIP1 Gene Mutation","synonyms":["Deleterious BRCA1 Interacting Protein C-Terminal Helicase 1 Gene Mutation","Deleterious FANCJ Gene Mutation","Deleterious BACH1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131774","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious MSH6 Gene Mutation","name":"Deleterious MSH6 Gene Mutation","synonyms":["Deleterious MutS, E. coli, Homolog of, 6 Gene Mutation","Deleterious HNPCC5 Gene Mutation","Deleterious MutS Homolog 6 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131778","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious EPCAM Gene Mutation","name":"Deleterious EPCAM Gene Mutation","synonyms":["Deleterious TACSTD1 Gene Mutation","Deleterious Epithelial Cell Adhesion Molecule Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136970","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious MLH1 Gene Mutation","name":"Deleterious MLH1 Gene Mutation","synonyms":["Deleterious COCA2 Gene Mutation","Deleterious MutL Homolog 1 Gene Mutation","Deleterious MutL, E. coli, Homolog of, 1 Gene Mutation","Deleterious HNPCC2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131779","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"}]"
NCT03301597,220,"null"
NCT03036930,180,"null"
NCT02598557,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02273362,45,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"}]"
NCT01492582,981,"null"
NCT03063619,152,"null"
NCT02772003,32,"[{"assay_purpose":"Stratification Factor, Response Assessment, Eligibility Criterion - Inclusion","long_name":"Hepatitis C Virus Positive","name":"HCV Positive","synonyms":["Hepatitis C Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129452","eligibility_criterion":"inclusion"}]"
NCT02532062,500,"null"
NCT02297698,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT03315910,1152,"null"
NCT02867384,200,"null"
NCT02743364,30,"null"
NCT02636582,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT02566109,30,"null"
NCT02348203,66,"null"
NCT03457454,1701,"null"
NCT03383835,10,"null"
NCT03320642,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03300817,50,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Antinuclear Antibody (ANA) Positive","name":"Antinuclear Antibody (ANA) Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"exclusion"}]"
NCT03029286,1300,"null"
NCT02968810,80,"null"
NCT02942745,324,"null"
NCT02876640,40,"null"
NCT02780401,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02706249,50,"null"
NCT02167659,1100,"null"
NCT03569761,120,"null"
NCT03560752,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT03546972,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"}]"
NCT03519451,24,"null"
NCT03509467,1200,"null"
NCT03501576,100,"null"
NCT03495674,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Gene Mutation","name":"MMR Mutation","synonyms":["Mismatch Repair Gene Mutation","DNA Mismatch Repair Gene Mutation","MMR Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133706","eligibility_criterion":"inclusion"}]"
NCT03489213,80,"null"
NCT03448224,255,"null"
NCT03436433,232,"null"
NCT03404596,30,"null"
NCT03403712,400,"null"
NCT03402230,61,"null"
NCT03397030,30,"null"
NCT03340532,210,"null"
NCT03337230,60,"null"
NCT03323658,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT03322501,600,"null"
NCT03317470,100,"null"
NCT03284866,536,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Immunodeficiency Virus 1 Positive","name":"HIV-1 Positive","synonyms":["HIV1 Positive","Human Immunodeficiency Virus 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129253","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT03281746,30,"null"
NCT03270111,15,"null"
NCT03267186,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT03263442,60,"null"
NCT03247634,160,"null"
NCT03204279,92,"null"
NCT03192397,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Minimal Residual Disease","name":"MRD","synonyms":["Detection of Minimal Residual Disease","minimal residual disease","Detectable Residual Disease"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C3896","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Myeloblasts Less Than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36209","eligibility_criterion":"inclusion"}]"
NCT03182959,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Negative","name":"HPV Negative","synonyms":["Human Papilloma Virus Negative","Human Papillomavirus Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131488","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A-p16 Negative","name":"p16 Negative","synonyms":["Cyclin-Dependent Kinase 4 Inhibitor A Negative","p16INK4 Negative","CDKN2A-p16 Negative","Cyclin-Dependent Kinase Inhibitor 2A Negative","p16(INK4a) Negative","p16-INK4 Negative","CDKN2A-p16(INK4a) Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132226","eligibility_criterion":"inclusion"}]"
NCT03176485,45,"null"
NCT03149055,92,"null"
NCT03128359,38,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Blast Cells Present","name":"Blast Cells Present","synonyms":["Circulating Blasts"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C35880","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 10 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 10 Percent of Bone Marrow Nucleated Cells","Blasts Less Than 10 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41398","eligibility_criterion":"inclusion"}]"
NCT03110159,20,"null"
NCT03102060,70,"null"
NCT03089177,312,"null"
NCT03085602,30,"null"
NCT03082677,46,"null"
NCT03080844,110,"null"
NCT03069924,616,"null"
NCT03064971,1050,"null"
NCT03059940,630,"null"
NCT03021668,144,"null"
NCT03019939,100,"null"
NCT03018223,40,"null"
NCT02991456,170,"null"
NCT02989844,60,"null"
NCT02965703,90,"null"
NCT02963740,20,"null"
NCT02945787,1400,"null"
NCT02927899,60,"null"
NCT02923401,72,"null"
NCT02910219,52,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02891603,68,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT02891538,50,"null"
NCT02872844,12,"null"
NCT02871388,30,"null"
NCT02846714,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CDKN2A Gene Mutation","name":"CDKN2A Gene Mutation","synonyms":["p16-INK4A Gene Mutation","p14ARF Gene Mutation","p16INK4a Gene Mutation","CDK4I Gene Mutation","p16INK4 Gene Mutation","p16 Gene Mutation","p19ARF Gene Mutation","Cyclin-Dependent Kinase Inhibitor 2A Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128817","eligibility_criterion":"inclusion"}]"
NCT02796391,228,"null"
NCT02782949,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Helicobacter pylori Negative","name":"Helicobacter pylori Negative","synonyms":["H. pylori Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146647","eligibility_criterion":"inclusion"}]"
NCT02781805,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02772562,44,"null"
NCT02763033,60,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Clostridium difficile Positive","name":"Clostridium difficile Positive","synonyms":["C. diff. Positive","C. difficile Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146650","eligibility_criterion":"exclusion"}]"
NCT02737358,110,"null"
NCT02729701,40,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"exclusion"}]"
NCT02728700,8,"null"
NCT02714439,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus Positive","name":"HPV Positive","synonyms":["Human Papillomavirus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128839","eligibility_criterion":"inclusion"}]"
NCT02701829,144,"null"
NCT02697396,200,"null"
NCT02697227,240,"null"
NCT02683525,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5-10 Percent of Bone Marrow Nucleated Cells","name":"Blasts 5-10 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137703","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10-19 Percent of Bone Marrow Nucleated Cells","name":"Blasts 10-19 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41401","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 10-19 Percent of Peripheral Blood White Cells","name":"Blasts 10-19 Percent of Peripheral Blood White Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137704","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 11-20 Percent of Bone Marrow Nucleated Cells","name":"Blasts 11-20 Percent of Bone Marrow Nucleated Cells","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137706","eligibility_criterion":"inclusion"}]"
NCT02663297,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TNFRSF8 Positive","name":"TNFRSF8 Positive","synonyms":["CD30 Positive","CD30 Positive: TNFRSF8 Positive","CD30 Antigen Positive","Tumor Necrosis Factor Receptor Superfamily Member 8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129257","eligibility_criterion":"inclusion"}]"
NCT02642094,60,"null"
NCT02613689,130,"null"
NCT02611076,552,"null"
NCT02611063,18,"null"
NCT02588339,64,"null"
NCT02582008,60,"null"
NCT02567799,36,"null"
NCT02494869,100,"null"
NCT02439255,240,"null"
NCT02431676,120,"null"
NCT02394769,180,"null"
NCT02382419,200,"null"
NCT02381626,28,"null"
NCT02366871,400,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"F2 NM_000506.4:c.*97G>A","name":"Prothrombin G20210A","synonyms":["F2 NM_000506.4:c.*97G&gt;A","Factor II 20210G-A Mutation","NM_000506.4:c.*97G&gt;A","Prothrombin 20210G&gt;A","Coagulation Factor II, Thrombin 20210G&gt;A","F2 c.20210G&gt;A","Coagulation Factor II (Thrombin) 20210G&gt;A","F2, 20210G-A","F2 g.25313G&gt;A","F2 20210G-A","NG_008953.1:g.25313G&gt;A","F2 c.*97G&gt;A","F2 20210G&gt;A","F2 G20210A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128467","eligibility_criterion":"exclusion"}]"
NCT02360631,500,"null"
NCT02351167,720,"null"
NCT02295059,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02267096,160,"null"
NCT02237183,50,"null"
NCT02194387,368,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT02176902,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Twenty Five","name":"PSA Level Less than Twenty Five","synonyms":["PSA Level Less than 25","PSA Level Less than Twenty-Five"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141406","eligibility_criterion":"inclusion"}]"
NCT02168855,650,"null"
NCT02162849,510,"null"
NCT02106650,37,"null"
NCT02103140,300,"null"
NCT02068092,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious TP53 Gene Mutation","name":"Deleterious TP53 Gene Mutation","synonyms":["Deleterious TRP53 Gene Mutation","Deleterious LFS1 Gene Mutation","Deleterious BCC7 Gene Mutation","Deleterious Li-Fraumeni Syndrome Gene Mutation","Deleterious p53 Gene Mutation","Deleterious Tumor Protein p53 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146676","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Deleterious PTEN Gene Mutation","name":"Deleterious PTEN Gene Mutation","synonyms":["Deleterious PTEN1 Gene Mutation","Deleterious MMAC1 Gene Mutation","Deleterious TEP1 Gene Mutation","Deleterious Phosphatase and Tensin Homolog Gene Mutation","Deleterious Mutated in Multiple Advanced Cancers 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146675","eligibility_criterion":"inclusion"}]"
NCT02061800,15,"null"
NCT02050308,300,"null"
NCT01795573,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","name":"Blasts 5 Percent or Less of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than or Equal to 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"}]"
NCT01527045,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","name":"Blasts Under 5 Percent of Bone Marrow Nucleated Cells","synonyms":["Blasts Less than 5 Percent of Bone Marrow Nucleated Cells"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137685","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Loss of Chromosome 17p","name":"17p Deletion","synonyms":["Loss of Chromosome 17p","17p Chromosomal Deletion","del(17p)"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36499","eligibility_criterion":"inclusion"}]"
NCT00788164,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT03363945,75,"null"
NCT03324802,82,"null"
NCT03219372,180,"null"
NCT03182907,216,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Clostridium difficile Toxin Positive","name":"Clostridium difficile Toxin Positive","synonyms":["C. diff. Toxin Positive","C. difficile Toxin Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C150487","eligibility_criterion":"inclusion"}]"
NCT03057054,500,"null"
NCT02999854,195,"null"
NCT02760537,600,"null"
NCT01761877,175,"null"
NCT00801086,16,"null"
NCT00459238,340,"null"
NCT02721082,1000,"null"
NCT02537756,168,"null"
NCT03574012,40,"null"
NCT03382574,60,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT03278925,48,"null"
NCT03097796,18,"null"
NCT03607682,25,"null"
NCT03481296,400,"null"
NCT03448003,60,"null"
NCT03441321,400,"null"
NCT02991898,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","name":"BCR-ABL T315I Mutation","synonyms":["BCR/ABL Thr315Ile Mutation","BCR/ABL Fusion Gene with NM_005157.4:c.944C>T","BCR-ABL Thr315Ile Mutation","BCR-ABL1 T315I Mutation","BCR/ABL1 Fusion Protein with NP_005148.2:p.T315I","BCR/ABL Fusion Protein with T315I","BCR-ABL1 Thr315Ile Mutation","BCR/ABL1 Fusion Gene with NM_005157.4:c.944C>T","BCR/ABL1 Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL Fusion Protein with Thr315Ile","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Thr315Ile","BCR/ABL Fusion Gene with NM_005157.5:c.944C>T","BCR/ABL1 T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.5:c.944C>T","BCR/ABL1 Fusion Protein with NP_005148.2:p.Thr315Ile","BCR/ABL1 Thr315Ile Mutation","BCR/ABL T315I Mutation","BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation","BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I","BCR-ABL T315I Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123846:C123845","eligibility_criterion":"inclusion"}]"
NCT01105169,288,"null"
NCT03179761,138,"null"
NCT02326805,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT02365480,18,"null"
NCT03089151,30,"null"
NCT02942121,20,"null"
NCT02835755,120,"null"
NCT02581137,26,"null"
NCT02575885,36,"null"
NCT02513407,50,"null"
NCT02314156,85,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT02252484,20,"null"
NCT02202499,85,"null"
NCT02148445,398,"null"
NCT02128659,200,"null"
NCT02095145,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Fifteen","name":"PSA Level Fifteen or Less","synonyms":["PSA Level Less than or Equal to Fifteen","PSA Level 15 or Less","PSA Level Fifteen or Less","PSA Level Less than or Equal to 15"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138939","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT02089386,12,"null"
NCT02052908,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"High-Frequency Microsatellite Instability","name":"Microsatellite Instability High","synonyms":["MSI-H","High-Frequency Microsatellite Instability"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36493","eligibility_criterion":"inclusion"}]"
NCT01981525,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"}]"
NCT01912820,30,"null"
NCT01686178,81900,"null"
NCT01465113,66,"null"
NCT01297959,1350,"null"
NCT01276704,242,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT01116336,34,"null"
NCT00983580,104,"null"
NCT01988571,278,"null"
NCT02555878,841,"null"
NCT02477202,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT01570036,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A*26 Positive Cells Present","name":"HLA-A*26 Positive Cells Present","synonyms":["HLA-A*26 Positive","HLA-A26 Positive Cells Present","HLA-A26 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142097","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A3 Positive Cells Present","name":"HLA-A*03 Positive","synonyms":["HLA-A3 Positive Cells Present","HLA-A*03 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69409","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A24 Positive Cells Present","name":"HLA-A*024 Positive","synonyms":["HLA-A24 Positive Cells Present","HLA-A*024 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69410","eligibility_criterion":"inclusion"}]"
NCT02960594,93,"null"
NCT02703597,194,"null"
NCT02576561,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-18 Positive","name":"HPV-18 Positive","synonyms":["Human Papilloma Virus 18 Positive","HPV18 Positive","Human Papillomavirus-18 Positive","Human Papilloma Virus-18 Positive","Human Papillomavirus 18 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131711","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Papillomavirus-16 Positive","name":"HPV-16 Positive","synonyms":["Human Papilloma Virus 16 Positive","Human Papillomavirus-16 Positive","HPV16 Positive","Human Papillomavirus 16 Positive","Human Papilloma Virus-16 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129455","eligibility_criterion":"inclusion"}]"
NCT02500550,15,"null"
NCT02452034,84,"null"
NCT02269150,96,"null"
NCT02063724,18,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01975363,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT01834287,200,"null"
NCT01586260,89,"null"
NCT01298999,20,"null"
NCT03457480,756,"null"
NCT03199365,120,"null"
NCT03028935,54,"null"
NCT02960542,21,"null"
NCT02873377,126,"null"
NCT02790866,50,"null"
NCT02780284,20,"null"
NCT02750254,51,"null"
NCT02723604,50,"null"
NCT02630186,3,"null"
NCT02575079,35,"null"
NCT02568566,200,"null"
NCT02521285,40,"null"
NCT02510716,50,"null"
NCT02456636,1440,"null"
NCT02446808,80,"null"
NCT02426853,420,"null"
NCT02416011,2992,"null"
NCT02395666,142,"null"
NCT02276664,105,"null"
NCT02266355,12,"null"
NCT02235051,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02169271,128,"null"
NCT02154984,80,"null"
NCT02134925,110,"null"
NCT02103582,108,"null"
NCT02100254,3500,"null"
NCT02067104,56,"null"
NCT02028221,150,"null"
NCT01907789,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"}]"
NCT01901367,30,"null"
NCT01877655,514,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT01849250,64,"null"
NCT01793948,24,"null"
NCT01697566,100,"null"
NCT01661764,150,"null"
NCT01599754,700,"null"
NCT01446874,323,"null"
NCT01414426,54,"null"
NCT01302379,340,"null"
NCT01163682,50,"null"
NCT00780234,391,"null"
NCT00553410,4884,"null"
NCT00524277,600,"null"
NCT00463489,2150,"null"
NCT02997189,12,"null"
NCT02877641,42,"null"
NCT02877082,38,"null"
NCT02542215,47,"null"
NCT02519842,75,"null"
NCT01883362,60,"null"
NCT02960100,100,"null"
NCT02272244,400,"null"
NCT01904890,1500,"null"
NCT01798394,46,"null"
NCT01744574,312,"null"
NCT02596711,36,"null"
NCT02577718,60,"null"
NCT02566265,150,"null"
NCT02417948,124,"null"
NCT02399228,7,"null"
NCT02361047,42,"null"
NCT02302859,50,"null"
NCT02269631,14,"null"
NCT02268526,86,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Cytomegalovirus Positive","name":"CMV Positive","synonyms":["Human Herpesvirus 5 Positive","Cytomegalovirus Positive","HHV-5 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131328","eligibility_criterion":"inclusion"}]"
NCT02208037,279,"null"
NCT02137772,570,"null"
NCT02123849,56,"null"
NCT02069093,92,"null"
NCT02064439,3365,"null"
NCT02019524,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HLA-A2 Positive Cells Present","name":"HLA-A*02 Positive","synonyms":["HLA-A2 Positive Cells Present","HLA-A*02 Positive Cells Present"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C69408","eligibility_criterion":"inclusion"}]"
NCT01950403,54,"null"
NCT01935960,40,"null"
NCT01929122,45,"null"
NCT01836276,448,"null"
NCT01767467,568,"null"
NCT01610414,1877,"null"
NCT01588522,30,"null"
NCT01583218,7513,"null"
NCT01574560,212,"null"
NCT01568996,18,"null"
NCT01479244,758,"null"
NCT01400620,110,"null"
NCT01352000,3830,"null"
NCT01209325,150,"[{"assay_purpose":"Research, Eligibility Criterion - Inclusion","long_name":"HIV Positivity","name":"HIV Positive","synonyms":["HIV Positivity","Human Immunodeficiency Virus Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15175","eligibility_criterion":"inclusion"}]"
NCT01190189,137,"null"
NCT00691132,107,"null"
NCT00690924,40,"null"
NCT02527876,0,"null"
NCT02451462,50,"null"
NCT02442739,40,"null"
NCT01972048,0,"null"
NCT03188393,175,"null"
NCT01805076,317,"[{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA1 Gene Mutation","name":"Deleterious BRCA1 Gene Mutation","synonyms":["Deleterious BROVCA1 Gene Mutation","Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128814","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Deleterious BRCA2 Gene Mutation","name":"Deleterious BRCA2 Gene Mutation","synonyms":["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation","Deleterious BROVCA2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128815","eligibility_criterion":"exclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Stratification Factor, Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03115333,165,"null"
NCT02489617,210,"null"
NCT02670525,200,"null"
NCT02398773,99,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT02520713,825,"null"
NCT02392429,57,"null"
NCT03318380,640,"null"
NCT03255577,100,"null"
NCT02744053,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"}]"
NCT02477124,500,"null"
NCT02422498,54,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"}]"
NCT02312401,165,"null"
NCT02285192,40,"null"
NCT01621906,20,"null"
NCT01244737,75,"null"
NCT03289195,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT03204123,500,"null"
NCT02589366,25,"null"
NCT02507141,120,"null"
NCT01992861,237,"null"
NCT03070340,125,"null"
NCT02950987,175,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"TP53 Gene Mutation","name":"TP53 Gene Mutation","synonyms":["p53 Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118396","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Chromosomal Rearrangement","name":"Chromosomal rearrangement","synonyms":["Chromosomal Rearrangements","Chromosomal Rearrangement","Structural Chromosomal Abnormality","Genomic Rearrangement","Structural Chromosome Aberration","Structural Chromosome Anomalies"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36541","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Succinate Dehydrogenase Mutation","name":"SDH Complex Gene Mutation","synonyms":["Mitochondrial Complex II Gene Mutation","Succinate-Coenzyme Q Reductase Gene Mutation","SDH Family Gene Mutation","Mitochondrial Respiratory Chain Complex II Gene Mutation","Succinate-CoQ Reductase Gene Mutation","SDH Gene Mutation","Succinate Dehydrogenase Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C48301","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"VHL Gene Mutation","name":"VHL Gene Mutation","synonyms":["HRCA1 Gene Mutation","Von Hippel-Lindau Tumor Supressor Gene Mutation","VHL Mutation","VHL1 Gene Mutation","Von Hippel-Lindau Syndrome Gene Mutation","RCA1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118400","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PHOX2B Gene Mutation","name":"PHOX2B Gene Mutation","synonyms":["PMX2B Gene Mutation","Neuroblastoma Paired-Type Homeobox Gene Mutation","Paired-Like Homeobox 2b Gene Mutation","NBPhox Gene Mutation","NBLST2 Gene Mutation","Paired Mesoderm Homeobox 2b Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C135016","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK Gene Mutation","name":"ALK Gene Mutation","synonyms":["Anaplastic Lymphoma Kinase Receptor Gene Mutation","Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation","CD246 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C81945","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"MEN1 Gene Mutation","name":"MEN1 Gene Mutation","synonyms":["Multiple Endocrine Neoplasia I Gene Mutation","Menin 1 Gene Mutation","MEAI Gene Mutation","SCG2 Gene Mutation","MEA I Gene Mutation","Menin Gene Mutation","MEN I Gene Mutation","MEN1 Mutation","Multiple Endocrine Neoplasia 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C118387","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RB1 Gene Mutation","name":"RB1 Gene Mutation","synonyms":["Retinoblastoma Gene Mutation","RB Gene Mutation","Retinoblastoma 1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133696","eligibility_criterion":"inclusion"}]"
NCT02431572,40,"null"
NCT01666808,162,"null"
NCT02872701,110,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FOLR2 Positive","name":"FOLR2 Positive","synonyms":["FRbeta Positive","Placental Folate-Binding Protein Positive","BETA-HFR Positive","Folate Receptor, Fetal/Placental Positive","Folate Receptor Beta Positive","FR-Beta Positive","Folate Receptor 2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142835","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT02528942,70,"null"
NCT01906437,77,"null"
NCT00264602,114,"null"
NCT03412630,184,"null"
NCT03338049,150,"null"
NCT03307694,36,"null"
NCT02956473,74,"[{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"exclusion"}]"
NCT02947373,12,"null"
NCT02881554,60,"null"
NCT02764801,210,"null"
NCT02725658,200,"null"
NCT02710396,90,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ALK wt Allele","name":"ALK wt Allele","synonyms":["CD246","Anaplastic Lymphoma Receptor Tyrosine Kinase wt Allele","Anaplastic Lymphoma Kinase (Ki-1) wt Allele","NBLST3"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51738","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR wt Allele","name":"EGFR wt Allele","synonyms":["Epidermal Growth Factor Receptor wt Allele","V-ERB-B Avian Erythroblastic Leukemia Viral Oncogene Homolog wt Allele","Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog wt Allele","ERBB1","Epidermal Growth Factor Receptor (Erythroblastic Leukemia Viral (V-ERB-B) Oncogene Homolog, Avian) wt Allele","PIG61","MENA","SA7","ERBB","Species Antigen 7 wt Allele","Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian) wt Allele","NISBD2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51744","eligibility_criterion":"inclusion"}]"
NCT02700464,500,"null"
NCT02420665,800,"null"
NCT02391025,50,"null"
NCT02359097,90,"null"
NCT02355340,30,"null"
NCT02335671,43,"null"
NCT02141490,56,"null"
NCT02076152,40,"null"
NCT02018107,75,"null"
NCT01799135,20,"null"
NCT01542879,50,"null"
NCT01410630,137,"null"
NCT01372631,220,"null"
NCT01336803,50,"null"
NCT00900575,480,"null"
NCT00752323,120,"null"
NCT00544427,800,"null"
NCT03582774,193,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.1","name":"PSA Level 0.1 or Greater","synonyms":["PSA Level Greater than or Equal to 0.1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138940","eligibility_criterion":"inclusion"}]"
NCT03541720,15,"null"
NCT03539731,25,"null"
NCT03536026,20,"null"
NCT03532581,50,"null"
NCT03515577,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level 0.2 to Two","name":"PSA Level 0.2 to Two","synonyms":["PSA Level 0.2 to 2","PSA Level Between 0.2 and 2","PSA Level Between 0.2 and Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148234","eligibility_criterion":"inclusion"}]"
NCT03510208,22,"null"
NCT03508765,18,"null"
NCT03493789,15,"null"
NCT03483337,80,"null"
NCT03465618,19,"null"
NCT03463889,40,"null"
NCT03458676,50,"null"
NCT03448458,20,"null"
NCT03444844,10,"null"
NCT03427476,10,"null"
NCT03426306,85,"null"
NCT03423407,60,"null"
NCT03417570,170,"null"
NCT03409419,10,"null"
NCT03403465,130,"null"
NCT03403361,40,"null"
NCT03396874,1500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03392181,48,"null"
NCT03389451,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03388346,40,"null"
NCT03387514,15,"null"
NCT03384238,24,"null"
NCT03376971,200,"null"
NCT03371420,10,"null"
NCT03368547,271,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Ten","name":"PSA Level Greater Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137686","eligibility_criterion":"inclusion"}]"
NCT03367962,30,"null"
NCT03365895,20,"null"
NCT03353740,1500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to 0.2","name":"PSA Level 0.2 or Greater","synonyms":["PSA Level Greater than or Equal to 0.2"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138952","eligibility_criterion":"inclusion"}]"
NCT03342586,50,"null"
NCT03335670,30,"null"
NCT03318497,25,"null"
NCT03318107,10,"null"
NCT03315065,8,"null"
NCT03311828,12,"null"
NCT03302156,52,"null"
NCT03300401,19,"null"
NCT03297957,50,"null"
NCT03297489,24,"null"
NCT03297112,45,"null"
NCT03286062,53,"null"
NCT03276676,30,"null"
NCT03275974,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Wild Type","name":"RAS wt Allele","synonyms":["RAS Wild Type","RAS Mutation Negative","Wild Type RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132847","eligibility_criterion":"inclusion"}]"
NCT03270670,50,"null"
NCT03270059,150,"null"
NCT03262818,40,"null"
NCT03234309,100,"null"
NCT03232164,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT03220217,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor 2 Positive","name":"Somatostatin Receptor 2 Positive","synonyms":["Somatostatin Receptor Type 2 Positive","SSR2 Positive","SSTR2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131558","eligibility_criterion":"inclusion"}]"
NCT03215992,40,"null"
NCT03212170,28,"null"
NCT03196518,5,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RET Gene Mutation","name":"RET Gene Mutation","synonyms":["Ret Proto-Oncogene Mutation","Ret Proto-Oncogene Gene Mutation","RET/PTC Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C43293","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"RAS Family Gene Mutation","name":"RAS Family Gene Mutation","synonyms":["RAS Mutation","RAS Family Mutation","Mutant RAS Family Gene","Mutant RAS"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C132229","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF wt Allele","name":"BRAF wt Allele","synonyms":["NS7","B-RAF1","B-raf-1","RAFB1","v-Raf Murine Sarcoma Viral Oncogene Homolog B","BRAF1","B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)","B-Raf Proto-Oncogene, Serine/Threonine Kinase wt Allele","v-raf Murine Sarcoma Viral Oncogene Homolog B1","Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C51194","eligibility_criterion":"inclusion"}]"
NCT03190083,150,"null"
NCT03181867,330,"null"
NCT03176979,40,"null"
NCT03174925,53,"null"
NCT03173924,90,"null"
NCT03168737,15,"null"
NCT03164486,27,"null"
NCT03151642,44,"null"
NCT03151564,104,"null"
NCT03146117,50,"null"
NCT03139435,20,"null"
NCT03129061,24,"null"
NCT03122470,115,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03121300,20,"null"
NCT03121287,20,"null"
NCT03113617,90,"null"
NCT03111914,100,"null"
NCT03109262,75,"null"
NCT03107663,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT03091803,40,"null"
NCT03089606,25,"null"
NCT03085147,30,"null"
NCT03085043,86,"null"
NCT03083288,30,"null"
NCT03081884,88,"null"
NCT03078452,100,"null"
NCT03071328,15,"null"
NCT03065790,25,"null"
NCT03065712,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT03057743,30,"null"
NCT03041493,60,"null"
NCT03039413,30,"null"
NCT03038568,100,"null"
NCT03038152,50,"null"
NCT03007719,31,"null"
NCT02989623,20,"null"
NCT02986815,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Elevated Alpha-Hydroxyglutarate","name":"Elevated 2-HG","synonyms":["Elevated 2-Hydroxypentanedioic Acid","Elevated 2-Hydroxy-Pentanedioic Acid","Elevated 2HG","Elevated Alpha-Hydroxyglutaric Acid","Elevated 2-Hydroxyglutaric Acid","Elevated Alpha-Hydroxyglutarate","Elevated 2-Hydroxyglutarate"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C153233","eligibility_criterion":"inclusion"}]"
NCT02978586,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSMA Positive","name":"PSMA Positive","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02978170,20,"null"
NCT02968680,20,"null"
NCT02966223,50,"null"
NCT02960308,50,"null"
NCT02952469,30,"null"
NCT02940262,600,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02926729,98,"null"
NCT02919111,271,"null"
NCT02914067,150,"null"
NCT02913131,52,"null"
NCT02911467,75,"null"
NCT02910726,59,"null"
NCT02902757,50,"null"
NCT02891681,60,"null"
NCT02891616,30,"null"
NCT02890979,30,"null"
NCT02885272,20,"null"
NCT02873741,100,"null"
NCT02867371,200,"null"
NCT02857374,35,"null"
NCT02857218,7,"null"
NCT02851368,25,"null"
NCT02849171,6,"null"
NCT02843230,85,"null"
NCT02830880,30,"null"
NCT02825875,400,"null"
NCT02819024,10,"null"
NCT02809690,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02790294,20,"null"
NCT02783950,350,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than 0.1","name":"PSA Level Less than 0.1","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138071","eligibility_criterion":"inclusion"}]"
NCT02769533,50,"null"
NCT02762110,30,"null"
NCT02754544,20,"null"
NCT02740933,40,"null"
NCT02738398,30,"null"
NCT02722525,30,"null"
NCT02722395,10,"null"
NCT02719847,150,"null"
NCT02717572,40,"null"
NCT02716077,35,"null"
NCT02715583,15,"null"
NCT02710240,75,"null"
NCT02695628,5,"null"
NCT02693080,20,"null"
NCT02690805,75,"null"
NCT02687230,28,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CA19-9 Antigen Positive","name":"CA19-9 Antigen Positive","synonyms":["CA 19-9 Positive","Carbohydrate Antigen 19-9 Positive","Sialyl LeA Positive","Sialyl LewisA Positive","Sialyl Le(a) Antigen Positive","Sialylated Lewis a Antigen Positive","Sialyl-Lewis A Positive","Cancer Antigen 19-9 Positive","c-erbB1 Positive","Sialylated Lewis (a) Antigen Positive","SLeA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142809","eligibility_criterion":"inclusion"}]"
NCT02684435,75,"null"
NCT02681614,6,"null"
NCT02678351,200,"null"
NCT02652923,102,"null"
NCT02624518,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02608619,5,"null"
NCT02599194,50,"null"
NCT02584413,80,"null"
NCT02559115,20,"null"
NCT02526511,50,"null"
NCT02526368,50,"null"
NCT02494453,25,"null"
NCT02478255,45,"null"
NCT02469129,60,"null"
NCT02455453,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02448225,70,"null"
NCT02441062,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor 2 Positive","name":"Somatostatin Receptor 2 Positive","synonyms":["Somatostatin Receptor Type 2 Positive","SSR2 Positive","SSTR2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131558","eligibility_criterion":"inclusion"}]"
NCT02434809,19,"null"
NCT02430480,55,"null"
NCT02425228,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Twenty Five","name":"PSA Level Less than Twenty Five","synonyms":["PSA Level Less than 25","PSA Level Less than Twenty-Five"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C141406","eligibility_criterion":"inclusion"}]"
NCT02422550,212,"null"
NCT02421380,100,"null"
NCT02420977,24,"null"
NCT02415816,99,"null"
NCT02410252,50,"null"
NCT02409316,75,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02405078,50,"null"
NCT02405000,20,"null"
NCT02390635,55,"null"
NCT02379377,90,"null"
NCT02376127,30,"null"
NCT02374931,10,"null"
NCT02371031,20,"null"
NCT02348749,70,"null"
NCT02337465,16,"null"
NCT02324387,100,"null"
NCT02323295,30,"null"
NCT02317783,15,"null"
NCT02307630,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Ganglioside GD2 Positive","name":"GD2 Positive","synonyms":["Ganglioside GD2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129573","eligibility_criterion":"inclusion"}]"
NCT02293954,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Carcinoembryonic Antigen Positive","name":"Carcinoembryonic Antigen Positive","synonyms":["CEA Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128808","eligibility_criterion":"inclusion"}]"
NCT02286843,50,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02284321,83,"null"
NCT02278198,15,"null"
NCT02275871,220,"null"
NCT02242773,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT02240381,40,"null"
NCT02227654,840,"null"
NCT02211768,15,"null"
NCT02206048,20,"null"
NCT02191488,540,"null"
NCT02175628,60,"null"
NCT02156739,100,"null"
NCT02151760,70,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Ten","name":"PSA Level Ten or Greater","synonyms":["PSA Level 10 or Greater","PSA Level Ten or Greater","PSA Level Greater than or Equal to Ten","PSA Level Greater than or Equal to 10"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136534","eligibility_criterion":"inclusion"}]"
NCT02130453,300,"null"
NCT02117440,25,"null"
NCT02111824,36,"null"
NCT02106598,75,"null"
NCT02095808,92,"null"
NCT02095678,170,"null"
NCT02084147,530,"null"
NCT02079181,30,"null"
NCT02070705,160,"null"
NCT02048150,20,"null"
NCT02023996,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02020720,90,"null"
NCT02019303,100,"null"
NCT02016872,25,"null"
NCT01996046,75,"null"
NCT01991977,150,"null"
NCT01988272,70,"null"
NCT01974804,36,"null"
NCT01973881,20,"null"
NCT01916122,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01894451,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT01871545,150,"null"
NCT01834001,190,"null"
NCT01816841,283,"null"
NCT01815515,25,"null"
NCT01813877,331,"null"
NCT01755208,110,"null"
NCT01751737,66,"null"
NCT01733173,7,"null"
NCT01719562,130,"null"
NCT01698658,750,"null"
NCT01697930,65,"null"
NCT01653093,170,"null"
NCT01653080,160,"null"
NCT01631318,50,"null"
NCT01607008,10,"null"
NCT01604512,150,"null"
NCT01583842,30,"null"
NCT01544335,270,"null"
NCT01535456,5,"null"
NCT01534104,185,"null"
NCT01494324,160,"null"
NCT01269593,67,"null"
NCT01269190,275,"null"
NCT01266096,23,"null"
NCT01246869,40,"null"
NCT01228448,60,"null"
NCT01221506,20,"null"
NCT00938145,90,"null"
NCT00935090,80,"null"
NCT00870129,190,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"IDH Gene Family Mutation","name":"IDH Gene Mutation","synonyms":["IDH Gene Family Mutation","IDH Family Mutation","IDH Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129264","eligibility_criterion":"inclusion"}]"
NCT00840047,650,"null"
NCT00832429,20,"null"
NCT00813566,20,"null"
NCT00764920,500,"null"
NCT00734955,530,"null"
NCT00724191,190,"null"
NCT00659126,150,"null"
NCT00588185,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT00584233,320,"null"
NCT00581906,335,"null"
NCT00574353,50,"null"
NCT00542373,400,"null"
NCT00540774,150,"null"
NCT00464724,80,"null"
NCT00067821,150,"null"
NCT03504761,325,"null"
NCT03234556,400,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03032198,110,"null"
NCT02956291,84,"null"
NCT02937402,30,"null"
NCT02509598,27,"null"
NCT02013414,42,"null"
NCT01260480,60,"null"
NCT01121718,15,"null"
NCT00882609,550,"null"
NCT00805636,30,"null"
NCT02623712,39981,"null"
NCT02149173,50,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01908504,320,"null"
NCT02267876,8000,"null"
NCT03542695,6,"null"
NCT02426489,70,"null"
NCT02419807,130,"null"
NCT03076333,30,"null"
NCT03578224,40,"null"
NCT03565367,10,"null"
NCT03405142,20,"null"
NCT03280277,13,"null"
NCT03091816,7,"null"
NCT02872519,20,"null"
NCT02802553,10,"null"
NCT02597894,8,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02530606,20,"null"
NCT03125629,200,"null"
NCT00474604,200,"null"
NCT02774161,300,"null"
NCT02673151,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02387840,80,"null"
NCT02115607,50,"null"
NCT01933269,10,"null"
NCT01930968,10,"null"
NCT01869725,112,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT01858688,130,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT01712815,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01123005,48,"null"
NCT00375830,170,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Ten","name":"PSA Level Greater Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137686","eligibility_criterion":"inclusion"}]"
NCT01839747,20,"null"
NCT03057509,30,"null"
NCT02423148,5,"null"
NCT02290834,200,"null"
NCT00983697,292,"null"
NCT02856100,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"}]"
NCT01243333,50,"null"
NCT02523924,50,"null"
NCT02488187,200,"null"
NCT02106416,25,"null"
NCT02035852,250,"null"
NCT01967862,56,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01939275,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01931709,65,"null"
NCT01886235,30,"null"
NCT01808222,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01395030,80,"null"
NCT00977457,1200,"null"
NCT00582283,34,"null"
NCT00026793,32,"null"
NCT01937117,88,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02981368,377,"null"
NCT02154698,200,"null"
NCT02736578,10,"null"
NCT02928640,200,"null"
NCT02708511,10,"null"
NCT02702830,32,"null"
NCT02645409,20,"null"
NCT02613325,25,"null"
NCT02476734,8,"null"
NCT02406274,250,"null"
NCT02146131,214,"null"
NCT02139150,200,"null"
NCT02067884,50,"null"
NCT02028377,100,"null"
NCT02000999,110,"null"
NCT01916135,20,"null"
NCT01821768,460,"null"
NCT01744054,80,"null"
NCT01421784,50,"null"
NCT00978562,15,"null"
NCT03202472,50,"null"
NCT03004586,120,"null"
NCT02967458,55,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT02918357,1500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 0.2","name":"PSA Level Greater than 0.2","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138946","eligibility_criterion":"inclusion"}]"
NCT02909075,30,"null"
NCT02744534,36,"null"
NCT02611882,225,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Fifteen","name":"PSA Level Greater than or Equal to Fifteen","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":null,"eligibility_criterion":"inclusion"}]"
NCT02579980,60,"null"
NCT02514499,350,"null"
NCT02470910,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT02462447,25,"null"
NCT02455791,40,"null"
NCT02440308,10,"null"
NCT02423356,150,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02411760,60,"null"
NCT02410577,10,"null"
NCT02384473,20,"null"
NCT02359500,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT02352883,350,"null"
NCT02317302,50,"null"
NCT02311556,23,"null"
NCT02303054,31,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT02297386,15,"null"
NCT02226276,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02180308,30,"null"
NCT02178345,100,"null"
NCT02144311,30,"null"
NCT02119065,60,"null"
NCT02088775,43,"null"
NCT02075320,100,"null"
NCT02065609,52,"null"
NCT02037945,30,"null"
NCT02019199,30,"null"
NCT01999270,10,"null"
NCT01987375,36,"null"
NCT01959542,30,"null"
NCT01929395,134,"null"
NCT01927887,20,"null"
NCT01880762,50,"null"
NCT01875666,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT01872130,60,"null"
NCT01867593,18,"null"
NCT01864083,33,"null"
NCT01840150,35,"null"
NCT01818739,200,"null"
NCT01817374,22,"null"
NCT01815333,18,"null"
NCT01806675,150,"null"
NCT01774071,27,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"STEAP1 Positive","name":"STEAP1 Positive","synonyms":["Metalloreductase STEAP1 Positive","STEAP Positive","PRSS24 Positive","Six Transmembrane Epithelial Antigen of the Prostate 1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C139793","eligibility_criterion":"inclusion"}]"
NCT01773551,36,"null"
NCT01737619,150,"null"
NCT01703195,25,"null"
NCT01672021,125,"null"
NCT01619865,153,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT01582204,30,"null"
NCT01574287,12,"null"
NCT01562223,30,"null"
NCT01490892,450,"null"
NCT01447238,390,"null"
NCT01277263,37,"null"
NCT01262040,220,"null"
NCT01224288,120,"null"
NCT01209962,30,"null"
NCT01116661,300,"null"
NCT01082224,440,"null"
NCT01061944,200,"null"
NCT01004718,10,"null"
NCT00606294,185,"null"
NCT00567684,135,"null"
NCT00543777,60,"null"
NCT00103038,150,"null"
NCT02509585,18,"null"
NCT02855086,10,"null"
NCT02167204,40,"null"
NCT02131207,24,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 2.5","name":"PSA Level Greater Than 2.5","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137692","eligibility_criterion":"inclusion"}]"
NCT03206216,59,"null"
NCT02720796,17,"null"
NCT02610920,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02590497,30,"null"
NCT02564549,192,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less Than Ten","name":"PSA Level Less Than Ten","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137689","eligibility_criterion":"inclusion"}]"
NCT02450201,10,"null"
NCT02429804,15,"null"
NCT02390011,70,"null"
NCT02370563,26,"null"
NCT02269111,24,"null"
NCT02245217,22,"null"
NCT02236546,23,"null"
NCT02233595,20,"null"
NCT02175745,50,"null"
NCT02127073,40,"null"
NCT02061007,40,"null"
NCT02057874,38,"null"
NCT02011087,50,"null"
NCT01996527,22,"null"
NCT01939028,200,"null"
NCT01934114,30,"null"
NCT01898273,7,"null"
NCT01882231,24,"null"
NCT01479348,20,"null"
NCT01034514,60,"null"
NCT00507182,395,"null"
NCT02615067,531,"null"
NCT02143115,1400,"null"
NCT02560584,304,"null"
NCT02190279,125,"null"
NCT02633501,312,"null"
NCT01982123,20,"null"
NCT03109977,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"inclusion"}]"
NCT02864043,150,"null"
NCT02607423,68,"null"
NCT02397408,25,"null"
NCT02380027,500,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than or Equal to Twenty","name":"PSA Level Twenty or Less","synonyms":["PSA Level 20 or Less","PSA Level Twenty or Less","PSA Level Less than or Equal to Twenty","PSA Level Less than or Equal to 20"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138067","eligibility_criterion":"inclusion"}]"
NCT02167074,615,"null"
NCT02034708,279,"null"
NCT01908166,200,"null"
NCT01867424,25,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SLCO1B3 Gene Positive","name":"SLCO1B3 Gene Positive","synonyms":["OATP-8 Gene Positive","OATP8 Gene Positive","Solute Carrier Organic Anion Transporter Family Member 1B3 Gene Positive","SLC21A8 Gene Positive","OATP1B3 Gene Positive","LST3 Gene Positive","LST2 Gene Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C148172","eligibility_criterion":"inclusion"}]"
NCT01445691,83,"null"
NCT03077126,20,"null"
NCT03077113,10,"null"
NCT02925351,30,"null"
NCT02916537,20,"null"
NCT02752009,75,"null"
NCT02680041,220,"null"
NCT02618447,15,"null"
NCT02606292,30,"null"
NCT02582944,20,"null"
NCT02543294,45,"null"
NCT02488070,10,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than or Equal to Two","name":"PSA Level Two or Greater","synonyms":["PSA Level Greater than or Equal to Two"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137697","eligibility_criterion":"inclusion"}]"
NCT02452216,10,"null"
NCT02440334,100,"null"
NCT02380209,50,"null"
NCT02354326,45,"null"
NCT02336737,160,"null"
NCT02331381,40,"null"
NCT02321527,21,"null"
NCT02316795,20,"null"
NCT02287701,30,"null"
NCT02194452,30,"null"
NCT02177773,394,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT02165683,11,"null"
NCT02142608,19,"null"
NCT02112162,25,"null"
NCT02103634,50,"null"
NCT02092948,20,"null"
NCT02080689,286,"null"
NCT02056015,20,"null"
NCT01968629,10,"null"
NCT01967537,390,"null"
NCT01962909,11,"null"
NCT01938157,100,"null"
NCT01928186,40,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"HER2/Neu Positive","name":"HER2/Neu Positive","synonyms":["HER-2 Positive","HER2 Positive","ERBB2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68748","eligibility_criterion":"exclusion"}]"
NCT01923727,38,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT01888510,10,"null"
NCT01873248,300,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Somatostatin Receptor Positive","name":"Somatostatin Receptor Positive","synonyms":["SSTR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128873","eligibility_criterion":"inclusion"}]"
NCT01830582,100,"null"
NCT01753479,445,"null"
NCT01664936,60,"null"
NCT01662284,108,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT01646697,80,"null"
NCT01639417,42,"null"
NCT01502605,12,"null"
NCT01501487,226,"null"
NCT01320059,15,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"KRAS Gene Mutation","name":"KRAS Gene Mutation","synonyms":["KRAS2 Gene Mutation","v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Gene Mutation","c-K-ras Gene Mutation","KRAS-2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41361","eligibility_criterion":"exclusion"}]"
NCT01110174,20,"null"
NCT00982449,15,"null"
NCT00832715,120,"null"
NCT00709891,47208,"null"
NCT00580892,170,"null"
NCT02628496,44,"null"
NCT02432118,30,"null"
NCT02252978,550,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than 2.5","name":"PSA Level Greater Than 2.5","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C137692","eligibility_criterion":"inclusion"}]"
NCT02251639,500,"null"
NCT02169063,40,"null"
NCT02165995,20,"null"
NCT02108587,4,"null"
NCT01663090,7,"null"
NCT02841540,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SRSF2 Gene Mutation","name":"SRSF2 Gene Mutation","synonyms":["Splicing Factor, Arginine/Serine-Rich 2 Gene Mutation","SC35 Gene Mutation","SFRS2 Gene Mutation","Serine/Arginine-Rich Splicing Factor 2 Gene Mutation","Serine and Arginine Rich Splicing Factor 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133698","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SF3B1 Gene Mutation","name":"SF3B1 Gene Mutation","synonyms":["Pre-mRNA Processing 10 Gene Mutation","Spliceosome-Associated Protein, 155-kD Gene Mutation","SAP155 Gene Mutation","PRP10 Gene Mutation","PRPF10 Gene Mutation","Splicing Factor 3b, Subunit 1, 155kDa Gene Mutation","Splicing Factor 3b Subunit 1 Gene Mutation","Splicing Factor 3b, Subunit 1 Gene Mutation","Hsh155 Gene Mutation","MDS Gene Mutation","SF3b155 Gene Mutation","SF3B, 155-kD Subunit Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133702","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"SRSF2 Gene Deletion","name":"SRSF2 Deletion","synonyms":["SRSF2 Gene Deletion","SC35 Gene Deletion","SFRS2 Gene Deletion","Serine and Arginine Rich Splicing Factor 2 Gene Deletion","Splicing Factor, Arginine/Serine-Rich 2 Gene Deletion","Serine/Arginine-Rich Splicing Factor 2 Gene Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133699","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 8 Chromosome 21 Chromosomal Translocation","name":"t(8;21)","synonyms":["C13224:C13217:C3420"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119608","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Inversion","name":"inv(16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C119609","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"U2AF1 Gene Mutation","name":"U2AF1 Gene Mutation","synonyms":["FP793 Gene Mutation","RN Gene Mutation","U2AFBP Gene Mutation","U2AF35 Gene Mutation","U2 Small Nuclear RNA Auxiliary Factor 1 Gene Mutation","RNU2AF1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133700","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Exclusion","long_name":"Chromosome 16 Chromosomal Translocation","name":"t(16;16)","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128645","eligibility_criterion":"exclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"ZRSR2 Gene Mutation","name":"ZRSR2 Gene Mutation","synonyms":["U2AF1-RS2 Gene Mutation","U2AF1L2 Gene Mutation","U2AF1RS2 Gene Mutation","Zinc Finger CCCH-type, RNA Binding Motif and Serine/Arginine Rich 2 Gene Mutation","ZC3H22 Gene Mutation","URP Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C133701","eligibility_criterion":"inclusion"}]"
NCT00900198,4000,"null"
NCT02659241,30,"null"
NCT02834780,128,"null"
NCT02241187,10,"null"
NCT02172651,60,"null"
NCT02036918,20,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03477162,20,"null"
NCT03436745,30,"null"
NCT03261271,40,"null"
NCT03084315,300,"null"
NCT03056599,12,"null"
NCT03027388,20,"null"
NCT02999399,48,"null"
NCT02949726,100,"null"
NCT02947035,90,"null"
NCT02928510,30,"null"
NCT02901925,12,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Positive","name":"EGFR Positive","synonyms":["c-erbB1 Positive","ERBB Positive","Epidermal Growth Factor Receptor Positive","ERBB1 Positive","HER1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C134501","eligibility_criterion":"inclusion"}]"
NCT02767362,24,"null"
NCT02761486,30,"null"
NCT02683824,25,"null"
NCT02652715,30,"null"
NCT02637934,40,"null"
NCT02630030,3,"null"
NCT02596685,60,"null"
NCT02575638,65,"null"
NCT02538484,60,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT01957709,10,"null"
NCT01869777,102,"null"
NCT01753908,30,"null"
NCT01413451,20,"[{"assay_purpose":"Research, Response Assessment, Eligibility Criterion - Inclusion","long_name":"Mesothelin Positive","name":"Mesothelin Positive","synonyms":["Mesothelin-Expressing","MSLN Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C128841","eligibility_criterion":"inclusion"}]"
NCT03185871,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02873650,32,"null"
NCT01920061,124,"null"
NCT03397186,12,"null"
NCT02470299,20,"null"
NCT02000921,150,"null"
NCT01896778,20,"null"
NCT02145559,64,"null"
NCT01698294,350,"null"
NCT02650713,410,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"CEACAM5 Positive","name":"CEACAM5 Positive","synonyms":["Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Positive","Meconium Antigen 100 Positive","CEA Positive","Carcinoembryonic Antigen CGM2 Positive","Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Positive","CD66e Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146670","eligibility_criterion":"inclusion"}]"
NCT01621490,237,"null"
NCT02178072,20,"null"
NCT01990196,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Greater than Twenty","name":"PSA Level Greater than Twenty","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136646","eligibility_criterion":"inclusion"}]"
NCT01424007,234,"null"
NCT02729753,12,"null"
NCT02688088,48,"null"
NCT02555176,40,"null"
NCT02520115,336,"null"
NCT02316834,30,"null"
NCT02259010,24,"null"
NCT01709292,22,"[{"assay_purpose":"Response Assessment, Eligibility Criterion - Inclusion","long_name":"BRAF NP_004324.2:p.V600E","name":"BRAF V600E Mutation","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98342","eligibility_criterion":"inclusion"}]"
NCT01597388,99,"null"
NCT02991196,4,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Mismatch Repair Proficiency","name":"Mismatch Repair Protein Proficient","synonyms":["MMRP","pMMR"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131458","eligibility_criterion":"inclusion"}]"
NCT01832974,9,"null"
NCT01707823,40,"null"
NCT02500472,30,"null"
NCT02265536,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Castration Levels of Testosterone","name":"Castration Levels of Testosterone","synonyms":[],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C129259","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Progression","name":"PSA Progression","synonyms":["PSA Elevated","Elevated Prostate Specific Antigen","Increasing PSA","Elevated PSA","Rising PSA"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C123611","eligibility_criterion":"inclusion"}]"
NCT03113526,142,"null"
NCT02888301,30,"null"
NCT02304419,10,"null"
NCT01930162,9,"null"
NCT01576406,70,"null"
NCT01467310,15,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT00953849,21,"null"
NCT02637375,30,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02823652,400,"null"
NCT03186638,86,"null"
NCT02728596,3960,"null"
NCT01789684,3780,"null"
NCT02270450,200,"null"
NCT01885455,222,"null"
NCT03103321,172,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"PSA Level Less than Fifty","name":"PSA Level Less than Fifty","synonyms":["PSA Level Less than 50"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C136611","eligibility_criterion":"inclusion"}]"
NCT03244826,408,"null"
NCT03322891,130,"null"
NCT02823262,395,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"}]"
NCT02619604,30,"null"
NCT02906241,464,"null"
NCT03530969,108,"null"
NCT03507725,432,"null"
NCT03459352,100,"null"
NCT03375827,50,"null"
NCT03346161,100,"null"
NCT03339518,200,"null"
NCT03255291,1650,"null"
NCT03226405,900,"null"
NCT03199651,2994,"null"
NCT03168763,108,"null"
NCT03154190,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03141437,160,"null"
NCT03135782,400,"null"
NCT03040102,300,"null"
NCT03028961,80,"null"
NCT02969031,1920,"null"
NCT02798224,2125,"null"
NCT02751580,65,"null"
NCT02717403,240,"null"
NCT02658123,300,"null"
NCT02562027,400,"null"
NCT02508363,900,"null"
NCT02366806,80,"null"
NCT02298998,50,"null"
NCT02112747,12000,"null"
NCT01365169,290,"null"
NCT00685256,200,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA1 Gene Mutation","name":"BRCA1 Gene Mutation","synonyms":["Breast Cancer 1, Early Onset Gene Mutation","BROVCA1 Gene Mutation","Breast Cancer 1 Gene Mutation","BRCA1 Mutation","Breast Cancer Type 1 Susceptibility Gene Mutation","Mutation of the BRCA1 Gene"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19635","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRCA2 Gene Mutation","name":"BRCA2 Gene Mutation","synonyms":["Breast Cancer Type 2 Susceptibility Gene Mutation","Mutation of the BRCA2 Gene","BRCA2 Mutation","Breast Cancer 2, Early Onset Gene Mutation","BROVCA2 Gene Mutation","Breast Cancer 2 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C19636","eligibility_criterion":"inclusion"}]"
NCT00901732,100,"null"
NCT01954641,500,"null"
NCT03181334,165000,"null"
NCT02943265,1500,"null"
NCT03408561,160,"null"
NCT03194958,2000,"null"
NCT02850939,120,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02375477,600,"null"
NCT03077230,110,"null"
NCT02088333,530,"null"
NCT01912131,75,"null"
NCT02523378,128,"null"
NCT03350854,100,"null"
NCT02957565,120,"null"
NCT02663817,200,"null"
NCT02498899,128,"null"
NCT02312817,2400,"null"
NCT02081248,198,"null"
NCT01726296,1440,"null"
NCT02999529,50,"null"
NCT02611622,86,"null"
NCT02529280,112,"null"
NCT02489799,90,"null"
NCT02405819,89,"null"
NCT02324881,30,"null"
NCT02228824,455,"null"
NCT01951534,75,"null"
NCT02445222,620,"null"
NCT01288222,600,"null"
NCT00785525,40000,"null"
NCT01566682,350,"null"
NCT03490396,60,"null"
NCT03344861,10,"null"
NCT03330106,45,"null"
NCT03195192,100,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"}]"
NCT02773940,100,"null"
NCT02747888,165,"null"
NCT01419561,80,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Human Herpesvirus 8 Positive","name":"Human Herpesvirus 8 Positive","synonyms":["Human Herpesvirus-8 Positive","Kaposi Sarcoma-Associated Herpes Virus Positive","Kaposi Sarcoma Herpes Virus Positive","HHV8 Positive","KSHV Positive","HHV-8 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C146672","eligibility_criterion":"inclusion"}]"
NCT03523377,50,"null"
NCT03478904,14,"null"
NCT03449030,95,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"GUCY2C Positive","name":"GUCY2C Positive","synonyms":["STAR Positive","GC-C Positive","Guanylate Cyclase 2C Positive","Heat-Stable Enterotoxin Receptor Positive","Guanylyl Cyclase C Positive","hSTAR Positive","Intestinal Guanylate Cyclase Positive","Heat Stable Enterotoxin Receptor Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C138955","eligibility_criterion":"inclusion"}]"
NCT03406013,200,"null"
NCT03357627,53,"null"
NCT03321929,165,"null"
NCT03256344,36,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"}]"
NCT03180307,147,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"FOLR2 Positive","name":"FOLR2 Positive","synonyms":["FRbeta Positive","Placental Folate-Binding Protein Positive","BETA-HFR Positive","Folate Receptor, Fetal/Placental Positive","Folate Receptor Beta Positive","FR-Beta Positive","Folate Receptor 2 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C142835","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Folate Receptor Alpha Positive","name":"Folate Receptor Alpha Positive","synonyms":["Folate-Binding Protein, Adult Positive","FBP Positive","FOLR Positive","Folate Receptor 1 Positive","FOLR1 Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C131327","eligibility_criterion":"inclusion"}]"
NCT02969109,380,"null"
NCT02533674,36,"null"
NCT02356549,948,"null"
NCT02045381,160,"null"
NCT00819208,962,"null"
NCT03050398,140,"null"
NCT02294565,147,"null"
NCT01511913,1800,"null"
NCT03012282,75,"null"
NCT02735083,200,"null"
NCT02678754,8000,"null"
NCT03439280,42,"null"
NCT03486314,20,"null"
NCT01840137,70,"null"
NCT01867242,224,"null"
NCT01770353,45,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Negative","name":"Progesterone Receptor Negative","synonyms":["PGR Negative","PR Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Negative","name":"Estrogen Receptor Negative","synonyms":["ESR Negative","ER Negative","Negative Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15493","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Triple-Negative Breast Cancer Finding","name":"Triple-Negative Breast Cancer Finding","synonyms":["Triple-Negative Breast Cancer Result","Triple Negative Breast Cancer Result","ER/PR/HER2 Negative","ER-negative PR-negative HER2/neu-negative","ESR1/PGR/ERBB2 Negative Finding","ER-Negative PR-Negative ERBB2-Negative","Triple Negative Breast Cancer Finding","ER-PR-HER2/neu-"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C71428","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Progesterone Receptor Positive","name":"Progesterone Receptor Positive","synonyms":[" PGR Positive","PR Positive"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15496","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"HER2/Neu Negative","name":"HER2/Neu Negative","synonyms":["HER-2 Negative","ERBB2 Negative","HER2 Negative"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C68749","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"Estrogen Receptor Positive","name":"Estrogen Receptor Positive","synonyms":["ER Positive","ESR Positive","Positive Estrogen Receptor"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C15492","eligibility_criterion":"inclusion"}]"
NCT02596035,150,"null"
NCT02462629,32,"null"
NCT02079025,2000,"null"
NCT01850004,84,"null"
NCT02626000,36,"null"
NCT02357173,68,"null"
NCT02197247,41,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Mutation","name":"EGFR Gene Mutation","synonyms":["ERBB Gene Mutation","HER1 Gene Mutation","Epidermal Growth Factor Receptor Gene Mutation","ERBB1 Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98357","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR-TKI Sensitizing Mutation","name":"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation","synonyms":["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity","EGFR-TKI Sensitizing Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C96861","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"}]"
NCT02189343,16,"null"
NCT02157883,39,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.L861Q","name":"EGFR Exon 21 L861Q Mutation","synonyms":["EGFR L861Q","ERBB c.2582T>A","EGFR Leu861Gln","Proto-Oncogene c-ErbB-1 L861Q","NP_005219.2:p.Leu861Gln","EGFR p.L861Q","EGFR p.Leu861Gln","EGFR NP_005219.2:p.Leu861Gln","Receptor Tyrosine-Protein Kinase erbB-1 L861Q","Epidermal Growth Factor Receptor L861Q","HER1 c.2582T>A","Epidermal Growth Factor Receptor Gene c.2852T>A","EGFR NM_005228.3:c.2582T>A","ERBB1 c.2582T>A","EGFR c.2582T>A","EGFR NP_005219.2:p.L861Q","NM_005228.3:c.2582T>A"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98497","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR exon 21 L858R mutation","name":"EGFR exon 21 L858R mutation","synonyms":["HER1 c.2572_2573CT>AG","ERBB1 c.2573_2574TG>GT","EGFR NM_005228.3:c.2573T>G","Epidermal Growth Factor Receptor L858R","ERBB1 c.2572_2573CT>AG","NM_005228.3:c.2572_2573CT>AG","EGFR c.2572_2573delCTinsAG","Proto-Oncogene c-ErbB-1 L858R","ERBB1 c.2573T>G","EGFR NM_005228.3:c.2572_2573delCTinsAG","EGFR NP_005219.2:p.Leu858Arg","ERBB c.2573T>G","ERBB c.2573_2574TG>GT","EGFR NP_005219.2:p.L858R","EGFR c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573T>G","EGFR p.Leu858Arg","NM_005228.3:c.2573T>G","EGFR p.L858R","HER1 c.2573_2574TG>GT","EGFR c.2573_2574delTGinsGT","Receptor Tyrosine-Protein Kinase erbB-1 L858R","Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG","EGFR c.2572_2573CT>AG","EGFR NM_005228.3:c.2573_2574delTGinsGT","NM_005228.3:c.2573_2574TG>GT","Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT","ERBB c.2572_2573CT>AG","C98515:C98357","NM_005228.3:c.2573_2574delTGinsGT","EGFR L858R","NM_005228.3:c.2572_2573delCTinsAG","HER1 c.2573T>G","EGFR Leu858Arg","NP_005219.2:p.Leu858Arg","EGFR c.2573T>G"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C98516:C98517:C98518:C98515","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR NP_005219.2:p.G719X","name":"EGFR exon 18 G719X","synonyms":["Epidermal Growth Factor Receptor G719X","Proto-Oncogene c-ErbB-1 G719X","EGFR p.G719X","NP_005219.2:p.G719X","NP_005219.2:p.Gly719Xxx","Receptor Tyrosine-Protein Kinase erbB-1 G719X","EGFR G719X","EGFR Gly719Xxx","EGFR NP_005219.2:p.G719X","EGFR NP_005219.2:p.Gly719Xxx"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C107154","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"EGFR Gene Exon Deletion Mutation Nineteen","name":"EGFR Exon 19 Deletion","synonyms":["mENA Exon 19 Deletion Mutation","HER1 Exon 19 Deletion Mutation","mENA Exon 19 Deletion","HER1 Exon 19 Deletion","ERBB1 Exon 19 Deletion Mutation","ERBB Exon 19 Deletion","ERBB Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion Mutation","PIG61 Exon 19 Deletion","ERBB1 Exon 19 Deletion","EGFR Exon 19 Deletion Mutation","Epidermal Growth Factor Receptor Exon 19 Deletion"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C17757:C13231:C19296:C105801","eligibility_criterion":"inclusion"}]"
NCT01903733,281,"null"
NCT01784068,222,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BCR-ABL1 Fusion Protein Expression","name":"BCR-ABL1 Fusion Protein Positive","synonyms":["BCR-ABL1 Fusion Protein Expression","BCR-ABL1 Fusion Protein Positive","BCR/ABL1 Fusion Protein Expression"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C36715","eligibility_criterion":"inclusion"}]"
NCT01543698,179,"null"
NCT01525550,106,"null"
NCT01261312,300,"null"
NCT00903565,1200,"null"
NCT02723006,22,"[{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"BRAF V600 Protein Variation","name":"BRAF V600 Mutation","synonyms":["BRAF NP_004324.2:p.V600 Mutation","BRAF NP_004324.2:p.Val600 Mutation","BRAF p.Val600 Mutation","BRAF p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation","NP_004324.2:p.Val600 Mutation","NP_004324.2:p.V600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation","Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C105823","eligibility_criterion":"inclusion"},{"assay_purpose":"Eligibility Criterion - Inclusion","long_name":"NRAS Gene Mutation","name":"NRAS Gene Mutation","synonyms":["Neuroblastoma RAS Viral Oncogene Homolog Gene Mutation","N-RAS Gene Mutation"],"hugo_biomarker_code":null,"nci_thesaurus_concept_id":"C41381","eligibility_criterion":"inclusion"}]"
NCT02472977,61,"null"
NCT02078960,10,"null"
NCT01632696,11,"null"
NCT02438358,60,"null"
NCT02584296,23,"null"
NCT02496065,30,"null"
NCT02451007,39,"null"
NCT02422589,33,"null"
NCT02401412,170,"null"
NCT02317705,48,"null"
NCT02161770,30,"null"
NCT02096029,1278,"null"
NCT01957735,45,"null"
NCT01949545,46,"null"
NCT01949532,26,"null"
NCT01927341,90,"null"
NCT01911208,50,"null"
NCT01875705,40,"null"
NCT01701050,121,"null"
NCT01618344,32,"null"
NCT01396551,69,"null"
NCT01391533,72,"null"
NCT01099358,47,"null"
NCT01063075,34,"null"
NCT00310115,469,"null"
NCT03359733,0,"null"
NCT02087787,0,"null"
NCT03585660,100,"null"
NCT03517228,40,"null"
NCT03389347,15,"null"
NCT03340714,21,"null"
NCT02584244,21,"null"
NCT02226497,40,"null"
NCT03489252,21,"null"
NCT02729948,5,"null"
